KR20240014102A - 레버 유전성 시신경병증의 치료를 위한 조성물 및 방법 - Google Patents
레버 유전성 시신경병증의 치료를 위한 조성물 및 방법 Download PDFInfo
- Publication number
- KR20240014102A KR20240014102A KR1020247001775A KR20247001775A KR20240014102A KR 20240014102 A KR20240014102 A KR 20240014102A KR 1020247001775 A KR1020247001775 A KR 1020247001775A KR 20247001775 A KR20247001775 A KR 20247001775A KR 20240014102 A KR20240014102 A KR 20240014102A
- Authority
- KR
- South Korea
- Prior art keywords
- pharmaceutical composition
- sequence
- seq
- nucleic acid
- opt
- Prior art date
Links
- 208000032087 Hereditary Leber Optic Atrophy Diseases 0.000 title claims abstract description 42
- 201000000639 Leber hereditary optic neuropathy Diseases 0.000 title claims abstract description 42
- 239000000203 mixture Substances 0.000 title claims description 63
- 238000000034 method Methods 0.000 title abstract description 70
- 150000007523 nucleic acids Chemical group 0.000 claims abstract description 180
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 124
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 124
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 89
- 239000007924 injection Substances 0.000 claims description 37
- 238000002347 injection Methods 0.000 claims description 37
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 28
- 230000003612 virological effect Effects 0.000 claims description 24
- 150000003839 salts Chemical class 0.000 claims description 21
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims description 19
- 239000002953 phosphate buffered saline Substances 0.000 claims description 19
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 18
- FQISKWAFAHGMGT-SGJOWKDISA-M Methylprednisolone sodium succinate Chemical compound [Na+].C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)COC(=O)CCC([O-])=O)CC[C@H]21 FQISKWAFAHGMGT-SGJOWKDISA-M 0.000 claims description 16
- 229960004584 methylprednisolone Drugs 0.000 claims description 16
- 239000011780 sodium chloride Substances 0.000 claims description 16
- 229920001993 poloxamer 188 Polymers 0.000 claims description 13
- CTKXFMQHOOWWEB-UHFFFAOYSA-N Ethylene oxide/propylene oxide copolymer Chemical compound CCCOC(C)COCCO CTKXFMQHOOWWEB-UHFFFAOYSA-N 0.000 claims description 12
- 229940044519 poloxamer 188 Drugs 0.000 claims description 12
- 239000011734 sodium Substances 0.000 claims description 12
- 241000702421 Dependoparvovirus Species 0.000 claims description 11
- 230000004438 eyesight Effects 0.000 claims description 8
- 238000011084 recovery Methods 0.000 claims description 8
- DRBBFCLWYRJSJZ-UHFFFAOYSA-N N-phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 claims description 6
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 4
- CMXXUDSWGMGYLZ-XRIGFGBMSA-N (2s)-2-amino-3-(1h-imidazol-5-yl)propanoic acid;hydron;chloride;hydrate Chemical compound O.Cl.OC(=O)[C@@H](N)CC1=CN=CN1 CMXXUDSWGMGYLZ-XRIGFGBMSA-N 0.000 claims description 4
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 4
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 4
- 238000001990 intravenous administration Methods 0.000 claims description 4
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 4
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 4
- 229940068977 polysorbate 20 Drugs 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 235000019799 monosodium phosphate Nutrition 0.000 claims description 2
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 2
- RNTXMYSPASRLFT-UHFFFAOYSA-L disodium;2-[[n'-[hydroxy(oxido)phosphoryl]carbamimidoyl]-methylamino]acetate Chemical compound [Na+].[Na+].OC(=O)CN(C)C(N)=NP([O-])([O-])=O RNTXMYSPASRLFT-UHFFFAOYSA-L 0.000 claims 1
- 229910000162 sodium phosphate Inorganic materials 0.000 claims 1
- 230000002438 mitochondrial effect Effects 0.000 abstract description 60
- 230000008685 targeting Effects 0.000 abstract description 60
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 44
- 102000006404 Mitochondrial Proteins Human genes 0.000 abstract description 43
- 108010058682 Mitochondrial Proteins Proteins 0.000 abstract description 43
- 108020005345 3' Untranslated Regions Proteins 0.000 abstract description 42
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 34
- 229920001184 polypeptide Polymers 0.000 abstract description 33
- 108091026890 Coding region Proteins 0.000 abstract description 27
- 108020004414 DNA Proteins 0.000 description 159
- 102100021506 NADH-ubiquinone oxidoreductase chain 4 Human genes 0.000 description 82
- 101001109052 Homo sapiens NADH-ubiquinone oxidoreductase chain 4 Proteins 0.000 description 80
- 210000004027 cell Anatomy 0.000 description 73
- 108090000623 proteins and genes Proteins 0.000 description 56
- 239000013598 vector Substances 0.000 description 56
- 230000014509 gene expression Effects 0.000 description 52
- 102100028386 NADH-ubiquinone oxidoreductase chain 6 Human genes 0.000 description 50
- 241000700605 Viruses Species 0.000 description 49
- 101000632623 Homo sapiens NADH-ubiquinone oxidoreductase chain 6 Proteins 0.000 description 48
- 239000000523 sample Substances 0.000 description 47
- 241000282414 Homo sapiens Species 0.000 description 46
- 102100038625 NADH-ubiquinone oxidoreductase chain 1 Human genes 0.000 description 45
- 101000604411 Homo sapiens NADH-ubiquinone oxidoreductase chain 1 Proteins 0.000 description 43
- 108091028043 Nucleic acid sequence Proteins 0.000 description 42
- 239000003795 chemical substances by application Substances 0.000 description 36
- 241000283973 Oryctolagus cuniculus Species 0.000 description 29
- 238000009472 formulation Methods 0.000 description 29
- 210000000234 capsid Anatomy 0.000 description 21
- 239000002773 nucleotide Substances 0.000 description 21
- 125000003729 nucleotide group Chemical group 0.000 description 21
- 239000002245 particle Substances 0.000 description 21
- 239000000243 solution Substances 0.000 description 20
- -1 i.e. Proteins 0.000 description 19
- 108091033319 polynucleotide Proteins 0.000 description 19
- 102000040430 polynucleotide Human genes 0.000 description 19
- 239000002157 polynucleotide Substances 0.000 description 19
- 102000004169 proteins and genes Human genes 0.000 description 19
- 108010061238 threonyl-glycine Proteins 0.000 description 19
- BQSLGJHIAGOZCD-CIUDSAMLSA-N Leu-Ala-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O BQSLGJHIAGOZCD-CIUDSAMLSA-N 0.000 description 17
- 108090000565 Capsid Proteins Proteins 0.000 description 16
- 102100023321 Ceruloplasmin Human genes 0.000 description 16
- WSGXUIQTEZDVHJ-GARJFASQSA-N Leu-Ala-Pro Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@@H]1C(O)=O WSGXUIQTEZDVHJ-GARJFASQSA-N 0.000 description 16
- 239000013612 plasmid Substances 0.000 description 16
- 150000001413 amino acids Chemical class 0.000 description 15
- 108010092114 histidylphenylalanine Proteins 0.000 description 15
- SITWEMZOJNKJCH-UHFFFAOYSA-N L-alanine-L-arginine Natural products CC(N)C(=O)NC(C(O)=O)CCCNC(N)=N SITWEMZOJNKJCH-UHFFFAOYSA-N 0.000 description 14
- SNXUIBACCONSOH-BWBBJGPYSA-N Ser-Thr-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CO)C(O)=O SNXUIBACCONSOH-BWBBJGPYSA-N 0.000 description 14
- 229940024606 amino acid Drugs 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 14
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 13
- DCVYRWFAMZFSDA-ZLUOBGJFSA-N Ala-Ser-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DCVYRWFAMZFSDA-ZLUOBGJFSA-N 0.000 description 13
- MWMJCGBSIORNCD-AVGNSLFASA-N Glu-Leu-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O MWMJCGBSIORNCD-AVGNSLFASA-N 0.000 description 13
- SBANPBVRHYIMRR-UHFFFAOYSA-N Leu-Ser-Pro Natural products CC(C)CC(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O SBANPBVRHYIMRR-UHFFFAOYSA-N 0.000 description 13
- BRTVHXHCUSXYRI-CIUDSAMLSA-N Leu-Ser-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O BRTVHXHCUSXYRI-CIUDSAMLSA-N 0.000 description 13
- 108010044940 alanylglutamine Proteins 0.000 description 13
- 108010060035 arginylproline Proteins 0.000 description 13
- 230000006870 function Effects 0.000 description 13
- 108010051242 phenylalanylserine Proteins 0.000 description 13
- 238000003752 polymerase chain reaction Methods 0.000 description 13
- 230000001105 regulatory effect Effects 0.000 description 13
- 210000001519 tissue Anatomy 0.000 description 13
- REWSWYIDQIELBE-FXQIFTODSA-N Ala-Val-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O REWSWYIDQIELBE-FXQIFTODSA-N 0.000 description 12
- BSYKSCBTTQKOJG-GUBZILKMSA-N Arg-Pro-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O BSYKSCBTTQKOJG-GUBZILKMSA-N 0.000 description 12
- XVZCXCTYGHPNEM-UHFFFAOYSA-N Leu-Leu-Pro Natural products CC(C)CC(N)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(O)=O XVZCXCTYGHPNEM-UHFFFAOYSA-N 0.000 description 12
- 108700019146 Transgenes Proteins 0.000 description 12
- 108010086434 alanyl-seryl-glycine Proteins 0.000 description 12
- 108010000434 glycyl-alanyl-leucine Proteins 0.000 description 12
- 108010050848 glycylleucine Proteins 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 12
- 108010026333 seryl-proline Proteins 0.000 description 12
- 241000702423 Adeno-associated virus - 2 Species 0.000 description 11
- VSRCAOIHMGCIJK-SRVKXCTJSA-N Glu-Leu-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O VSRCAOIHMGCIJK-SRVKXCTJSA-N 0.000 description 11
- 241000880493 Leptailurus serval Species 0.000 description 11
- APFJUBGRZGMQFF-QWRGUYRKSA-N Leu-Gly-Lys Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCCN APFJUBGRZGMQFF-QWRGUYRKSA-N 0.000 description 11
- DSFYPIUSAMSERP-IHRRRGAJSA-N Leu-Leu-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N DSFYPIUSAMSERP-IHRRRGAJSA-N 0.000 description 11
- 108010047495 alanylglycine Proteins 0.000 description 11
- 230000002068 genetic effect Effects 0.000 description 11
- 239000000463 material Substances 0.000 description 11
- 108010016686 methionyl-alanyl-serine Proteins 0.000 description 11
- 230000002207 retinal effect Effects 0.000 description 11
- 238000013518 transcription Methods 0.000 description 11
- 230000035897 transcription Effects 0.000 description 11
- SUMYEVXWCAYLLJ-GUBZILKMSA-N Ala-Leu-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O SUMYEVXWCAYLLJ-GUBZILKMSA-N 0.000 description 10
- WMIOEVKKYIMVKI-DCAQKATOSA-N Leu-Pro-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O WMIOEVKKYIMVKI-DCAQKATOSA-N 0.000 description 10
- QEVRUYFHWJJUHZ-DCAQKATOSA-N Met-Ala-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(C)C QEVRUYFHWJJUHZ-DCAQKATOSA-N 0.000 description 10
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 10
- PEYNRYREGPAOAK-LSJOCFKGSA-N Pro-His-Ala Chemical compound C([C@@H](C(=O)N[C@@H](C)C([O-])=O)NC(=O)[C@H]1[NH2+]CCC1)C1=CN=CN1 PEYNRYREGPAOAK-LSJOCFKGSA-N 0.000 description 10
- FKYWFUYPVKLJLP-DCAQKATOSA-N Ser-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO FKYWFUYPVKLJLP-DCAQKATOSA-N 0.000 description 10
- 239000013543 active substance Substances 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 10
- 230000004410 intraocular pressure Effects 0.000 description 10
- 239000003755 preservative agent Substances 0.000 description 10
- 108010031719 prolyl-serine Proteins 0.000 description 10
- 230000010076 replication Effects 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- IBIDRSSEHFLGSD-UHFFFAOYSA-N valinyl-arginine Natural products CC(C)C(N)C(=O)NC(C(O)=O)CCCN=C(N)N IBIDRSSEHFLGSD-UHFFFAOYSA-N 0.000 description 10
- MDNAVFBZPROEHO-UHFFFAOYSA-N Ala-Lys-Val Natural products CC(C)C(C(O)=O)NC(=O)C(NC(=O)C(C)N)CCCCN MDNAVFBZPROEHO-UHFFFAOYSA-N 0.000 description 9
- AWHJQEYGWRKPHE-LSJOCFKGSA-N His-Ala-Arg Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O AWHJQEYGWRKPHE-LSJOCFKGSA-N 0.000 description 9
- BABSVXFGKFLIGW-UWVGGRQHSA-N Leu-Gly-Arg Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCNC(N)=N BABSVXFGKFLIGW-UWVGGRQHSA-N 0.000 description 9
- RXGLHDWAZQECBI-SRVKXCTJSA-N Leu-Leu-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O RXGLHDWAZQECBI-SRVKXCTJSA-N 0.000 description 9
- BRKHVZNDAOMAHX-BIIVOSGPSA-N Ser-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N BRKHVZNDAOMAHX-BIIVOSGPSA-N 0.000 description 9
- HBZBPFLJNDXRAY-FXQIFTODSA-N Ser-Ala-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O HBZBPFLJNDXRAY-FXQIFTODSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 239000002502 liposome Substances 0.000 description 9
- 239000004005 microsphere Substances 0.000 description 9
- 108010070409 phenylalanyl-glycyl-glycine Proteins 0.000 description 9
- 238000003753 real-time PCR Methods 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 238000001890 transfection Methods 0.000 description 9
- 239000013603 viral vector Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
- NZGRHTKZFSVPAN-BIIVOSGPSA-N Ala-Ser-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N NZGRHTKZFSVPAN-BIIVOSGPSA-N 0.000 description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 8
- YJIUYQKQBBQYHZ-ACZMJKKPSA-N Gln-Ala-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O YJIUYQKQBBQYHZ-ACZMJKKPSA-N 0.000 description 8
- NUMFTVCBONFQIQ-DRZSPHRISA-N Gln-Ala-Phe Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O NUMFTVCBONFQIQ-DRZSPHRISA-N 0.000 description 8
- DBJYVKDPGIFXFO-BQBZGAKWSA-N Gly-Met-Ala Chemical compound [H]NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(O)=O DBJYVKDPGIFXFO-BQBZGAKWSA-N 0.000 description 8
- PMMMQRVUMVURGJ-XUXIUFHCSA-N Ile-Leu-Pro Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O PMMMQRVUMVURGJ-XUXIUFHCSA-N 0.000 description 8
- SWWCDAGDQHTKIE-RHYQMDGZSA-N Lys-Arg-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SWWCDAGDQHTKIE-RHYQMDGZSA-N 0.000 description 8
- YRAWWKUTNBILNT-FXQIFTODSA-N Met-Ala-Ala Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O YRAWWKUTNBILNT-FXQIFTODSA-N 0.000 description 8
- WXHHTBVYQOSYSL-FXQIFTODSA-N Met-Ala-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O WXHHTBVYQOSYSL-FXQIFTODSA-N 0.000 description 8
- 108010047562 NGR peptide Proteins 0.000 description 8
- XQLBWXHVZVBNJM-FXQIFTODSA-N Pro-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 XQLBWXHVZVBNJM-FXQIFTODSA-N 0.000 description 8
- XJDMUQCLVSCRSJ-VZFHVOOUSA-N Ser-Thr-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O XJDMUQCLVSCRSJ-VZFHVOOUSA-N 0.000 description 8
- 108010024078 alanyl-glycyl-serine Proteins 0.000 description 8
- 238000012217 deletion Methods 0.000 description 8
- 230000037430 deletion Effects 0.000 description 8
- 239000012634 fragment Substances 0.000 description 8
- 108010018006 histidylserine Proteins 0.000 description 8
- 238000003780 insertion Methods 0.000 description 8
- 230000037431 insertion Effects 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 230000035772 mutation Effects 0.000 description 8
- 210000001328 optic nerve Anatomy 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 108010070643 prolylglutamic acid Proteins 0.000 description 8
- 108010007375 seryl-seryl-seryl-arginine Proteins 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 239000003826 tablet Substances 0.000 description 8
- 108010073969 valyllysine Proteins 0.000 description 8
- 239000003981 vehicle Substances 0.000 description 8
- XVZCXCTYGHPNEM-IHRRRGAJSA-N (2s)-1-[(2s)-2-[[(2s)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O XVZCXCTYGHPNEM-IHRRRGAJSA-N 0.000 description 7
- 241001634120 Adeno-associated virus - 5 Species 0.000 description 7
- HHGYNJRJIINWAK-FXQIFTODSA-N Ala-Ala-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N HHGYNJRJIINWAK-FXQIFTODSA-N 0.000 description 7
- CVGNCMIULZNYES-WHFBIAKZSA-N Ala-Asn-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O CVGNCMIULZNYES-WHFBIAKZSA-N 0.000 description 7
- LSLIRHLIUDVNBN-CIUDSAMLSA-N Ala-Asp-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN LSLIRHLIUDVNBN-CIUDSAMLSA-N 0.000 description 7
- MNZHHDPWDWQJCQ-YUMQZZPRSA-N Ala-Leu-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O MNZHHDPWDWQJCQ-YUMQZZPRSA-N 0.000 description 7
- XSPKAHFVDKRGRL-DCAQKATOSA-N Arg-Pro-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O XSPKAHFVDKRGRL-DCAQKATOSA-N 0.000 description 7
- 108020004635 Complementary DNA Proteins 0.000 description 7
- KZEUVLLVULIPNX-GUBZILKMSA-N Gln-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)N)N KZEUVLLVULIPNX-GUBZILKMSA-N 0.000 description 7
- KLKYKPXITJBSNI-CIUDSAMLSA-N Gln-Met-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(O)=O KLKYKPXITJBSNI-CIUDSAMLSA-N 0.000 description 7
- ROHVCXBMIAAASL-HJGDQZAQSA-N Gln-Met-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)N)N)O ROHVCXBMIAAASL-HJGDQZAQSA-N 0.000 description 7
- LHRXAHLCRMQBGJ-RYUDHWBXSA-N Gly-Glu-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CN LHRXAHLCRMQBGJ-RYUDHWBXSA-N 0.000 description 7
- JJGBXTYGTKWGAT-YUMQZZPRSA-N Gly-Pro-Glu Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O JJGBXTYGTKWGAT-YUMQZZPRSA-N 0.000 description 7
- IPIVXQQRZXEUGW-UWJYBYFXSA-N His-Ala-His Chemical compound C([C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CN=CN1 IPIVXQQRZXEUGW-UWJYBYFXSA-N 0.000 description 7
- UROVZOUMHNXPLZ-AVGNSLFASA-N His-Leu-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CN=CN1 UROVZOUMHNXPLZ-AVGNSLFASA-N 0.000 description 7
- AIPUZFXMXAHZKY-QWRGUYRKSA-N His-Leu-Gly Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O AIPUZFXMXAHZKY-QWRGUYRKSA-N 0.000 description 7
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 7
- MPGJIHFJCXTVEX-KKUMJFAQSA-N Phe-Arg-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O MPGJIHFJCXTVEX-KKUMJFAQSA-N 0.000 description 7
- IYCBDVBJWDXQRR-FXQIFTODSA-N Ser-Ala-Met Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(O)=O IYCBDVBJWDXQRR-FXQIFTODSA-N 0.000 description 7
- NRCJWSGXMAPYQX-LPEHRKFASA-N Ser-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)N)C(=O)O NRCJWSGXMAPYQX-LPEHRKFASA-N 0.000 description 7
- KDGARKCAKHBEDB-NKWVEPMBSA-N Ser-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CO)N)C(=O)O KDGARKCAKHBEDB-NKWVEPMBSA-N 0.000 description 7
- XNCUYZKGQOCOQH-YUMQZZPRSA-N Ser-Leu-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O XNCUYZKGQOCOQH-YUMQZZPRSA-N 0.000 description 7
- BMKNXTJLHFIAAH-CIUDSAMLSA-N Ser-Ser-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O BMKNXTJLHFIAAH-CIUDSAMLSA-N 0.000 description 7
- DEGCBBCMYWNJNA-RHYQMDGZSA-N Thr-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)[C@@H](C)O DEGCBBCMYWNJNA-RHYQMDGZSA-N 0.000 description 7
- XEYUMGGWQCIWAR-XVKPBYJWSA-N Val-Gln-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)O)N XEYUMGGWQCIWAR-XVKPBYJWSA-N 0.000 description 7
- 108010087924 alanylproline Proteins 0.000 description 7
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 7
- 239000000872 buffer Substances 0.000 description 7
- 238000010804 cDNA synthesis Methods 0.000 description 7
- 239000002299 complementary DNA Substances 0.000 description 7
- 238000009396 hybridization Methods 0.000 description 7
- 108010057821 leucylproline Proteins 0.000 description 7
- 108010005942 methionylglycine Proteins 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- 238000006467 substitution reaction Methods 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- 238000013519 translation Methods 0.000 description 7
- 241000580270 Adeno-associated virus - 4 Species 0.000 description 6
- BUANFPRKJKJSRR-ACZMJKKPSA-N Ala-Ala-Gln Chemical compound C[C@H]([NH3+])C(=O)N[C@@H](C)C(=O)N[C@H](C([O-])=O)CCC(N)=O BUANFPRKJKJSRR-ACZMJKKPSA-N 0.000 description 6
- UCIYCBSJBQGDGM-LPEHRKFASA-N Ala-Arg-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)O)N UCIYCBSJBQGDGM-LPEHRKFASA-N 0.000 description 6
- BLGHHPHXVJWCNK-GUBZILKMSA-N Ala-Gln-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O BLGHHPHXVJWCNK-GUBZILKMSA-N 0.000 description 6
- YIGLXQRFQVWFEY-NRPADANISA-N Ala-Gln-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O YIGLXQRFQVWFEY-NRPADANISA-N 0.000 description 6
- YHKANGMVQWRMAP-DCAQKATOSA-N Ala-Leu-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YHKANGMVQWRMAP-DCAQKATOSA-N 0.000 description 6
- KYDYGANDJHFBCW-DRZSPHRISA-N Ala-Phe-Gln Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N KYDYGANDJHFBCW-DRZSPHRISA-N 0.000 description 6
- OLVCTPPSXNRGKV-GUBZILKMSA-N Ala-Pro-Pro Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 OLVCTPPSXNRGKV-GUBZILKMSA-N 0.000 description 6
- VYSRNGOMGHOJCK-GUBZILKMSA-N Arg-Ala-Met Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N VYSRNGOMGHOJCK-GUBZILKMSA-N 0.000 description 6
- IASNWHAGGYTEKX-IUCAKERBSA-N Arg-Arg-Gly Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(O)=O IASNWHAGGYTEKX-IUCAKERBSA-N 0.000 description 6
- PCQXGEUALSFGIA-WDSOQIARSA-N Arg-His-Trp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O PCQXGEUALSFGIA-WDSOQIARSA-N 0.000 description 6
- IARGXWMWRFOQPG-GCJQMDKQSA-N Asn-Ala-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IARGXWMWRFOQPG-GCJQMDKQSA-N 0.000 description 6
- NLCDVZJDEXIDDL-BIIVOSGPSA-N Asn-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)N)C(=O)O NLCDVZJDEXIDDL-BIIVOSGPSA-N 0.000 description 6
- PPCORQFLAZWUNO-QWRGUYRKSA-N Asn-Phe-Gly Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CC(=O)N)N PPCORQFLAZWUNO-QWRGUYRKSA-N 0.000 description 6
- ZXRQJQCXPSMNMR-XIRDDKMYSA-N Asp-Lys-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)N ZXRQJQCXPSMNMR-XIRDDKMYSA-N 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- LPYPANUXJGFMGV-FXQIFTODSA-N Gln-Gln-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)N)N LPYPANUXJGFMGV-FXQIFTODSA-N 0.000 description 6
- VSXBYIJUAXPAAL-WDSKDSINSA-N Gln-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CCC(N)=O VSXBYIJUAXPAAL-WDSKDSINSA-N 0.000 description 6
- VGTDBGYFVWOQTI-RYUDHWBXSA-N Gln-Gly-Phe Chemical compound NC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 VGTDBGYFVWOQTI-RYUDHWBXSA-N 0.000 description 6
- MLSKFHLRFVGNLL-WDCWCFNPSA-N Gln-Leu-Thr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MLSKFHLRFVGNLL-WDCWCFNPSA-N 0.000 description 6
- YYXJFBMCOUSYSF-RYUDHWBXSA-N Gly-Phe-Gln Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O YYXJFBMCOUSYSF-RYUDHWBXSA-N 0.000 description 6
- ABPRMMYHROQBLY-NKWVEPMBSA-N Gly-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)CN)C(=O)O ABPRMMYHROQBLY-NKWVEPMBSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 6
- 101001040800 Homo sapiens Integral membrane protein GPR180 Proteins 0.000 description 6
- 101000919980 Homo sapiens Protoheme IX farnesyltransferase, mitochondrial Proteins 0.000 description 6
- JRYQSFOFUFXPTB-RWRJDSDZSA-N Ile-Gln-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N JRYQSFOFUFXPTB-RWRJDSDZSA-N 0.000 description 6
- PHRWFSFCNJPWRO-PPCPHDFISA-N Ile-Leu-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N PHRWFSFCNJPWRO-PPCPHDFISA-N 0.000 description 6
- 102100021244 Integral membrane protein GPR180 Human genes 0.000 description 6
- SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 6
- CIVKXGPFXDIQBV-WDCWCFNPSA-N Leu-Gln-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CIVKXGPFXDIQBV-WDCWCFNPSA-N 0.000 description 6
- ZALAVHVPPOHAOL-XUXIUFHCSA-N Leu-Ile-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC(C)C)N ZALAVHVPPOHAOL-XUXIUFHCSA-N 0.000 description 6
- JLWZLIQRYCTYBD-IHRRRGAJSA-N Leu-Lys-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O JLWZLIQRYCTYBD-IHRRRGAJSA-N 0.000 description 6
- VWPJQIHBBOJWDN-DCAQKATOSA-N Lys-Val-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O VWPJQIHBBOJWDN-DCAQKATOSA-N 0.000 description 6
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 6
- IFMDQWDAJUMMJC-DCAQKATOSA-N Pro-Ala-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O IFMDQWDAJUMMJC-DCAQKATOSA-N 0.000 description 6
- LHALYDBUDCWMDY-CIUDSAMLSA-N Pro-Glu-Ala Chemical compound C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1)C(O)=O LHALYDBUDCWMDY-CIUDSAMLSA-N 0.000 description 6
- CGSOWZUPLOKYOR-AVGNSLFASA-N Pro-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 CGSOWZUPLOKYOR-AVGNSLFASA-N 0.000 description 6
- 102100030729 Protoheme IX farnesyltransferase, mitochondrial Human genes 0.000 description 6
- FYUIFUJFNCLUIX-XVYDVKMFSA-N Ser-His-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(O)=O FYUIFUJFNCLUIX-XVYDVKMFSA-N 0.000 description 6
- DOSZISJPMCYEHT-NAKRPEOUSA-N Ser-Ile-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O DOSZISJPMCYEHT-NAKRPEOUSA-N 0.000 description 6
- YUJLIIRMIAGMCQ-CIUDSAMLSA-N Ser-Leu-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YUJLIIRMIAGMCQ-CIUDSAMLSA-N 0.000 description 6
- XNXRTQZTFVMJIJ-DCAQKATOSA-N Ser-Met-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O XNXRTQZTFVMJIJ-DCAQKATOSA-N 0.000 description 6
- CUXJENOFJXOSOZ-BIIVOSGPSA-N Ser-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CO)N)C(=O)O CUXJENOFJXOSOZ-BIIVOSGPSA-N 0.000 description 6
- JURQXQBJKUHGJS-UHFFFAOYSA-N Ser-Ser-Ser-Ser Chemical compound OCC(N)C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(CO)C(O)=O JURQXQBJKUHGJS-UHFFFAOYSA-N 0.000 description 6
- LHUBVKCLOVALIA-HJGDQZAQSA-N Thr-Arg-Gln Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O LHUBVKCLOVALIA-HJGDQZAQSA-N 0.000 description 6
- JNQZPAWOPBZGIX-RCWTZXSCSA-N Thr-Arg-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)CCCN=C(N)N JNQZPAWOPBZGIX-RCWTZXSCSA-N 0.000 description 6
- JNKAYADBODLPMQ-HSHDSVGOSA-N Thr-Trp-Val Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@@H](N)[C@@H](C)O)=CNC2=C1 JNKAYADBODLPMQ-HSHDSVGOSA-N 0.000 description 6
- RGJZPXFZIUUQDN-BPNCWPANSA-N Tyr-Val-Ala Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O RGJZPXFZIUUQDN-BPNCWPANSA-N 0.000 description 6
- UBTBGUDNDFZLGP-SRVKXCTJSA-N Val-Arg-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C(C)C)C(=O)O)N UBTBGUDNDFZLGP-SRVKXCTJSA-N 0.000 description 6
- 150000001408 amides Chemical class 0.000 description 6
- 230000003321 amplification Effects 0.000 description 6
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 6
- 108010092854 aspartyllysine Proteins 0.000 description 6
- 230000000295 complement effect Effects 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 108010060199 cysteinylproline Proteins 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 6
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 6
- 108010015792 glycyllysine Proteins 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- 108010034529 leucyl-lysine Proteins 0.000 description 6
- 108010054155 lysyllysine Proteins 0.000 description 6
- 108010017391 lysylvaline Proteins 0.000 description 6
- 108020004999 messenger RNA Proteins 0.000 description 6
- 238000003199 nucleic acid amplification method Methods 0.000 description 6
- 238000004806 packaging method and process Methods 0.000 description 6
- 108010090894 prolylleucine Proteins 0.000 description 6
- 239000000829 suppository Substances 0.000 description 6
- GJLXVWOMRRWCIB-MERZOTPQSA-N (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanamide Chemical compound C([C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)C1=CC=C(O)C=C1 GJLXVWOMRRWCIB-MERZOTPQSA-N 0.000 description 5
- 108010085238 Actins Proteins 0.000 description 5
- 241001164825 Adeno-associated virus - 8 Species 0.000 description 5
- LGQPPBQRUBVTIF-JBDRJPRFSA-N Ala-Ala-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LGQPPBQRUBVTIF-JBDRJPRFSA-N 0.000 description 5
- FCXAUASCMJOFEY-NDKCEZKHSA-N Ala-Leu-Thr-Pro Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(O)=O FCXAUASCMJOFEY-NDKCEZKHSA-N 0.000 description 5
- IPZQNYYAYVRKKK-FXQIFTODSA-N Ala-Pro-Ala Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O IPZQNYYAYVRKKK-FXQIFTODSA-N 0.000 description 5
- YHBDGLZYNIARKJ-GUBZILKMSA-N Ala-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N YHBDGLZYNIARKJ-GUBZILKMSA-N 0.000 description 5
- VJVQKGYHIZPSNS-FXQIFTODSA-N Ala-Ser-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCN=C(N)N VJVQKGYHIZPSNS-FXQIFTODSA-N 0.000 description 5
- WQKAQKZRDIZYNV-VZFHVOOUSA-N Ala-Ser-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WQKAQKZRDIZYNV-VZFHVOOUSA-N 0.000 description 5
- MTDDMSUUXNQMKK-BPNCWPANSA-N Ala-Tyr-Arg Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N MTDDMSUUXNQMKK-BPNCWPANSA-N 0.000 description 5
- 108700028369 Alleles Proteins 0.000 description 5
- DFCIPNHFKOQAME-FXQIFTODSA-N Arg-Ala-Asn Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O DFCIPNHFKOQAME-FXQIFTODSA-N 0.000 description 5
- YWENWUYXQUWRHQ-LPEHRKFASA-N Arg-Cys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CS)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O YWENWUYXQUWRHQ-LPEHRKFASA-N 0.000 description 5
- OWSMKCJUBAPHED-JYJNAYRXSA-N Arg-Pro-Tyr Chemical compound NC(N)=NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 OWSMKCJUBAPHED-JYJNAYRXSA-N 0.000 description 5
- QXOPPIDJKPEKCW-GUBZILKMSA-N Asn-Pro-Arg Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC(=O)N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O QXOPPIDJKPEKCW-GUBZILKMSA-N 0.000 description 5
- GVPSCJQLUGIKAM-GUBZILKMSA-N Asp-Arg-Arg Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O GVPSCJQLUGIKAM-GUBZILKMSA-N 0.000 description 5
- DXQOQMCLWWADMU-ACZMJKKPSA-N Asp-Gln-Ser Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O DXQOQMCLWWADMU-ACZMJKKPSA-N 0.000 description 5
- LIVXPXUVXFRWNY-CIUDSAMLSA-N Asp-Lys-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O LIVXPXUVXFRWNY-CIUDSAMLSA-N 0.000 description 5
- ZQFRDAZBTSFGGW-SRVKXCTJSA-N Asp-Ser-Phe Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ZQFRDAZBTSFGGW-SRVKXCTJSA-N 0.000 description 5
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 5
- 206010010741 Conjunctivitis Diseases 0.000 description 5
- ARYKRXHBIPLULY-XKBZYTNZSA-N Gln-Thr-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O ARYKRXHBIPLULY-XKBZYTNZSA-N 0.000 description 5
- RUFHOVYUYSNDNY-ACZMJKKPSA-N Glu-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O RUFHOVYUYSNDNY-ACZMJKKPSA-N 0.000 description 5
- CBOVGULVQSVMPT-CIUDSAMLSA-N Glu-Pro-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O CBOVGULVQSVMPT-CIUDSAMLSA-N 0.000 description 5
- LJPIRKICOISLKN-WHFBIAKZSA-N Gly-Ala-Ser Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O LJPIRKICOISLKN-WHFBIAKZSA-N 0.000 description 5
- RJIVPOXLQFJRTG-LURJTMIESA-N Gly-Arg-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N RJIVPOXLQFJRTG-LURJTMIESA-N 0.000 description 5
- CQZDZKRHFWJXDF-WDSKDSINSA-N Gly-Gln-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CN CQZDZKRHFWJXDF-WDSKDSINSA-N 0.000 description 5
- UHPAZODVFFYEEL-QWRGUYRKSA-N Gly-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CN UHPAZODVFFYEEL-QWRGUYRKSA-N 0.000 description 5
- MIIVFRCYJABHTQ-ONGXEEELSA-N Gly-Leu-Val Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O MIIVFRCYJABHTQ-ONGXEEELSA-N 0.000 description 5
- QGDOOCIPHSSADO-STQMWFEESA-N Gly-Met-Phe Chemical compound [H]NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O QGDOOCIPHSSADO-STQMWFEESA-N 0.000 description 5
- WCORRBXVISTKQL-WHFBIAKZSA-N Gly-Ser-Ser Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WCORRBXVISTKQL-WHFBIAKZSA-N 0.000 description 5
- KSOBNUBCYHGUKH-UWVGGRQHSA-N Gly-Val-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN KSOBNUBCYHGUKH-UWVGGRQHSA-N 0.000 description 5
- QLBXWYXMLHAREM-PYJNHQTQSA-N His-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC1=CN=CN1)N QLBXWYXMLHAREM-PYJNHQTQSA-N 0.000 description 5
- VAXBXNPRXPHGHG-BJDJZHNGSA-N Ile-Ala-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)N VAXBXNPRXPHGHG-BJDJZHNGSA-N 0.000 description 5
- TZCGZYWNIDZZMR-UHFFFAOYSA-N Ile-Arg-Ala Natural products CCC(C)C(N)C(=O)NC(C(=O)NC(C)C(O)=O)CCCN=C(N)N TZCGZYWNIDZZMR-UHFFFAOYSA-N 0.000 description 5
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 5
- KAFOIVJDVSZUMD-UHFFFAOYSA-N Leu-Gln-Gln Natural products CC(C)CC(N)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(N)=O)C(O)=O KAFOIVJDVSZUMD-UHFFFAOYSA-N 0.000 description 5
- YOKVEHGYYQEQOP-QWRGUYRKSA-N Leu-Leu-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YOKVEHGYYQEQOP-QWRGUYRKSA-N 0.000 description 5
- KMSMNUFBNCHMII-IHRRRGAJSA-N Met-Leu-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCCN KMSMNUFBNCHMII-IHRRRGAJSA-N 0.000 description 5
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 5
- 108010079364 N-glycylalanine Proteins 0.000 description 5
- 241000221961 Neurospora crassa Species 0.000 description 5
- CYZBFPYMSJGBRL-DRZSPHRISA-N Phe-Ala-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O CYZBFPYMSJGBRL-DRZSPHRISA-N 0.000 description 5
- RMKGXGPQIPLTFC-KKUMJFAQSA-N Phe-Lys-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O RMKGXGPQIPLTFC-KKUMJFAQSA-N 0.000 description 5
- XALFIVXGQUEGKV-JSGCOSHPSA-N Phe-Val-Gly Chemical compound OC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 XALFIVXGQUEGKV-JSGCOSHPSA-N 0.000 description 5
- CYQQWUPHIZVCNY-GUBZILKMSA-N Pro-Arg-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O CYQQWUPHIZVCNY-GUBZILKMSA-N 0.000 description 5
- UREQLMJCKFLLHM-NAKRPEOUSA-N Pro-Ile-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O UREQLMJCKFLLHM-NAKRPEOUSA-N 0.000 description 5
- ITUDDXVFGFEKPD-NAKRPEOUSA-N Pro-Ser-Ile Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ITUDDXVFGFEKPD-NAKRPEOUSA-N 0.000 description 5
- WDXYVIIVDIDOSX-DCAQKATOSA-N Ser-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CCCN=C(N)N WDXYVIIVDIDOSX-DCAQKATOSA-N 0.000 description 5
- QVOGDCQNGLBNCR-FXQIFTODSA-N Ser-Arg-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O QVOGDCQNGLBNCR-FXQIFTODSA-N 0.000 description 5
- UAJAYRMZGNQILN-BQBZGAKWSA-N Ser-Gly-Met Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCSC)C(O)=O UAJAYRMZGNQILN-BQBZGAKWSA-N 0.000 description 5
- ADJDNJCSPNFFPI-FXQIFTODSA-N Ser-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO ADJDNJCSPNFFPI-FXQIFTODSA-N 0.000 description 5
- QPPYAWVLAVXISR-DCAQKATOSA-N Ser-Pro-His Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CO)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O QPPYAWVLAVXISR-DCAQKATOSA-N 0.000 description 5
- HHJFMHQYEAAOBM-ZLUOBGJFSA-N Ser-Ser-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O HHJFMHQYEAAOBM-ZLUOBGJFSA-N 0.000 description 5
- GZYNMZQXFRWDFH-YTWAJWBKSA-N Thr-Arg-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)O)N)O GZYNMZQXFRWDFH-YTWAJWBKSA-N 0.000 description 5
- KRPKYGOFYUNIGM-XVSYOHENSA-N Thr-Asp-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N)O KRPKYGOFYUNIGM-XVSYOHENSA-N 0.000 description 5
- RRXPAFGTFQIEMD-IVJVFBROSA-N Trp-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N RRXPAFGTFQIEMD-IVJVFBROSA-N 0.000 description 5
- RKISDJMICOREEL-QRTARXTBSA-N Trp-Val-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N RKISDJMICOREEL-QRTARXTBSA-N 0.000 description 5
- XWYUBUYQMOUFRQ-IFFSRLJSSA-N Val-Glu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)N)O XWYUBUYQMOUFRQ-IFFSRLJSSA-N 0.000 description 5
- BTWMICVCQLKKNR-DCAQKATOSA-N Val-Leu-Ser Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C([O-])=O BTWMICVCQLKKNR-DCAQKATOSA-N 0.000 description 5
- CKTMJBPRVQWPHU-JSGCOSHPSA-N Val-Phe-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)O)N CKTMJBPRVQWPHU-JSGCOSHPSA-N 0.000 description 5
- QIVPZSWBBHRNBA-JYJNAYRXSA-N Val-Pro-Phe Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O QIVPZSWBBHRNBA-JYJNAYRXSA-N 0.000 description 5
- QPJSIBAOZBVELU-BPNCWPANSA-N Val-Tyr-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C(C)C)N QPJSIBAOZBVELU-BPNCWPANSA-N 0.000 description 5
- 230000005856 abnormality Effects 0.000 description 5
- 108010005233 alanylglutamic acid Proteins 0.000 description 5
- 108010070783 alanyltyrosine Proteins 0.000 description 5
- 229920000249 biocompatible polymer Polymers 0.000 description 5
- 239000000969 carrier Substances 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 206010014801 endophthalmitis Diseases 0.000 description 5
- 108010077515 glycylproline Proteins 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 108010040030 histidinoalanine Proteins 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 108010000761 leucylarginine Proteins 0.000 description 5
- 239000003446 ligand Substances 0.000 description 5
- 108010064235 lysylglycine Proteins 0.000 description 5
- 108010085203 methionylmethionine Proteins 0.000 description 5
- 210000003470 mitochondria Anatomy 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 210000002569 neuron Anatomy 0.000 description 5
- 108010024607 phenylalanylalanine Proteins 0.000 description 5
- 239000013646 rAAV2 vector Substances 0.000 description 5
- 210000003583 retinal pigment epithelium Anatomy 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 108010071207 serylmethionine Proteins 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 239000013607 AAV vector Substances 0.000 description 4
- 102000007469 Actins Human genes 0.000 description 4
- 241001655883 Adeno-associated virus - 1 Species 0.000 description 4
- 241000972680 Adeno-associated virus - 6 Species 0.000 description 4
- DECCMEWNXSNSDO-ZLUOBGJFSA-N Ala-Cys-Ala Chemical compound C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(O)=O DECCMEWNXSNSDO-ZLUOBGJFSA-N 0.000 description 4
- MAZZQZWCCYJQGZ-GUBZILKMSA-N Ala-Pro-Arg Chemical compound [H]N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O MAZZQZWCCYJQGZ-GUBZILKMSA-N 0.000 description 4
- YEBZNKPPOHFZJM-BPNCWPANSA-N Ala-Tyr-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O YEBZNKPPOHFZJM-BPNCWPANSA-N 0.000 description 4
- YJHKTAMKPGFJCT-NRPADANISA-N Ala-Val-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O YJHKTAMKPGFJCT-NRPADANISA-N 0.000 description 4
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 4
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 4
- KJGNDQCYBNBXDA-GUBZILKMSA-N Arg-Arg-Cys Chemical compound C(C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)O)N)CN=C(N)N KJGNDQCYBNBXDA-GUBZILKMSA-N 0.000 description 4
- AQPVUEJJARLJHB-BQBZGAKWSA-N Arg-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CCCN=C(N)N AQPVUEJJARLJHB-BQBZGAKWSA-N 0.000 description 4
- JTZUZBADHGISJD-SRVKXCTJSA-N Arg-His-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(O)=O JTZUZBADHGISJD-SRVKXCTJSA-N 0.000 description 4
- DGFXIWKPTDKBLF-AVGNSLFASA-N Arg-His-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCCN=C(N)N)N DGFXIWKPTDKBLF-AVGNSLFASA-N 0.000 description 4
- LKDHUGLXOHYINY-XUXIUFHCSA-N Arg-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N LKDHUGLXOHYINY-XUXIUFHCSA-N 0.000 description 4
- WMEVEPXNCMKNGH-IHRRRGAJSA-N Arg-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N WMEVEPXNCMKNGH-IHRRRGAJSA-N 0.000 description 4
- YNSUUAOAFCVINY-OSUNSFLBSA-N Arg-Thr-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O YNSUUAOAFCVINY-OSUNSFLBSA-N 0.000 description 4
- QQEWINYJRFBLNN-DLOVCJGASA-N Asn-Ala-Phe Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 QQEWINYJRFBLNN-DLOVCJGASA-N 0.000 description 4
- FTCGGKNCJZOPNB-WHFBIAKZSA-N Asn-Gly-Ser Chemical compound NC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O FTCGGKNCJZOPNB-WHFBIAKZSA-N 0.000 description 4
- KYQJHBWHRASMKG-ZLUOBGJFSA-N Asn-Ser-Cys Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(O)=O KYQJHBWHRASMKG-ZLUOBGJFSA-N 0.000 description 4
- MGSVBZIBCCKGCY-ZLUOBGJFSA-N Asp-Ser-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MGSVBZIBCCKGCY-ZLUOBGJFSA-N 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- IGNGBUVODQLMRJ-CIUDSAMLSA-N Gln-Ala-Met Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(O)=O IGNGBUVODQLMRJ-CIUDSAMLSA-N 0.000 description 4
- GURIQZQSTBBHRV-SRVKXCTJSA-N Gln-Lys-Arg Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O GURIQZQSTBBHRV-SRVKXCTJSA-N 0.000 description 4
- OSCLNNWLKKIQJM-WDSKDSINSA-N Gln-Ser-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O OSCLNNWLKKIQJM-WDSKDSINSA-N 0.000 description 4
- ININBLZFFVOQIO-JHEQGTHGSA-N Gln-Thr-Gly Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)N)N)O ININBLZFFVOQIO-JHEQGTHGSA-N 0.000 description 4
- OXEMJGCAJFFREE-FXQIFTODSA-N Glu-Gln-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O OXEMJGCAJFFREE-FXQIFTODSA-N 0.000 description 4
- UMIRPYLZFKOEOH-YVNDNENWSA-N Glu-Gln-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O UMIRPYLZFKOEOH-YVNDNENWSA-N 0.000 description 4
- BUAKRRKDHSSIKK-IHRRRGAJSA-N Glu-Glu-Tyr Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 BUAKRRKDHSSIKK-IHRRRGAJSA-N 0.000 description 4
- OPAINBJQDQTGJY-JGVFFNPUSA-N Glu-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CCC(=O)O)N)C(=O)O OPAINBJQDQTGJY-JGVFFNPUSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- VSVZIEVNUYDAFR-YUMQZZPRSA-N Gly-Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN VSVZIEVNUYDAFR-YUMQZZPRSA-N 0.000 description 4
- CCQOOWAONKGYKQ-BYPYZUCNSA-N Gly-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)CN CCQOOWAONKGYKQ-BYPYZUCNSA-N 0.000 description 4
- GDOZQTNZPCUARW-YFKPBYRVSA-N Gly-Gly-Glu Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O GDOZQTNZPCUARW-YFKPBYRVSA-N 0.000 description 4
- NSTUFLGQJCOCDL-UWVGGRQHSA-N Gly-Leu-Arg Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N NSTUFLGQJCOCDL-UWVGGRQHSA-N 0.000 description 4
- IEGFSKKANYKBDU-QWHCGFSZSA-N Gly-Phe-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)CN)C(=O)O IEGFSKKANYKBDU-QWHCGFSZSA-N 0.000 description 4
- WNGHUXFWEWTKAO-YUMQZZPRSA-N Gly-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN WNGHUXFWEWTKAO-YUMQZZPRSA-N 0.000 description 4
- MDBYBTWRMOAJAY-NHCYSSNCSA-N His-Asn-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC1=CN=CN1)N MDBYBTWRMOAJAY-NHCYSSNCSA-N 0.000 description 4
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 4
- ZYVTXBXHIKGZMD-QSFUFRPTSA-N Ile-Val-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)O)N ZYVTXBXHIKGZMD-QSFUFRPTSA-N 0.000 description 4
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 description 4
- NTRAGDHVSGKUSF-AVGNSLFASA-N Leu-Arg-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O NTRAGDHVSGKUSF-AVGNSLFASA-N 0.000 description 4
- GPICTNQYKHHHTH-GUBZILKMSA-N Leu-Gln-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O GPICTNQYKHHHTH-GUBZILKMSA-N 0.000 description 4
- LAPSXOAUPNOINL-YUMQZZPRSA-N Leu-Gly-Asp Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O LAPSXOAUPNOINL-YUMQZZPRSA-N 0.000 description 4
- AVEGDIAXTDVBJS-XUXIUFHCSA-N Leu-Ile-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O AVEGDIAXTDVBJS-XUXIUFHCSA-N 0.000 description 4
- ZDBMWELMUCLUPL-QEJZJMRPSA-N Leu-Phe-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=CC=C1 ZDBMWELMUCLUPL-QEJZJMRPSA-N 0.000 description 4
- SBANPBVRHYIMRR-GARJFASQSA-N Leu-Ser-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N SBANPBVRHYIMRR-GARJFASQSA-N 0.000 description 4
- PPGBXYKMUMHFBF-KATARQTJSA-N Leu-Ser-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PPGBXYKMUMHFBF-KATARQTJSA-N 0.000 description 4
- VDIARPPNADFEAV-WEDXCCLWSA-N Leu-Thr-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O VDIARPPNADFEAV-WEDXCCLWSA-N 0.000 description 4
- AAKRWBIIGKPOKQ-ONGXEEELSA-N Leu-Val-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O AAKRWBIIGKPOKQ-ONGXEEELSA-N 0.000 description 4
- MYZMQWHPDAYKIE-SRVKXCTJSA-N Lys-Leu-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O MYZMQWHPDAYKIE-SRVKXCTJSA-N 0.000 description 4
- RBEATVHTWHTHTJ-KKUMJFAQSA-N Lys-Leu-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O RBEATVHTWHTHTJ-KKUMJFAQSA-N 0.000 description 4
- YPLVCBKEPJPBDQ-MELADBBJSA-N Lys-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N YPLVCBKEPJPBDQ-MELADBBJSA-N 0.000 description 4
- OIQSIMFSVLLWBX-VOAKCMCISA-N Lys-Leu-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OIQSIMFSVLLWBX-VOAKCMCISA-N 0.000 description 4
- ZBLSZPYQQRIHQU-RCWTZXSCSA-N Met-Thr-Val Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O ZBLSZPYQQRIHQU-RCWTZXSCSA-N 0.000 description 4
- 108010035095 NADH dehydrogenase subunit 4 Proteins 0.000 description 4
- BQVUABVGYYSDCJ-UHFFFAOYSA-N Nalpha-L-Leucyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)CC(C)C)C(O)=O)=CNC2=C1 BQVUABVGYYSDCJ-UHFFFAOYSA-N 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- HHOOEUSPFGPZFP-QWRGUYRKSA-N Phe-Asn-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O HHOOEUSPFGPZFP-QWRGUYRKSA-N 0.000 description 4
- MVIJMIZJPHQGEN-IHRRRGAJSA-N Phe-Ser-Val Chemical compound CC(C)[C@@H](C([O-])=O)NC(=O)[C@H](CO)NC(=O)[C@@H]([NH3+])CC1=CC=CC=C1 MVIJMIZJPHQGEN-IHRRRGAJSA-N 0.000 description 4
- QBFONMUYNSNKIX-AVGNSLFASA-N Pro-Arg-His Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O QBFONMUYNSNKIX-AVGNSLFASA-N 0.000 description 4
- LGSANCBHSMDFDY-GARJFASQSA-N Pro-Glu-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCC[C@@H]2C(=O)O LGSANCBHSMDFDY-GARJFASQSA-N 0.000 description 4
- ZOHGLPQGEHSLPD-FXQIFTODSA-N Ser-Gln-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZOHGLPQGEHSLPD-FXQIFTODSA-N 0.000 description 4
- NUEHQDHDLDXCRU-GUBZILKMSA-N Ser-Pro-Arg Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O NUEHQDHDLDXCRU-GUBZILKMSA-N 0.000 description 4
- RXUOAOOZIWABBW-XGEHTFHBSA-N Ser-Thr-Arg Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N RXUOAOOZIWABBW-XGEHTFHBSA-N 0.000 description 4
- PCJLFYBAQZQOFE-KATARQTJSA-N Ser-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N)O PCJLFYBAQZQOFE-KATARQTJSA-N 0.000 description 4
- CAGTXGDOIFXLPC-KZVJFYERSA-N Thr-Arg-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CCCN=C(N)N CAGTXGDOIFXLPC-KZVJFYERSA-N 0.000 description 4
- ZTPXSEUVYNNZRB-CDMKHQONSA-N Thr-Gly-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ZTPXSEUVYNNZRB-CDMKHQONSA-N 0.000 description 4
- DJDSEDOKJTZBAR-ZDLURKLDSA-N Thr-Gly-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O DJDSEDOKJTZBAR-ZDLURKLDSA-N 0.000 description 4
- LCCSEJSPBWKBNT-OSUNSFLBSA-N Thr-Ile-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N LCCSEJSPBWKBNT-OSUNSFLBSA-N 0.000 description 4
- VDCGPCSLAJAKBB-XIRDDKMYSA-N Trp-Ser-His Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC3=CN=CN3)C(=O)O)N VDCGPCSLAJAKBB-XIRDDKMYSA-N 0.000 description 4
- DDRBQONWVBDQOY-GUBZILKMSA-N Val-Ala-Arg Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O DDRBQONWVBDQOY-GUBZILKMSA-N 0.000 description 4
- RUCNAYOMFXRIKJ-DCAQKATOSA-N Val-Ala-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN RUCNAYOMFXRIKJ-DCAQKATOSA-N 0.000 description 4
- CVIXTAITYJQMPE-LAEOZQHASA-N Val-Glu-Asn Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O CVIXTAITYJQMPE-LAEOZQHASA-N 0.000 description 4
- WMRWZYSRQUORHJ-YDHLFZDLSA-N Val-Phe-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)O)C(=O)O)N WMRWZYSRQUORHJ-YDHLFZDLSA-N 0.000 description 4
- JAIZPWVHPQRYOU-ZJDVBMNYSA-N Val-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C(C)C)N)O JAIZPWVHPQRYOU-ZJDVBMNYSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 229960000686 benzalkonium chloride Drugs 0.000 description 4
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 229960002685 biotin Drugs 0.000 description 4
- 235000020958 biotin Nutrition 0.000 description 4
- 239000011616 biotin Substances 0.000 description 4
- 238000009530 blood pressure measurement Methods 0.000 description 4
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- 108010016616 cysteinylglycine Proteins 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 108010048367 enhanced green fluorescent protein Proteins 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 238000012239 gene modification Methods 0.000 description 4
- 230000005017 genetic modification Effects 0.000 description 4
- 235000013617 genetically modified food Nutrition 0.000 description 4
- 108010049041 glutamylalanine Proteins 0.000 description 4
- 108010081551 glycylphenylalanine Proteins 0.000 description 4
- 108010025306 histidylleucine Proteins 0.000 description 4
- 238000003119 immunoblot Methods 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 108010020755 prolyl-glycyl-glycine Proteins 0.000 description 4
- 108010029020 prolylglycine Proteins 0.000 description 4
- 210000001525 retina Anatomy 0.000 description 4
- 108010048818 seryl-histidine Proteins 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 238000010561 standard procedure Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 230000010415 tropism Effects 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- AXFMEGAFCUULFV-BLFANLJRSA-N (2s)-2-[[(2s)-1-[(2s,3r)-2-amino-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]pentanedioic acid Chemical compound CC[C@@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O AXFMEGAFCUULFV-BLFANLJRSA-N 0.000 description 3
- 101150093272 ATP9 gene Proteins 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000202702 Adeno-associated virus - 3 Species 0.000 description 3
- 241001164823 Adeno-associated virus - 7 Species 0.000 description 3
- SBGXWWCLHIOABR-UHFFFAOYSA-N Ala Ala Gly Ala Chemical compound CC(N)C(=O)NC(C)C(=O)NCC(=O)NC(C)C(O)=O SBGXWWCLHIOABR-UHFFFAOYSA-N 0.000 description 3
- RLMISHABBKUNFO-WHFBIAKZSA-N Ala-Ala-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O RLMISHABBKUNFO-WHFBIAKZSA-N 0.000 description 3
- PBAMJJXWDQXOJA-FXQIFTODSA-N Ala-Asp-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PBAMJJXWDQXOJA-FXQIFTODSA-N 0.000 description 3
- CSAHOYQKNHGDHX-ACZMJKKPSA-N Ala-Gln-Asn Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O CSAHOYQKNHGDHX-ACZMJKKPSA-N 0.000 description 3
- QHASENCZLDHBGX-ONGXEEELSA-N Ala-Gly-Phe Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 QHASENCZLDHBGX-ONGXEEELSA-N 0.000 description 3
- NBTGEURICRTMGL-WHFBIAKZSA-N Ala-Gly-Ser Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O NBTGEURICRTMGL-WHFBIAKZSA-N 0.000 description 3
- TZDNWXDLYFIFPT-BJDJZHNGSA-N Ala-Ile-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O TZDNWXDLYFIFPT-BJDJZHNGSA-N 0.000 description 3
- VNYMOTCMNHJGTG-JBDRJPRFSA-N Ala-Ile-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O VNYMOTCMNHJGTG-JBDRJPRFSA-N 0.000 description 3
- YCRAFFCYWOUEOF-DLOVCJGASA-N Ala-Phe-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 YCRAFFCYWOUEOF-DLOVCJGASA-N 0.000 description 3
- MMLHRUJLOUSRJX-CIUDSAMLSA-N Ala-Ser-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN MMLHRUJLOUSRJX-CIUDSAMLSA-N 0.000 description 3
- NCQMBSJGJMYKCK-ZLUOBGJFSA-N Ala-Ser-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O NCQMBSJGJMYKCK-ZLUOBGJFSA-N 0.000 description 3
- KUFVXLQLDHJVOG-SHGPDSBTSA-N Ala-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C)N)O KUFVXLQLDHJVOG-SHGPDSBTSA-N 0.000 description 3
- NABSCJGZKWSNHX-RCWTZXSCSA-N Arg-Arg-Thr Chemical compound NC(N)=NCCC[C@@H](C(=O)N[C@@H]([C@H](O)C)C(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N NABSCJGZKWSNHX-RCWTZXSCSA-N 0.000 description 3
- HKRXJBBCQBAGIM-FXQIFTODSA-N Arg-Asp-Ser Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)O)N)CN=C(N)N HKRXJBBCQBAGIM-FXQIFTODSA-N 0.000 description 3
- OHYQKYUTLIPFOX-ZPFDUUQYSA-N Arg-Glu-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O OHYQKYUTLIPFOX-ZPFDUUQYSA-N 0.000 description 3
- IIAXFBUTKIDDIP-ULQDDVLXSA-N Arg-Leu-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O IIAXFBUTKIDDIP-ULQDDVLXSA-N 0.000 description 3
- ICRHGPYYXMWHIE-LPEHRKFASA-N Arg-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O ICRHGPYYXMWHIE-LPEHRKFASA-N 0.000 description 3
- LYJXHXGPWDTLKW-HJGDQZAQSA-N Arg-Thr-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O LYJXHXGPWDTLKW-HJGDQZAQSA-N 0.000 description 3
- VLIJAPRTSXSGFY-STQMWFEESA-N Arg-Tyr-Gly Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 VLIJAPRTSXSGFY-STQMWFEESA-N 0.000 description 3
- 108090001008 Avidin Proteins 0.000 description 3
- IQXSTXKVEMRMMB-XAVMHZPKSA-N Cys-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CS)N)O IQXSTXKVEMRMMB-XAVMHZPKSA-N 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 101000834253 Gallus gallus Actin, cytoplasmic 1 Proteins 0.000 description 3
- LZRMPXRYLLTAJX-GUBZILKMSA-N Gln-Arg-Glu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O LZRMPXRYLLTAJX-GUBZILKMSA-N 0.000 description 3
- PSERKXGRRADTKA-MNXVOIDGSA-N Gln-Leu-Ile Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O PSERKXGRRADTKA-MNXVOIDGSA-N 0.000 description 3
- NHMRJKKAVMENKJ-WDCWCFNPSA-N Gln-Thr-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O NHMRJKKAVMENKJ-WDCWCFNPSA-N 0.000 description 3
- SBYVDRJAXWSXQL-AVGNSLFASA-N Glu-Asn-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SBYVDRJAXWSXQL-AVGNSLFASA-N 0.000 description 3
- WTMZXOPHTIVFCP-QEWYBTABSA-N Glu-Ile-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 WTMZXOPHTIVFCP-QEWYBTABSA-N 0.000 description 3
- PMNHJLASAAWELO-FOHZUACHSA-N Gly-Asp-Thr Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PMNHJLASAAWELO-FOHZUACHSA-N 0.000 description 3
- YABRDIBSPZONIY-BQBZGAKWSA-N Gly-Ser-Met Chemical compound [H]NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(O)=O YABRDIBSPZONIY-BQBZGAKWSA-N 0.000 description 3
- LCRDMSSAKLTKBU-ZDLURKLDSA-N Gly-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN LCRDMSSAKLTKBU-ZDLURKLDSA-N 0.000 description 3
- LYZYGGWCBLBDMC-QWHCGFSZSA-N Gly-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)CN)C(=O)O LYZYGGWCBLBDMC-QWHCGFSZSA-N 0.000 description 3
- SBVMXEZQJVUARN-XPUUQOCRSA-N Gly-Val-Ser Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O SBVMXEZQJVUARN-XPUUQOCRSA-N 0.000 description 3
- KZTLOHBDLMIFSH-XVYDVKMFSA-N His-Ala-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O KZTLOHBDLMIFSH-XVYDVKMFSA-N 0.000 description 3
- WCNXUTNLSRWWQN-DCAQKATOSA-N His-Asp-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC1=CN=CN1)N WCNXUTNLSRWWQN-DCAQKATOSA-N 0.000 description 3
- TXLQHACKRLWYCM-DCAQKATOSA-N His-Glu-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O TXLQHACKRLWYCM-DCAQKATOSA-N 0.000 description 3
- HYWZHNUGAYVEEW-KKUMJFAQSA-N His-Phe-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC2=CN=CN2)N HYWZHNUGAYVEEW-KKUMJFAQSA-N 0.000 description 3
- GGXUJBKENKVYNV-ULQDDVLXSA-N His-Val-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CC2=CN=CN2)N GGXUJBKENKVYNV-ULQDDVLXSA-N 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- CDGLBYSAZFIIJO-RCOVLWMOSA-N Ile-Gly-Gly Chemical compound CC[C@H](C)[C@H]([NH3+])C(=O)NCC(=O)NCC([O-])=O CDGLBYSAZFIIJO-RCOVLWMOSA-N 0.000 description 3
- FZWVCYCYWCLQDH-NHCYSSNCSA-N Ile-Leu-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)N FZWVCYCYWCLQDH-NHCYSSNCSA-N 0.000 description 3
- FFJQAEYLAQMGDL-MGHWNKPDSA-N Ile-Lys-Tyr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 FFJQAEYLAQMGDL-MGHWNKPDSA-N 0.000 description 3
- JHNJNTMTZHEDLJ-NAKRPEOUSA-N Ile-Ser-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O JHNJNTMTZHEDLJ-NAKRPEOUSA-N 0.000 description 3
- HQLSBZFLOUHQJK-STECZYCISA-N Ile-Tyr-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N HQLSBZFLOUHQJK-STECZYCISA-N 0.000 description 3
- HGCNKOLVKRAVHD-UHFFFAOYSA-N L-Met-L-Phe Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 HGCNKOLVKRAVHD-UHFFFAOYSA-N 0.000 description 3
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 3
- JUWJEAPUNARGCF-DCAQKATOSA-N Leu-Arg-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O JUWJEAPUNARGCF-DCAQKATOSA-N 0.000 description 3
- STAVRDQLZOTNKJ-RHYQMDGZSA-N Leu-Arg-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O STAVRDQLZOTNKJ-RHYQMDGZSA-N 0.000 description 3
- JKGHDYGZRDWHGA-SRVKXCTJSA-N Leu-Asn-Leu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JKGHDYGZRDWHGA-SRVKXCTJSA-N 0.000 description 3
- CSFVADKICPDRRF-KKUMJFAQSA-N Leu-His-Leu Chemical compound CC(C)C[C@H]([NH3+])C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C([O-])=O)CC1=CN=CN1 CSFVADKICPDRRF-KKUMJFAQSA-N 0.000 description 3
- DBSLVQBXKVKDKJ-BJDJZHNGSA-N Leu-Ile-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O DBSLVQBXKVKDKJ-BJDJZHNGSA-N 0.000 description 3
- IEWBEPKLKUXQBU-VOAKCMCISA-N Leu-Leu-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IEWBEPKLKUXQBU-VOAKCMCISA-N 0.000 description 3
- UCBPDSYUVAAHCD-UWVGGRQHSA-N Leu-Pro-Gly Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O UCBPDSYUVAAHCD-UWVGGRQHSA-N 0.000 description 3
- IDGZVZJLYFTXSL-DCAQKATOSA-N Leu-Ser-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IDGZVZJLYFTXSL-DCAQKATOSA-N 0.000 description 3
- YQFZRHYZLARWDY-IHRRRGAJSA-N Leu-Val-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN YQFZRHYZLARWDY-IHRRRGAJSA-N 0.000 description 3
- WALVCOOOKULCQM-ULQDDVLXSA-N Lys-Arg-Phe Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O WALVCOOOKULCQM-ULQDDVLXSA-N 0.000 description 3
- GQFDWEDHOQRNLC-QWRGUYRKSA-N Lys-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN GQFDWEDHOQRNLC-QWRGUYRKSA-N 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- MIAZEQZXAFTCCG-UBHSHLNASA-N Met-Phe-Ala Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=CC=C1 MIAZEQZXAFTCCG-UBHSHLNASA-N 0.000 description 3
- GWADARYJIJDYRC-XGEHTFHBSA-N Met-Thr-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O GWADARYJIJDYRC-XGEHTFHBSA-N 0.000 description 3
- YGNUDKAPJARTEM-GUBZILKMSA-N Met-Val-Ala Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O YGNUDKAPJARTEM-GUBZILKMSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 101100324954 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) oli gene Proteins 0.000 description 3
- 101150096101 OLI1 gene Proteins 0.000 description 3
- 235000019483 Peanut oil Nutrition 0.000 description 3
- OYQBFWWQSVIHBN-FHWLQOOXSA-N Phe-Glu-Phe Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O OYQBFWWQSVIHBN-FHWLQOOXSA-N 0.000 description 3
- SMFGCTXUBWEPKM-KBPBESRZSA-N Phe-Leu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 SMFGCTXUBWEPKM-KBPBESRZSA-N 0.000 description 3
- MCIXMYKSPQUMJG-SRVKXCTJSA-N Phe-Ser-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MCIXMYKSPQUMJG-SRVKXCTJSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 241000288906 Primates Species 0.000 description 3
- WPQKSRHDTMRSJM-CIUDSAMLSA-N Pro-Asp-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1 WPQKSRHDTMRSJM-CIUDSAMLSA-N 0.000 description 3
- VTFXTWDFPTWNJY-RHYQMDGZSA-N Pro-Leu-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VTFXTWDFPTWNJY-RHYQMDGZSA-N 0.000 description 3
- GOMUXSCOIWIJFP-GUBZILKMSA-N Pro-Ser-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O GOMUXSCOIWIJFP-GUBZILKMSA-N 0.000 description 3
- LNICFEXCAHIJOR-DCAQKATOSA-N Pro-Ser-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O LNICFEXCAHIJOR-DCAQKATOSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- WTUJZHKANPDPIN-CIUDSAMLSA-N Ser-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N WTUJZHKANPDPIN-CIUDSAMLSA-N 0.000 description 3
- OOKCGAYXSNJBGQ-ZLUOBGJFSA-N Ser-Asn-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O OOKCGAYXSNJBGQ-ZLUOBGJFSA-N 0.000 description 3
- YRBGKVIWMNEVCZ-WDSKDSINSA-N Ser-Glu-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O YRBGKVIWMNEVCZ-WDSKDSINSA-N 0.000 description 3
- CICQXRWZNVXFCU-SRVKXCTJSA-N Ser-His-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O CICQXRWZNVXFCU-SRVKXCTJSA-N 0.000 description 3
- IXZHZUGGKLRHJD-DCAQKATOSA-N Ser-Leu-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O IXZHZUGGKLRHJD-DCAQKATOSA-N 0.000 description 3
- JCLAFVNDBJMLBC-JBDRJPRFSA-N Ser-Ser-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JCLAFVNDBJMLBC-JBDRJPRFSA-N 0.000 description 3
- WUXCHQZLUHBSDJ-LKXGYXEUSA-N Ser-Thr-Asp Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(O)=O)C(O)=O WUXCHQZLUHBSDJ-LKXGYXEUSA-N 0.000 description 3
- FHXGMDRKJHKLKW-QWRGUYRKSA-N Ser-Tyr-Gly Chemical compound OC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 FHXGMDRKJHKLKW-QWRGUYRKSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- AQAMPXBRJJWPNI-JHEQGTHGSA-N Thr-Gly-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O AQAMPXBRJJWPNI-JHEQGTHGSA-N 0.000 description 3
- XPNSAQMEAVSQRD-FBCQKBJTSA-N Thr-Gly-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)NCC(=O)NCC(O)=O XPNSAQMEAVSQRD-FBCQKBJTSA-N 0.000 description 3
- BVOVIGCHYNFJBZ-JXUBOQSCSA-N Thr-Leu-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O BVOVIGCHYNFJBZ-JXUBOQSCSA-N 0.000 description 3
- WPSKTVVMQCXPRO-BWBBJGPYSA-N Thr-Ser-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WPSKTVVMQCXPRO-BWBBJGPYSA-N 0.000 description 3
- VLDMQVZZWDOKQF-AUTRQRHGSA-N Val-Glu-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N VLDMQVZZWDOKQF-AUTRQRHGSA-N 0.000 description 3
- ZRSZTKTVPNSUNA-IHRRRGAJSA-N Val-Lys-Leu Chemical compound CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(O)=O ZRSZTKTVPNSUNA-IHRRRGAJSA-N 0.000 description 3
- QTPQHINADBYBNA-DCAQKATOSA-N Val-Ser-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN QTPQHINADBYBNA-DCAQKATOSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 108010068380 arginylarginine Proteins 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000000601 blood cell Anatomy 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 230000002759 chromosomal effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 239000008121 dextrose Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- 238000012377 drug delivery Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 208000030533 eye disease Diseases 0.000 description 3
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 3
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 3
- 108010074027 glycyl-seryl-phenylalanine Proteins 0.000 description 3
- 108010089804 glycyl-threonine Proteins 0.000 description 3
- 108010037850 glycylvaline Proteins 0.000 description 3
- 239000005090 green fluorescent protein Substances 0.000 description 3
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 108010044311 leucyl-glycyl-glycine Proteins 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 108010068488 methionylphenylalanine Proteins 0.000 description 3
- 239000002480 mineral oil Substances 0.000 description 3
- 235000010446 mineral oil Nutrition 0.000 description 3
- 239000003068 molecular probe Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000000312 peanut oil Substances 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 210000001210 retinal vessel Anatomy 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 238000013268 sustained release Methods 0.000 description 3
- 239000012730 sustained-release form Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- QEQDLKUMPUDNPG-UHFFFAOYSA-N 2-(7-amino-4-methyl-2-oxochromen-3-yl)acetic acid Chemical compound C1=C(N)C=CC2=C1OC(=O)C(CC(O)=O)=C2C QEQDLKUMPUDNPG-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- 241000649045 Adeno-associated virus 10 Species 0.000 description 2
- 241000649046 Adeno-associated virus 11 Species 0.000 description 2
- 241000649047 Adeno-associated virus 12 Species 0.000 description 2
- 241000300529 Adeno-associated virus 13 Species 0.000 description 2
- YYSWCHMLFJLLBJ-ZLUOBGJFSA-N Ala-Ala-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YYSWCHMLFJLLBJ-ZLUOBGJFSA-N 0.000 description 2
- XCVRVWZTXPCYJT-BIIVOSGPSA-N Ala-Asn-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N XCVRVWZTXPCYJT-BIIVOSGPSA-N 0.000 description 2
- OBVSBEYOMDWLRJ-BFHQHQDPSA-N Ala-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N OBVSBEYOMDWLRJ-BFHQHQDPSA-N 0.000 description 2
- VHVVPYOJIIQCKS-QEJZJMRPSA-N Ala-Leu-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 VHVVPYOJIIQCKS-QEJZJMRPSA-N 0.000 description 2
- VCSABYLVNWQYQE-UHFFFAOYSA-N Ala-Lys-Lys Natural products NCCCCC(NC(=O)C(N)C)C(=O)NC(CCCCN)C(O)=O VCSABYLVNWQYQE-UHFFFAOYSA-N 0.000 description 2
- RAAWHFXHAACDFT-FXQIFTODSA-N Ala-Met-Asn Chemical compound CSCC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(N)=O)C(O)=O RAAWHFXHAACDFT-FXQIFTODSA-N 0.000 description 2
- KLALXKYLOMZDQT-ZLUOBGJFSA-N Ala-Ser-Asn Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(N)=O KLALXKYLOMZDQT-ZLUOBGJFSA-N 0.000 description 2
- YYAVDNKUWLAFCV-ACZMJKKPSA-N Ala-Ser-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O YYAVDNKUWLAFCV-ACZMJKKPSA-N 0.000 description 2
- RTZCUEHYUQZIDE-WHFBIAKZSA-N Ala-Ser-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O RTZCUEHYUQZIDE-WHFBIAKZSA-N 0.000 description 2
- HOVPGJUNRLMIOZ-CIUDSAMLSA-N Ala-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)N HOVPGJUNRLMIOZ-CIUDSAMLSA-N 0.000 description 2
- ARHJJAAWNWOACN-FXQIFTODSA-N Ala-Ser-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O ARHJJAAWNWOACN-FXQIFTODSA-N 0.000 description 2
- IYKVSFNGSWTTNZ-GUBZILKMSA-N Ala-Val-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IYKVSFNGSWTTNZ-GUBZILKMSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- JGDGLDNAQJJGJI-AVGNSLFASA-N Arg-Arg-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)N JGDGLDNAQJJGJI-AVGNSLFASA-N 0.000 description 2
- PVSNBTCXCQIXSE-JYJNAYRXSA-N Arg-Arg-Phe Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 PVSNBTCXCQIXSE-JYJNAYRXSA-N 0.000 description 2
- FEZJJKXNPSEYEV-CIUDSAMLSA-N Arg-Gln-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O FEZJJKXNPSEYEV-CIUDSAMLSA-N 0.000 description 2
- BEXGZLUHRXTZCC-CIUDSAMLSA-N Arg-Gln-Ser Chemical compound C(C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N)CN=C(N)N BEXGZLUHRXTZCC-CIUDSAMLSA-N 0.000 description 2
- GSUFZRURORXYTM-STQMWFEESA-N Arg-Phe-Gly Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=CC=C1 GSUFZRURORXYTM-STQMWFEESA-N 0.000 description 2
- DNBMCNQKNOKOSD-DCAQKATOSA-N Arg-Pro-Gln Chemical compound NC(N)=NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O DNBMCNQKNOKOSD-DCAQKATOSA-N 0.000 description 2
- DNLQVHBBMPZUGJ-BQBZGAKWSA-N Arg-Ser-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O DNLQVHBBMPZUGJ-BQBZGAKWSA-N 0.000 description 2
- KMFPQTITXUKJOV-DCAQKATOSA-N Arg-Ser-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O KMFPQTITXUKJOV-DCAQKATOSA-N 0.000 description 2
- KEZVOBAKAXHMOF-GUBZILKMSA-N Arg-Val-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCN=C(N)N KEZVOBAKAXHMOF-GUBZILKMSA-N 0.000 description 2
- OOWSBIOUKIUWLO-RCOVLWMOSA-N Asn-Gly-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O OOWSBIOUKIUWLO-RCOVLWMOSA-N 0.000 description 2
- MYVBTYXSWILFCG-BQBZGAKWSA-N Asn-Met-Gly Chemical compound CSCC[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CC(=O)N)N MYVBTYXSWILFCG-BQBZGAKWSA-N 0.000 description 2
- BYLSYQASFJJBCL-DCAQKATOSA-N Asn-Pro-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O BYLSYQASFJJBCL-DCAQKATOSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- DCJNIJAWIRPPBB-CIUDSAMLSA-N Cys-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CS)N DCJNIJAWIRPPBB-CIUDSAMLSA-N 0.000 description 2
- FIADUEYFRSCCIK-CIUDSAMLSA-N Cys-Glu-Arg Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O FIADUEYFRSCCIK-CIUDSAMLSA-N 0.000 description 2
- DQUWSUWXPWGTQT-DCAQKATOSA-N Cys-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CS DQUWSUWXPWGTQT-DCAQKATOSA-N 0.000 description 2
- 102100039259 Cytochrome c oxidase subunit 8A, mitochondrial Human genes 0.000 description 2
- 241000701022 Cytomegalovirus Species 0.000 description 2
- 230000004543 DNA replication Effects 0.000 description 2
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 208000003098 Ganglion Cysts Diseases 0.000 description 2
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 2
- KWUSGAIFNHQCBY-DCAQKATOSA-N Gln-Arg-Arg Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O KWUSGAIFNHQCBY-DCAQKATOSA-N 0.000 description 2
- ZPDVKYLJTOFQJV-WDSKDSINSA-N Gln-Asn-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O ZPDVKYLJTOFQJV-WDSKDSINSA-N 0.000 description 2
- SNLOOPZHAQDMJG-CIUDSAMLSA-N Gln-Glu-Glu Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O SNLOOPZHAQDMJG-CIUDSAMLSA-N 0.000 description 2
- BYKZWDGMJLNFJY-XKBZYTNZSA-N Gln-Ser-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N)N)O BYKZWDGMJLNFJY-XKBZYTNZSA-N 0.000 description 2
- OTQSTOXRUBVWAP-NRPADANISA-N Gln-Ser-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O OTQSTOXRUBVWAP-NRPADANISA-N 0.000 description 2
- SVZIKUHLRKVZIF-GUBZILKMSA-N Glu-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N SVZIKUHLRKVZIF-GUBZILKMSA-N 0.000 description 2
- VGBSZQSKQRMLHD-MNXVOIDGSA-N Glu-Leu-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VGBSZQSKQRMLHD-MNXVOIDGSA-N 0.000 description 2
- GMVCSRBOSIUTFC-FXQIFTODSA-N Glu-Ser-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O GMVCSRBOSIUTFC-FXQIFTODSA-N 0.000 description 2
- WGYHAAXZWPEBDQ-IFFSRLJSSA-N Glu-Val-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WGYHAAXZWPEBDQ-IFFSRLJSSA-N 0.000 description 2
- XTQFHTHIAKKCTM-YFKPBYRVSA-N Gly-Glu-Gly Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O XTQFHTHIAKKCTM-YFKPBYRVSA-N 0.000 description 2
- XPJBQTCXPJNIFE-ZETCQYMHSA-N Gly-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)CN XPJBQTCXPJNIFE-ZETCQYMHSA-N 0.000 description 2
- FQKKPCWTZZEDIC-XPUUQOCRSA-N Gly-His-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 FQKKPCWTZZEDIC-XPUUQOCRSA-N 0.000 description 2
- ITZOBNKQDZEOCE-NHCYSSNCSA-N Gly-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)CN ITZOBNKQDZEOCE-NHCYSSNCSA-N 0.000 description 2
- PAWIVEIWWYGBAM-YUMQZZPRSA-N Gly-Leu-Ala Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O PAWIVEIWWYGBAM-YUMQZZPRSA-N 0.000 description 2
- GMTXWRIDLGTVFC-IUCAKERBSA-N Gly-Lys-Glu Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O GMTXWRIDLGTVFC-IUCAKERBSA-N 0.000 description 2
- ZWRDOVYMQAAISL-UWVGGRQHSA-N Gly-Met-Lys Chemical compound CSCC[C@H](NC(=O)CN)C(=O)N[C@H](C(O)=O)CCCCN ZWRDOVYMQAAISL-UWVGGRQHSA-N 0.000 description 2
- YOBGUCWZPXJHTN-BQBZGAKWSA-N Gly-Ser-Arg Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YOBGUCWZPXJHTN-BQBZGAKWSA-N 0.000 description 2
- OHUKZZYSJBKFRR-WHFBIAKZSA-N Gly-Ser-Asp Chemical compound [H]NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O OHUKZZYSJBKFRR-WHFBIAKZSA-N 0.000 description 2
- CUVBTVWFVIIDOC-YEPSODPASA-N Gly-Thr-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)CN CUVBTVWFVIIDOC-YEPSODPASA-N 0.000 description 2
- NGRPGJGKJMUGDM-XVKPBYJWSA-N Gly-Val-Gln Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O NGRPGJGKJMUGDM-XVKPBYJWSA-N 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- MBSSHYPAEHPSGY-LSJOCFKGSA-N His-Ala-Met Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(O)=O MBSSHYPAEHPSGY-LSJOCFKGSA-N 0.000 description 2
- YAALVYQFVJNXIV-KKUMJFAQSA-N His-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CN=CN1 YAALVYQFVJNXIV-KKUMJFAQSA-N 0.000 description 2
- PYNPBMCLAKTHJL-SRVKXCTJSA-N His-Pro-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O PYNPBMCLAKTHJL-SRVKXCTJSA-N 0.000 description 2
- XIGFLVCAVQQGNS-IHRRRGAJSA-N His-Pro-His Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CN=CN1 XIGFLVCAVQQGNS-IHRRRGAJSA-N 0.000 description 2
- PZAJPILZRFPYJJ-SRVKXCTJSA-N His-Ser-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O PZAJPILZRFPYJJ-SRVKXCTJSA-N 0.000 description 2
- GIRSNERMXCMDBO-GARJFASQSA-N His-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CC2=CN=CN2)N)C(=O)O GIRSNERMXCMDBO-GARJFASQSA-N 0.000 description 2
- 101000745956 Homo sapiens Cytochrome c oxidase subunit 8A, mitochondrial Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- QYZYJFXHXYUZMZ-UGYAYLCHSA-N Ile-Asn-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N QYZYJFXHXYUZMZ-UGYAYLCHSA-N 0.000 description 2
- LWWILHPVAKKLQS-QXEWZRGKSA-N Ile-Gly-Met Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CCSC)C(=O)O)N LWWILHPVAKKLQS-QXEWZRGKSA-N 0.000 description 2
- KEKTTYCXKGBAAL-VGDYDELISA-N Ile-His-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CO)C(=O)O)N KEKTTYCXKGBAAL-VGDYDELISA-N 0.000 description 2
- PXKACEXYLPBMAD-JBDRJPRFSA-N Ile-Ser-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PXKACEXYLPBMAD-JBDRJPRFSA-N 0.000 description 2
- CNMOKANDJMLAIF-CIQUZCHMSA-N Ile-Thr-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O CNMOKANDJMLAIF-CIQUZCHMSA-N 0.000 description 2
- KBDIBHQICWDGDL-PPCPHDFISA-N Ile-Thr-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)O)N KBDIBHQICWDGDL-PPCPHDFISA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 108010065920 Insulin Lispro Proteins 0.000 description 2
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 2
- IBMVEYRWAWIOTN-UHFFFAOYSA-N L-Leucyl-L-Arginyl-L-Proline Natural products CC(C)CC(N)C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(O)=O IBMVEYRWAWIOTN-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- WGNOPSQMIQERPK-GARJFASQSA-N Leu-Asn-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N WGNOPSQMIQERPK-GARJFASQSA-N 0.000 description 2
- WGNOPSQMIQERPK-UHFFFAOYSA-N Leu-Asn-Pro Natural products CC(C)CC(N)C(=O)NC(CC(=O)N)C(=O)N1CCCC1C(=O)O WGNOPSQMIQERPK-UHFFFAOYSA-N 0.000 description 2
- PNUCWVAGVNLUMW-CIUDSAMLSA-N Leu-Cys-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O PNUCWVAGVNLUMW-CIUDSAMLSA-N 0.000 description 2
- DLCXCECTCPKKCD-GUBZILKMSA-N Leu-Gln-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O DLCXCECTCPKKCD-GUBZILKMSA-N 0.000 description 2
- HYMLKESRWLZDBR-WEDXCCLWSA-N Leu-Gly-Thr Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O HYMLKESRWLZDBR-WEDXCCLWSA-N 0.000 description 2
- UBZGNBKMIJHOHL-BZSNNMDCSA-N Leu-Leu-Phe Chemical compound CC(C)C[C@H]([NH3+])C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C([O-])=O)CC1=CC=CC=C1 UBZGNBKMIJHOHL-BZSNNMDCSA-N 0.000 description 2
- YWKNKRAKOCLOLH-OEAJRASXSA-N Leu-Phe-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(O)=O)CC1=CC=CC=C1 YWKNKRAKOCLOLH-OEAJRASXSA-N 0.000 description 2
- QMKFDEUJGYNFMC-AVGNSLFASA-N Leu-Pro-Arg Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O QMKFDEUJGYNFMC-AVGNSLFASA-N 0.000 description 2
- KWLWZYMNUZJKMZ-IHRRRGAJSA-N Leu-Pro-Leu Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O KWLWZYMNUZJKMZ-IHRRRGAJSA-N 0.000 description 2
- DPURXCQCHSQPAN-AVGNSLFASA-N Leu-Pro-Pro Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DPURXCQCHSQPAN-AVGNSLFASA-N 0.000 description 2
- IRMLZWSRWSGTOP-CIUDSAMLSA-N Leu-Ser-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O IRMLZWSRWSGTOP-CIUDSAMLSA-N 0.000 description 2
- GZRABTMNWJXFMH-UVOCVTCTSA-N Leu-Thr-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GZRABTMNWJXFMH-UVOCVTCTSA-N 0.000 description 2
- QESXLSQLQHHTIX-RHYQMDGZSA-N Leu-Val-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QESXLSQLQHHTIX-RHYQMDGZSA-N 0.000 description 2
- IVFUVMSKSFSFBT-NHCYSSNCSA-N Lys-Ile-Gly Chemical compound OC(=O)CNC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCCCN IVFUVMSKSFSFBT-NHCYSSNCSA-N 0.000 description 2
- OVAOHZIOUBEQCJ-IHRRRGAJSA-N Lys-Leu-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O OVAOHZIOUBEQCJ-IHRRRGAJSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- GAELMDJMQDUDLJ-BQBZGAKWSA-N Met-Ala-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O GAELMDJMQDUDLJ-BQBZGAKWSA-N 0.000 description 2
- LQMHZERGCQJKAH-STQMWFEESA-N Met-Gly-Phe Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 LQMHZERGCQJKAH-STQMWFEESA-N 0.000 description 2
- CNTNPWWHFWAZGA-JYJNAYRXSA-N Met-Met-Phe Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 CNTNPWWHFWAZGA-JYJNAYRXSA-N 0.000 description 2
- UZBQXELAFPCGRV-SZMVWBNQSA-N Met-Trp-Arg Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O UZBQXELAFPCGRV-SZMVWBNQSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 108020005196 Mitochondrial DNA Proteins 0.000 description 2
- HSHXDCVZWHOWCS-UHFFFAOYSA-N N'-hexadecylthiophene-2-carbohydrazide Chemical compound CCCCCCCCCCCCCCCCNNC(=O)c1cccs1 HSHXDCVZWHOWCS-UHFFFAOYSA-N 0.000 description 2
- XZFYRXDAULDNFX-UHFFFAOYSA-N N-L-cysteinyl-L-phenylalanine Natural products SCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XZFYRXDAULDNFX-UHFFFAOYSA-N 0.000 description 2
- 101710106575 NADH-ubiquinone oxidoreductase chain 1 Proteins 0.000 description 2
- 101710106566 NADH-ubiquinone oxidoreductase chain 6 Proteins 0.000 description 2
- 208000028389 Nerve injury Diseases 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- JEGFCFLCRSJCMA-IHRRRGAJSA-N Phe-Arg-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)O)N JEGFCFLCRSJCMA-IHRRRGAJSA-N 0.000 description 2
- APJPXSFJBMMOLW-KBPBESRZSA-N Phe-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 APJPXSFJBMMOLW-KBPBESRZSA-N 0.000 description 2
- GPSMLZQVIIYLDK-ULQDDVLXSA-N Phe-Lys-Val Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O GPSMLZQVIIYLDK-ULQDDVLXSA-N 0.000 description 2
- SZYBZVANEAOIPE-UBHSHLNASA-N Phe-Met-Ala Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(O)=O SZYBZVANEAOIPE-UBHSHLNASA-N 0.000 description 2
- IEOHQGFKHXUALJ-JYJNAYRXSA-N Phe-Met-Arg Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O IEOHQGFKHXUALJ-JYJNAYRXSA-N 0.000 description 2
- RBRNEFJTEHPDSL-ACRUOGEOSA-N Phe-Phe-Lys Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 RBRNEFJTEHPDSL-ACRUOGEOSA-N 0.000 description 2
- IIEOLPMQYRBZCN-SRVKXCTJSA-N Phe-Ser-Cys Chemical compound N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O IIEOLPMQYRBZCN-SRVKXCTJSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- CGBYDGAJHSOGFQ-LPEHRKFASA-N Pro-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 CGBYDGAJHSOGFQ-LPEHRKFASA-N 0.000 description 2
- HFZNNDWPHBRNPV-KZVJFYERSA-N Pro-Ala-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O HFZNNDWPHBRNPV-KZVJFYERSA-N 0.000 description 2
- OOLOTUZJUBOMAX-GUBZILKMSA-N Pro-Ala-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O OOLOTUZJUBOMAX-GUBZILKMSA-N 0.000 description 2
- ORPZXBQTEHINPB-SRVKXCTJSA-N Pro-Arg-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1)C(O)=O ORPZXBQTEHINPB-SRVKXCTJSA-N 0.000 description 2
- XZONQWUEBAFQPO-HJGDQZAQSA-N Pro-Gln-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XZONQWUEBAFQPO-HJGDQZAQSA-N 0.000 description 2
- NXEYSLRNNPWCRN-SRVKXCTJSA-N Pro-Glu-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NXEYSLRNNPWCRN-SRVKXCTJSA-N 0.000 description 2
- JMVQDLDPDBXAAX-YUMQZZPRSA-N Pro-Gly-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 JMVQDLDPDBXAAX-YUMQZZPRSA-N 0.000 description 2
- WSRWHZRUOCACLJ-UWVGGRQHSA-N Pro-Gly-His Chemical compound C([C@@H](C(=O)O)NC(=O)CNC(=O)[C@H]1NCCC1)C1=CN=CN1 WSRWHZRUOCACLJ-UWVGGRQHSA-N 0.000 description 2
- DXTOOBDIIAJZBJ-BQBZGAKWSA-N Pro-Gly-Ser Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(O)=O DXTOOBDIIAJZBJ-BQBZGAKWSA-N 0.000 description 2
- LXLFEIHKWGHJJB-XUXIUFHCSA-N Pro-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@@H]1CCCN1 LXLFEIHKWGHJJB-XUXIUFHCSA-N 0.000 description 2
- GURGCNUWVSDYTP-SRVKXCTJSA-N Pro-Leu-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O GURGCNUWVSDYTP-SRVKXCTJSA-N 0.000 description 2
- MRYUJHGPZQNOAD-IHRRRGAJSA-N Pro-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@@H]1CCCN1 MRYUJHGPZQNOAD-IHRRRGAJSA-N 0.000 description 2
- FKYKZHOKDOPHSA-DCAQKATOSA-N Pro-Leu-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O FKYKZHOKDOPHSA-DCAQKATOSA-N 0.000 description 2
- LZHHZYDPMZEMRX-STQMWFEESA-N Pro-Tyr-Gly Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(O)=O LZHHZYDPMZEMRX-STQMWFEESA-N 0.000 description 2
- FHJQROWZEJFZPO-SRVKXCTJSA-N Pro-Val-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 FHJQROWZEJFZPO-SRVKXCTJSA-N 0.000 description 2
- 108010003201 RGH 0205 Proteins 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 108091028664 Ribonucleotide Proteins 0.000 description 2
- QFBNNYNWKYKVJO-DCAQKATOSA-N Ser-Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CCCN=C(N)N QFBNNYNWKYKVJO-DCAQKATOSA-N 0.000 description 2
- OYEDZGNMSBZCIM-XGEHTFHBSA-N Ser-Arg-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OYEDZGNMSBZCIM-XGEHTFHBSA-N 0.000 description 2
- GHPQVUYZQQGEDA-BIIVOSGPSA-N Ser-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)N)C(=O)O GHPQVUYZQQGEDA-BIIVOSGPSA-N 0.000 description 2
- IOVHBRCQOGWAQH-ZKWXMUAHSA-N Ser-Gly-Ile Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O IOVHBRCQOGWAQH-ZKWXMUAHSA-N 0.000 description 2
- FUMGHWDRRFCKEP-CIUDSAMLSA-N Ser-Leu-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O FUMGHWDRRFCKEP-CIUDSAMLSA-N 0.000 description 2
- KCGIREHVWRXNDH-GARJFASQSA-N Ser-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N KCGIREHVWRXNDH-GARJFASQSA-N 0.000 description 2
- GDUZTEQRAOXYJS-SRVKXCTJSA-N Ser-Phe-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CO)N GDUZTEQRAOXYJS-SRVKXCTJSA-N 0.000 description 2
- FBLNYDYPCLFTSP-IXOXFDKPSA-N Ser-Phe-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FBLNYDYPCLFTSP-IXOXFDKPSA-N 0.000 description 2
- SRSPTFBENMJHMR-WHFBIAKZSA-N Ser-Ser-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SRSPTFBENMJHMR-WHFBIAKZSA-N 0.000 description 2
- NADLKBTYNKUJEP-KATARQTJSA-N Ser-Thr-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O NADLKBTYNKUJEP-KATARQTJSA-N 0.000 description 2
- LSHUNRICNSEEAN-BPUTZDHNSA-N Ser-Val-Trp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CO)N LSHUNRICNSEEAN-BPUTZDHNSA-N 0.000 description 2
- 108020004682 Single-Stranded DNA Proteins 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 208000005400 Synovial Cyst Diseases 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- OYTNZCBFDXGQGE-XQXXSGGOSA-N Thr-Gln-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)O)N)O OYTNZCBFDXGQGE-XQXXSGGOSA-N 0.000 description 2
- KRGDDWVBBDLPSJ-CUJWVEQBSA-N Thr-His-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O KRGDDWVBBDLPSJ-CUJWVEQBSA-N 0.000 description 2
- FLPZMPOZGYPBEN-PPCPHDFISA-N Thr-Leu-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FLPZMPOZGYPBEN-PPCPHDFISA-N 0.000 description 2
- MECLEFZMPPOEAC-VOAKCMCISA-N Thr-Leu-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N)O MECLEFZMPPOEAC-VOAKCMCISA-N 0.000 description 2
- YOOAQCZYZHGUAZ-KATARQTJSA-N Thr-Leu-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YOOAQCZYZHGUAZ-KATARQTJSA-N 0.000 description 2
- ABWNZPOIUJMNKT-IXOXFDKPSA-N Thr-Phe-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O ABWNZPOIUJMNKT-IXOXFDKPSA-N 0.000 description 2
- IQPWNQRRAJHOKV-KATARQTJSA-N Thr-Ser-Lys Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN IQPWNQRRAJHOKV-KATARQTJSA-N 0.000 description 2
- CCZXBOFIBYQLEV-IHPCNDPISA-N Trp-Leu-Leu Chemical compound CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(O)=O CCZXBOFIBYQLEV-IHPCNDPISA-N 0.000 description 2
- ZWZOCUWOXSDYFZ-CQDKDKBSSA-N Tyr-Ala-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 ZWZOCUWOXSDYFZ-CQDKDKBSSA-N 0.000 description 2
- OLWFDNLLBWQWCP-STQMWFEESA-N Tyr-Gly-Met Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](CCSC)C(O)=O OLWFDNLLBWQWCP-STQMWFEESA-N 0.000 description 2
- KSCVLGXNQXKUAR-JYJNAYRXSA-N Tyr-Leu-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O KSCVLGXNQXKUAR-JYJNAYRXSA-N 0.000 description 2
- SBLZVFCEOCWRLS-BPNCWPANSA-N Tyr-Met-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC1=CC=C(C=C1)O)N SBLZVFCEOCWRLS-BPNCWPANSA-N 0.000 description 2
- WTTRJMAZPDHPGS-KKXDTOCCSA-N Tyr-Phe-Ala Chemical compound C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O WTTRJMAZPDHPGS-KKXDTOCCSA-N 0.000 description 2
- KLQPIEVIKOQRAW-IZPVPAKOSA-N Tyr-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N)O KLQPIEVIKOQRAW-IZPVPAKOSA-N 0.000 description 2
- IZFVRRYRMQFVGX-NRPADANISA-N Val-Ala-Gln Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N IZFVRRYRMQFVGX-NRPADANISA-N 0.000 description 2
- HNWQUBBOBKSFQV-AVGNSLFASA-N Val-Arg-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N HNWQUBBOBKSFQV-AVGNSLFASA-N 0.000 description 2
- PIFJAFRUVWZRKR-QMMMGPOBSA-N Val-Gly-Gly Chemical compound CC(C)[C@H]([NH3+])C(=O)NCC(=O)NCC([O-])=O PIFJAFRUVWZRKR-QMMMGPOBSA-N 0.000 description 2
- URIRWLJVWHYLET-ONGXEEELSA-N Val-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)C(C)C URIRWLJVWHYLET-ONGXEEELSA-N 0.000 description 2
- CPGJELLYDQEDRK-NAKRPEOUSA-N Val-Ile-Ala Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(O)=O CPGJELLYDQEDRK-NAKRPEOUSA-N 0.000 description 2
- AEMPCGRFEZTWIF-IHRRRGAJSA-N Val-Leu-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O AEMPCGRFEZTWIF-IHRRRGAJSA-N 0.000 description 2
- IJGPOONOTBNTFS-GVXVVHGQSA-N Val-Lys-Glu Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O IJGPOONOTBNTFS-GVXVVHGQSA-N 0.000 description 2
- HJSLDXZAZGFPDK-ULQDDVLXSA-N Val-Phe-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N HJSLDXZAZGFPDK-ULQDDVLXSA-N 0.000 description 2
- VSCIANXXVZOYOC-AVGNSLFASA-N Val-Pro-His Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N VSCIANXXVZOYOC-AVGNSLFASA-N 0.000 description 2
- RYHUIHUOYRNNIE-NRPADANISA-N Val-Ser-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N RYHUIHUOYRNNIE-NRPADANISA-N 0.000 description 2
- VBTFUDNTMCHPII-UHFFFAOYSA-N Val-Trp-Tyr Natural products C=1NC2=CC=CC=C2C=1CC(NC(=O)C(N)C(C)C)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 VBTFUDNTMCHPII-UHFFFAOYSA-N 0.000 description 2
- GTACFKZDQFTVAI-STECZYCISA-N Val-Tyr-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)CC1=CC=C(O)C=C1 GTACFKZDQFTVAI-STECZYCISA-N 0.000 description 2
- JVGDAEKKZKKZFO-RCWTZXSCSA-N Val-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N)O JVGDAEKKZKKZFO-RCWTZXSCSA-N 0.000 description 2
- 108010081404 acein-2 Proteins 0.000 description 2
- RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 108010069020 alanyl-prolyl-glycine Proteins 0.000 description 2
- 108010004469 allophycocyanin Proteins 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 108010013835 arginine glutamate Proteins 0.000 description 2
- 108010008355 arginyl-glutamine Proteins 0.000 description 2
- 108010069926 arginyl-glycyl-serine Proteins 0.000 description 2
- 108010043240 arginyl-leucyl-glycine Proteins 0.000 description 2
- 238000000149 argon plasma sintering Methods 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 108010038633 aspartylglutamate Proteins 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 229920002988 biodegradable polymer Polymers 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 239000012888 bovine serum Substances 0.000 description 2
- 239000008366 buffered solution Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- OSQPUMRCKZAIOZ-UHFFFAOYSA-N carbon dioxide;ethanol Chemical compound CCO.O=C=O OSQPUMRCKZAIOZ-UHFFFAOYSA-N 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 150000005829 chemical entities Chemical class 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229960004926 chlorobutanol Drugs 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000013270 controlled release Methods 0.000 description 2
- 239000006184 cosolvent Substances 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000001212 derivatisation Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 2
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000003889 eye drop Substances 0.000 description 2
- 229940012356 eye drops Drugs 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000000684 flow cytometry Methods 0.000 description 2
- 108020001507 fusion proteins Proteins 0.000 description 2
- 102000037865 fusion proteins Human genes 0.000 description 2
- 238000001415 gene therapy Methods 0.000 description 2
- 238000003205 genotyping method Methods 0.000 description 2
- 108010026364 glycyl-glycyl-leucine Proteins 0.000 description 2
- 108010079413 glycyl-prolyl-glutamic acid Proteins 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 2
- 108010085325 histidylproline Proteins 0.000 description 2
- 210000003917 human chromosome Anatomy 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 108010027338 isoleucylcysteine Proteins 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 108010044056 leucyl-phenylalanine Proteins 0.000 description 2
- 108010073472 leucyl-prolyl-proline Proteins 0.000 description 2
- 238000007834 ligase chain reaction Methods 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 108010025153 lysyl-alanyl-alanine Proteins 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000002077 nanosphere Substances 0.000 description 2
- 230000008764 nerve damage Effects 0.000 description 2
- 210000000440 neutrophil Anatomy 0.000 description 2
- 210000004940 nucleus Anatomy 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- RDOWQLZANAYVLL-UHFFFAOYSA-N phenanthridine Chemical compound C1=CC=C2C3=CC=CC=C3C=NC2=C1 RDOWQLZANAYVLL-UHFFFAOYSA-N 0.000 description 2
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 2
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
- 230000008488 polyadenylation Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 102000054765 polymorphisms of proteins Human genes 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
- 239000002096 quantum dot Substances 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 238000010188 recombinant method Methods 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 210000003994 retinal ganglion cell Anatomy 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
- 239000002336 ribonucleotide Substances 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000008159 sesame oil Substances 0.000 description 2
- 235000011803 sesame oil Nutrition 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 239000008174 sterile solution Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- WGTODYJZXSJIAG-UHFFFAOYSA-N tetramethylrhodamine chloride Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C(O)=O WGTODYJZXSJIAG-UHFFFAOYSA-N 0.000 description 2
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 2
- 108010072986 threonyl-seryl-lysine Proteins 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 238000010361 transduction Methods 0.000 description 2
- 230000026683 transduction Effects 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 108010017949 tyrosyl-glycyl-glycine Proteins 0.000 description 2
- 108010003137 tyrosyltyrosine Proteins 0.000 description 2
- 230000004304 visual acuity Effects 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 1
- QRXMUCSWCMTJGU-UHFFFAOYSA-L (5-bromo-4-chloro-1h-indol-3-yl) phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP([O-])(=O)[O-])=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-L 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 1
- KKTUQAYCCLMNOA-UHFFFAOYSA-N 2,3-diaminobenzoic acid Chemical compound NC1=CC=CC(C(O)=O)=C1N KKTUQAYCCLMNOA-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- IOOMXAQUNPWDLL-UHFFFAOYSA-N 2-[6-(diethylamino)-3-(diethyliminiumyl)-3h-xanthen-9-yl]-5-sulfobenzene-1-sulfonate Chemical compound C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S(O)(=O)=O)C=C1S([O-])(=O)=O IOOMXAQUNPWDLL-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- NOIIUHRQUVNIDD-UHFFFAOYSA-N 3-[[oxo(pyridin-4-yl)methyl]hydrazo]-N-(phenylmethyl)propanamide Chemical compound C=1C=CC=CC=1CNC(=O)CCNNC(=O)C1=CC=NC=C1 NOIIUHRQUVNIDD-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- VIIIJFZJKFXOGG-UHFFFAOYSA-N 3-methylchromen-2-one Chemical compound C1=CC=C2OC(=O)C(C)=CC2=C1 VIIIJFZJKFXOGG-UHFFFAOYSA-N 0.000 description 1
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- 108020003589 5' Untranslated Regions Proteins 0.000 description 1
- BPVHBBXCESDRKW-UHFFFAOYSA-N 5(6)-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C21OC(=O)C1=CC(C(=O)O)=CC=C21.C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BPVHBBXCESDRKW-UHFFFAOYSA-N 0.000 description 1
- BGWLYQZDNFIFRX-UHFFFAOYSA-N 5-[3-[2-[3-(3,8-diamino-6-phenylphenanthridin-5-ium-5-yl)propylamino]ethylamino]propyl]-6-phenylphenanthridin-5-ium-3,8-diamine;dichloride Chemical compound [Cl-].[Cl-].C=1C(N)=CC=C(C2=CC=C(N)C=C2[N+]=2CCCNCCNCCC[N+]=3C4=CC(N)=CC=C4C4=CC=C(N)C=C4C=3C=3C=CC=CC=3)C=1C=2C1=CC=CC=C1 BGWLYQZDNFIFRX-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- XYJODUBPWNZLML-UHFFFAOYSA-N 5-ethyl-6-phenyl-6h-phenanthridine-3,8-diamine Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2N(CC)C1C1=CC=CC=C1 XYJODUBPWNZLML-UHFFFAOYSA-N 0.000 description 1
- DBMJYWPMRSOUGB-UHFFFAOYSA-N 5-hexyl-6-phenylphenanthridin-5-ium-3,8-diamine;iodide Chemical compound [I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCCCCC)=C1C1=CC=CC=C1 DBMJYWPMRSOUGB-UHFFFAOYSA-N 0.000 description 1
- IHHSSHCBRVYGJX-UHFFFAOYSA-N 6-chloro-2-methoxyacridin-9-amine Chemical compound C1=C(Cl)C=CC2=C(N)C3=CC(OC)=CC=C3N=C21 IHHSSHCBRVYGJX-UHFFFAOYSA-N 0.000 description 1
- WHCPTFFIERCDSB-UHFFFAOYSA-N 7-(diethylamino)-2-oxochromene-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)OC2=CC(N(CC)CC)=CC=C21 WHCPTFFIERCDSB-UHFFFAOYSA-N 0.000 description 1
- 108700012813 7-aminoactinomycin D Proteins 0.000 description 1
- YXHLJMWYDTXDHS-IRFLANFNSA-N 7-aminoactinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=C(N)C=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 YXHLJMWYDTXDHS-IRFLANFNSA-N 0.000 description 1
- LKLWLDOUZJEHDY-UHFFFAOYSA-N 7-hydroxy-2-oxochromene-3-carboxylic acid Chemical compound C1=C(O)C=C2OC(=O)C(C(=O)O)=CC2=C1 LKLWLDOUZJEHDY-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- 102000012440 Acetylcholinesterase Human genes 0.000 description 1
- 108010022752 Acetylcholinesterase Proteins 0.000 description 1
- ORILYTVJVMAKLC-UHFFFAOYSA-N Adamantane Natural products C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 description 1
- 101100524317 Adeno-associated virus 2 (isolate Srivastava/1982) Rep40 gene Proteins 0.000 description 1
- 101100524319 Adeno-associated virus 2 (isolate Srivastava/1982) Rep52 gene Proteins 0.000 description 1
- 101100524321 Adeno-associated virus 2 (isolate Srivastava/1982) Rep68 gene Proteins 0.000 description 1
- 101100524324 Adeno-associated virus 2 (isolate Srivastava/1982) Rep78 gene Proteins 0.000 description 1
- 241000958487 Adeno-associated virus 3B Species 0.000 description 1
- FJVAQLJNTSUQPY-CIUDSAMLSA-N Ala-Ala-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN FJVAQLJNTSUQPY-CIUDSAMLSA-N 0.000 description 1
- CXRCVCURMBFFOL-FXQIFTODSA-N Ala-Ala-Pro Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O CXRCVCURMBFFOL-FXQIFTODSA-N 0.000 description 1
- JBGSZRYCXBPWGX-BQBZGAKWSA-N Ala-Arg-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N JBGSZRYCXBPWGX-BQBZGAKWSA-N 0.000 description 1
- IMMKUCQIKKXKNP-DCAQKATOSA-N Ala-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CCCN=C(N)N IMMKUCQIKKXKNP-DCAQKATOSA-N 0.000 description 1
- YAXNATKKPOWVCP-ZLUOBGJFSA-N Ala-Asn-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O YAXNATKKPOWVCP-ZLUOBGJFSA-N 0.000 description 1
- FXKNPWNXPQZLES-ZLUOBGJFSA-N Ala-Asn-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O FXKNPWNXPQZLES-ZLUOBGJFSA-N 0.000 description 1
- LZRNYBIJOSKKRJ-XVYDVKMFSA-N Ala-Asp-His Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N LZRNYBIJOSKKRJ-XVYDVKMFSA-N 0.000 description 1
- OILNWMNBLIHXQK-ZLUOBGJFSA-N Ala-Cys-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O OILNWMNBLIHXQK-ZLUOBGJFSA-N 0.000 description 1
- UQJUGHFKNKGHFQ-VZFHVOOUSA-N Ala-Cys-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(O)=O UQJUGHFKNKGHFQ-VZFHVOOUSA-N 0.000 description 1
- AWAXZRDKUHOPBO-GUBZILKMSA-N Ala-Gln-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O AWAXZRDKUHOPBO-GUBZILKMSA-N 0.000 description 1
- CRWFEKLFPVRPBV-CIUDSAMLSA-N Ala-Gln-Met Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(O)=O CRWFEKLFPVRPBV-CIUDSAMLSA-N 0.000 description 1
- SFNFGFDRYJKZKN-XQXXSGGOSA-N Ala-Gln-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C)N)O SFNFGFDRYJKZKN-XQXXSGGOSA-N 0.000 description 1
- NWVVKQZOVSTDBQ-CIUDSAMLSA-N Ala-Glu-Arg Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NWVVKQZOVSTDBQ-CIUDSAMLSA-N 0.000 description 1
- PAIHPOGPJVUFJY-WDSKDSINSA-N Ala-Glu-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O PAIHPOGPJVUFJY-WDSKDSINSA-N 0.000 description 1
- HXNNRBHASOSVPG-GUBZILKMSA-N Ala-Glu-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O HXNNRBHASOSVPG-GUBZILKMSA-N 0.000 description 1
- XYTNPQNAZREREP-XQXXSGGOSA-N Ala-Glu-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XYTNPQNAZREREP-XQXXSGGOSA-N 0.000 description 1
- MQIGTEQXYCRLGK-BQBZGAKWSA-N Ala-Gly-Pro Chemical compound C[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O MQIGTEQXYCRLGK-BQBZGAKWSA-N 0.000 description 1
- JDIQCVUDDFENPU-ZKWXMUAHSA-N Ala-His-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CNC=N1 JDIQCVUDDFENPU-ZKWXMUAHSA-N 0.000 description 1
- JEPNLGMEZMCFEX-QSFUFRPTSA-N Ala-His-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](C)N JEPNLGMEZMCFEX-QSFUFRPTSA-N 0.000 description 1
- CKLDHDOIYBVUNP-KBIXCLLPSA-N Ala-Ile-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O CKLDHDOIYBVUNP-KBIXCLLPSA-N 0.000 description 1
- CFPQUJZTLUQUTJ-HTFCKZLJSA-N Ala-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](C)N CFPQUJZTLUQUTJ-HTFCKZLJSA-N 0.000 description 1
- LXAARTARZJJCMB-CIQUZCHMSA-N Ala-Ile-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LXAARTARZJJCMB-CIQUZCHMSA-N 0.000 description 1
- QQACQIHVWCVBBR-GVARAGBVSA-N Ala-Ile-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O QQACQIHVWCVBBR-GVARAGBVSA-N 0.000 description 1
- SOBIAADAMRHGKH-CIUDSAMLSA-N Ala-Leu-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O SOBIAADAMRHGKH-CIUDSAMLSA-N 0.000 description 1
- SUHLZMHFRALVSY-YUMQZZPRSA-N Ala-Lys-Gly Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)NCC(O)=O SUHLZMHFRALVSY-YUMQZZPRSA-N 0.000 description 1
- XUCHENWTTBFODJ-FXQIFTODSA-N Ala-Met-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(O)=O XUCHENWTTBFODJ-FXQIFTODSA-N 0.000 description 1
- DWYROCSXOOMOEU-CIUDSAMLSA-N Ala-Met-Glu Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N DWYROCSXOOMOEU-CIUDSAMLSA-N 0.000 description 1
- VEAPAYQQLSEKEM-GUBZILKMSA-N Ala-Met-Met Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(O)=O VEAPAYQQLSEKEM-GUBZILKMSA-N 0.000 description 1
- ZBLQIYPCUWZSRZ-QEJZJMRPSA-N Ala-Phe-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC1=CC=CC=C1 ZBLQIYPCUWZSRZ-QEJZJMRPSA-N 0.000 description 1
- RNHKOQHGYMTHFR-UBHSHLNASA-N Ala-Phe-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC1=CC=CC=C1 RNHKOQHGYMTHFR-UBHSHLNASA-N 0.000 description 1
- CYBJZLQSUJEMAS-LFSVMHDDSA-N Ala-Phe-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C)N)O CYBJZLQSUJEMAS-LFSVMHDDSA-N 0.000 description 1
- SGFBVLBKDSXGAP-GKCIPKSASA-N Ala-Phe-Trp Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)O)N SGFBVLBKDSXGAP-GKCIPKSASA-N 0.000 description 1
- FQNILRVJOJBFFC-FXQIFTODSA-N Ala-Pro-Asp Chemical compound C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)O)N FQNILRVJOJBFFC-FXQIFTODSA-N 0.000 description 1
- XAXHGSOBFPIRFG-LSJOCFKGSA-N Ala-Pro-His Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O XAXHGSOBFPIRFG-LSJOCFKGSA-N 0.000 description 1
- ADSGHMXEAZJJNF-DCAQKATOSA-N Ala-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N ADSGHMXEAZJJNF-DCAQKATOSA-N 0.000 description 1
- XWFWAXPOLRTDFZ-FXQIFTODSA-N Ala-Pro-Ser Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O XWFWAXPOLRTDFZ-FXQIFTODSA-N 0.000 description 1
- HIIJOGIBQXHFKE-HHKYUTTNSA-N Ala-Thr-Ala-Pro Chemical compound C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O HIIJOGIBQXHFKE-HHKYUTTNSA-N 0.000 description 1
- LFFOJBOTZUWINF-ZANVPECISA-N Ala-Trp-Gly Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)C)C(=O)NCC(O)=O)=CNC2=C1 LFFOJBOTZUWINF-ZANVPECISA-N 0.000 description 1
- DHONNEYAZPNGSG-UBHSHLNASA-N Ala-Val-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 DHONNEYAZPNGSG-UBHSHLNASA-N 0.000 description 1
- OMSKGWFGWCQFBD-KZVJFYERSA-N Ala-Val-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OMSKGWFGWCQFBD-KZVJFYERSA-N 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- SGYSTDWPNPKJPP-GUBZILKMSA-N Arg-Ala-Arg Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SGYSTDWPNPKJPP-GUBZILKMSA-N 0.000 description 1
- VKKYFICVTYKFIO-CIUDSAMLSA-N Arg-Ala-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N VKKYFICVTYKFIO-CIUDSAMLSA-N 0.000 description 1
- YFWTXMRJJDNTLM-LSJOCFKGSA-N Arg-Ala-His Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N YFWTXMRJJDNTLM-LSJOCFKGSA-N 0.000 description 1
- YYOVLDPHIJAOSY-DCAQKATOSA-N Arg-Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N YYOVLDPHIJAOSY-DCAQKATOSA-N 0.000 description 1
- DBKNLHKEVPZVQC-LPEHRKFASA-N Arg-Ala-Pro Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@@H]1C(O)=O DBKNLHKEVPZVQC-LPEHRKFASA-N 0.000 description 1
- IJPNNYWHXGADJG-GUBZILKMSA-N Arg-Ala-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O IJPNNYWHXGADJG-GUBZILKMSA-N 0.000 description 1
- YUIGJDNAGKJLDO-JYJNAYRXSA-N Arg-Arg-Tyr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O YUIGJDNAGKJLDO-JYJNAYRXSA-N 0.000 description 1
- DCGLNNVKIZXQOJ-FXQIFTODSA-N Arg-Asn-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N DCGLNNVKIZXQOJ-FXQIFTODSA-N 0.000 description 1
- BVBKBQRPOJFCQM-DCAQKATOSA-N Arg-Asn-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O BVBKBQRPOJFCQM-DCAQKATOSA-N 0.000 description 1
- OANWAFQRNQEDSY-DCAQKATOSA-N Arg-Cys-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCN=C(N)N)N OANWAFQRNQEDSY-DCAQKATOSA-N 0.000 description 1
- JVMKBJNSRZWDBO-FXQIFTODSA-N Arg-Cys-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O JVMKBJNSRZWDBO-FXQIFTODSA-N 0.000 description 1
- LLZXKVAAEWBUPB-KKUMJFAQSA-N Arg-Gln-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LLZXKVAAEWBUPB-KKUMJFAQSA-N 0.000 description 1
- SKTGPBFTMNLIHQ-KKUMJFAQSA-N Arg-Glu-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SKTGPBFTMNLIHQ-KKUMJFAQSA-N 0.000 description 1
- XUUXCWCKKCZEAW-YFKPBYRVSA-N Arg-Gly Chemical compound OC(=O)CNC(=O)[C@@H](N)CCCN=C(N)N XUUXCWCKKCZEAW-YFKPBYRVSA-N 0.000 description 1
- IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical class NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 description 1
- OQCWXQJLCDPRHV-UWVGGRQHSA-N Arg-Gly-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O OQCWXQJLCDPRHV-UWVGGRQHSA-N 0.000 description 1
- HAVKMRGWNXMCDR-STQMWFEESA-N Arg-Gly-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HAVKMRGWNXMCDR-STQMWFEESA-N 0.000 description 1
- WVNFNPGXYADPPO-BQBZGAKWSA-N Arg-Gly-Ser Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O WVNFNPGXYADPPO-BQBZGAKWSA-N 0.000 description 1
- KRQSPVKUISQQFS-FJXKBIBVSA-N Arg-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCN=C(N)N KRQSPVKUISQQFS-FJXKBIBVSA-N 0.000 description 1
- AGVNTAUPLWIQEN-ZPFDUUQYSA-N Arg-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N AGVNTAUPLWIQEN-ZPFDUUQYSA-N 0.000 description 1
- OKKMBOSPBDASEP-CYDGBPFRSA-N Arg-Ile-Met Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(O)=O OKKMBOSPBDASEP-CYDGBPFRSA-N 0.000 description 1
- YBZMTKUDWXZLIX-UWVGGRQHSA-N Arg-Leu-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YBZMTKUDWXZLIX-UWVGGRQHSA-N 0.000 description 1
- FSNVAJOPUDVQAR-AVGNSLFASA-N Arg-Lys-Arg Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O FSNVAJOPUDVQAR-AVGNSLFASA-N 0.000 description 1
- MJINRRBEMOLJAK-DCAQKATOSA-N Arg-Lys-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCN=C(N)N MJINRRBEMOLJAK-DCAQKATOSA-N 0.000 description 1
- BNYNOWJESJJIOI-XUXIUFHCSA-N Arg-Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)N BNYNOWJESJJIOI-XUXIUFHCSA-N 0.000 description 1
- CLICCYPMVFGUOF-IHRRRGAJSA-N Arg-Lys-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O CLICCYPMVFGUOF-IHRRRGAJSA-N 0.000 description 1
- RATVAFHGEFAWDH-JYJNAYRXSA-N Arg-Phe-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCN=C(N)N)N RATVAFHGEFAWDH-JYJNAYRXSA-N 0.000 description 1
- KXOPYFNQLVUOAQ-FXQIFTODSA-N Arg-Ser-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O KXOPYFNQLVUOAQ-FXQIFTODSA-N 0.000 description 1
- JPAWCMXVNZPJLO-IHRRRGAJSA-N Arg-Ser-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JPAWCMXVNZPJLO-IHRRRGAJSA-N 0.000 description 1
- FRBAHXABMQXSJQ-FXQIFTODSA-N Arg-Ser-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O FRBAHXABMQXSJQ-FXQIFTODSA-N 0.000 description 1
- RYQSYXFGFOTJDJ-RHYQMDGZSA-N Arg-Thr-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O RYQSYXFGFOTJDJ-RHYQMDGZSA-N 0.000 description 1
- ZJBUILVYSXQNSW-YTWAJWBKSA-N Arg-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O ZJBUILVYSXQNSW-YTWAJWBKSA-N 0.000 description 1
- UGJLILSJKSBVIR-ZFWWWQNUSA-N Arg-Trp-Gly Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCCN=C(N)N)N)C(=O)NCC(O)=O)=CNC2=C1 UGJLILSJKSBVIR-ZFWWWQNUSA-N 0.000 description 1
- AOJYORNRFWWEIV-IHRRRGAJSA-N Arg-Tyr-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(O)=O)C(O)=O)CC1=CC=C(O)C=C1 AOJYORNRFWWEIV-IHRRRGAJSA-N 0.000 description 1
- QLSRIZIDQXDQHK-RCWTZXSCSA-N Arg-Val-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QLSRIZIDQXDQHK-RCWTZXSCSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- GMRGSBAMMMVDGG-GUBZILKMSA-N Asn-Arg-Arg Chemical compound C(C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N)CN=C(N)N GMRGSBAMMMVDGG-GUBZILKMSA-N 0.000 description 1
- ACRYGQFHAQHDSF-ZLUOBGJFSA-N Asn-Asn-Asn Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O ACRYGQFHAQHDSF-ZLUOBGJFSA-N 0.000 description 1
- RCENDENBBJFJHZ-ACZMJKKPSA-N Asn-Asn-Gln Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O RCENDENBBJFJHZ-ACZMJKKPSA-N 0.000 description 1
- VJTWLBMESLDOMK-WDSKDSINSA-N Asn-Gln-Gly Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O VJTWLBMESLDOMK-WDSKDSINSA-N 0.000 description 1
- FUHFYEKSGWOWGZ-XHNCKOQMSA-N Asn-Gln-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)N)N)C(=O)O FUHFYEKSGWOWGZ-XHNCKOQMSA-N 0.000 description 1
- CTQIOCMSIJATNX-WHFBIAKZSA-N Asn-Gly-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(O)=O CTQIOCMSIJATNX-WHFBIAKZSA-N 0.000 description 1
- XVBDDUPJVQXDSI-PEFMBERDSA-N Asn-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N XVBDDUPJVQXDSI-PEFMBERDSA-N 0.000 description 1
- YYSYDIYQTUPNQQ-SXTJYALSSA-N Asn-Ile-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O YYSYDIYQTUPNQQ-SXTJYALSSA-N 0.000 description 1
- WIDVAWAQBRAKTI-YUMQZZPRSA-N Asn-Leu-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O WIDVAWAQBRAKTI-YUMQZZPRSA-N 0.000 description 1
- UBGGJTMETLEXJD-DCAQKATOSA-N Asn-Leu-Met Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(O)=O UBGGJTMETLEXJD-DCAQKATOSA-N 0.000 description 1
- ZYPWIUFLYMQZBS-SRVKXCTJSA-N Asn-Lys-Lys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N ZYPWIUFLYMQZBS-SRVKXCTJSA-N 0.000 description 1
- QDXQWFBLUVTOFL-FXQIFTODSA-N Asn-Met-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)N)N QDXQWFBLUVTOFL-FXQIFTODSA-N 0.000 description 1
- NNDSLVWAQAUPPP-GUBZILKMSA-N Asn-Met-Met Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC(=O)N)N NNDSLVWAQAUPPP-GUBZILKMSA-N 0.000 description 1
- ZVUMKOMKQCANOM-AVGNSLFASA-N Asn-Phe-Gln Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZVUMKOMKQCANOM-AVGNSLFASA-N 0.000 description 1
- REQUGIWGOGSOEZ-ZLUOBGJFSA-N Asn-Ser-Asn Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)C(=O)N REQUGIWGOGSOEZ-ZLUOBGJFSA-N 0.000 description 1
- ZNYKKCADEQAZKA-FXQIFTODSA-N Asn-Ser-Met Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(O)=O ZNYKKCADEQAZKA-FXQIFTODSA-N 0.000 description 1
- QYRMBFWDSFGSFC-OLHMAJIHSA-N Asn-Thr-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O QYRMBFWDSFGSFC-OLHMAJIHSA-N 0.000 description 1
- UXHYOWXTJLBEPG-GSSVUCPTSA-N Asn-Thr-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O UXHYOWXTJLBEPG-GSSVUCPTSA-N 0.000 description 1
- RTFXPCYMDYBZNQ-SRVKXCTJSA-N Asn-Tyr-Asn Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(O)=O RTFXPCYMDYBZNQ-SRVKXCTJSA-N 0.000 description 1
- NSTBNYOKCZKOMI-AVGNSLFASA-N Asn-Tyr-Glu Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O NSTBNYOKCZKOMI-AVGNSLFASA-N 0.000 description 1
- DPSUVAPLRQDWAO-YDHLFZDLSA-N Asn-Tyr-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)N)N DPSUVAPLRQDWAO-YDHLFZDLSA-N 0.000 description 1
- JZLFYAAGGYMRIK-BYULHYEWSA-N Asn-Val-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O JZLFYAAGGYMRIK-BYULHYEWSA-N 0.000 description 1
- WQAOZCVOOYUWKG-LSJOCFKGSA-N Asn-Val-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CC(=O)N)N WQAOZCVOOYUWKG-LSJOCFKGSA-N 0.000 description 1
- XBQSLMACWDXWLJ-GHCJXIJMSA-N Asp-Ala-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O XBQSLMACWDXWLJ-GHCJXIJMSA-N 0.000 description 1
- VBVKSAFJPVXMFJ-CIUDSAMLSA-N Asp-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)N VBVKSAFJPVXMFJ-CIUDSAMLSA-N 0.000 description 1
- FANQWNCPNFEPGZ-WHFBIAKZSA-N Asp-Asp-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O FANQWNCPNFEPGZ-WHFBIAKZSA-N 0.000 description 1
- DGKCOYGQLNWNCJ-ACZMJKKPSA-N Asp-Glu-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O DGKCOYGQLNWNCJ-ACZMJKKPSA-N 0.000 description 1
- POTCZYQVVNXUIG-BQBZGAKWSA-N Asp-Gly-Pro Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O POTCZYQVVNXUIG-BQBZGAKWSA-N 0.000 description 1
- SNDBKTFJWVEVPO-WHFBIAKZSA-N Asp-Gly-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(O)=O SNDBKTFJWVEVPO-WHFBIAKZSA-N 0.000 description 1
- TZOZNVLBTAFJRW-UGYAYLCHSA-N Asp-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)O)N TZOZNVLBTAFJRW-UGYAYLCHSA-N 0.000 description 1
- NHSDEZURHWEZPN-SXTJYALSSA-N Asp-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@H](CC(=O)O)N NHSDEZURHWEZPN-SXTJYALSSA-N 0.000 description 1
- HOBNTSHITVVNBN-ZPFDUUQYSA-N Asp-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC(=O)O)N HOBNTSHITVVNBN-ZPFDUUQYSA-N 0.000 description 1
- PAYPSKIBMDHZPI-CIUDSAMLSA-N Asp-Leu-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O PAYPSKIBMDHZPI-CIUDSAMLSA-N 0.000 description 1
- UJGRZQYSNYTCAX-SRVKXCTJSA-N Asp-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O UJGRZQYSNYTCAX-SRVKXCTJSA-N 0.000 description 1
- MVRGBQGZSDJBSM-GMOBBJLQSA-N Asp-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)N MVRGBQGZSDJBSM-GMOBBJLQSA-N 0.000 description 1
- ZBYLEBZCVKLPCY-FXQIFTODSA-N Asp-Ser-Arg Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O ZBYLEBZCVKLPCY-FXQIFTODSA-N 0.000 description 1
- JSHWXQIZOCVWIA-ZKWXMUAHSA-N Asp-Ser-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O JSHWXQIZOCVWIA-ZKWXMUAHSA-N 0.000 description 1
- KBJVTFWQWXCYCQ-IUKAMOBKSA-N Asp-Thr-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KBJVTFWQWXCYCQ-IUKAMOBKSA-N 0.000 description 1
- ITGFVUYOLWBPQW-KKHAAJSZSA-N Asp-Thr-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O ITGFVUYOLWBPQW-KKHAAJSZSA-N 0.000 description 1
- MFDPBZAFCRKYEY-LAEOZQHASA-N Asp-Val-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O MFDPBZAFCRKYEY-LAEOZQHASA-N 0.000 description 1
- IVRMZWNICZWHMI-UHFFFAOYSA-N Azide Chemical compound [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- TYBKADJAOBUHAD-UHFFFAOYSA-J BoBo-1 Chemical compound [I-].[I-].[I-].[I-].S1C2=CC=CC=C2[N+](C)=C1C=C1C=CN(CCC[N+](C)(C)CCC[N+](C)(C)CCCN2C=CC(=CC3=[N+](C4=CC=CC=C4S3)C)C=C2)C=C1 TYBKADJAOBUHAD-UHFFFAOYSA-J 0.000 description 1
- UIZZRDIAIPYKJZ-UHFFFAOYSA-J BoBo-3 Chemical compound [I-].[I-].[I-].[I-].S1C2=CC=CC=C2[N+](C)=C1C=CC=C1C=CN(CCC[N+](C)(C)CCC[N+](C)(C)CCCN2C=CC(=CC=CC3=[N+](C4=CC=CC=C4S3)C)C=C2)C=C1 UIZZRDIAIPYKJZ-UHFFFAOYSA-J 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 101150044789 Cap gene Proteins 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 241000195597 Chlamydomonas reinhardtii Species 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 208000006992 Color Vision Defects Diseases 0.000 description 1
- 208000036693 Color-vision disease Diseases 0.000 description 1
- 108091028732 Concatemer Proteins 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- GRNOCLDFUNCIDW-ACZMJKKPSA-N Cys-Ala-Glu Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CS)N GRNOCLDFUNCIDW-ACZMJKKPSA-N 0.000 description 1
- XEEIQMGZRFFSRD-XVYDVKMFSA-N Cys-Ala-His Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CS)N XEEIQMGZRFFSRD-XVYDVKMFSA-N 0.000 description 1
- BUIYOWKUSCTBRE-CIUDSAMLSA-N Cys-Arg-Gln Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O BUIYOWKUSCTBRE-CIUDSAMLSA-N 0.000 description 1
- LWTTURISBKEVAC-CIUDSAMLSA-N Cys-Cys-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CS)N LWTTURISBKEVAC-CIUDSAMLSA-N 0.000 description 1
- UXUSHQYYQCZWET-WDSKDSINSA-N Cys-Glu-Gly Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O UXUSHQYYQCZWET-WDSKDSINSA-N 0.000 description 1
- RRJOQIBQVZDVCW-SRVKXCTJSA-N Cys-His-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CS)N RRJOQIBQVZDVCW-SRVKXCTJSA-N 0.000 description 1
- ABLJDBFJPUWQQB-DCAQKATOSA-N Cys-Leu-Arg Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CS)N ABLJDBFJPUWQQB-DCAQKATOSA-N 0.000 description 1
- BNCKELUXXUYRNY-GUBZILKMSA-N Cys-Lys-Glu Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CS)N BNCKELUXXUYRNY-GUBZILKMSA-N 0.000 description 1
- UIKLEGZPIOXFHJ-DLOVCJGASA-N Cys-Phe-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(O)=O UIKLEGZPIOXFHJ-DLOVCJGASA-N 0.000 description 1
- BSGXXYRIDXUEOM-IHRRRGAJSA-N Cys-Phe-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CS)N BSGXXYRIDXUEOM-IHRRRGAJSA-N 0.000 description 1
- CHRCKSPMGYDLIA-SRVKXCTJSA-N Cys-Phe-Ser Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O CHRCKSPMGYDLIA-SRVKXCTJSA-N 0.000 description 1
- BCFXQBXXDSEHRS-FXQIFTODSA-N Cys-Ser-Arg Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O BCFXQBXXDSEHRS-FXQIFTODSA-N 0.000 description 1
- WZJLBUPPZRZNTO-CIUDSAMLSA-N Cys-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CS)N WZJLBUPPZRZNTO-CIUDSAMLSA-N 0.000 description 1
- ABLQPNMKLMFDQU-BIIVOSGPSA-N Cys-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CS)N)C(=O)O ABLQPNMKLMFDQU-BIIVOSGPSA-N 0.000 description 1
- NAPULYCVEVVFRB-HEIBUPTGSA-N Cys-Thr-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](N)CS NAPULYCVEVVFRB-HEIBUPTGSA-N 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 108010092160 Dactinomycin Proteins 0.000 description 1
- XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 1
- 229910052693 Europium Inorganic materials 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 102000004437 G-Protein-Coupled Receptor Kinase 1 Human genes 0.000 description 1
- 108091004242 G-Protein-Coupled Receptor Kinase 1 Proteins 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- RGXXLQWXBFNXTG-CIUDSAMLSA-N Gln-Arg-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O RGXXLQWXBFNXTG-CIUDSAMLSA-N 0.000 description 1
- RGRMOYQUIJVQQD-SRVKXCTJSA-N Gln-Arg-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)N)N RGRMOYQUIJVQQD-SRVKXCTJSA-N 0.000 description 1
- RMOCFPBLHAOTDU-ACZMJKKPSA-N Gln-Asn-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O RMOCFPBLHAOTDU-ACZMJKKPSA-N 0.000 description 1
- BTSPOOHJBYJRKO-CIUDSAMLSA-N Gln-Asp-Arg Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O BTSPOOHJBYJRKO-CIUDSAMLSA-N 0.000 description 1
- ZQPOVSJFBBETHQ-CIUDSAMLSA-N Gln-Glu-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZQPOVSJFBBETHQ-CIUDSAMLSA-N 0.000 description 1
- LLRJEFPKIIBGJP-DCAQKATOSA-N Gln-Glu-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)N)N LLRJEFPKIIBGJP-DCAQKATOSA-N 0.000 description 1
- PNENQZWRFMUZOM-DCAQKATOSA-N Gln-Glu-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O PNENQZWRFMUZOM-DCAQKATOSA-N 0.000 description 1
- FGYPOQPQTUNESW-IUCAKERBSA-N Gln-Gly-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)N FGYPOQPQTUNESW-IUCAKERBSA-N 0.000 description 1
- LTXLIIZACMCQTO-GUBZILKMSA-N Gln-His-Asp Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N LTXLIIZACMCQTO-GUBZILKMSA-N 0.000 description 1
- IWUFOVSLWADEJC-AVGNSLFASA-N Gln-His-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O IWUFOVSLWADEJC-AVGNSLFASA-N 0.000 description 1
- YRWWJCDWLVXTHN-LAEOZQHASA-N Gln-Ile-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)N)N YRWWJCDWLVXTHN-LAEOZQHASA-N 0.000 description 1
- ITZWDGBYBPUZRG-KBIXCLLPSA-N Gln-Ile-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O ITZWDGBYBPUZRG-KBIXCLLPSA-N 0.000 description 1
- XFAUJGNLHIGXET-AVGNSLFASA-N Gln-Leu-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O XFAUJGNLHIGXET-AVGNSLFASA-N 0.000 description 1
- KHNJVFYHIKLUPD-SRVKXCTJSA-N Gln-Leu-Met Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CCC(=O)N)N KHNJVFYHIKLUPD-SRVKXCTJSA-N 0.000 description 1
- JNENSVNAUWONEZ-GUBZILKMSA-N Gln-Lys-Asn Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O JNENSVNAUWONEZ-GUBZILKMSA-N 0.000 description 1
- ZEEPYMXTJWIMSN-GUBZILKMSA-N Gln-Lys-Ser Chemical compound NCCCC[C@@H](C(=O)N[C@@H](CO)C(O)=O)NC(=O)[C@@H](N)CCC(N)=O ZEEPYMXTJWIMSN-GUBZILKMSA-N 0.000 description 1
- UESYBOXFJWJVSB-AVGNSLFASA-N Gln-Phe-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O UESYBOXFJWJVSB-AVGNSLFASA-N 0.000 description 1
- FNAJNWPDTIXYJN-CIUDSAMLSA-N Gln-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(N)=O FNAJNWPDTIXYJN-CIUDSAMLSA-N 0.000 description 1
- MQJDLNRXBOELJW-KKUMJFAQSA-N Gln-Pro-Phe Chemical compound N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O MQJDLNRXBOELJW-KKUMJFAQSA-N 0.000 description 1
- DYVMTEWCGAVKSE-HJGDQZAQSA-N Gln-Thr-Arg Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O DYVMTEWCGAVKSE-HJGDQZAQSA-N 0.000 description 1
- VOUSELYGTNGEPB-NUMRIWBASA-N Gln-Thr-Asp Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O VOUSELYGTNGEPB-NUMRIWBASA-N 0.000 description 1
- IIMZHVKZBGSEKZ-SZMVWBNQSA-N Gln-Trp-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(O)=O IIMZHVKZBGSEKZ-SZMVWBNQSA-N 0.000 description 1
- FITIQFSXXBKFFM-NRPADANISA-N Gln-Val-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O FITIQFSXXBKFFM-NRPADANISA-N 0.000 description 1
- SOEXCCGNHQBFPV-DLOVCJGASA-N Gln-Val-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(O)=O SOEXCCGNHQBFPV-DLOVCJGASA-N 0.000 description 1
- UTKUTMJSWKKHEM-WDSKDSINSA-N Glu-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O UTKUTMJSWKKHEM-WDSKDSINSA-N 0.000 description 1
- ATRHMOJQJWPVBQ-DRZSPHRISA-N Glu-Ala-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ATRHMOJQJWPVBQ-DRZSPHRISA-N 0.000 description 1
- KKCUFHUTMKQQCF-SRVKXCTJSA-N Glu-Arg-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O KKCUFHUTMKQQCF-SRVKXCTJSA-N 0.000 description 1
- ZOXBSICWUDAOHX-GUBZILKMSA-N Glu-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(O)=O ZOXBSICWUDAOHX-GUBZILKMSA-N 0.000 description 1
- VAZZOGXDUQSVQF-NUMRIWBASA-N Glu-Asn-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N)O VAZZOGXDUQSVQF-NUMRIWBASA-N 0.000 description 1
- KUTPGXNAAOQSPD-LPEHRKFASA-N Glu-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)N)C(=O)O KUTPGXNAAOQSPD-LPEHRKFASA-N 0.000 description 1
- MTAOBYXRYJZRGQ-WDSKDSINSA-N Glu-Gly-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O MTAOBYXRYJZRGQ-WDSKDSINSA-N 0.000 description 1
- OGNJZUXUTPQVBR-BQBZGAKWSA-N Glu-Gly-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O OGNJZUXUTPQVBR-BQBZGAKWSA-N 0.000 description 1
- RAUDKMVXNOWDLS-WDSKDSINSA-N Glu-Gly-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O RAUDKMVXNOWDLS-WDSKDSINSA-N 0.000 description 1
- XMPAXPSENRSOSV-RYUDHWBXSA-N Glu-Gly-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O XMPAXPSENRSOSV-RYUDHWBXSA-N 0.000 description 1
- ATVYZJGOZLVXDK-IUCAKERBSA-N Glu-Leu-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O ATVYZJGOZLVXDK-IUCAKERBSA-N 0.000 description 1
- FBEJIDRSQCGFJI-GUBZILKMSA-N Glu-Leu-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O FBEJIDRSQCGFJI-GUBZILKMSA-N 0.000 description 1
- FQFWFZWOHOEVMZ-IHRRRGAJSA-N Glu-Phe-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O FQFWFZWOHOEVMZ-IHRRRGAJSA-N 0.000 description 1
- SYWCGQOIIARSIX-SRVKXCTJSA-N Glu-Pro-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O SYWCGQOIIARSIX-SRVKXCTJSA-N 0.000 description 1
- DCBSZJJHOTXMHY-DCAQKATOSA-N Glu-Pro-Pro Chemical compound OC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DCBSZJJHOTXMHY-DCAQKATOSA-N 0.000 description 1
- BIYNPVYAZOUVFQ-CIUDSAMLSA-N Glu-Pro-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O BIYNPVYAZOUVFQ-CIUDSAMLSA-N 0.000 description 1
- WXONSNSSBYQGNN-AVGNSLFASA-N Glu-Ser-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O WXONSNSSBYQGNN-AVGNSLFASA-N 0.000 description 1
- GWKBAXRZPLSWJS-QEJZJMRPSA-N Glu-Trp-Cys Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)O)N GWKBAXRZPLSWJS-QEJZJMRPSA-N 0.000 description 1
- HVKAAUOFFTUSAA-XDTLVQLUSA-N Glu-Tyr-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O HVKAAUOFFTUSAA-XDTLVQLUSA-N 0.000 description 1
- PMSDOVISAARGAV-FHWLQOOXSA-N Glu-Tyr-Phe Chemical compound C([C@H](NC(=O)[C@H](CCC(O)=O)N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 PMSDOVISAARGAV-FHWLQOOXSA-N 0.000 description 1
- BKMOHWJHXQLFEX-IRIUXVKKSA-N Glu-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CCC(=O)O)N)O BKMOHWJHXQLFEX-IRIUXVKKSA-N 0.000 description 1
- KCCNSVHJSMMGFS-NRPADANISA-N Glu-Val-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)O)N KCCNSVHJSMMGFS-NRPADANISA-N 0.000 description 1
- VIPDPMHGICREIS-GVXVVHGQSA-N Glu-Val-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O VIPDPMHGICREIS-GVXVVHGQSA-N 0.000 description 1
- UGVQELHRNUDMAA-BYPYZUCNSA-N Gly-Ala-Gly Chemical compound [NH3+]CC(=O)N[C@@H](C)C(=O)NCC([O-])=O UGVQELHRNUDMAA-BYPYZUCNSA-N 0.000 description 1
- JRDYDYXZKFNNRQ-XPUUQOCRSA-N Gly-Ala-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN JRDYDYXZKFNNRQ-XPUUQOCRSA-N 0.000 description 1
- UPOJUWHGMDJUQZ-IUCAKERBSA-N Gly-Arg-Arg Chemical compound NC(=N)NCCC[C@H](NC(=O)CN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O UPOJUWHGMDJUQZ-IUCAKERBSA-N 0.000 description 1
- XUDLUKYPXQDCRX-BQBZGAKWSA-N Gly-Arg-Asn Chemical compound [H]NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O XUDLUKYPXQDCRX-BQBZGAKWSA-N 0.000 description 1
- OGCIHJPYKVSMTE-YUMQZZPRSA-N Gly-Arg-Glu Chemical compound [H]NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O OGCIHJPYKVSMTE-YUMQZZPRSA-N 0.000 description 1
- OVSKVOOUFAKODB-UWVGGRQHSA-N Gly-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N OVSKVOOUFAKODB-UWVGGRQHSA-N 0.000 description 1
- BGVYNAQWHSTTSP-BYULHYEWSA-N Gly-Asn-Ile Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BGVYNAQWHSTTSP-BYULHYEWSA-N 0.000 description 1
- KQDMENMTYNBWMR-WHFBIAKZSA-N Gly-Asp-Ala Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O KQDMENMTYNBWMR-WHFBIAKZSA-N 0.000 description 1
- PEZZSFLFXXFUQD-XPUUQOCRSA-N Gly-Cys-Val Chemical compound [H]NCC(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(O)=O PEZZSFLFXXFUQD-XPUUQOCRSA-N 0.000 description 1
- JMQFHZWESBGPFC-WDSKDSINSA-N Gly-Gln-Asp Chemical compound NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O JMQFHZWESBGPFC-WDSKDSINSA-N 0.000 description 1
- QPDUVFSVVAOUHE-XVKPBYJWSA-N Gly-Gln-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CN)C(O)=O QPDUVFSVVAOUHE-XVKPBYJWSA-N 0.000 description 1
- STVHDEHTKFXBJQ-LAEOZQHASA-N Gly-Glu-Ile Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O STVHDEHTKFXBJQ-LAEOZQHASA-N 0.000 description 1
- YYPFZVIXAVDHIK-IUCAKERBSA-N Gly-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CN YYPFZVIXAVDHIK-IUCAKERBSA-N 0.000 description 1
- KMSGYZQRXPUKGI-BYPYZUCNSA-N Gly-Gly-Asn Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC(N)=O KMSGYZQRXPUKGI-BYPYZUCNSA-N 0.000 description 1
- QPCVIQJVRGXUSA-LURJTMIESA-N Gly-Gly-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)CNC(=O)CN QPCVIQJVRGXUSA-LURJTMIESA-N 0.000 description 1
- BUEFQXUHTUZXHR-LURJTMIESA-N Gly-Gly-Pro zwitterion Chemical compound NCC(=O)NCC(=O)N1CCC[C@H]1C(O)=O BUEFQXUHTUZXHR-LURJTMIESA-N 0.000 description 1
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 description 1
- HMHRTKOWRUPPNU-RCOVLWMOSA-N Gly-Ile-Gly Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O HMHRTKOWRUPPNU-RCOVLWMOSA-N 0.000 description 1
- SCWYHUQOOFRVHP-MBLNEYKQSA-N Gly-Ile-Thr Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SCWYHUQOOFRVHP-MBLNEYKQSA-N 0.000 description 1
- IUZGUFAJDBHQQV-YUMQZZPRSA-N Gly-Leu-Asn Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O IUZGUFAJDBHQQV-YUMQZZPRSA-N 0.000 description 1
- CCBIBMKQNXHNIN-ZETCQYMHSA-N Gly-Leu-Gly Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O CCBIBMKQNXHNIN-ZETCQYMHSA-N 0.000 description 1
- YSDLIYZLOTZZNP-UWVGGRQHSA-N Gly-Leu-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CN YSDLIYZLOTZZNP-UWVGGRQHSA-N 0.000 description 1
- LHYJCVCQPWRMKZ-WEDXCCLWSA-N Gly-Leu-Thr Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LHYJCVCQPWRMKZ-WEDXCCLWSA-N 0.000 description 1
- MHXKHKWHPNETGG-QWRGUYRKSA-N Gly-Lys-Leu Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O MHXKHKWHPNETGG-QWRGUYRKSA-N 0.000 description 1
- VEPBEGNDJYANCF-QWRGUYRKSA-N Gly-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCCN VEPBEGNDJYANCF-QWRGUYRKSA-N 0.000 description 1
- LXTRSHQLGYINON-DTWKUNHWSA-N Gly-Met-Pro Chemical compound CSCC[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN LXTRSHQLGYINON-DTWKUNHWSA-N 0.000 description 1
- YLEIWGJJBFBFHC-KBPBESRZSA-N Gly-Phe-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 YLEIWGJJBFBFHC-KBPBESRZSA-N 0.000 description 1
- GGLIDLCEPDHEJO-BQBZGAKWSA-N Gly-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)CN GGLIDLCEPDHEJO-BQBZGAKWSA-N 0.000 description 1
- JNGHLWWFPGIJER-STQMWFEESA-N Gly-Pro-Tyr Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 JNGHLWWFPGIJER-STQMWFEESA-N 0.000 description 1
- LBDXVCBAJJNJNN-WHFBIAKZSA-N Gly-Ser-Cys Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(O)=O LBDXVCBAJJNJNN-WHFBIAKZSA-N 0.000 description 1
- CSMYMGFCEJWALV-WDSKDSINSA-N Gly-Ser-Gln Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(N)=O CSMYMGFCEJWALV-WDSKDSINSA-N 0.000 description 1
- SOEGEPHNZOISMT-BYPYZUCNSA-N Gly-Ser-Gly Chemical compound NCC(=O)N[C@@H](CO)C(=O)NCC(O)=O SOEGEPHNZOISMT-BYPYZUCNSA-N 0.000 description 1
- JSLVAHYTAJJEQH-QWRGUYRKSA-N Gly-Ser-Phe Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 JSLVAHYTAJJEQH-QWRGUYRKSA-N 0.000 description 1
- NVTPVQLIZCOJFK-FOHZUACHSA-N Gly-Thr-Asp Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O NVTPVQLIZCOJFK-FOHZUACHSA-N 0.000 description 1
- JQFILXICXLDTRR-FBCQKBJTSA-N Gly-Thr-Gly Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)NCC(O)=O JQFILXICXLDTRR-FBCQKBJTSA-N 0.000 description 1
- HUFUVTYGPOUCBN-MBLNEYKQSA-N Gly-Thr-Ile Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HUFUVTYGPOUCBN-MBLNEYKQSA-N 0.000 description 1
- UMBDRSMLCUYIRI-DVJZZOLTSA-N Gly-Trp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)CN)O UMBDRSMLCUYIRI-DVJZZOLTSA-N 0.000 description 1
- MREVELMMFOLESM-HOCLYGCPSA-N Gly-Trp-Val Chemical compound [H]NCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C(C)C)C(O)=O MREVELMMFOLESM-HOCLYGCPSA-N 0.000 description 1
- NWOSHVVPKDQKKT-RYUDHWBXSA-N Gly-Tyr-Gln Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O NWOSHVVPKDQKKT-RYUDHWBXSA-N 0.000 description 1
- IHDKKJVBLGXLEL-STQMWFEESA-N Gly-Tyr-Met Chemical compound CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CN)C(O)=O IHDKKJVBLGXLEL-STQMWFEESA-N 0.000 description 1
- OCRQUYDOYKCOQG-IRXDYDNUSA-N Gly-Tyr-Phe Chemical compound C([C@H](NC(=O)CN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 OCRQUYDOYKCOQG-IRXDYDNUSA-N 0.000 description 1
- FULZDMOZUZKGQU-ONGXEEELSA-N Gly-Val-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)CN FULZDMOZUZKGQU-ONGXEEELSA-N 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 101100412102 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) rec2 gene Proteins 0.000 description 1
- DZMVESFTHXSSPZ-XVYDVKMFSA-N His-Ala-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O DZMVESFTHXSSPZ-XVYDVKMFSA-N 0.000 description 1
- HXKZJLWGSWQKEA-LSJOCFKGSA-N His-Ala-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CN=CN1 HXKZJLWGSWQKEA-LSJOCFKGSA-N 0.000 description 1
- ZPVJJPAIUZLSNE-DCAQKATOSA-N His-Arg-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O ZPVJJPAIUZLSNE-DCAQKATOSA-N 0.000 description 1
- MWWOPNQSBXEUHO-ULQDDVLXSA-N His-Arg-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CN=CN1 MWWOPNQSBXEUHO-ULQDDVLXSA-N 0.000 description 1
- MPXGJGBXCRQQJE-MXAVVETBSA-N His-Ile-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O MPXGJGBXCRQQJE-MXAVVETBSA-N 0.000 description 1
- SKYULSWNBYAQMG-IHRRRGAJSA-N His-Leu-Arg Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SKYULSWNBYAQMG-IHRRRGAJSA-N 0.000 description 1
- LJUIEESLIAZSFR-SRVKXCTJSA-N His-Leu-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N LJUIEESLIAZSFR-SRVKXCTJSA-N 0.000 description 1
- YYOCMTFVGKDNQP-IHRRRGAJSA-N His-Met-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N YYOCMTFVGKDNQP-IHRRRGAJSA-N 0.000 description 1
- YAEKRYQASVCDLK-JYJNAYRXSA-N His-Phe-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC2=CN=CN2)N YAEKRYQASVCDLK-JYJNAYRXSA-N 0.000 description 1
- VCBWXASUBZIFLQ-IHRRRGAJSA-N His-Pro-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O VCBWXASUBZIFLQ-IHRRRGAJSA-N 0.000 description 1
- OWYIDJCNRWRSJY-QTKMDUPCSA-N His-Pro-Thr Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O OWYIDJCNRWRSJY-QTKMDUPCSA-N 0.000 description 1
- JMSONHOUHFDOJH-GUBZILKMSA-N His-Ser-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CN=CN1 JMSONHOUHFDOJH-GUBZILKMSA-N 0.000 description 1
- DGLAHESNTJWGDO-SRVKXCTJSA-N His-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N DGLAHESNTJWGDO-SRVKXCTJSA-N 0.000 description 1
- CUEQQFOGARVNHU-VGDYDELISA-N His-Ser-Ile Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O CUEQQFOGARVNHU-VGDYDELISA-N 0.000 description 1
- VIJMRAIWYWRXSR-CIUDSAMLSA-N His-Ser-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CN=CN1 VIJMRAIWYWRXSR-CIUDSAMLSA-N 0.000 description 1
- YBDOQKVAGTWZMI-XIRDDKMYSA-N His-Trp-Ser Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC3=CN=CN3)N YBDOQKVAGTWZMI-XIRDDKMYSA-N 0.000 description 1
- DMAPKBANYNZHNR-ULQDDVLXSA-N His-Val-Tyr Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CC2=CN=CN2)N DMAPKBANYNZHNR-ULQDDVLXSA-N 0.000 description 1
- 101000729271 Homo sapiens Retinoid isomerohydrolase Proteins 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- AQCUAZTZSPQJFF-ZKWXMUAHSA-N Ile-Ala-Gly Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O AQCUAZTZSPQJFF-ZKWXMUAHSA-N 0.000 description 1
- YPWHUFAAMNHMGS-QSFUFRPTSA-N Ile-Ala-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N YPWHUFAAMNHMGS-QSFUFRPTSA-N 0.000 description 1
- TZCGZYWNIDZZMR-NAKRPEOUSA-N Ile-Arg-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)O)N TZCGZYWNIDZZMR-NAKRPEOUSA-N 0.000 description 1
- FVEWRQXNISSYFO-ZPFDUUQYSA-N Ile-Arg-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N FVEWRQXNISSYFO-ZPFDUUQYSA-N 0.000 description 1
- AZEYWPUCOYXFOE-CYDGBPFRSA-N Ile-Arg-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C(C)C)C(=O)O)N AZEYWPUCOYXFOE-CYDGBPFRSA-N 0.000 description 1
- HGNUKGZQASSBKQ-PCBIJLKTSA-N Ile-Asp-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N HGNUKGZQASSBKQ-PCBIJLKTSA-N 0.000 description 1
- GYAFMRQGWHXMII-IUKAMOBKSA-N Ile-Asp-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N GYAFMRQGWHXMII-IUKAMOBKSA-N 0.000 description 1
- BSWLQVGEVFYGIM-ZPFDUUQYSA-N Ile-Gln-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N BSWLQVGEVFYGIM-ZPFDUUQYSA-N 0.000 description 1
- PHIXPNQDGGILMP-YVNDNENWSA-N Ile-Glu-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N PHIXPNQDGGILMP-YVNDNENWSA-N 0.000 description 1
- DFFTXLCCDFYRKD-MBLNEYKQSA-N Ile-Gly-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)O)N DFFTXLCCDFYRKD-MBLNEYKQSA-N 0.000 description 1
- CMNMPCTVCWWYHY-MXAVVETBSA-N Ile-His-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC(C)C)C(=O)O)N CMNMPCTVCWWYHY-MXAVVETBSA-N 0.000 description 1
- TWPSALMCEHCIOY-YTFOTSKYSA-N Ile-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O)N TWPSALMCEHCIOY-YTFOTSKYSA-N 0.000 description 1
- UWLHDGMRWXHFFY-HPCHECBXSA-N Ile-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@@H]1C(=O)O)N UWLHDGMRWXHFFY-HPCHECBXSA-N 0.000 description 1
- PFPUFNLHBXKPHY-HTFCKZLJSA-N Ile-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)O)N PFPUFNLHBXKPHY-HTFCKZLJSA-N 0.000 description 1
- AXNGDPAKKCEKGY-QPHKQPEJSA-N Ile-Ile-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N AXNGDPAKKCEKGY-QPHKQPEJSA-N 0.000 description 1
- KLBVGHCGHUNHEA-BJDJZHNGSA-N Ile-Leu-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)N KLBVGHCGHUNHEA-BJDJZHNGSA-N 0.000 description 1
- FCWFBHMAJZGWRY-XUXIUFHCSA-N Ile-Leu-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)O)N FCWFBHMAJZGWRY-XUXIUFHCSA-N 0.000 description 1
- GVKKVHNRTUFCCE-BJDJZHNGSA-N Ile-Leu-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)N GVKKVHNRTUFCCE-BJDJZHNGSA-N 0.000 description 1
- PWUMCBLVWPCKNO-MGHWNKPDSA-N Ile-Leu-Tyr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 PWUMCBLVWPCKNO-MGHWNKPDSA-N 0.000 description 1
- MASWXTFJVNRZPT-NAKRPEOUSA-N Ile-Met-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)O)N MASWXTFJVNRZPT-NAKRPEOUSA-N 0.000 description 1
- DNKDIDZHXZAGRY-HJWJTTGWSA-N Ile-Met-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N DNKDIDZHXZAGRY-HJWJTTGWSA-N 0.000 description 1
- SNHYFFQZRFIRHO-CYDGBPFRSA-N Ile-Met-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)O)N SNHYFFQZRFIRHO-CYDGBPFRSA-N 0.000 description 1
- PELCGFMHLZXWBQ-BJDJZHNGSA-N Ile-Ser-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)N PELCGFMHLZXWBQ-BJDJZHNGSA-N 0.000 description 1
- WLRJHVNFGAOYPS-HJPIBITLSA-N Ile-Ser-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N WLRJHVNFGAOYPS-HJPIBITLSA-N 0.000 description 1
- HXIDVIFHRYRXLZ-NAKRPEOUSA-N Ile-Ser-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)O)N HXIDVIFHRYRXLZ-NAKRPEOUSA-N 0.000 description 1
- NURNJECQNNCRBK-FLBSBUHZSA-N Ile-Thr-Thr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NURNJECQNNCRBK-FLBSBUHZSA-N 0.000 description 1
- XVUAQNRNFMVWBR-BLMTYFJBSA-N Ile-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N XVUAQNRNFMVWBR-BLMTYFJBSA-N 0.000 description 1
- PRTZQMBYUZFSFA-XEGUGMAKSA-N Ile-Tyr-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)NCC(=O)O)N PRTZQMBYUZFSFA-XEGUGMAKSA-N 0.000 description 1
- GVEODXUBBFDBPW-MGHWNKPDSA-N Ile-Tyr-Leu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 GVEODXUBBFDBPW-MGHWNKPDSA-N 0.000 description 1
- ZGKVPOSSTGHJAF-HJPIBITLSA-N Ile-Tyr-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CO)C(=O)O)N ZGKVPOSSTGHJAF-HJPIBITLSA-N 0.000 description 1
- AUIYHFRUOOKTGX-UKJIMTQDSA-N Ile-Val-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N AUIYHFRUOOKTGX-UKJIMTQDSA-N 0.000 description 1
- RQZFWBLDTBDEOF-RNJOBUHISA-N Ile-Val-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N RQZFWBLDTBDEOF-RNJOBUHISA-N 0.000 description 1
- JZBVBOKASHNXAD-NAKRPEOUSA-N Ile-Val-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)O)N JZBVBOKASHNXAD-NAKRPEOUSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- LHSGPCFBGJHPCY-UHFFFAOYSA-N L-leucine-L-tyrosine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 LHSGPCFBGJHPCY-UHFFFAOYSA-N 0.000 description 1
- KFKWRHQBZQICHA-STQMWFEESA-N L-leucyl-L-phenylalanine Natural products CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KFKWRHQBZQICHA-STQMWFEESA-N 0.000 description 1
- TYYLDKGBCJGJGW-UHFFFAOYSA-N L-tryptophan-L-tyrosine Natural products C=1NC2=CC=CC=C2C=1CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 TYYLDKGBCJGJGW-UHFFFAOYSA-N 0.000 description 1
- FGBAVQUHSKYMTC-UHFFFAOYSA-M LDS 751 dye Chemical compound [O-]Cl(=O)(=O)=O.C1=CC2=CC(N(C)C)=CC=C2[N+](CC)=C1C=CC=CC1=CC=C(N(C)C)C=C1 FGBAVQUHSKYMTC-UHFFFAOYSA-M 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241001596950 Larimichthys crocea Species 0.000 description 1
- KVRKAGGMEWNURO-CIUDSAMLSA-N Leu-Ala-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(C)C)N KVRKAGGMEWNURO-CIUDSAMLSA-N 0.000 description 1
- MJOZZTKJZQFKDK-GUBZILKMSA-N Leu-Ala-Gln Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(N)=O MJOZZTKJZQFKDK-GUBZILKMSA-N 0.000 description 1
- GRZSCTXVCDUIPO-SRVKXCTJSA-N Leu-Arg-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O GRZSCTXVCDUIPO-SRVKXCTJSA-N 0.000 description 1
- YOZCKMXHBYKOMQ-IHRRRGAJSA-N Leu-Arg-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)O)N YOZCKMXHBYKOMQ-IHRRRGAJSA-N 0.000 description 1
- IBMVEYRWAWIOTN-RWMBFGLXSA-N Leu-Arg-Pro Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(O)=O IBMVEYRWAWIOTN-RWMBFGLXSA-N 0.000 description 1
- DLCOFDAHNMMQPP-SRVKXCTJSA-N Leu-Asp-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DLCOFDAHNMMQPP-SRVKXCTJSA-N 0.000 description 1
- PPBKJAQJAUHZKX-SRVKXCTJSA-N Leu-Cys-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(O)=O)CC(C)C PPBKJAQJAUHZKX-SRVKXCTJSA-N 0.000 description 1
- CQGSYZCULZMEDE-UHFFFAOYSA-N Leu-Gln-Pro Natural products CC(C)CC(N)C(=O)NC(CCC(N)=O)C(=O)N1CCCC1C(O)=O CQGSYZCULZMEDE-UHFFFAOYSA-N 0.000 description 1
- KUEVMUXNILMJTK-JYJNAYRXSA-N Leu-Gln-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 KUEVMUXNILMJTK-JYJNAYRXSA-N 0.000 description 1
- LLBQJYDYOLIQAI-JYJNAYRXSA-N Leu-Glu-Tyr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O LLBQJYDYOLIQAI-JYJNAYRXSA-N 0.000 description 1
- VWHGTYCRDRBSFI-ZETCQYMHSA-N Leu-Gly-Gly Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)NCC(O)=O VWHGTYCRDRBSFI-ZETCQYMHSA-N 0.000 description 1
- VBZOAGIPCULURB-QWRGUYRKSA-N Leu-Gly-His Chemical compound CC(C)C[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N VBZOAGIPCULURB-QWRGUYRKSA-N 0.000 description 1
- HYIFFZAQXPUEAU-QWRGUYRKSA-N Leu-Gly-Leu Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(C)C HYIFFZAQXPUEAU-QWRGUYRKSA-N 0.000 description 1
- UCDHVOALNXENLC-KBPBESRZSA-N Leu-Gly-Tyr Chemical compound CC(C)C[C@H]([NH3+])C(=O)NCC(=O)N[C@H](C([O-])=O)CC1=CC=C(O)C=C1 UCDHVOALNXENLC-KBPBESRZSA-N 0.000 description 1
- POZULHZYLPGXMR-ONGXEEELSA-N Leu-Gly-Val Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O POZULHZYLPGXMR-ONGXEEELSA-N 0.000 description 1
- AUBMZAMQCOYSIC-MNXVOIDGSA-N Leu-Ile-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(O)=O AUBMZAMQCOYSIC-MNXVOIDGSA-N 0.000 description 1
- JFSGIJSCJFQGSZ-MXAVVETBSA-N Leu-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC(C)C)N JFSGIJSCJFQGSZ-MXAVVETBSA-N 0.000 description 1
- KUIDCYNIEJBZBU-AJNGGQMLSA-N Leu-Ile-Leu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O KUIDCYNIEJBZBU-AJNGGQMLSA-N 0.000 description 1
- NRFGTHFONZYFNY-MGHWNKPDSA-N Leu-Ile-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NRFGTHFONZYFNY-MGHWNKPDSA-N 0.000 description 1
- JKSIBWITFMQTOA-XUXIUFHCSA-N Leu-Ile-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O JKSIBWITFMQTOA-XUXIUFHCSA-N 0.000 description 1
- IFMPDNRWZZEZSL-SRVKXCTJSA-N Leu-Leu-Cys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(O)=O IFMPDNRWZZEZSL-SRVKXCTJSA-N 0.000 description 1
- FAELBUXXFQLUAX-AJNGGQMLSA-N Leu-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C FAELBUXXFQLUAX-AJNGGQMLSA-N 0.000 description 1
- LXKNSJLSGPNHSK-KKUMJFAQSA-N Leu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N LXKNSJLSGPNHSK-KKUMJFAQSA-N 0.000 description 1
- PPQRKXHCLYCBSP-IHRRRGAJSA-N Leu-Leu-Met Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)O)N PPQRKXHCLYCBSP-IHRRRGAJSA-N 0.000 description 1
- FOBUGKUBUJOWAD-IHPCNDPISA-N Leu-Leu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(O)=O)=CNC2=C1 FOBUGKUBUJOWAD-IHPCNDPISA-N 0.000 description 1
- LVTJJOJKDCVZGP-QWRGUYRKSA-N Leu-Lys-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O LVTJJOJKDCVZGP-QWRGUYRKSA-N 0.000 description 1
- VCHVSKNMTXWIIP-SRVKXCTJSA-N Leu-Lys-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O VCHVSKNMTXWIIP-SRVKXCTJSA-N 0.000 description 1
- MJTOYIHCKVQICL-ULQDDVLXSA-N Leu-Met-Phe Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N MJTOYIHCKVQICL-ULQDDVLXSA-N 0.000 description 1
- HDHQQEDVWQGBEE-DCAQKATOSA-N Leu-Met-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(O)=O HDHQQEDVWQGBEE-DCAQKATOSA-N 0.000 description 1
- GSSMYQHXZNERFX-WDSOQIARSA-N Leu-Met-Trp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N GSSMYQHXZNERFX-WDSOQIARSA-N 0.000 description 1
- PTRKPHUGYULXPU-KKUMJFAQSA-N Leu-Phe-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O PTRKPHUGYULXPU-KKUMJFAQSA-N 0.000 description 1
- XWEVVRRSIOBJOO-SRVKXCTJSA-N Leu-Pro-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O XWEVVRRSIOBJOO-SRVKXCTJSA-N 0.000 description 1
- CHJKEDSZNSONPS-DCAQKATOSA-N Leu-Pro-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O CHJKEDSZNSONPS-DCAQKATOSA-N 0.000 description 1
- KIZIOFNVSOSKJI-CIUDSAMLSA-N Leu-Ser-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N KIZIOFNVSOSKJI-CIUDSAMLSA-N 0.000 description 1
- MVHXGBZUJLWZOH-BJDJZHNGSA-N Leu-Ser-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O MVHXGBZUJLWZOH-BJDJZHNGSA-N 0.000 description 1
- AMSSKPUHBUQBOQ-SRVKXCTJSA-N Leu-Ser-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N AMSSKPUHBUQBOQ-SRVKXCTJSA-N 0.000 description 1
- SVBJIZVVYJYGLA-DCAQKATOSA-N Leu-Ser-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O SVBJIZVVYJYGLA-DCAQKATOSA-N 0.000 description 1
- ZJZNLRVCZWUONM-JXUBOQSCSA-N Leu-Thr-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O ZJZNLRVCZWUONM-JXUBOQSCSA-N 0.000 description 1
- ZDJQVSIPFLMNOX-RHYQMDGZSA-N Leu-Thr-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N ZDJQVSIPFLMNOX-RHYQMDGZSA-N 0.000 description 1
- AEDWWMMHUGYIFD-HJGDQZAQSA-N Leu-Thr-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O AEDWWMMHUGYIFD-HJGDQZAQSA-N 0.000 description 1
- LCNASHSOFMRYFO-WDCWCFNPSA-N Leu-Thr-Gln Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCC(N)=O LCNASHSOFMRYFO-WDCWCFNPSA-N 0.000 description 1
- LFSQWRSVPNKJGP-WDCWCFNPSA-N Leu-Thr-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCC(O)=O LFSQWRSVPNKJGP-WDCWCFNPSA-N 0.000 description 1
- LJBVRCDPWOJOEK-PPCPHDFISA-N Leu-Thr-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LJBVRCDPWOJOEK-PPCPHDFISA-N 0.000 description 1
- QWWPYKKLXWOITQ-VOAKCMCISA-N Leu-Thr-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(C)C QWWPYKKLXWOITQ-VOAKCMCISA-N 0.000 description 1
- DAYQSYGBCUKVKT-VOAKCMCISA-N Leu-Thr-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O DAYQSYGBCUKVKT-VOAKCMCISA-N 0.000 description 1
- KLSUAWUZBMAZCL-RHYQMDGZSA-N Leu-Thr-Pro Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(O)=O KLSUAWUZBMAZCL-RHYQMDGZSA-N 0.000 description 1
- ILDSIMPXNFWKLH-KATARQTJSA-N Leu-Thr-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O ILDSIMPXNFWKLH-KATARQTJSA-N 0.000 description 1
- HGLKOTPFWOMPOB-MEYUZBJRSA-N Leu-Thr-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 HGLKOTPFWOMPOB-MEYUZBJRSA-N 0.000 description 1
- AIQWYVFNBNNOLU-RHYQMDGZSA-N Leu-Thr-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O AIQWYVFNBNNOLU-RHYQMDGZSA-N 0.000 description 1
- IDGRADDMTTWOQC-WDSOQIARSA-N Leu-Trp-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O IDGRADDMTTWOQC-WDSOQIARSA-N 0.000 description 1
- HOMFINRJHIIZNJ-HOCLYGCPSA-N Leu-Trp-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(O)=O HOMFINRJHIIZNJ-HOCLYGCPSA-N 0.000 description 1
- YLMIDMSLKLRNHX-HSCHXYMDSA-N Leu-Trp-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O YLMIDMSLKLRNHX-HSCHXYMDSA-N 0.000 description 1
- FPFOYSCDUWTZBF-IHPCNDPISA-N Leu-Trp-Leu Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H]([NH3+])CC(C)C)C(=O)N[C@@H](CC(C)C)C([O-])=O)=CNC2=C1 FPFOYSCDUWTZBF-IHPCNDPISA-N 0.000 description 1
- WBRJVRXEGQIDRK-XIRDDKMYSA-N Leu-Trp-Ser Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CO)C(O)=O)=CNC2=C1 WBRJVRXEGQIDRK-XIRDDKMYSA-N 0.000 description 1
- ISSAURVGLGAPDK-KKUMJFAQSA-N Leu-Tyr-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O ISSAURVGLGAPDK-KKUMJFAQSA-N 0.000 description 1
- WFCKERTZVCQXKH-KBPBESRZSA-N Leu-Tyr-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(O)=O WFCKERTZVCQXKH-KBPBESRZSA-N 0.000 description 1
- ARNIBBOXIAWUOP-MGHWNKPDSA-N Leu-Tyr-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ARNIBBOXIAWUOP-MGHWNKPDSA-N 0.000 description 1
- UFPLDOKWDNTTRP-ULQDDVLXSA-N Leu-Tyr-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)CC1=CC=C(O)C=C1 UFPLDOKWDNTTRP-ULQDDVLXSA-N 0.000 description 1
- VUBIPAHVHMZHCM-KKUMJFAQSA-N Leu-Tyr-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(O)=O)CC1=CC=C(O)C=C1 VUBIPAHVHMZHCM-KKUMJFAQSA-N 0.000 description 1
- BGGTYDNTOYRTTR-MEYUZBJRSA-N Leu-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(C)C)N)O BGGTYDNTOYRTTR-MEYUZBJRSA-N 0.000 description 1
- XZNJZXJZBMBGGS-NHCYSSNCSA-N Leu-Val-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O XZNJZXJZBMBGGS-NHCYSSNCSA-N 0.000 description 1
- VKVDRTGWLVZJOM-DCAQKATOSA-N Leu-Val-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O VKVDRTGWLVZJOM-DCAQKATOSA-N 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- FZIJIFCXUCZHOL-CIUDSAMLSA-N Lys-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN FZIJIFCXUCZHOL-CIUDSAMLSA-N 0.000 description 1
- BTSXLXFPMZXVPR-DLOVCJGASA-N Lys-Ala-His Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCCCN)N BTSXLXFPMZXVPR-DLOVCJGASA-N 0.000 description 1
- UWKNTTJNVSYXPC-CIUDSAMLSA-N Lys-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN UWKNTTJNVSYXPC-CIUDSAMLSA-N 0.000 description 1
- YVSHZSUKQHNDHD-KKUMJFAQSA-N Lys-Asn-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCCN)N YVSHZSUKQHNDHD-KKUMJFAQSA-N 0.000 description 1
- DGWXCIORNLWGGG-CIUDSAMLSA-N Lys-Asn-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O DGWXCIORNLWGGG-CIUDSAMLSA-N 0.000 description 1
- OVIVOCSURJYCTM-GUBZILKMSA-N Lys-Asp-Glu Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCC(O)=O OVIVOCSURJYCTM-GUBZILKMSA-N 0.000 description 1
- BYEBKXRNDLTGFW-CIUDSAMLSA-N Lys-Cys-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O BYEBKXRNDLTGFW-CIUDSAMLSA-N 0.000 description 1
- MRWXLRGAFDOILG-DCAQKATOSA-N Lys-Gln-Gln Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MRWXLRGAFDOILG-DCAQKATOSA-N 0.000 description 1
- LLSUNJYOSCOOEB-GUBZILKMSA-N Lys-Glu-Asp Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O LLSUNJYOSCOOEB-GUBZILKMSA-N 0.000 description 1
- CRNNMTHBMRFQNG-GUBZILKMSA-N Lys-Glu-Cys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)O)N CRNNMTHBMRFQNG-GUBZILKMSA-N 0.000 description 1
- VEGLGAOVLFODGC-GUBZILKMSA-N Lys-Glu-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O VEGLGAOVLFODGC-GUBZILKMSA-N 0.000 description 1
- RFQATBGBLDAKGI-VHSXEESVSA-N Lys-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CCCCN)N)C(=O)O RFQATBGBLDAKGI-VHSXEESVSA-N 0.000 description 1
- FHIAJWBDZVHLAH-YUMQZZPRSA-N Lys-Gly-Ser Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O FHIAJWBDZVHLAH-YUMQZZPRSA-N 0.000 description 1
- NNKLKUUGESXCBS-KBPBESRZSA-N Lys-Gly-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O NNKLKUUGESXCBS-KBPBESRZSA-N 0.000 description 1
- KKFVKBWCXXLKIK-AVGNSLFASA-N Lys-His-Glu Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CCCCN)N KKFVKBWCXXLKIK-AVGNSLFASA-N 0.000 description 1
- YXTKSLRSRXKXNV-IHRRRGAJSA-N Lys-His-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCCCN)N YXTKSLRSRXKXNV-IHRRRGAJSA-N 0.000 description 1
- SPCHLZUWJTYZFC-IHRRRGAJSA-N Lys-His-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C(C)C)C(O)=O SPCHLZUWJTYZFC-IHRRRGAJSA-N 0.000 description 1
- MXMDJEJWERYPMO-XUXIUFHCSA-N Lys-Ile-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O MXMDJEJWERYPMO-XUXIUFHCSA-N 0.000 description 1
- ONPDTSFZAIWMDI-AVGNSLFASA-N Lys-Leu-Gln Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O ONPDTSFZAIWMDI-AVGNSLFASA-N 0.000 description 1
- VMTYLUGCXIEDMV-QWRGUYRKSA-N Lys-Leu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN VMTYLUGCXIEDMV-QWRGUYRKSA-N 0.000 description 1
- XIZQPFCRXLUNMK-BZSNNMDCSA-N Lys-Leu-Phe Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCCCN)N XIZQPFCRXLUNMK-BZSNNMDCSA-N 0.000 description 1
- VUTWYNQUSJWBHO-BZSNNMDCSA-N Lys-Leu-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O VUTWYNQUSJWBHO-BZSNNMDCSA-N 0.000 description 1
- RIJCHEVHFWMDKD-SRVKXCTJSA-N Lys-Lys-Asn Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O RIJCHEVHFWMDKD-SRVKXCTJSA-N 0.000 description 1
- YUAXTFMFMOIMAM-QWRGUYRKSA-N Lys-Lys-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O YUAXTFMFMOIMAM-QWRGUYRKSA-N 0.000 description 1
- YDDDRTIPNTWGIG-SRVKXCTJSA-N Lys-Lys-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O YDDDRTIPNTWGIG-SRVKXCTJSA-N 0.000 description 1
- SKUOQDYMJFUMOE-ULQDDVLXSA-N Lys-Met-Phe Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCCCN)N SKUOQDYMJFUMOE-ULQDDVLXSA-N 0.000 description 1
- LMGNWHDWJDIOPK-DKIMLUQUSA-N Lys-Phe-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LMGNWHDWJDIOPK-DKIMLUQUSA-N 0.000 description 1
- LUAJJLPHUXPQLH-KKUMJFAQSA-N Lys-Phe-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCCCN)N LUAJJLPHUXPQLH-KKUMJFAQSA-N 0.000 description 1
- WLXGMVVHTIUPHE-ULQDDVLXSA-N Lys-Phe-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O WLXGMVVHTIUPHE-ULQDDVLXSA-N 0.000 description 1
- MSSABBQOBUZFKZ-IHRRRGAJSA-N Lys-Pro-His Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CCCCN)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O MSSABBQOBUZFKZ-IHRRRGAJSA-N 0.000 description 1
- SQXZLVXQXWILKW-KKUMJFAQSA-N Lys-Ser-Phe Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SQXZLVXQXWILKW-KKUMJFAQSA-N 0.000 description 1
- MIFFFXHMAHFACR-KATARQTJSA-N Lys-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCCN MIFFFXHMAHFACR-KATARQTJSA-N 0.000 description 1
- PLOUVAYOMTYJRG-JXUBOQSCSA-N Lys-Thr-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O PLOUVAYOMTYJRG-JXUBOQSCSA-N 0.000 description 1
- JHNOXVASMSXSNB-WEDXCCLWSA-N Lys-Thr-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O JHNOXVASMSXSNB-WEDXCCLWSA-N 0.000 description 1
- RPWTZTBIFGENIA-VOAKCMCISA-N Lys-Thr-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O RPWTZTBIFGENIA-VOAKCMCISA-N 0.000 description 1
- CAVRAQIDHUPECU-UVOCVTCTSA-N Lys-Thr-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CAVRAQIDHUPECU-UVOCVTCTSA-N 0.000 description 1
- XABXVVSWUVCZST-GVXVVHGQSA-N Lys-Val-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCCN XABXVVSWUVCZST-GVXVVHGQSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000283923 Marmota monax Species 0.000 description 1
- LMKSBGIUPVRHEH-FXQIFTODSA-N Met-Ala-Asn Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(N)=O LMKSBGIUPVRHEH-FXQIFTODSA-N 0.000 description 1
- WYEXWKAWMNJKPN-UBHSHLNASA-N Met-Ala-Phe Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCSC)N WYEXWKAWMNJKPN-UBHSHLNASA-N 0.000 description 1
- BVXXDMUMHMXFER-BPNCWPANSA-N Met-Ala-Tyr Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O BVXXDMUMHMXFER-BPNCWPANSA-N 0.000 description 1
- DTICLBJHRYSJLH-GUBZILKMSA-N Met-Ala-Val Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O DTICLBJHRYSJLH-GUBZILKMSA-N 0.000 description 1
- WDTLNWHPIPCMMP-AVGNSLFASA-N Met-Arg-Leu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O WDTLNWHPIPCMMP-AVGNSLFASA-N 0.000 description 1
- OLWAOWXIADGIJG-AVGNSLFASA-N Met-Arg-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(O)=O OLWAOWXIADGIJG-AVGNSLFASA-N 0.000 description 1
- VOOINLQYUZOREH-SRVKXCTJSA-N Met-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCSC)N VOOINLQYUZOREH-SRVKXCTJSA-N 0.000 description 1
- MYAPQOBHGWJZOM-UWVGGRQHSA-N Met-Gly-Leu Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(C)C MYAPQOBHGWJZOM-UWVGGRQHSA-N 0.000 description 1
- SXWQMBGNFXAGAT-FJXKBIBVSA-N Met-Gly-Thr Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O SXWQMBGNFXAGAT-FJXKBIBVSA-N 0.000 description 1
- TZHFJXDKXGZHEN-IHRRRGAJSA-N Met-His-Leu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O TZHFJXDKXGZHEN-IHRRRGAJSA-N 0.000 description 1
- WPTDJKDGICUFCP-XUXIUFHCSA-N Met-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCSC)N WPTDJKDGICUFCP-XUXIUFHCSA-N 0.000 description 1
- FTQOFRPGLYXRFM-CYDGBPFRSA-N Met-Ile-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CCSC)N FTQOFRPGLYXRFM-CYDGBPFRSA-N 0.000 description 1
- FWAHLGXNBLWIKB-NAKRPEOUSA-N Met-Ile-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCSC FWAHLGXNBLWIKB-NAKRPEOUSA-N 0.000 description 1
- ODFBIJXEWPWSAN-CYDGBPFRSA-N Met-Ile-Val Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O ODFBIJXEWPWSAN-CYDGBPFRSA-N 0.000 description 1
- AFFKUNVPPLQUGA-DCAQKATOSA-N Met-Leu-Ala Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O AFFKUNVPPLQUGA-DCAQKATOSA-N 0.000 description 1
- SODXFJOPSCXOHE-IHRRRGAJSA-N Met-Leu-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O SODXFJOPSCXOHE-IHRRRGAJSA-N 0.000 description 1
- IRVONVRHHJXWTK-RWMBFGLXSA-N Met-Lys-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@@H]1C(=O)O)N IRVONVRHHJXWTK-RWMBFGLXSA-N 0.000 description 1
- VAGCEUUEMMXFEX-GUBZILKMSA-N Met-Met-Asn Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(O)=O VAGCEUUEMMXFEX-GUBZILKMSA-N 0.000 description 1
- YHBHDYYHOUAKLR-AVGNSLFASA-N Met-Met-His Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N YHBHDYYHOUAKLR-AVGNSLFASA-N 0.000 description 1
- QTMIXEQWGNIPBL-JYJNAYRXSA-N Met-Met-Tyr Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N QTMIXEQWGNIPBL-JYJNAYRXSA-N 0.000 description 1
- BQHLZUMZOXUWNU-DCAQKATOSA-N Met-Pro-Glu Chemical compound CSCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)O)N BQHLZUMZOXUWNU-DCAQKATOSA-N 0.000 description 1
- QLESZRANMSYLCZ-CYDGBPFRSA-N Met-Pro-Ile Chemical compound [H]N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(O)=O QLESZRANMSYLCZ-CYDGBPFRSA-N 0.000 description 1
- LXCSZPUQKMTXNW-BQBZGAKWSA-N Met-Ser-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O LXCSZPUQKMTXNW-BQBZGAKWSA-N 0.000 description 1
- GGXZOTSDJJTDGB-GUBZILKMSA-N Met-Ser-Val Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O GGXZOTSDJJTDGB-GUBZILKMSA-N 0.000 description 1
- VOAKKHOIAFKOQZ-JYJNAYRXSA-N Met-Tyr-Arg Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)CC1=CC=C(O)C=C1 VOAKKHOIAFKOQZ-JYJNAYRXSA-N 0.000 description 1
- VYDLZDRMOFYOGV-TUAOUCFPSA-N Met-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCSC)N VYDLZDRMOFYOGV-TUAOUCFPSA-N 0.000 description 1
- WYBVBIHNJWOLCJ-UHFFFAOYSA-N N-L-arginyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCCN=C(N)N WYBVBIHNJWOLCJ-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 1
- 108010086428 NADH Dehydrogenase Proteins 0.000 description 1
- 102000006746 NADH Dehydrogenase Human genes 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 108091093037 Peptide nucleic acid Proteins 0.000 description 1
- WSXKXSBOJXEZDV-DLOVCJGASA-N Phe-Ala-Asn Chemical compound NC(=O)C[C@@H](C([O-])=O)NC(=O)[C@H](C)NC(=O)[C@@H]([NH3+])CC1=CC=CC=C1 WSXKXSBOJXEZDV-DLOVCJGASA-N 0.000 description 1
- QMMRHASQEVCJGR-UBHSHLNASA-N Phe-Ala-Pro Chemical compound C([C@H](N)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=CC=C1 QMMRHASQEVCJGR-UBHSHLNASA-N 0.000 description 1
- MRNRMSDVVSKPGM-AVGNSLFASA-N Phe-Asn-Gln Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MRNRMSDVVSKPGM-AVGNSLFASA-N 0.000 description 1
- KIEPQOIQHFKQLK-PCBIJLKTSA-N Phe-Asn-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KIEPQOIQHFKQLK-PCBIJLKTSA-N 0.000 description 1
- CDNPIRSCAFMMBE-SRVKXCTJSA-N Phe-Asn-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O CDNPIRSCAFMMBE-SRVKXCTJSA-N 0.000 description 1
- DDYIRGBOZVKRFR-AVGNSLFASA-N Phe-Asp-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N DDYIRGBOZVKRFR-AVGNSLFASA-N 0.000 description 1
- RIYZXJVARWJLKS-KKUMJFAQSA-N Phe-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 RIYZXJVARWJLKS-KKUMJFAQSA-N 0.000 description 1
- OJUMUUXGSXUZJZ-SRVKXCTJSA-N Phe-Asp-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O OJUMUUXGSXUZJZ-SRVKXCTJSA-N 0.000 description 1
- FRPVPGRXUKFEQE-YDHLFZDLSA-N Phe-Asp-Val Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O FRPVPGRXUKFEQE-YDHLFZDLSA-N 0.000 description 1
- LXUJDHOKVUYHRC-KKUMJFAQSA-N Phe-Cys-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC1=CC=CC=C1)N LXUJDHOKVUYHRC-KKUMJFAQSA-N 0.000 description 1
- WYPVCIACUMJRIB-JYJNAYRXSA-N Phe-Gln-Lys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N WYPVCIACUMJRIB-JYJNAYRXSA-N 0.000 description 1
- NKLDZIPTGKBDBB-HTUGSXCWSA-N Phe-Gln-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC1=CC=CC=C1)N)O NKLDZIPTGKBDBB-HTUGSXCWSA-N 0.000 description 1
- BFYHIHGIHGROAT-HTUGSXCWSA-N Phe-Glu-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BFYHIHGIHGROAT-HTUGSXCWSA-N 0.000 description 1
- WFHRXJOZEXUKLV-IRXDYDNUSA-N Phe-Gly-Tyr Chemical compound C([C@H](N)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 WFHRXJOZEXUKLV-IRXDYDNUSA-N 0.000 description 1
- FXYXBEZMRACDDR-KKUMJFAQSA-N Phe-His-Asp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(O)=O FXYXBEZMRACDDR-KKUMJFAQSA-N 0.000 description 1
- FINLZXKJWTYYLC-ACRUOGEOSA-N Phe-His-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 FINLZXKJWTYYLC-ACRUOGEOSA-N 0.000 description 1
- BEEVXUYVEHXWRQ-YESZJQIVSA-N Phe-His-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC3=CC=CC=C3)N)C(=O)O BEEVXUYVEHXWRQ-YESZJQIVSA-N 0.000 description 1
- KBVJZCVLQWCJQN-KKUMJFAQSA-N Phe-Leu-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O KBVJZCVLQWCJQN-KKUMJFAQSA-N 0.000 description 1
- KPEIBEPEUAZWNS-ULQDDVLXSA-N Phe-Leu-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 KPEIBEPEUAZWNS-ULQDDVLXSA-N 0.000 description 1
- VHDNDCPMHQMXIR-IHRRRGAJSA-N Phe-Met-Cys Chemical compound SC[C@@H](C(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CC1=CC=CC=C1 VHDNDCPMHQMXIR-IHRRRGAJSA-N 0.000 description 1
- MMJJFXWMCMJMQA-STQMWFEESA-N Phe-Pro-Gly Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)NCC(O)=O)C1=CC=CC=C1 MMJJFXWMCMJMQA-STQMWFEESA-N 0.000 description 1
- AFNJAQVMTIQTCB-DLOVCJGASA-N Phe-Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=CC=C1 AFNJAQVMTIQTCB-DLOVCJGASA-N 0.000 description 1
- YMIZSYUAZJSOFL-SRVKXCTJSA-N Phe-Ser-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O YMIZSYUAZJSOFL-SRVKXCTJSA-N 0.000 description 1
- ILGCZYGFYQLSDZ-KKUMJFAQSA-N Phe-Ser-His Chemical compound N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O ILGCZYGFYQLSDZ-KKUMJFAQSA-N 0.000 description 1
- GMWNQSGWWGKTSF-LFSVMHDDSA-N Phe-Thr-Ala Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O GMWNQSGWWGKTSF-LFSVMHDDSA-N 0.000 description 1
- YDUGVDGFKNXFPL-IXOXFDKPSA-N Phe-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N)O YDUGVDGFKNXFPL-IXOXFDKPSA-N 0.000 description 1
- BSKMOCNNLNDIMU-CDMKHQONSA-N Phe-Thr-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O BSKMOCNNLNDIMU-CDMKHQONSA-N 0.000 description 1
- GNRMAQSIROFNMI-IXOXFDKPSA-N Phe-Thr-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O GNRMAQSIROFNMI-IXOXFDKPSA-N 0.000 description 1
- YFXXRYFWJFQAFW-JHYOHUSXSA-N Phe-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N)O YFXXRYFWJFQAFW-JHYOHUSXSA-N 0.000 description 1
- MHNBYYFXWDUGBW-RPTUDFQQSA-N Phe-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC2=CC=CC=C2)N)O MHNBYYFXWDUGBW-RPTUDFQQSA-N 0.000 description 1
- MWQXFDIQXIXPMS-UNQGMJICSA-N Phe-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC1=CC=CC=C1)N)O MWQXFDIQXIXPMS-UNQGMJICSA-N 0.000 description 1
- 108010004729 Phycoerythrin Proteins 0.000 description 1
- ZYFVNVRFVHJEIU-UHFFFAOYSA-N PicoGreen Chemical compound CN(C)CCCN(CCCN(C)C)C1=CC(=CC2=[N+](C3=CC=CC=C3S2)C)C2=CC=CC=C2N1C1=CC=CC=C1 ZYFVNVRFVHJEIU-UHFFFAOYSA-N 0.000 description 1
- QBKMWMZYHZILHF-UHFFFAOYSA-L Po-Pro-1 Chemical compound [I-].[I-].O1C2=CC=CC=C2[N+](C)=C1C=C1C=CN(CCC[N+](C)(C)C)C=C1 QBKMWMZYHZILHF-UHFFFAOYSA-L 0.000 description 1
- CZQJZBNARVNSLQ-UHFFFAOYSA-L Po-Pro-3 Chemical compound [I-].[I-].O1C2=CC=CC=C2[N+](C)=C1C=CC=C1C=CN(CCC[N+](C)(C)C)C=C1 CZQJZBNARVNSLQ-UHFFFAOYSA-L 0.000 description 1
- BOLJGYHEBJNGBV-UHFFFAOYSA-J PoPo-1 Chemical compound [I-].[I-].[I-].[I-].O1C2=CC=CC=C2[N+](C)=C1C=C1C=CN(CCC[N+](C)(C)CCC[N+](C)(C)CCCN2C=CC(=CC3=[N+](C4=CC=CC=C4O3)C)C=C2)C=C1 BOLJGYHEBJNGBV-UHFFFAOYSA-J 0.000 description 1
- GYPIAQJSRPTNTI-UHFFFAOYSA-J PoPo-3 Chemical compound [I-].[I-].[I-].[I-].O1C2=CC=CC=C2[N+](C)=C1C=CC=C1C=CN(CCC[N+](C)(C)CCC[N+](C)(C)CCCN2C=CC(=CC=CC3=[N+](C4=CC=CC=C4O3)C)C=C2)C=C1 GYPIAQJSRPTNTI-UHFFFAOYSA-J 0.000 description 1
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 description 1
- DZZCICYRSZASNF-FXQIFTODSA-N Pro-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 DZZCICYRSZASNF-FXQIFTODSA-N 0.000 description 1
- AJLVKXCNXIJHDV-CIUDSAMLSA-N Pro-Ala-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O AJLVKXCNXIJHDV-CIUDSAMLSA-N 0.000 description 1
- LNLNHXIQPGKRJQ-SRVKXCTJSA-N Pro-Arg-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1 LNLNHXIQPGKRJQ-SRVKXCTJSA-N 0.000 description 1
- KDIIENQUNVNWHR-JYJNAYRXSA-N Pro-Arg-Phe Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O KDIIENQUNVNWHR-JYJNAYRXSA-N 0.000 description 1
- WWAQEUOYCYMGHB-FXQIFTODSA-N Pro-Asn-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1 WWAQEUOYCYMGHB-FXQIFTODSA-N 0.000 description 1
- OBVCYFIHIIYIQF-CIUDSAMLSA-N Pro-Asn-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O OBVCYFIHIIYIQF-CIUDSAMLSA-N 0.000 description 1
- AHXPYZRZRMQOAU-QXEWZRGKSA-N Pro-Asn-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1)C(O)=O AHXPYZRZRMQOAU-QXEWZRGKSA-N 0.000 description 1
- UPJGUQPLYWTISV-GUBZILKMSA-N Pro-Gln-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O UPJGUQPLYWTISV-GUBZILKMSA-N 0.000 description 1
- ZTVCLZLGHZXLOT-ULQDDVLXSA-N Pro-Glu-Trp Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)O ZTVCLZLGHZXLOT-ULQDDVLXSA-N 0.000 description 1
- GBRUQFBAJOKCTF-DCAQKATOSA-N Pro-His-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(O)=O GBRUQFBAJOKCTF-DCAQKATOSA-N 0.000 description 1
- STASJMBVVHNWCG-IHRRRGAJSA-N Pro-His-Leu Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C([O-])=O)NC(=O)[C@H]1[NH2+]CCC1)C1=CN=CN1 STASJMBVVHNWCG-IHRRRGAJSA-N 0.000 description 1
- XYHMFGGWNOFUOU-QXEWZRGKSA-N Pro-Ile-Gly Chemical compound OC(=O)CNC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]1CCCN1 XYHMFGGWNOFUOU-QXEWZRGKSA-N 0.000 description 1
- FKVNLUZHSFCNGY-RVMXOQNASA-N Pro-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 FKVNLUZHSFCNGY-RVMXOQNASA-N 0.000 description 1
- FXGIMYRVJJEIIM-UWVGGRQHSA-N Pro-Leu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1 FXGIMYRVJJEIIM-UWVGGRQHSA-N 0.000 description 1
- HATVCTYBNCNMAA-AVGNSLFASA-N Pro-Leu-Met Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(O)=O HATVCTYBNCNMAA-AVGNSLFASA-N 0.000 description 1
- OFGUOWQVEGTVNU-DCAQKATOSA-N Pro-Lys-Ala Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O OFGUOWQVEGTVNU-DCAQKATOSA-N 0.000 description 1
- ANESFYPBAJPYNJ-SDDRHHMPSA-N Pro-Met-Pro Chemical compound CSCC[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 ANESFYPBAJPYNJ-SDDRHHMPSA-N 0.000 description 1
- LGMBKOAPPTYKLC-JYJNAYRXSA-N Pro-Phe-Arg Chemical compound C([C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(O)=O)NC(=O)[C@H]1NCCC1)C1=CC=CC=C1 LGMBKOAPPTYKLC-JYJNAYRXSA-N 0.000 description 1
- AWQGDZBKQTYNMN-IHRRRGAJSA-N Pro-Phe-Asp Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC(=O)O)C(=O)O AWQGDZBKQTYNMN-IHRRRGAJSA-N 0.000 description 1
- WHNJMTHJGCEKGA-ULQDDVLXSA-N Pro-Phe-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O WHNJMTHJGCEKGA-ULQDDVLXSA-N 0.000 description 1
- QKDIHFHGHBYTKB-IHRRRGAJSA-N Pro-Ser-Phe Chemical compound N([C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C(=O)[C@@H]1CCCN1 QKDIHFHGHBYTKB-IHRRRGAJSA-N 0.000 description 1
- SNGZLPOXVRTNMB-LPEHRKFASA-N Pro-Ser-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CO)C(=O)N2CCC[C@@H]2C(=O)O SNGZLPOXVRTNMB-LPEHRKFASA-N 0.000 description 1
- DCHQYSOGURGJST-FJXKBIBVSA-N Pro-Thr-Gly Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O DCHQYSOGURGJST-FJXKBIBVSA-N 0.000 description 1
- CHYAYDLYYIJCKY-OSUNSFLBSA-N Pro-Thr-Ile Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O CHYAYDLYYIJCKY-OSUNSFLBSA-N 0.000 description 1
- FDMCIBSQRKFSTJ-RHYQMDGZSA-N Pro-Thr-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O FDMCIBSQRKFSTJ-RHYQMDGZSA-N 0.000 description 1
- VPBQDHMASPJHGY-JYJNAYRXSA-N Pro-Trp-Ser Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CO)C(=O)O VPBQDHMASPJHGY-JYJNAYRXSA-N 0.000 description 1
- WWXNZNWZNZPDIF-SRVKXCTJSA-N Pro-Val-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 WWXNZNWZNZPDIF-SRVKXCTJSA-N 0.000 description 1
- ZMLRZBWCXPQADC-TUAOUCFPSA-N Pro-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 ZMLRZBWCXPQADC-TUAOUCFPSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 238000001069 Raman spectroscopy Methods 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 108700005075 Regulator Genes Proteins 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- 206010048955 Retinal toxicity Diseases 0.000 description 1
- 102100031176 Retinoid isomerohydrolase Human genes 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 101150107345 Rhag gene Proteins 0.000 description 1
- 108090000799 Rhodopsin kinases Proteins 0.000 description 1
- 239000008156 Ringer's lactate solution Substances 0.000 description 1
- CGNLCCVKSWNSDG-UHFFFAOYSA-N SYBR Green I Chemical compound CN(C)CCCN(CCC)C1=CC(C=C2N(C3=CC=CC=C3S2)C)=C2C=CC=CC2=[N+]1C1=CC=CC=C1 CGNLCCVKSWNSDG-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
- ZUGXSSFMTXKHJS-ZLUOBGJFSA-N Ser-Ala-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O ZUGXSSFMTXKHJS-ZLUOBGJFSA-N 0.000 description 1
- FIXILCYTSAUERA-FXQIFTODSA-N Ser-Ala-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O FIXILCYTSAUERA-FXQIFTODSA-N 0.000 description 1
- MWMKFWJYRRGXOR-ZLUOBGJFSA-N Ser-Ala-Asn Chemical compound N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(N)=O)C)CO MWMKFWJYRRGXOR-ZLUOBGJFSA-N 0.000 description 1
- WTWGOQRNRFHFQD-JBDRJPRFSA-N Ser-Ala-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WTWGOQRNRFHFQD-JBDRJPRFSA-N 0.000 description 1
- HRNQLKCLPVKZNE-CIUDSAMLSA-N Ser-Ala-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O HRNQLKCLPVKZNE-CIUDSAMLSA-N 0.000 description 1
- FCRMLGJMPXCAHD-FXQIFTODSA-N Ser-Arg-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O FCRMLGJMPXCAHD-FXQIFTODSA-N 0.000 description 1
- QEDMOZUJTGEIBF-FXQIFTODSA-N Ser-Arg-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O QEDMOZUJTGEIBF-FXQIFTODSA-N 0.000 description 1
- JJKSSJVYOVRJMZ-FXQIFTODSA-N Ser-Arg-Cys Chemical compound C(C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CO)N)CN=C(N)N JJKSSJVYOVRJMZ-FXQIFTODSA-N 0.000 description 1
- YUSRGTQIPCJNHQ-CIUDSAMLSA-N Ser-Arg-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O YUSRGTQIPCJNHQ-CIUDSAMLSA-N 0.000 description 1
- QGMLKFGTGXWAHF-IHRRRGAJSA-N Ser-Arg-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O QGMLKFGTGXWAHF-IHRRRGAJSA-N 0.000 description 1
- FIDMVVBUOCMMJG-CIUDSAMLSA-N Ser-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO FIDMVVBUOCMMJG-CIUDSAMLSA-N 0.000 description 1
- RDFQNDHEHVSONI-ZLUOBGJFSA-N Ser-Asn-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O RDFQNDHEHVSONI-ZLUOBGJFSA-N 0.000 description 1
- RFBKULCUBJAQFT-BIIVOSGPSA-N Ser-Cys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CS)NC(=O)[C@H](CO)N)C(=O)O RFBKULCUBJAQFT-BIIVOSGPSA-N 0.000 description 1
- MIJWOJAXARLEHA-WDSKDSINSA-N Ser-Gly-Glu Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O MIJWOJAXARLEHA-WDSKDSINSA-N 0.000 description 1
- GZFAWAQTEYDKII-YUMQZZPRSA-N Ser-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CO GZFAWAQTEYDKII-YUMQZZPRSA-N 0.000 description 1
- UIGMAMGZOJVTDN-WHFBIAKZSA-N Ser-Gly-Ser Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O UIGMAMGZOJVTDN-WHFBIAKZSA-N 0.000 description 1
- XXXAXOWMBOKTRN-XPUUQOCRSA-N Ser-Gly-Val Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O XXXAXOWMBOKTRN-XPUUQOCRSA-N 0.000 description 1
- QBUWQRKEHJXTOP-DCAQKATOSA-N Ser-His-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QBUWQRKEHJXTOP-DCAQKATOSA-N 0.000 description 1
- RJHJPZQOMKCSTP-CIUDSAMLSA-N Ser-His-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(O)=O RJHJPZQOMKCSTP-CIUDSAMLSA-N 0.000 description 1
- XERQKTRGJIKTRB-CIUDSAMLSA-N Ser-His-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)N)CC1=CN=CN1 XERQKTRGJIKTRB-CIUDSAMLSA-N 0.000 description 1
- HZNFKPJCGZXKIC-DCAQKATOSA-N Ser-His-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CO)N HZNFKPJCGZXKIC-DCAQKATOSA-N 0.000 description 1
- IFPBAGJBHSNYPR-ZKWXMUAHSA-N Ser-Ile-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O IFPBAGJBHSNYPR-ZKWXMUAHSA-N 0.000 description 1
- RIAKPZVSNBBNRE-BJDJZHNGSA-N Ser-Ile-Leu Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O RIAKPZVSNBBNRE-BJDJZHNGSA-N 0.000 description 1
- MOINZPRHJGTCHZ-MMWGEVLESA-N Ser-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N MOINZPRHJGTCHZ-MMWGEVLESA-N 0.000 description 1
- MQQBBLVOUUJKLH-HJPIBITLSA-N Ser-Ile-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O MQQBBLVOUUJKLH-HJPIBITLSA-N 0.000 description 1
- QYSFWUIXDFJUDW-DCAQKATOSA-N Ser-Leu-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QYSFWUIXDFJUDW-DCAQKATOSA-N 0.000 description 1
- KCNSGAMPBPYUAI-CIUDSAMLSA-N Ser-Leu-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O KCNSGAMPBPYUAI-CIUDSAMLSA-N 0.000 description 1
- HEUVHBXOVZONPU-BJDJZHNGSA-N Ser-Leu-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HEUVHBXOVZONPU-BJDJZHNGSA-N 0.000 description 1
- VMLONWHIORGALA-SRVKXCTJSA-N Ser-Leu-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CO VMLONWHIORGALA-SRVKXCTJSA-N 0.000 description 1
- VZQRNAYURWAEFE-KKUMJFAQSA-N Ser-Leu-Phe Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 VZQRNAYURWAEFE-KKUMJFAQSA-N 0.000 description 1
- JWOBLHJRDADHLN-KKUMJFAQSA-N Ser-Leu-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JWOBLHJRDADHLN-KKUMJFAQSA-N 0.000 description 1
- PPNPDKGQRFSCAC-CIUDSAMLSA-N Ser-Lys-Asp Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(O)=O)C(O)=O PPNPDKGQRFSCAC-CIUDSAMLSA-N 0.000 description 1
- GVMUJUPXFQFBBZ-GUBZILKMSA-N Ser-Lys-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O GVMUJUPXFQFBBZ-GUBZILKMSA-N 0.000 description 1
- LRWBCWGEUCKDTN-BJDJZHNGSA-N Ser-Lys-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LRWBCWGEUCKDTN-BJDJZHNGSA-N 0.000 description 1
- ASGYVPAVFNDZMA-GUBZILKMSA-N Ser-Met-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)N ASGYVPAVFNDZMA-GUBZILKMSA-N 0.000 description 1
- FZEUTKVQGMVGHW-AVGNSLFASA-N Ser-Phe-Gln Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O FZEUTKVQGMVGHW-AVGNSLFASA-N 0.000 description 1
- RWDVVSKYZBNDCO-MELADBBJSA-N Ser-Phe-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CO)N)C(=O)O RWDVVSKYZBNDCO-MELADBBJSA-N 0.000 description 1
- WNDUPCKKKGSKIQ-CIUDSAMLSA-N Ser-Pro-Gln Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O WNDUPCKKKGSKIQ-CIUDSAMLSA-N 0.000 description 1
- GZGFSPWOMUKKCV-NAKRPEOUSA-N Ser-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO GZGFSPWOMUKKCV-NAKRPEOUSA-N 0.000 description 1
- AZWNCEBQZXELEZ-FXQIFTODSA-N Ser-Pro-Ser Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O AZWNCEBQZXELEZ-FXQIFTODSA-N 0.000 description 1
- XZKQVQKUZMAADP-IMJSIDKUSA-N Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(O)=O XZKQVQKUZMAADP-IMJSIDKUSA-N 0.000 description 1
- KQNDIKOYWZTZIX-FXQIFTODSA-N Ser-Ser-Arg Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCNC(N)=N KQNDIKOYWZTZIX-FXQIFTODSA-N 0.000 description 1
- WLJPJRGQRNCIQS-ZLUOBGJFSA-N Ser-Ser-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O WLJPJRGQRNCIQS-ZLUOBGJFSA-N 0.000 description 1
- VFWQQZMRKFOGLE-ZLUOBGJFSA-N Ser-Ser-Cys Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N)O VFWQQZMRKFOGLE-ZLUOBGJFSA-N 0.000 description 1
- NVNPWELENFJOHH-CIUDSAMLSA-N Ser-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)N NVNPWELENFJOHH-CIUDSAMLSA-N 0.000 description 1
- OZPDGESCTGGNAD-CIUDSAMLSA-N Ser-Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CO OZPDGESCTGGNAD-CIUDSAMLSA-N 0.000 description 1
- XQJCEKXQUJQNNK-ZLUOBGJFSA-N Ser-Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O XQJCEKXQUJQNNK-ZLUOBGJFSA-N 0.000 description 1
- OLKICIBQRVSQMA-SRVKXCTJSA-N Ser-Ser-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O OLKICIBQRVSQMA-SRVKXCTJSA-N 0.000 description 1
- SOACHCFYJMCMHC-BWBBJGPYSA-N Ser-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CO)N)O SOACHCFYJMCMHC-BWBBJGPYSA-N 0.000 description 1
- SZRNDHWMVSFPSP-XKBZYTNZSA-N Ser-Thr-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CO)N)O SZRNDHWMVSFPSP-XKBZYTNZSA-N 0.000 description 1
- ZSDXEKUKQAKZFE-XAVMHZPKSA-N Ser-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N)O ZSDXEKUKQAKZFE-XAVMHZPKSA-N 0.000 description 1
- BDMWLJLPPUCLNV-XGEHTFHBSA-N Ser-Thr-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O BDMWLJLPPUCLNV-XGEHTFHBSA-N 0.000 description 1
- VEVYMLNYMULSMS-AVGNSLFASA-N Ser-Tyr-Gln Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O VEVYMLNYMULSMS-AVGNSLFASA-N 0.000 description 1
- OQSQCUWQOIHECT-YJRXYDGGSA-N Ser-Tyr-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OQSQCUWQOIHECT-YJRXYDGGSA-N 0.000 description 1
- PMTWIUBUQRGCSB-FXQIFTODSA-N Ser-Val-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O PMTWIUBUQRGCSB-FXQIFTODSA-N 0.000 description 1
- HNDMFDBQXYZSRM-IHRRRGAJSA-N Ser-Val-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HNDMFDBQXYZSRM-IHRRRGAJSA-N 0.000 description 1
- ANOQEBQWIAYIMV-AEJSXWLSSA-N Ser-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N ANOQEBQWIAYIMV-AEJSXWLSSA-N 0.000 description 1
- 108010034546 Serratia marcescens nuclease Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 230000024932 T cell mediated immunity Effects 0.000 description 1
- 101150006914 TRP1 gene Proteins 0.000 description 1
- 101000834248 Takifugu rubripes Actin, cytoplasmic 1 Proteins 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229910052771 Terbium Inorganic materials 0.000 description 1
- DDPVJPIGACCMEH-XQXXSGGOSA-N Thr-Ala-Gln Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O DDPVJPIGACCMEH-XQXXSGGOSA-N 0.000 description 1
- GFDUZZACIWNMPE-KZVJFYERSA-N Thr-Ala-Met Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(O)=O GFDUZZACIWNMPE-KZVJFYERSA-N 0.000 description 1
- LVHHEVGYAZGXDE-KDXUFGMBSA-N Thr-Ala-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)N1CCC[C@@H]1C(=O)O)N)O LVHHEVGYAZGXDE-KDXUFGMBSA-N 0.000 description 1
- DWYAUVCQDTZIJI-VZFHVOOUSA-N Thr-Ala-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O DWYAUVCQDTZIJI-VZFHVOOUSA-N 0.000 description 1
- DGDCHPCRMWEOJR-FQPOAREZSA-N Thr-Ala-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 DGDCHPCRMWEOJR-FQPOAREZSA-N 0.000 description 1
- NRUPKQSXTJNQGD-XGEHTFHBSA-N Thr-Cys-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NRUPKQSXTJNQGD-XGEHTFHBSA-N 0.000 description 1
- MMTOHPRBJKEZHT-BWBBJGPYSA-N Thr-Cys-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O MMTOHPRBJKEZHT-BWBBJGPYSA-N 0.000 description 1
- QILPDQCTQZDHFM-HJGDQZAQSA-N Thr-Gln-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QILPDQCTQZDHFM-HJGDQZAQSA-N 0.000 description 1
- LHEZGZQRLDBSRR-WDCWCFNPSA-N Thr-Glu-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O LHEZGZQRLDBSRR-WDCWCFNPSA-N 0.000 description 1
- MPUMPERGHHJGRP-WEDXCCLWSA-N Thr-Gly-Lys Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)N)O MPUMPERGHHJGRP-WEDXCCLWSA-N 0.000 description 1
- VUSAEKOXGNEYNE-PBCZWWQYSA-N Thr-His-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O VUSAEKOXGNEYNE-PBCZWWQYSA-N 0.000 description 1
- WPSDXXQRIVKBAY-NKIYYHGXSA-N Thr-His-Glu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N)O WPSDXXQRIVKBAY-NKIYYHGXSA-N 0.000 description 1
- XSTGOZBBXFKGHA-YJRXYDGGSA-N Thr-His-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N)O XSTGOZBBXFKGHA-YJRXYDGGSA-N 0.000 description 1
- AYCQVUUPIJHJTA-IXOXFDKPSA-N Thr-His-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O AYCQVUUPIJHJTA-IXOXFDKPSA-N 0.000 description 1
- PAXANSWUSVPFNK-IUKAMOBKSA-N Thr-Ile-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N PAXANSWUSVPFNK-IUKAMOBKSA-N 0.000 description 1
- UYTYTDMCDBPDSC-URLPEUOOSA-N Thr-Ile-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N UYTYTDMCDBPDSC-URLPEUOOSA-N 0.000 description 1
- FQPDRTDDEZXCEC-SVSWQMSJSA-N Thr-Ile-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O FQPDRTDDEZXCEC-SVSWQMSJSA-N 0.000 description 1
- GXUWHVZYDAHFSV-FLBSBUHZSA-N Thr-Ile-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GXUWHVZYDAHFSV-FLBSBUHZSA-N 0.000 description 1
- RFKVQLIXNVEOMB-WEDXCCLWSA-N Thr-Leu-Gly Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)N)O RFKVQLIXNVEOMB-WEDXCCLWSA-N 0.000 description 1
- MEJHFIOYJHTWMK-VOAKCMCISA-N Thr-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O MEJHFIOYJHTWMK-VOAKCMCISA-N 0.000 description 1
- VRUFCJZQDACGLH-UVOCVTCTSA-N Thr-Leu-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VRUFCJZQDACGLH-UVOCVTCTSA-N 0.000 description 1
- KZSYAEWQMJEGRZ-RHYQMDGZSA-N Thr-Leu-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O KZSYAEWQMJEGRZ-RHYQMDGZSA-N 0.000 description 1
- BDGBHYCAZJPLHX-HJGDQZAQSA-N Thr-Lys-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O BDGBHYCAZJPLHX-HJGDQZAQSA-N 0.000 description 1
- SCSVNSNWUTYSFO-WDCWCFNPSA-N Thr-Lys-Glu Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O SCSVNSNWUTYSFO-WDCWCFNPSA-N 0.000 description 1
- MXNAOGFNFNKUPD-JHYOHUSXSA-N Thr-Phe-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MXNAOGFNFNKUPD-JHYOHUSXSA-N 0.000 description 1
- JAJOFWABAUKAEJ-QTKMDUPCSA-N Thr-Pro-His Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N)O JAJOFWABAUKAEJ-QTKMDUPCSA-N 0.000 description 1
- KERCOYANYUPLHJ-XGEHTFHBSA-N Thr-Pro-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O KERCOYANYUPLHJ-XGEHTFHBSA-N 0.000 description 1
- IWAVRIPRTCJAQO-HSHDSVGOSA-N Thr-Pro-Trp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O IWAVRIPRTCJAQO-HSHDSVGOSA-N 0.000 description 1
- YGCDFAJJCRVQKU-RCWTZXSCSA-N Thr-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)[C@@H](C)O YGCDFAJJCRVQKU-RCWTZXSCSA-N 0.000 description 1
- FWTFAZKJORVTIR-VZFHVOOUSA-N Thr-Ser-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O FWTFAZKJORVTIR-VZFHVOOUSA-N 0.000 description 1
- DOBIBIXIHJKVJF-XKBZYTNZSA-N Thr-Ser-Gln Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(N)=O DOBIBIXIHJKVJF-XKBZYTNZSA-N 0.000 description 1
- AHERARIZBPOMNU-KATARQTJSA-N Thr-Ser-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O AHERARIZBPOMNU-KATARQTJSA-N 0.000 description 1
- WKGAAMOJPMBBMC-IXOXFDKPSA-N Thr-Ser-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O WKGAAMOJPMBBMC-IXOXFDKPSA-N 0.000 description 1
- QYDKSNXSBXZPFK-ZJDVBMNYSA-N Thr-Thr-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QYDKSNXSBXZPFK-ZJDVBMNYSA-N 0.000 description 1
- NHQVWACSJZJCGJ-FLBSBUHZSA-N Thr-Thr-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O NHQVWACSJZJCGJ-FLBSBUHZSA-N 0.000 description 1
- BZTSQFWJNJYZSX-JRQIVUDYSA-N Thr-Tyr-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O BZTSQFWJNJYZSX-JRQIVUDYSA-N 0.000 description 1
- PELIQFPESHBTMA-WLTAIBSBSA-N Thr-Tyr-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 PELIQFPESHBTMA-WLTAIBSBSA-N 0.000 description 1
- AKHDFZHUPGVFEJ-YEPSODPASA-N Thr-Val-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O AKHDFZHUPGVFEJ-YEPSODPASA-N 0.000 description 1
- BKVICMPZWRNWOC-RHYQMDGZSA-N Thr-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)[C@@H](C)O BKVICMPZWRNWOC-RHYQMDGZSA-N 0.000 description 1
- SPIFGZFZMVLPHN-UNQGMJICSA-N Thr-Val-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SPIFGZFZMVLPHN-UNQGMJICSA-N 0.000 description 1
- MNYNCKZAEIAONY-XGEHTFHBSA-N Thr-Val-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O MNYNCKZAEIAONY-XGEHTFHBSA-N 0.000 description 1
- KZTLZZQTJMCGIP-ZJDVBMNYSA-N Thr-Val-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KZTLZZQTJMCGIP-ZJDVBMNYSA-N 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- DPXHITFUCHFTKR-UHFFFAOYSA-L To-Pro-1 Chemical compound [I-].[I-].S1C2=CC=CC=C2[N+](C)=C1C=C1C2=CC=CC=C2N(CCC[N+](C)(C)C)C=C1 DPXHITFUCHFTKR-UHFFFAOYSA-L 0.000 description 1
- QHNORJFCVHUPNH-UHFFFAOYSA-L To-Pro-3 Chemical compound [I-].[I-].S1C2=CC=CC=C2[N+](C)=C1C=CC=C1C2=CC=CC=C2N(CCC[N+](C)(C)C)C=C1 QHNORJFCVHUPNH-UHFFFAOYSA-L 0.000 description 1
- MZZINWWGSYUHGU-UHFFFAOYSA-J ToTo-1 Chemical compound [I-].[I-].[I-].[I-].C12=CC=CC=C2C(C=C2N(C3=CC=CC=C3S2)C)=CC=[N+]1CCC[N+](C)(C)CCC[N+](C)(C)CCC[N+](C1=CC=CC=C11)=CC=C1C=C1N(C)C2=CC=CC=C2S1 MZZINWWGSYUHGU-UHFFFAOYSA-J 0.000 description 1
- 108020004566 Transfer RNA Proteins 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- BDWDMRSGCXEDMR-WFBYXXMGSA-N Trp-Ala-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N BDWDMRSGCXEDMR-WFBYXXMGSA-N 0.000 description 1
- AVYVKJMBNLPWRX-WFBYXXMGSA-N Trp-Ala-Ser Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O)=CNC2=C1 AVYVKJMBNLPWRX-WFBYXXMGSA-N 0.000 description 1
- CXPJPTFWKXNDKV-NUTKFTJISA-N Trp-Leu-Ala Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O)=CNC2=C1 CXPJPTFWKXNDKV-NUTKFTJISA-N 0.000 description 1
- GWBWCGITOYODER-YTQUADARSA-N Trp-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N GWBWCGITOYODER-YTQUADARSA-N 0.000 description 1
- WMBFONUKQXGLMU-WDSOQIARSA-N Trp-Leu-Val Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N WMBFONUKQXGLMU-WDSOQIARSA-N 0.000 description 1
- RIKLKPANMFNREP-FDARSICLSA-N Trp-Met-Ile Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O)=CNC2=C1 RIKLKPANMFNREP-FDARSICLSA-N 0.000 description 1
- LVTKHGUGBGNBPL-UHFFFAOYSA-N Trp-P-1 Chemical compound N1C2=CC=CC=C2C2=C1C(C)=C(N)N=C2C LVTKHGUGBGNBPL-UHFFFAOYSA-N 0.000 description 1
- WHJVRIBYQWHRQA-NQCBNZPSSA-N Trp-Phe-Ile Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CC=CC=C1 WHJVRIBYQWHRQA-NQCBNZPSSA-N 0.000 description 1
- XOLLWQIBBLBAHQ-WDSOQIARSA-N Trp-Pro-Leu Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O XOLLWQIBBLBAHQ-WDSOQIARSA-N 0.000 description 1
- KBKTUNYBNJWFRL-UBHSHLNASA-N Trp-Ser-Asn Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O)=CNC2=C1 KBKTUNYBNJWFRL-UBHSHLNASA-N 0.000 description 1
- UJGDFQRPYGJBEH-AAEUAGOBSA-N Trp-Ser-Gly Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)O)N UJGDFQRPYGJBEH-AAEUAGOBSA-N 0.000 description 1
- 241000223105 Trypanosoma brucei Species 0.000 description 1
- TVOGEPLDNYTAHD-CQDKDKBSSA-N Tyr-Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 TVOGEPLDNYTAHD-CQDKDKBSSA-N 0.000 description 1
- MBFJIHUHHCJBSN-AVGNSLFASA-N Tyr-Asn-Gln Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MBFJIHUHHCJBSN-AVGNSLFASA-N 0.000 description 1
- JWHOIHCOHMZSAR-QWRGUYRKSA-N Tyr-Asp-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 JWHOIHCOHMZSAR-QWRGUYRKSA-N 0.000 description 1
- QUILOGWWLXMSAT-IHRRRGAJSA-N Tyr-Gln-Gln Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O QUILOGWWLXMSAT-IHRRRGAJSA-N 0.000 description 1
- LHTGRUZSZOIAKM-SOUVJXGZSA-N Tyr-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)C(=O)O LHTGRUZSZOIAKM-SOUVJXGZSA-N 0.000 description 1
- PMDWYLVWHRTJIW-STQMWFEESA-N Tyr-Gly-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 PMDWYLVWHRTJIW-STQMWFEESA-N 0.000 description 1
- AZZLDIDWPZLCCW-ZEWNOJEFSA-N Tyr-Ile-Phe Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O AZZLDIDWPZLCCW-ZEWNOJEFSA-N 0.000 description 1
- SINRIKQYQJRGDQ-MEYUZBJRSA-N Tyr-Lys-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 SINRIKQYQJRGDQ-MEYUZBJRSA-N 0.000 description 1
- FWOVTJKVUCGVND-UFYCRDLUSA-N Tyr-Met-Phe Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N FWOVTJKVUCGVND-UFYCRDLUSA-N 0.000 description 1
- SCZJKZLFSSPJDP-ACRUOGEOSA-N Tyr-Phe-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O SCZJKZLFSSPJDP-ACRUOGEOSA-N 0.000 description 1
- XJPXTYLVMUZGNW-IHRRRGAJSA-N Tyr-Pro-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O XJPXTYLVMUZGNW-IHRRRGAJSA-N 0.000 description 1
- QKXAEWMHAAVVGS-KKUMJFAQSA-N Tyr-Pro-Glu Chemical compound N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O QKXAEWMHAAVVGS-KKUMJFAQSA-N 0.000 description 1
- XFEMMSGONWQACR-KJEVXHAQSA-N Tyr-Thr-Met Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N)O XFEMMSGONWQACR-KJEVXHAQSA-N 0.000 description 1
- RVGVIWNHABGIFH-IHRRRGAJSA-N Tyr-Val-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O RVGVIWNHABGIFH-IHRRRGAJSA-N 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- UEOOXDLMQZBPFR-ZKWXMUAHSA-N Val-Ala-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N UEOOXDLMQZBPFR-ZKWXMUAHSA-N 0.000 description 1
- WOCYUGQDXPTQPY-FXQIFTODSA-N Val-Ala-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](C(C)C)N WOCYUGQDXPTQPY-FXQIFTODSA-N 0.000 description 1
- JIODCDXKCJRMEH-NHCYSSNCSA-N Val-Arg-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N JIODCDXKCJRMEH-NHCYSSNCSA-N 0.000 description 1
- XPYNXORPPVTVQK-SRVKXCTJSA-N Val-Arg-Met Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCSC)C(=O)O)N XPYNXORPPVTVQK-SRVKXCTJSA-N 0.000 description 1
- CVUDMNSZAIZFAE-TUAOUCFPSA-N Val-Arg-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)O)N CVUDMNSZAIZFAE-TUAOUCFPSA-N 0.000 description 1
- CVUDMNSZAIZFAE-UHFFFAOYSA-N Val-Arg-Pro Natural products NC(N)=NCCCC(NC(=O)C(N)C(C)C)C(=O)N1CCCC1C(O)=O CVUDMNSZAIZFAE-UHFFFAOYSA-N 0.000 description 1
- LNYOXPDEIZJDEI-NHCYSSNCSA-N Val-Asn-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)N LNYOXPDEIZJDEI-NHCYSSNCSA-N 0.000 description 1
- QGFPYRPIUXBYGR-YDHLFZDLSA-N Val-Asn-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N QGFPYRPIUXBYGR-YDHLFZDLSA-N 0.000 description 1
- IQQYYFPCWKWUHW-YDHLFZDLSA-N Val-Asn-Tyr Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N IQQYYFPCWKWUHW-YDHLFZDLSA-N 0.000 description 1
- FPCIBLUVDNXPJO-XPUUQOCRSA-N Val-Cys-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CS)C(=O)NCC(O)=O FPCIBLUVDNXPJO-XPUUQOCRSA-N 0.000 description 1
- LHADRQBREKTRLR-DCAQKATOSA-N Val-Cys-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](C(C)C)N LHADRQBREKTRLR-DCAQKATOSA-N 0.000 description 1
- QHFQQRKNGCXTHL-AUTRQRHGSA-N Val-Gln-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O QHFQQRKNGCXTHL-AUTRQRHGSA-N 0.000 description 1
- VFOHXOLPLACADK-GVXVVHGQSA-N Val-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)N VFOHXOLPLACADK-GVXVVHGQSA-N 0.000 description 1
- XGJLNBNZNMVJRS-NRPADANISA-N Val-Glu-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O XGJLNBNZNMVJRS-NRPADANISA-N 0.000 description 1
- MDYSKHBSPXUOPV-JSGCOSHPSA-N Val-Gly-Phe Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N MDYSKHBSPXUOPV-JSGCOSHPSA-N 0.000 description 1
- LAYSXAOGWHKNED-XPUUQOCRSA-N Val-Gly-Ser Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O LAYSXAOGWHKNED-XPUUQOCRSA-N 0.000 description 1
- VXDSPJJQUQDCKH-UKJIMTQDSA-N Val-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N VXDSPJJQUQDCKH-UKJIMTQDSA-N 0.000 description 1
- XTDDIVQWDXMRJL-IHRRRGAJSA-N Val-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](C(C)C)N XTDDIVQWDXMRJL-IHRRRGAJSA-N 0.000 description 1
- RFKJNTRMXGCKFE-FHWLQOOXSA-N Val-Leu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)CC(C)C)C(O)=O)=CNC2=C1 RFKJNTRMXGCKFE-FHWLQOOXSA-N 0.000 description 1
- DIOSYUIWOQCXNR-ONGXEEELSA-N Val-Lys-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O DIOSYUIWOQCXNR-ONGXEEELSA-N 0.000 description 1
- IEBGHUMBJXIXHM-AVGNSLFASA-N Val-Lys-Met Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)O)N IEBGHUMBJXIXHM-AVGNSLFASA-N 0.000 description 1
- HPANGHISDXDUQY-ULQDDVLXSA-N Val-Lys-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N HPANGHISDXDUQY-ULQDDVLXSA-N 0.000 description 1
- JAKHAONCJJZVHT-DCAQKATOSA-N Val-Lys-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O)N JAKHAONCJJZVHT-DCAQKATOSA-N 0.000 description 1
- JVGHIFMSFBZDHH-WPRPVWTQSA-N Val-Met-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)O)N JVGHIFMSFBZDHH-WPRPVWTQSA-N 0.000 description 1
- SJRUJQFQVLMZFW-WPRPVWTQSA-N Val-Pro-Gly Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O SJRUJQFQVLMZFW-WPRPVWTQSA-N 0.000 description 1
- USLVEJAHTBLSIL-CYDGBPFRSA-N Val-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)C(C)C USLVEJAHTBLSIL-CYDGBPFRSA-N 0.000 description 1
- AJNUKMZFHXUBMK-GUBZILKMSA-N Val-Ser-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N AJNUKMZFHXUBMK-GUBZILKMSA-N 0.000 description 1
- JQTYTBPCSOAZHI-FXQIFTODSA-N Val-Ser-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N JQTYTBPCSOAZHI-FXQIFTODSA-N 0.000 description 1
- VHIZXDZMTDVFGX-DCAQKATOSA-N Val-Ser-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N VHIZXDZMTDVFGX-DCAQKATOSA-N 0.000 description 1
- GBIUHAYJGWVNLN-UHFFFAOYSA-N Val-Ser-Pro Natural products CC(C)C(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O GBIUHAYJGWVNLN-UHFFFAOYSA-N 0.000 description 1
- PZTZYZUTCPZWJH-FXQIFTODSA-N Val-Ser-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PZTZYZUTCPZWJH-FXQIFTODSA-N 0.000 description 1
- UJMCYJKPDFQLHX-XGEHTFHBSA-N Val-Ser-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N)O UJMCYJKPDFQLHX-XGEHTFHBSA-N 0.000 description 1
- NZYNRRGJJVSSTJ-GUBZILKMSA-N Val-Ser-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O NZYNRRGJJVSSTJ-GUBZILKMSA-N 0.000 description 1
- OFTXTCGQJXTNQS-XGEHTFHBSA-N Val-Thr-Ser Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](C(C)C)N)O OFTXTCGQJXTNQS-XGEHTFHBSA-N 0.000 description 1
- DFQZDQPLWBSFEJ-LSJOCFKGSA-N Val-Val-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)O)N DFQZDQPLWBSFEJ-LSJOCFKGSA-N 0.000 description 1
- 108010003533 Viral Envelope Proteins Proteins 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- ULHRKLSNHXXJLO-UHFFFAOYSA-L Yo-Pro-1 Chemical compound [I-].[I-].C1=CC=C2C(C=C3N(C4=CC=CC=C4O3)C)=CC=[N+](CCC[N+](C)(C)C)C2=C1 ULHRKLSNHXXJLO-UHFFFAOYSA-L 0.000 description 1
- ZVUUXEGAYWQURQ-UHFFFAOYSA-L Yo-Pro-3 Chemical compound [I-].[I-].O1C2=CC=CC=C2[N+](C)=C1C=CC=C1C2=CC=CC=C2N(CCC[N+](C)(C)C)C=C1 ZVUUXEGAYWQURQ-UHFFFAOYSA-L 0.000 description 1
- GRRMZXFOOGQMFA-UHFFFAOYSA-J YoYo-1 Chemical compound [I-].[I-].[I-].[I-].C12=CC=CC=C2C(C=C2N(C3=CC=CC=C3O2)C)=CC=[N+]1CCC[N+](C)(C)CCC[N+](C)(C)CCC[N+](C1=CC=CC=C11)=CC=C1C=C1N(C)C2=CC=CC=C2O1 GRRMZXFOOGQMFA-UHFFFAOYSA-J 0.000 description 1
- JSBNEYNPYQFYNM-UHFFFAOYSA-J YoYo-3 Chemical compound [I-].[I-].[I-].[I-].C12=CC=CC=C2C(C=CC=C2N(C3=CC=CC=C3O2)C)=CC=[N+]1CCC(=[N+](C)C)CCCC(=[N+](C)C)CC[N+](C1=CC=CC=C11)=CC=C1C=CC=C1N(C)C2=CC=CC=C2O1 JSBNEYNPYQFYNM-UHFFFAOYSA-J 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000007244 Zea mays Nutrition 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229940022698 acetylcholinesterase Drugs 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 1
- RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 210000004504 adult stem cell Anatomy 0.000 description 1
- 238000012387 aerosolization Methods 0.000 description 1
- 108010087049 alanyl-alanyl-prolyl-valine Proteins 0.000 description 1
- 108010076324 alanyl-glycyl-glycine Proteins 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 239000008135 aqueous vehicle Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 108010072041 arginyl-glycyl-aspartic acid Proteins 0.000 description 1
- 108010062796 arginyllysine Proteins 0.000 description 1
- 108010036533 arginylvaline Proteins 0.000 description 1
- 108010077245 asparaginyl-proline Proteins 0.000 description 1
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 1
- 108010093581 aspartyl-proline Proteins 0.000 description 1
- 108010068265 aspartyltyrosine Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 210000001130 astrocyte Anatomy 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 239000003855 balanced salt solution Substances 0.000 description 1
- 210000003651 basophil Anatomy 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 108010006025 bovine growth hormone Proteins 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- BMLSTPRTEKLIPM-UHFFFAOYSA-I calcium;potassium;disodium;hydrogen carbonate;dichloride;dihydroxide;hydrate Chemical compound O.[OH-].[OH-].[Na+].[Na+].[Cl-].[Cl-].[K+].[Ca+2].OC([O-])=O BMLSTPRTEKLIPM-UHFFFAOYSA-I 0.000 description 1
- ZEWYCNBZMPELPF-UHFFFAOYSA-J calcium;potassium;sodium;2-hydroxypropanoic acid;sodium;tetrachloride Chemical compound [Na].[Na+].[Cl-].[Cl-].[Cl-].[Cl-].[K+].[Ca+2].CC(O)C(O)=O ZEWYCNBZMPELPF-UHFFFAOYSA-J 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940096529 carboxypolymethylene Drugs 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 210000002230 centromere Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- TUESWZZJYCLFNL-DAFODLJHSA-N chembl1301 Chemical compound C1=CC(C(=N)N)=CC=C1\C=C\C1=CC=C(C(N)=N)C=C1O TUESWZZJYCLFNL-DAFODLJHSA-N 0.000 description 1
- 239000012707 chemical precursor Substances 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 210000001608 connective tissue cell Anatomy 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 108010004073 cysteinylcysteine Proteins 0.000 description 1
- 229960000640 dactinomycin Drugs 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 229940124274 edetate disodium Drugs 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- XHXYXYGSUXANME-UHFFFAOYSA-N eosin 5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC(Br)=C(O)C(Br)=C1OC1=C(Br)C(O)=C(Br)C=C21 XHXYXYGSUXANME-UHFFFAOYSA-N 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 1
- 229940011411 erythrosine Drugs 0.000 description 1
- 239000004174 erythrosine Substances 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- HQPMKSGTIOYHJT-UHFFFAOYSA-N ethane-1,2-diol;propane-1,2-diol Chemical compound OCCO.CC(O)CO HQPMKSGTIOYHJT-UHFFFAOYSA-N 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 229940066493 expectorants Drugs 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 108091006047 fluorescent proteins Proteins 0.000 description 1
- 102000034287 fluorescent proteins Human genes 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000012395 formulation development Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000012215 gene cloning Methods 0.000 description 1
- 238000001476 gene delivery Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 108010078144 glutaminyl-glycine Proteins 0.000 description 1
- 108010042598 glutamyl-aspartyl-glycine Proteins 0.000 description 1
- 108010079547 glutamylmethionine Proteins 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 1
- 108010072405 glycyl-aspartyl-glycine Proteins 0.000 description 1
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 description 1
- 108010084389 glycyltryptophan Proteins 0.000 description 1
- 108010087823 glycyltyrosine Proteins 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 108010036413 histidylglycine Proteins 0.000 description 1
- 108010028295 histidylhistidine Proteins 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229940014041 hyaluronate Drugs 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 210000004754 hybrid cell Anatomy 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 229950005911 hydroxystilbamidine Drugs 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 239000007972 injectable composition Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000007913 intrathecal administration Methods 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 108010031424 isoleucyl-prolyl-proline Proteins 0.000 description 1
- 108010044374 isoleucyl-tyrosine Proteins 0.000 description 1
- 108010078274 isoleucylvaline Proteins 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229910052747 lanthanoid Inorganic materials 0.000 description 1
- 150000002602 lanthanoids Chemical class 0.000 description 1
- 108010012058 leucyltyrosine Proteins 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 208000018769 loss of vision Diseases 0.000 description 1
- 231100000864 loss of vision Toxicity 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- DLBFLQKQABVKGT-UHFFFAOYSA-L lucifer yellow dye Chemical compound [Li+].[Li+].[O-]S(=O)(=O)C1=CC(C(N(C(=O)NN)C2=O)=O)=C3C2=CC(S([O-])(=O)=O)=CC3=C1N DLBFLQKQABVKGT-UHFFFAOYSA-L 0.000 description 1
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 108010003700 lysyl aspartic acid Proteins 0.000 description 1
- 108010012988 lysyl-glutamyl-aspartyl-glycine Proteins 0.000 description 1
- 108010009298 lysylglutamic acid Proteins 0.000 description 1
- 108010038320 lysylphenylalanine Proteins 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- FDZZZRQASAIRJF-UHFFFAOYSA-M malachite green Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](C)C)C=C1 FDZZZRQASAIRJF-UHFFFAOYSA-M 0.000 description 1
- 229940107698 malachite green Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000011880 melting curve analysis Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000004779 membrane envelope Anatomy 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 108010022588 methionyl-lysyl-proline Proteins 0.000 description 1
- 108010034507 methionyltryptophan Proteins 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- YACKEPLHDIMKIO-UHFFFAOYSA-L methylphosphonate(2-) Chemical compound CP([O-])([O-])=O YACKEPLHDIMKIO-UHFFFAOYSA-L 0.000 description 1
- 238000001531 micro-dissection Methods 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000009126 molecular therapy Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- ZTLGJPIZUOVDMT-UHFFFAOYSA-N n,n-dichlorotriazin-4-amine Chemical compound ClN(Cl)C1=CC=NN=N1 ZTLGJPIZUOVDMT-UHFFFAOYSA-N 0.000 description 1
- VMCOQLKKSNQANE-UHFFFAOYSA-N n,n-dimethyl-4-[6-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-benzimidazol-2-yl]aniline Chemical compound C1=CC(N(C)C)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 VMCOQLKKSNQANE-UHFFFAOYSA-N 0.000 description 1
- GWVCIJWBGGVDJJ-UHFFFAOYSA-N n-(4-aminophenyl)sulfonyl-n-(3-methoxypyrazin-2-yl)acetamide Chemical compound COC1=NC=CN=C1N(C(C)=O)S(=O)(=O)C1=CC=C(N)C=C1 GWVCIJWBGGVDJJ-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000030147 nuclear export Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 239000002997 ophthalmic solution Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 230000010627 oxidative phosphorylation Effects 0.000 description 1
- 239000006174 pH buffer Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000006320 pegylation Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000005043 peripheral vision Effects 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000003209 petroleum derivative Substances 0.000 description 1
- 108010064486 phenylalanyl-leucyl-valine Proteins 0.000 description 1
- 108010018625 phenylalanylarginine Proteins 0.000 description 1
- 108010073101 phenylalanylleucine Proteins 0.000 description 1
- 229940067107 phenylethyl alcohol Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 1
- 238000013492 plasmid preparation Methods 0.000 description 1
- 210000001778 pluripotent stem cell Anatomy 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940068965 polysorbates Drugs 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 108010015796 prolylisoleucine Proteins 0.000 description 1
- 108010053725 prolylvaline Proteins 0.000 description 1
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 230000004952 protein activity Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 239000013608 rAAV vector Substances 0.000 description 1
- 239000012857 radioactive material Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 101150066583 rep gene Proteins 0.000 description 1
- 210000005132 reproductive cell Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000000964 retinal cone photoreceptor cell Anatomy 0.000 description 1
- 231100000385 retinal toxicity Toxicity 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000014438 salad dressings Nutrition 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 239000004054 semiconductor nanocrystal Substances 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 108010069117 seryl-lysyl-aspartic acid Proteins 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 239000008354 sodium chloride injection Substances 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 108010005652 splenotritin Proteins 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000008227 sterile water for injection Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 210000002536 stromal cell Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- GZCRRIHWUXGPOV-UHFFFAOYSA-N terbium atom Chemical compound [Tb] GZCRRIHWUXGPOV-UHFFFAOYSA-N 0.000 description 1
- JGVWCANSWKRBCS-UHFFFAOYSA-N tetramethylrhodamine thiocyanate Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=C(SC#N)C=C1C(O)=O JGVWCANSWKRBCS-UHFFFAOYSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
- 229940033663 thimerosal Drugs 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
- 108010031491 threonyl-lysyl-glutamic acid Proteins 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- XJCQPMRCZSJDPA-UHFFFAOYSA-L trimethyl-[3-[4-[(e)-(3-methyl-1,3-benzothiazol-2-ylidene)methyl]pyridin-1-ium-1-yl]propyl]azanium;diiodide Chemical compound [I-].[I-].S1C2=CC=CC=C2N(C)\C1=C\C1=CC=[N+](CCC[N+](C)(C)C)C=C1 XJCQPMRCZSJDPA-UHFFFAOYSA-L 0.000 description 1
- 108700004896 tripeptide FEG Proteins 0.000 description 1
- 108010020532 tyrosyl-proline Proteins 0.000 description 1
- 108010071635 tyrosyl-prolyl-arginine Proteins 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 108010027345 wheylin-1 peptide Proteins 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/664—Amides of phosphorus acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
- C12N9/0036—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y106/00—Oxidoreductases acting on NADH or NADPH (1.6)
- C12Y106/99—Oxidoreductases acting on NADH or NADPH (1.6) with other acceptors (1.6.99)
- C12Y106/99003—NADH dehydrogenase (1.6.99.3)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/107—Rabbit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/07—Fusion polypeptide containing a localisation/targetting motif containing a mitochondrial localisation signal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Ophthalmology & Optometry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
미토콘드리아 표적화 서열; 미토콘드리아 단백질을 포함하는 폴리펩티드를 인코딩하는 미토콘드리아 단백질 코딩 서열; 및 3'UTR 핵산 서열을 포함하는 재조합 핵산이 본원에 개시된다. 또한, 재조합 핵산을 포함하는 약제학적 조성물 및 상기 약제학적 조성물을 사용한 레버 유전성 시신경병증 (LHON)의 치료 방법이 개시된다.
Description
상호-참조
본 출원은 2018년 7월 9일 출원된 PCT 출원 번호 PCT/CN2018/095023; 2018년 9월 4일 출원된 PCT 출원 번호 PCT/CN2018/103937; 2018년 6월 29일 출원된 중국 출원 번호 CN201810703168.7 및 CN201810702492.7; 2018년 11월 2일 출원된 PCT 출원 번호 PCT/CN2018/113799; 2018년 10월 22일 출원된 중국 출원 번호 CN201811230856.2; 2018년 11월 30일 출원된 PCT 출원 번호 PCT/CN2018/118662; 2018년 10월 19일 출원된 중국 출원 번호 CN201811221305.X; 2019년 1월 4일 출원된 PCT 출원 번호 PCT/CN2019/070461; 2018년 8월 20일 출원된 중국 출원 번호 CN201810948193.1의 이익을 청구하며; 이들 모두 그 전체가 본원에 참조로 포함된다.
서열 목록의 참조
본 출원은 EFS-Web을 통해 ASCII 포맷으로 제출된 서열 목록을 함유하며, 이는 그 전체가 본원에 참조로 포함된다. 2019년 6월 30일 생성된 상기 ASCII 카피는 파일명이 207298476_1.txt이며 크기가 304,914 바이트이다.
레버 유전성 시신경병증(LHON)은 중심 시력의 급성 또는 아급성 손실을 초래하는 미토콘드리아 유전되는 (모체로부터 자손으로 전염되는) 망막 신경절 세포 (RGC) 및 그의 축색돌기의 퇴행이며; 이는 주로 젊은 성인 남성에게 영향을 준다. LHON은, 이것이 주로 (핵이 아닌) 미토콘드리아 게놈의 돌연변이에 기인하며 난자만이 미토콘드리아를 배아에 기여함에 따라, 단지 모체를 통해 전염된다. LHON은 통상적으로 3개의 병원성 미토콘드리아 DNA (mtDNA) 점 돌연변이 중 하나에 기인한다. 이들 돌연변이는 미토콘드리아에서 산화적 인산화 사슬의 복합체 I의 NADH 데히드로게나제 서브유닛-4 단백질 (ND4), NADH 데히드로게나제 서브유닛-1 단백질 (ND1) 및 NADH 데히드로게나제 서브유닛-6 단백질 (ND6) 서브유닛 유전자에서 각각 하기 뉴클레오티드 위치에 존재한다: 11778 G에서 A로 (G11778A), 3460 G에서 A로 (G3460A), 또한 14484 T에서 C로 (T14484C). 각각의 돌연변이는 시력의 영구 손실의 상당한 위험을 갖는 것으로 믿어진다. 이는 전형적으로, 양안 시력이 0.1 미만으로 저하될 때까지, 통증 없이 수주 내지 수개월 내에 진행되고, 이는 환자의 삶의 질에 심각하게 영향을 준다. 2종의 LHON 돌연변이체, G3460A 및 T14484C는 환자의 혈소판 단리된 미토콘드리아 NADH 데히드로게나제 활성을 80%만큼 감소시킨다. 중국 LHON 환자의 90 퍼센트가 G11778A 돌연변이를 갖는다. G11778A 돌연변이는 ND4 단백질에서 아르기닌을 히스티딘으로 변화시키고, 이는 LHON 환자에서 기능장애 및 시신경 손상을 초래한다.
보다 높은 트랜스펙션 효율 및 치료 효능을 갖는 LHON의 치료를 위한 조성물 및 방법의 개발이 필요하다.
LHON의 치료를 위한 재조합 핵산, 약제학적 조성물, 및 방법이 본원에 개시된다. 하나의 양태에서, 미토콘드리아 표적화 서열; 서열 번호: 7, 8, 10, 및 12로 이루어진 군으로부터 선택된 서열과 적어도 99% 동일한 서열을 포함하는 미토콘드리아 단백질 코딩 서열; 및 3'UTR 핵산 서열을 포함하는 재조합 핵산이 본원에 개시된다.
일부 경우에, 미토콘드리아 표적화 서열은 서열 번호: 129-159로 이루어진 군으로부터 선택된 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 펩티드 서열을 포함하는 폴리펩티드이다. 일부 경우에, 미토콘드리아 표적화 서열은 서열 번호: 2에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 미토콘드리아 표적화 서열은 서열 번호: 3에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 미토콘드리아 표적화 서열은 서열 번호: 4에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 미토콘드리아 표적화 서열은 서열 번호: 5에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다.
일부 경우에, 미토콘드리아 단백질 코딩 서열은 서열 번호: 7 또는 8에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 미토콘드리아 단백질 코딩 서열은 서열 번호: 10에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 미토콘드리아 단백질 코딩 서열은 서열 번호: 12에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다.
일부 경우에, 3'UTR 핵산 서열은 서열 번호: 111-125로 이루어진 군으로부터 선택된 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 3'UTR 핵산 서열은 서열 번호: 13 또는 서열 번호: 14에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다.
일부 경우에, 재조합 핵산은 서열 번호: 17-20, 23-24, 27-28, 31-34, 37-38, 41-42, 45-48, 51-52, 55-56, 59-62, 65-66, 69-70, 73-76, 79-80, 및 83-84로 이루어진 군으로부터 선택된 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다.
또 다른 양태에서, 서열 번호: 2, 3, 4, 및 5로 이루어진 군으로부터 선택된 서열과 적어도 90% 동일한 서열을 포함하는 미토콘드리아 표적화 서열; 미토콘드리아 단백질을 포함하는 폴리펩티드를 인코딩하는 미토콘드리아 단백질 코딩 서열; 및 3'UTR 핵산 서열을 포함하는 재조합 핵산이 본원에 개시된다.
일부 경우에, 미토콘드리아 표적화 서열은 서열 번호: 2에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 미토콘드리아 표적화 서열은 서열 번호: 3에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 미토콘드리아 표적화 서열은 서열 번호: 4에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 미토콘드리아 표적화 서열은 서열 번호: 5에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다.
일부 경우에, 미토콘드리아 단백질은 NADH 데히드로게나제 4 (ND4), NADH 데히드로게나제 6 (ND6), NADH 데히드로게나제 1 (ND1), 및 이들의 변종으로 이루어진 군으로부터 선택된다. 일부 경우에, 미토콘드리아 단백질은 NADH 데히드로게나제 4 (ND4), 또는 그의 변종을 포함한다. 일부 경우에, 미토콘드리아 단백질은 서열 번호: 160에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 펩티드 서열을 포함한다. 일부 경우에, 미토콘드리아 단백질 코딩 서열은 서열 번호: 6, 7, 또는 8에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 미토콘드리아 단백질은 NADH 데히드로게나제 6 (ND6), 또는 그의 변종을 포함한다. 일부 경우에, 미토콘드리아 단백질은 서열 번호: 161에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 미토콘드리아 단백질 코딩 서열은 서열 번호: 9 또는 10에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 미토콘드리아 단백질은 NADH 데히드로게나제 1 (ND1), 또는 그의 변종을 포함한다. 일부 경우에, 미토콘드리아 단백질은 서열 번호: 162에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 미토콘드리아 단백질 코딩 서열은 서열 번호: 11 또는 12에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다.
일부 경우에, 3'UTR 핵산 서열은 미토콘드리아 표적화 서열의 3'에 위치한다. 일부 경우에, 3'UTR 핵산 서열은 hsACO2, hsATP5B, hsAK2, hsALDH2, hsCOX10, hsUQCRFS1, hsNDUFV1, hsNDUFV2, hsSOD2, hsCOX6c, hsIRP1, hsMRPS12, hsATP5J2, rnSOD2, 및 hsOXA1L로 이루어진 군으로부터 선택된 서열을 포함한다. 일부 경우에, 3'UTR 핵산 서열은 서열 번호: 111-125로 이루어진 군으로부터 선택된 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 3'UTR 핵산 서열은 서열 번호: 13 또는 서열 번호: 14에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다.
일부 경우에, 미토콘드리아 표적화 서열은 3'UTR 핵산 서열의 5'에 위치한다. 일부 경우에, 미토콘드리아 표적화 서열은 미토콘드리아 표적화 서열의 3'에 위치한다.
일부 경우에, 재조합 핵산은 서열 번호: 29-84로 이루어진 군으로부터 선택된 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다.
또 다른 양태에서, 미토콘드리아 표적화 서열; 서열 번호: 7, 8, 10, 및 12로 이루어진 군으로부터 선택된 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함하는 미토콘드리아 단백질 코딩 서열; 및 3'UTR 핵산 서열을 포함하는 재조합 핵산이 본원에 개시된다.
일부 경우에, 미토콘드리아 표적화 서열은 hsCOX10, hsCOX8, scRPM2, lcSirt5, tbNDUS7, ncQCR2, hsATP5G2, hsLACTB, spilv1, gmCOX2, crATP6, hsOPA1, hsSDHD, hsADCK3, osP0644B06.24-2, 뉴로스포라 크라사(Neurospora crassa) ATP9 (ncATP9), hsGHITM, hsNDUFAB1, hsATP5G3, crATP6 _hsADCK3, ncATP9_ncATP9, zmLOC100282174, ncATP9_zmLOC100282174_spilv1_ncATP9, zmLOC100282174_hsADCK3_crATP6 _hsATP5G3, zmLOC100282174_hsADCK3_hsATP5G3, ncATP9_zmLOC100282174, hsADCK3_zmLOC100282174_crATP6 _hsATP5G3, crATP6_hsADCK3_zmLOC100282174_hsATP5G3, hsADCK3_zmLOC100282174, hsADCK3_zmLOC100282174_crATP6, ncATP9_zmLOC100282174_spilv1_GNFP_ncATP9, 및 ncATP9_zmLOC100282174_spilv1_lcSirt5_osP0644B06.24-2_hsATP5G2_ncATP9로 이루어진 군으로부터 선택된 폴리펩티드를 인코딩하는 서열을 포함한다. 일부 경우에, 미토콘드리아 표적화 서열은 서열 번호: 129-159로 이루어진 군으로부터 선택된 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 펩티드 서열을 포함하는 폴리펩티드를 인코딩한다. 일부 경우에, 미토콘드리아 표적화 서열은 서열 번호: 2 또는 3에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 미토콘드리아 표적화 서열은 서열 번호: 4에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 미토콘드리아 표적화 서열은 서열 번호: 5에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다.
일부 경우에, 미토콘드리아 단백질 코딩 서열은 서열 번호: 7 또는 8에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 미토콘드리아 단백질 코딩 서열은 서열 번호: 10에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 미토콘드리아 단백질 코딩 서열은 서열 번호: 12에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다.
일부 경우에, 3'UTR 핵산 서열은 미토콘드리아 표적화 서열의 3'에 위치한다. 일부 경우에, 3'UTR 핵산 서열은 hsACO2, hsATP5B, hsAK2, hsALDH2, hsCOX10, hsUQCRFS1, hsNDUFV1, hsNDUFV2, hsSOD2, hsCOX6c, hsIRP1, hsMRPS12, hsATP5J2, rnSOD2, 및 hsOXA1L로 이루어진 군으로부터 선택된 서열을 포함한다. 일부 경우에, 3'UTR 핵산 서열은 서열 번호: 111-125로 이루어진 군으로부터 선택된 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 3'UTR 핵산 서열은 서열 번호: 13 또는 서열 번호: 14에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다.
일부 경우에, 미토콘드리아 표적화 서열은 3'UTR 핵산 서열의 5'에 위치한다. 일부 경우에, 미토콘드리아 표적화 서열은 미토콘드리아 표적화 서열의 3'에 위치한다.
일부 경우에, 재조합 핵산은 서열 번호: 17-20, 23-24, 27-28, 31-34, 37-38, 41-42, 45-48, 51-52, 55-56, 59-62, 65-66, 69-70, 73-76, 79-80, 및 83-84로 이루어진 군으로부터 선택된 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다.
또 다른 양태에서, 서열 번호: 2, 3, 및 4로 이루어진 군으로부터 선택된 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 미토콘드리아 표적화 서열을 포함하는 재조합 핵산이 본원에 개시된다. 일부 경우에, 미토콘드리아 표적화 서열은 서열 번호: 2에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 미토콘드리아 표적화 서열은 서열 번호: 3에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 미토콘드리아 표적화 서열은 서열 번호: 4에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다.
일부 경우에, 재조합 핵산은 미토콘드리아 단백질 코딩 서열을 추가로 포함하며, 여기서 미토콘드리아 단백질 코딩 서열은 미토콘드리아 단백질을 포함하는 폴리펩티드를 인코딩한다. 일부 경우에, 미토콘드리아 단백질은 NADH 데히드로게나제 4 (ND4), NADH 데히드로게나제 6 (ND6), NADH 데히드로게나제 1 (ND1), 및 이들의 변종으로 이루어진 군으로부터 선택된다. 일부 경우에, 미토콘드리아 단백질은 NADH 데히드로게나제 4 (ND4), 또는 그의 변종을 포함한다. 일부 경우에, 미토콘드리아 단백질은 서열 번호: 160에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 펩티드 서열을 포함한다. 일부 경우에, 미토콘드리아 단백질 코딩 서열은 서열 번호: 6, 7, 또는 8에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 미토콘드리아 단백질은 NADH 데히드로게나제 6 (ND6), 또는 그의 변종을 포함한다. 일부 경우에, 미토콘드리아 단백질은 서열 번호: 161에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 미토콘드리아 단백질 코딩 서열은 서열 번호: 9 또는 10에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 미토콘드리아 단백질은 NADH 데히드로게나제 1 (ND1), 또는 그의 변종을 포함한다. 일부 경우에, 미토콘드리아 단백질은 서열 번호: 162에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 미토콘드리아 단백질 코딩 서열은 서열 번호: 11 또는 12에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다.
일부 경우에, 재조합 핵산은 3'UTR 핵산 서열을 추가로 포함한다. 일부 경우에, 3'UTR 핵산 서열은 미토콘드리아 표적화 서열의 3'에 위치한다. 일부 경우에, 3'UTR 핵산 서열은 hsACO2, hsATP5B, hsAK2, hsALDH2, hsCOX10, hsUQCRFS1, hsNDUFV1, hsNDUFV2, hsSOD2, hsCOX6c, hsIRP1, hsMRPS12, hsATP5J2, rnSOD2, 및 hsOXA1L로 이루어진 군으로부터 선택된 서열을 포함한다. 일부 경우에, 3'UTR 핵산 서열은 서열 번호: 111-125로 이루어진 군으로부터 선택된 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 3'UTR 핵산 서열은 서열 번호: 13 또는 서열 번호: 14에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 미토콘드리아 표적화 서열은 3'UTR 핵산 서열의 5'에 위치한다. 일부 경우에, 미토콘드리아 표적화 서열은 미토콘드리아 표적화 서열의 3'에 위치한다.
일부 경우에, 재조합 핵산은 서열 번호: 29-70로 이루어진 군으로부터 선택된 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다.
또 다른 양태에서, 미토콘드리아 단백질 코딩 서열을 포함하며, 여기서 미토콘드리아 단백질 코딩 서열은 미토콘드리아 단백질을 포함하는 폴리펩티드를 인코딩하고, 여기서 미토콘드리아 단백질 코딩 서열은 서열 번호: 7, 8, 10, 및 12로 이루어진 군으로부터 선택된 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함하는 것인 재조합 핵산이 본원에 개시된다.
일부 경우에, 재조합 핵산은 미토콘드리아 표적화 서열을 추가로 포함한다. 일부 경우에, 미토콘드리아 표적화 서열은 hsCOX10, hsCOX8, scRPM2, lcSirt5, tbNDUS7, ncQCR2, hsATP5G2, hsLACTB, spilv1, gmCOX2, crATP6, hsOPA1, hsSDHD, hsADCK3, osP0644B06.24-2, 뉴로스포라 크라사 ATP9 (ncATP9), hsGHITM, hsNDUFAB1, hsATP5G3, crATP6 _hsADCK3, ncATP9_ncATP9, zmLOC100282174, ncATP9_zmLOC100282174_spilv1_ncATP9, zmLOC100282174_hsADCK3_crATP6 _hsATP5G3, zmLOC100282174_hsADCK3_hsATP5G3, ncATP9_zmLOC100282174, hsADCK3_zmLOC100282174_crATP6 _hsATP5G3, crATP6_hsADCK3_zmLOC100282174_hsATP5G3, hsADCK3_zmLOC100282174, hsADCK3_zmLOC100282174_crATP6, ncATP9_zmLOC100282174_spilv1_GNFP_ncATP9, 및 ncATP9_zmLOC100282174_spilv1_lcSirt5_osP0644B06.24-2_hsATP5G2_ncATP9로 이루어진 군으로부터 선택된 폴리펩티드를 인코딩하는 서열을 포함한다. 일부 경우에, 미토콘드리아 표적화 서열은 서열 번호: 129-159로 이루어진 군으로부터 선택된 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 펩티드 서열을 포함하는 폴리펩티드를 인코딩한다. 일부 경우에, 미토콘드리아 표적화 서열은 서열 번호: 2에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 미토콘드리아 표적화 서열은 서열 번호: 3에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 미토콘드리아 표적화 서열은 서열 번호: 4에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 미토콘드리아 표적화 서열은 서열 번호: 5에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다.
일부 경우에, 미토콘드리아 단백질 코딩 서열은 서열 번호: 7 또는 8에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 미토콘드리아 단백질 코딩 서열은 서열 번호: 10에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 미토콘드리아 단백질 코딩 서열은 서열 번호: 12에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다.
일부 경우에, 재조합 핵산은 3'UTR 핵산 서열을 추가로 포함한다. 일부 경우에, 3'UTR 핵산 서열은 미토콘드리아 표적화 서열의 3'에 위치한다. 일부 경우에, 3'UTR 핵산 서열은 hsACO2, hsATP5B, hsAK2, hsALDH2, hsCOX10, hsUQCRFS1, hsNDUFV1, hsNDUFV2, hsSOD2, hsCOX6c, hsIRP1, hsMRPS12, hsATP5J2, rnSOD2, 및 hsOXA1L로 이루어진 군으로부터 선택된 서열을 포함한다. 일부 경우에, 3'UTR 핵산 서열은 서열 번호: 111-125로 이루어진 군으로부터 선택된 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 3'UTR 핵산 서열은 서열 번호: 13 또는 서열 번호: 14에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다. 일부 경우에, 미토콘드리아 표적화 서열은 3'UTR 핵산 서열의 5'에 위치한다. 일부 경우에, 미토콘드리아 표적화 서열은 미토콘드리아 표적화 서열의 3'에 위치한다.
일부 경우에, 재조합 핵산은 서열 번호: 17-20, 23-24, 27-28, 31-34, 37-38, 41-42, 45-48, 51-52, 55-56, 59-62, 65-66, 69-70, 73-76, 79-80, 및 83-84로 이루어진 군으로부터 선택된 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함한다.
또 다른 양태에서, 본원에 개시된 재조합 핵산을 포함하는 바이러스 벡터가 본원에 개시된다. 일부 경우에, 바이러스 벡터는 아데노-관련 바이러스 (AAV) 벡터이다. 일부 경우에, AAV 벡터는 AAV1, AAV2, AAV3, AAV4, AAV5, AAV6, AAV7, AAV8, AAV9, AAV10, AAV11, AAV12, AAV13, AAV14, AAV15, 및 AAV16 벡터로 이루어진 군으로부터 선택된다. 일부 경우에, AAV 벡터는 재조합 AAV (rAAV) 벡터이다. 일부 경우에, rAAV 벡터는 rAAV2 벡터이다.
또 다른 양태에서, 본원에 개시된 임의의 재조합 핵산을 포함하는 아데노-관련 바이러스 (AAV)를 포함하는 약제학적 조성물이 본원에 개시된다. 일부 경우에, 약제학적 조성물은 그의 약제학적으로 허용가능한 부형제를 추가로 포함한다. 본원에 개시된 바이러스 벡터 및 그의 약제학적으로 허용가능한 부형제를 포함하며, 여기서 바이러스 벡터는 본원에 개시된 임의의 재조합 핵산을 포함하는 것인 약제학적 조성물이 또한 개시된다. 본원에 개시된 임의의 재조합 핵산을 포함하는 아데노-관련 바이러스 (AAV); 및 약제학적으로 허용가능한 부형제를 포함하며, 여기서 재조합 핵산은 서열 번호: 15에 기재된 바와 같은 서열과 적어도 90%, 적어도 95%, 적어도 97%, 적어도 99%, 또는 100% 동일한 서열을 포함하는 것인 약제학적 조성물이 또한 개시된다.
일부 경우에, 약제학적으로 허용가능한 부형제는 인산염 완충 식염수 (PBS), α,α-트레할로스 탈수화물, L-히스티딘 모노히드로클로라이드 일수화물, 폴리소르베이트 20, NaCl, NaH2PO4, Na2HPO4, KH2PO4, K2HPO4, 폴록사머 188, 또는 임의의 이들의 조합을 포함한다. 일부 경우에, 약제학적으로 허용가능한 부형제는 인산염 완충 식염수 (PBS), α,α-트레할로스 탈수화물, L-히스티딘 모노히드로클로라이드 일수화물, 폴리소르베이트 20, NaCl, NaH2PO4, Na2HPO4, KH2PO4, K2HPO4, 폴록사머 188, 및 임의의 이들의 조합으로부터 선택된다. 일부 경우에, 약제학적으로 허용가능한 부형제는 폴록사머 188을 포함한다. 일부 경우에, 약제학적으로 허용가능한 부형제는 0.0001%-0.01% 폴록사머 188을 포함한다. 일부 경우에, 약제학적으로 허용가능한 부형제는 0.001% 폴록사머 188을 포함한다. 일부 경우에, 약제학적으로 허용가능한 부형제는 하나 이상의 염을 추가로 포함한다. 일부 경우에, 하나 이상의 염은 NaCl, NaH2PO4, Na2HPO4, 및 KH2PO4를 포함한다. 일부 경우에, 하나 이상의 염은 80 mM NaCl, 5 mM NaH2PO4, 40 mM Na2HPO4, 및 5 mM KH2PO4를 포함한다. 일부 경우에, 약제학적 조성물은 6-8의 pH를 갖는다. 일부 경우에, 약제학적 조성물은 7.2-7.4의 pH를 갖는다. 일부 경우에, 약제학적 조성물은 7.3의 pH를 갖는다. 일부 경우에, 약제학적 조성물은 적어도 1.0 × 1010 vg/mL의 바이러스 역가를 갖는다. 일부 경우에, 약제학적 조성물은 적어도 5.0 × 1010 vg/mL의 바이러스 역가를 갖는다.
일부 경우에, 약제학적 조성물은 5회의 동결/해동 사이클에 적용되고, 약제학적 조성물은 5회의 동결/해동 사이클 전의 바이러스 역가에 비해 적어도 60%, 70%, 80%, 또는 90%의 바이러스 역가를 보유한다. 일부 경우에, 약제학적 조성물은, 레버 유전성 시신경병증을 갖는 환자에게 투여시, 재조합 핵산이 없는 유사 약제학적 조성물에 비해 더 높은 시력의 평균 회복을 생성한다. 일부 경우에, 약제학적 조성물은, 레버 유전성 시신경병증을 갖는 환자에게 투여시, 서열 번호: 15에 기재된 바와 같은 재조합 핵산을 포함하는 유사 약제학적 조성물에 비해 더 높은 시력의 평균 회복을 생성한다.
또 다른 양태에서, 본원에 개시된 임의의 약제학적 조성물을 그를 필요로 하는 환자에게 투여하는 것을 포함하는, 눈 장애의 치료 방법이 본원에 개시된다. 일부 경우에, 눈 장애는 레버 유전성 시신경병증 (LHON)이다. 일부 경우에, 방법은 약제학적 조성물을 환자의 한쪽 또는 양쪽 눈에 투여하는 것을 포함한다. 일부 경우에, 약제학적 조성물은 안내 또는 유리체내 주사를 통해 투여된다. 일부 경우에, 약제학적 조성물은 유리체내 주사를 통해 투여된다. 일부 경우에는, 약 0.01-0.1 mL의 약제학적 조성물이 유리체내 주사를 통해 투여된다. 일부 경우에는, 약 0.05 mL의 약제학적 조성물이 유리체내 주사를 통해 투여된다.
일부 경우에, 방법은 메틸프레드니솔론을 환자에게 투여하는 것을 추가로 포함한다. 일부 경우에, 메틸프레드니솔론은 약제학적 조성물의 유리체내 주사 전에 투여된다. 일부 경우에, 메틸프레드니솔론은 경구 투여된다. 일부 경우에, 메틸프레드니솔론은 약제학적 조성물의 유리체내 주사 전에 적어도 1, 2, 3, 4, 5, 6, 또는 7일 동안 매일 투여된다. 일부 경우에, 메틸프레드니솔론은 매일 투여된다. 일부 경우에는, 약 32 mg/60 kg 메틸프레드니솔론의 일일 투여량이 투여된다. 일부 경우에, 메틸프레드니솔론은 약제학적 조성물의 유리체내 주사 후에 투여된다. 일부 경우에, 방법은 크레아틴 인산염 나트륨을 환자에게 투여하는 것을 추가로 포함한다. 일부 경우에, 크레아틴 인산염 나트륨은 정맥내 투여된다. 일부 경우에, 메틸프레드니솔론은 정맥내 또는 경구 투여된다. 일부 경우에, 방법은 적어도 하루동안 메틸프레드니솔론을 정맥내 투여한 후, 적어도 일주일 동안 메틸프레드니솔론을 경구 투여하는 것을 포함한다. 일부 경우에, 방법은 약 3일 동안 메틸프레드니솔론을 정맥내 투여한 후, 적어도 약 6주 동안 메틸프레드니솔론을 경구 투여하는 것을 포함한다. 일부 경우에, 메틸프레드니솔론은 약 80 mg/60 kg의 일일 용량으로 정맥내 투여된다. 일부 경우에, 약제학적 조성물의 투여는 재조합 핵산이 없는 유사 약제학적 조성물에 비해 더 높은 시력의 평균 회복을 생성한다. 일부 경우에, 약제학적 조성물의 투여는 서열 번호: 15에 기재된 바와 같은 재조합 핵산을 포함하는 유사 약제학적 조성물에 비해 더 높은 시력의 평균 회복을 생성한다.
참조문헌의 포함
본 명세서에서 언급된 모든 공개 문헌, 특허, 및 특허 출원은, 각각의 개별적 공개 문헌, 특허, 및 특허 출원이 구체적 및 개별적으로 참조로 포함된다고 지시되는 것과 동일한 정도로 본원에 참조로 포함된다.
본 발명은, 보다 높은 트랜스펙션 효율 및 치료 효능을 갖는 LHON의 치료를 위한 조성물 및 방법을 제공한다.
본 발명의 신규한 특징은 첨부된 청구범위에서 상세히 기재된다. 본 발명의 특징 및 이점의 보다 나은 이해는, 본 발명의 원리를 활용하는 예시적 구현예를 기재하는 하기 상세한 설명 및 첨부된 도면을 참조하여 얻어질 것이며, 도면은 하기와 같다:
도 1은 ND4 (레인 A) 및 최적화된 ND4 (레인 B) 유전자 클로닝 결과의 PCR 핵산 전기영동 확인을 나타낸다.
도 2는 rAAV2-opt_ND4 (좌측 흑색 컬럼)와 rAAV2-ND4 (우측 흑색 컬럼) 사이의 qPCR을 사용한 상대적 발현 수준 비교를 나타낸다. β-액틴은 내부 기준 유전자 (백색 컬럼)이다.
도 3은 rAAV2-opt_ND4 (좌측 흑색 컬럼)와 rAAV2-ND4 (우측 흑색 컬럼) 사이의 면역블롯팅을 사용한 상대적 발현 수준 비교를 나타낸다. β-액틴은 내부 기준 유전자 (백색 컬럼)이다.
도 4는 각각 rAAV2-opt_ND4 (우측) 및 rAAV2-ND4 (좌측)가 주사된 토끼에 대한 안저부(fundus) 사진 결과를 나타낸다.
도 5는 rAAV2-최적화된 ND4 주사 전 (좌측)과 후 (우측)의 환자에 대한 안저부 사진 결과를 나타낸다.
도 6은 rAAV2-ND4 (좌측) 및 rAAV2-opt_ND4* (우측)의 EGFP 발현 수준을 나타낸다.
도 7은 293T 세포에서의 ND4 발현: rAAV2-ND4 (좌측) 및 rAAV2-opt_ND4* (우측)를 나타낸다.
도 8은 293T 세포에서의 상대적 ND4 발현: rAAV2-ND4 (좌측) 및 rAAV2-opt_ND4* (우측)를 나타낸다.
도 9는 토끼 시신경 세포에서의 ND4 발현: rAAV2-ND4 (좌측) 및 rAAV2-opt_ND4* (우측)를 나타낸다.
도 10은 토끼 시신경 세포에서의 상대적 ND4 발현: rAAV2-ND4 (좌측) 및 rAAV2-opt_ND4* (우측)를 나타낸다.
도 11은 rAAV2-ND4 (좌측) 및 rAAV2-opt_ND4* (우측)에 대한 안저부 사진 결과를 나타낸다.
도 12는 rAAV2-ND4 (좌측) 및 rAAV2-opt_ND4* (우측)에 대한 현미경 검사 (HE 염색) 결과를 나타낸다.
도 13은 각각 rAAV2-ND6 (A), rAAV-GFP (B) 및 PBS가 주사된 토끼에 대한 안저부 사진 결과를 나타낸다.
도 14는 각각 rAAV2-opt_ND6 (A), rAAV2-ND6 (B), rAAV-EGFP (C)가 주사된 토끼에 대한 안저부 사진 결과를 나타낸다.
도 15는 토끼 시신경 세포에서의 상대적 ND6 발현: rAAV2-opt_ND6 (A), rAAV2-ND6 (B), 및 rAAV-EGFP (C)를 나타낸다.
도 16은 웨스턴 블롯에 의한 상대적 ND6 발현: rAAV2-opt_ND6 (A), rAAV2-ND6 (B), 및 rAAV-EGFP (C)를 나타낸다.
도 17은 토끼 시신경 세포에서의 상대적 ND1 발현: rAAV2-opt_ND1 (A), rAAV2-ND1 (B), 및 rAAV-EGFP (C)를 나타낸다.
도 18은 웨스턴 블롯에 의한 상대적 ND1 발현: rAAV2-opt_ND1 (A), rAAV2-ND1 (B), 및 rAAV-EGFP (C)를 나타낸다.
도 1은 ND4 (레인 A) 및 최적화된 ND4 (레인 B) 유전자 클로닝 결과의 PCR 핵산 전기영동 확인을 나타낸다.
도 2는 rAAV2-opt_ND4 (좌측 흑색 컬럼)와 rAAV2-ND4 (우측 흑색 컬럼) 사이의 qPCR을 사용한 상대적 발현 수준 비교를 나타낸다. β-액틴은 내부 기준 유전자 (백색 컬럼)이다.
도 3은 rAAV2-opt_ND4 (좌측 흑색 컬럼)와 rAAV2-ND4 (우측 흑색 컬럼) 사이의 면역블롯팅을 사용한 상대적 발현 수준 비교를 나타낸다. β-액틴은 내부 기준 유전자 (백색 컬럼)이다.
도 4는 각각 rAAV2-opt_ND4 (우측) 및 rAAV2-ND4 (좌측)가 주사된 토끼에 대한 안저부(fundus) 사진 결과를 나타낸다.
도 5는 rAAV2-최적화된 ND4 주사 전 (좌측)과 후 (우측)의 환자에 대한 안저부 사진 결과를 나타낸다.
도 6은 rAAV2-ND4 (좌측) 및 rAAV2-opt_ND4* (우측)의 EGFP 발현 수준을 나타낸다.
도 7은 293T 세포에서의 ND4 발현: rAAV2-ND4 (좌측) 및 rAAV2-opt_ND4* (우측)를 나타낸다.
도 8은 293T 세포에서의 상대적 ND4 발현: rAAV2-ND4 (좌측) 및 rAAV2-opt_ND4* (우측)를 나타낸다.
도 9는 토끼 시신경 세포에서의 ND4 발현: rAAV2-ND4 (좌측) 및 rAAV2-opt_ND4* (우측)를 나타낸다.
도 10은 토끼 시신경 세포에서의 상대적 ND4 발현: rAAV2-ND4 (좌측) 및 rAAV2-opt_ND4* (우측)를 나타낸다.
도 11은 rAAV2-ND4 (좌측) 및 rAAV2-opt_ND4* (우측)에 대한 안저부 사진 결과를 나타낸다.
도 12는 rAAV2-ND4 (좌측) 및 rAAV2-opt_ND4* (우측)에 대한 현미경 검사 (HE 염색) 결과를 나타낸다.
도 13은 각각 rAAV2-ND6 (A), rAAV-GFP (B) 및 PBS가 주사된 토끼에 대한 안저부 사진 결과를 나타낸다.
도 14는 각각 rAAV2-opt_ND6 (A), rAAV2-ND6 (B), rAAV-EGFP (C)가 주사된 토끼에 대한 안저부 사진 결과를 나타낸다.
도 15는 토끼 시신경 세포에서의 상대적 ND6 발현: rAAV2-opt_ND6 (A), rAAV2-ND6 (B), 및 rAAV-EGFP (C)를 나타낸다.
도 16은 웨스턴 블롯에 의한 상대적 ND6 발현: rAAV2-opt_ND6 (A), rAAV2-ND6 (B), 및 rAAV-EGFP (C)를 나타낸다.
도 17은 토끼 시신경 세포에서의 상대적 ND1 발현: rAAV2-opt_ND1 (A), rAAV2-ND1 (B), 및 rAAV-EGFP (C)를 나타낸다.
도 18은 웨스턴 블롯에 의한 상대적 ND1 발현: rAAV2-opt_ND1 (A), rAAV2-ND1 (B), 및 rAAV-EGFP (C)를 나타낸다.
발명의 상세한 설명
정의
달리 정의되지 않는 한, 본원에서 사용되는 모든 기술 및 과학 용어는 본 개시내용이 속하는 당업계의 숙련자에 의해 통상적으로 이해되는 것과 동일한 의미를 갖는다. 본원에 기재된 것들과 유사한 또는 동등한 임의의 방법 및 물질이 본원에서의 제제 또는 단위 용량의 실행 또는 시험에서 사용될 수 있으나, 이제 일부 방법 및 물질을 기재한다. 달리 언급되지 않는 한, 본원에서 사용되는 또는 고려되는 기술은 표준 방법론이다. 물질, 방법 및 예는 단지 예시적인 것이며 제한적인 것은 아니다.
본원에서, 또한 첨부된 청구범위에서 사용되는 바와 같이, 단수형 "a", "및", 및 "the"는 문맥에서 명백히 달리 지시하지 않는 한 복수 지시대상을 포함한다. 따라서, 예를 들어, "화합물"의 언급은 복수의 이러한 작용제를 포함하고, "염"의 언급은 하나 이상의 염 (또는 복수의 염)의 언급 및 당업자에게 공지된 그의 동등물을 포함하며, 기타 등등이다.
본원에서 사용되는 바와 같이, 달리 지시되지 않는 한, 용어 "또는"은 접속적 또는 이접적일 수 있다. 본원에서 사용되는 바와 같이, 달리 지시되지 않는 한, 임의의 구현예는 임의의 다른 구현예와 조합될 수 있다.
본원에서 사용되는 바와 같이, 달리 지시되지 않는 한, 본원에서 일부 본 발명의 구현예는 수치 범위를 고려한다. 범위가 존재하는 경우, 범위는 범위 종점을 포함한다. 추가로, 범위 내의 모든 하위범위 및 값은 이것이 명시적으로 기재되는 것과 같이 존재한다.
본원에서 사용되는 바와 같이 수치 및 그의 문법적 동등어 언급과 관련하여 용어 "약" 및 그의 문법적 동등어는 그 값으로부터의 플러스 또는 마이너스 10%의 값의 범위, 예컨대 그 값으로부터의 플러스 또는 마이너스 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 또는 1%의 값의 범위를 포함할 수 있다. 예를 들어, "약 10"의 양은 9 내지 11의 양을 포함한다.
용어 "포함하는" (및 관련 용어, 예컨대 "포함하다" 또는 "갖는" 또는 "포함한")은, 다른 특정 구현예에서, 예를 들어 본원에 기재된 임의의 물질 조성물, 조성물, 방법, 또는 공정 등의 구현예가 기재된 특징으로 "이루어질 수 있음" 또는 "본질적으로 이루어질 수 있음"을 배제하도록 의도되지 않는다.
용어 "대상체"는 치료, 관찰 또는 실험의 대상인 또는 이들의 대상이 될 포유류를 지칭한다. 용어 "포유류"는 그의 표준 의미를 갖도록 의도되고, 예를 들어, 인간, 개, 고양이, 양, 및 소를 포함한다. 본원에 기재된 방법은 인간 치료법 및 수의학 적용 둘 다에서 유용할 수 있다. 일부 구현예에서, 대상체는 인간이다.
용어 "치료하는" 또는 "치료"는 본원에 개시된 적어도 하나의 화합물, 또는 그의 약제학적으로 허용가능한 염을 그러한 투여를 필요로 하는 포유류 대상체, 특히 인간 대상체에게 투여하는 것을 포함하며, 이는 (i) 질환, 예컨대 암의 임상적 증상의 발달을 저지시키는 것, (ii) 질환, 예컨대 암의 임상적 증상의 퇴화를 일으키는 것, 및/또는 (iii) 질환, 예컨대 암의 발병을 막기 위한 예방적 치료를 포함한다.
본원에 기재된 화학적 엔티니(entity)의 "치료 유효량"이라는 용어는, 인간 또는 비-인간 대상체에게 투여시, 증상의 개선, 질환 진행의 지연, 또는 질환의 방지와 같은 치료적 이익을 제공하기에 효과적인 양을 지칭한다.
본원에서 사용되는 바와 같이, 달리 지시되지 않는 한, 용어 "핵산" 및 "폴리뉴클레오티드"는 상호교환가능하게 사용될 수 있다.
핵산 및 폴리펩티드 서열
표 1은 본원에 개시된 모든 핵산 및 폴리펩티드 서열을 개시한다. 제1 컬럼은 각각의 서열의 서열 번호를 나타낸다. 제2 컬럼은 핵산 또는 폴리펩티드 작제물을 기재한 것이다. 예를 들어, 작제물 COX10-ND6-3'UTR은 COX10 (서열 번호: 1), ND6 (서열 번호: 9), 및 3'UTR (서열 번호: 13)의 핵산 서열을 조합한 핵산이다 (5'로부터 3'까지, 핵산 서열 사이의 링커 없음).
표 1 - 핵산 및 폴리펩티드 서열 및 서열 번호
아데노-관련 바이러스 (AAV)
아데노-관련 바이러스 (AAV)는 인간 및 일부 다른 영장류 종을 감염시키는 작은 바이러스이다. 본원에 개시된 조성물은 먼저 아데노-관련 바이러스 (AAV) 게놈 또는 그의 유도체를 포함한다.
AAV 게놈은 AAV 바이러스 입자의 생성을 위해 필요한 기능을 인코딩하는 폴리뉴클레오티드 서열이다. 이들 기능은 숙주 세포에서 AAV에 대한 복제 및 패키징 사이클에서 작업하는 것들, 예컨대 AAV 게놈을 AAV 바이러스 입자로 캡시드화하는 것을 포함한다. 자연 발생 AAV 바이러스는 복제-결핍성이고, 복제 및 패키징 사이클의 완료를 위해 트랜스에서 헬퍼 기능의 제공에 의존한다. 따라서, 본 발명의 벡터의 AAV 게놈은 전형적으로 복제-결핍성이다.
AAV 게놈은 포지티브 또는 네가티브-센스의 단일-가닥 형태, 또는 대안적으로 이중-가닥 형태일 수 있다. 이중-가닥 형태의 사용은 표적 세포에서의 DNA 복제 단계의 우회를 가능하게 하고, 따라서 트랜스진 발현을 가속화시킬 수 있다.
AAV 게놈은 AAV의 임의의 자연 유래 혈청형 또는 단리물 또는 글레이드로부터 유래될 수 있다. 따라서, AAV 게놈은 자연 발생 AAV 바이러스의 전체 게놈일 수 있다. 당업자에게 공지되어 있는 바와 같이, 자연에서 발생하는 AAV 바이러스는 다양한 생물학적 시스템에 따라 분류될 수 있다.
통상적으로, AAV 바이러스는 이들의 혈청형과 관련하여 언급된다. 혈청형은 캡시드 표면 항원의 발현의 그의 프로파일로 인해 그를 다른 변종 아종과 구별하기 위해 사용될 수 있는 독특한 반응성을 갖는 AAV의 변종 아종에 상응한다. 전형적으로, 특정 AAV 혈청형을 갖는 바이러스는 임의의 다른 AAV 혈청형에 대해 특이적인 중화 항체와 효율적으로 교차-반응하지 않는다. AAV 혈청형은 AAV1, AAV2, AAV3, AAV4, AAV5, AAV6, AAV7, AAV8, AAV9, AAV10, AAV11, AAV12, AAV13, AAV14, AAV15, 및 AAV16, 또한 재조합 혈청형, 예컨대 Rec2 및 Rec3 (최근 영장류 뇌로부터 동정됨)을 포함한다.
본 발명에서의 사용을 위한 AAV의 바람직한 혈청형은 AAV2이다. 본 발명에서의 사용을 위한 특히 중요한 다른 혈청형은, 망막 색소 상피와 같은 눈에서의 조직을 효율적으로 형질도입하는 AAV4, AAV5 및 AAV8을 포함한다. 사용되는 AAV의 혈청형은 AAV4가 아닌 AAV 혈청형일 수 있다. AAV 혈청형의 검토는 Choi 등, Curr Gene Ther. 2005; 5(3); 299-310 및 Wu 등, Molecular Therapy. 2006; 14(3), 316-327에서 찾아볼 수 있다. 본 발명에서의 사용을 위한 ITR 서열, rep 또는 cap 유전자를 포함한 AAV 게놈 또는 AAV 게놈의 요소의 서열은 AAV 전체 게놈 서열에 대한 하기 수탁 번호로부터 유래될 수 있다: 아데노-관련 바이러스 1 NC_002077, AF063497; 아데노-관련 바이러스 2 NC_001401; 아데노-관련 바이러스 3 NC_001729; 아데노-관련 바이러스 3B NC_001863; 아데노-관련 바이러스 4 NC_001829; 아데노-관련 바이러스 5 Y18065, AF085716; 아데노-관련 바이러스 6 NC_001862; 조류(Avian) AAV ATCC VR-865 AY186198, AY629583, NC_004828; 조류 AAV 균주 DA-1 NC_006263, AY629583; 소(Bovine) AAV NC_005889, AY388617.
AAV 바이러스는 또한 클레이드 또는 클론과 관련하여 언급될 수 있다. 이는 자연 유래 AAV 바이러스의 계통발생 관계, 또한 전형적으로 공통의 조상으로 거슬러 올라갈 수 있고 이들의 모든 자손을 포함하는 AAV 바이러스의 계통발생 그룹을 나타낸다. 추가로, AAV 바이러스는 특정 단리물, 즉 자연에서 나타나는 특정 AAV 바이러스의 유전적 단리물과 관련하여 언급될 수 있다. 용어 유전적 단리물은 다른 자연 발생 AAV 바이러스와 제한된 유전적 혼합을 거치고, 이로써 유전적 수준에서 인식가능하게 뚜렷한 집단을 정의하는 AAV 바이러스의 집단을 나타낸다.
본 발명에서 사용될 수 있는 AAV의 클레이드 및 단리물의 예는 하기를 포함한다: 클레이드 A: AAV1 NC_002077, AF063497, AAV6 NC_001862, Hu. 48 AY530611, Hu 43 AY530606, Hu 44 AY530607, Hu 46 AY530609; 클레이드 B: Hu. 19 AY530584, Hu. 20 AY530586, Hu 23 AY530589, Hu22 AY530588, Hu24 AY530590, Hu21 AY530587, Hu27 AY530592, Hu28 AY530593, Hu 29 AY530594, Hu63 AY530624, Hu64 AY530625, Hu13 AY530578, Hu56 AY530618, Hu57 AY530619, Hu49 AY530612, Hu58 AY530620, Hu34 AY530598, Hu35 AY530599, AAV2 NC_001401, Hu45 AY530608, Hu47 AY530610, Hu51 AY530613, Hu52 AY530614, Hu T41 AY695378, Hu S17 AY695376, Hu T88 AY695375, Hu T71 AY695374, Hu T70 AY695373, Hu T40 AY695372, Hu T32 AY695371, Hu T17 AY695370, Hu LG15 AY695377; 클레이드 C: Hu9 AY530629, Hu10 AY530576, Hu11 AY530577, Hu53 AY530615, Hu55 AY530617, Hu54 AY530616, Hu7 AY530628, Hu18 AY530583, Hu15 AY530580, Hu16 AY530581, Hu25 AY530591, Hu60 AY530622, Ch5 AY243021, Hu3 AY530595, Hu1 AY530575, Hu4 AY530602 Hu2, AY530585, Hu61 AY530623; 클레이드 D: Rh62 AY530573, Rh48 AY530561, Rh54 AY530567, Rh55 AY530568, Cy2 AY243020, AAV7 AF513851, Rh35 AY243000, Rh37 AY242998, Rh36 AY242999, Cy6 AY243016, Cy4 AY243018, Cy3 AY243019, Cy5 AY243017, Rh13 AY243013; 클레이드 E: Rh38 AY530558, Hu66 AY530626, Hu42 AY530605, Hu67 AY530627, Hu40 AY530603, Hu41 AY530604, Hu37 AY530600, Rh40 AY530559, Rh2 AY243007, Bb1 AY243023, Bb2 AY243022, Rh10 AY243015, Hu17 AY530582, Hu6 AY530621, Rh25 AY530557, Pi2 AY530554, Pi1 AY530553, Pi3 AY530555, Rh57 AY530569, Rh50 AY530563, Rh49 AY530562, Hu39 AY530601, Rh58 AY530570, Rh61 AY530572, Rh52 AY530565, Rh53 AY530566, Rh51 AY530564, Rh64 AY530574, Rh43 AY530560, AAV8 AF513852, Rh8 AY242997, Rh1 AY530556; 클레이드 F: Hu14 (AAV9) AY530579, Hu31 AY530596, Hu32 AY530597, 클론 단리물 AAV5 Y18065, AF085716, AAV 3 NC_001729, AAV 3B NC_001863, AAV4 NC_001829, Rh34 AY243001, Rh33 AY243002, Rh32 AY243003.
당업자는 그들의 통상적 일반 지식에 기초하여 본 발명에서의 사용을 위한 AAV의 적절한 혈청형, 글레이드, 클론 또는 단리물을 선택할 수 있다. 예를 들어, AAV5 캡시드는 유전된 색각 결함의 성공적인 교정에 의해 입증되는 바와 같이 효율적으로 영장류 원뿔체 광수용체를 형질도입하는 것으로 나타났다 (Mancuso 등, Nature 2009, 461:784-7).
그러나, 본 발명은 또한 아직 동정되거나 특성화되지 않은 것일 수 있는 다른 혈청형의 AAV 게놈의 사용을 포함함을 이해하여야 한다. AAV 혈청형은 AAV 바이러스의 감염 (또는 향성(tropism))의 조직 특이성을 결정한다. 따라서, 본 발명에 따라 환자에게 투여되는 AAV 바이러스에서의 사용을 위해 바람직한 AAV 혈청형은 LHON에서 눈 안의 표적 세포의 감염의 높은 효율성 또는 그에 대한 자연적 향성을 갖는 것들이다. 따라서, 환자에게 투여되는 AAV 바이러스에서의 사용을 위한 AAV 혈청형은 감각신경 망막 및 망막 색소 상피의 세포를 감염시키는 것들일 수 있다.
전형적으로, AAV의 자연 유래 혈청형 또는 단리물 또는 글레이드의 AAV 게놈은 적어도 하나의 역위 말단 반복 서열 (ITR)을 포함한다. ITR 서열은 복제의 기능적 원점을 제공하도록 시스로 작용하고, 세포의 게놈으로부터의 벡터의 통합 및 절제를 가능하게 한다. 바람직한 구현예에서, 하나 이상의 ITR 서열은 ND4, ND6, 또는 ND1 또는 그의 변종을 인코딩하는 폴리뉴클레오티드 서열을 플랭킹한다. 바람직한 ITR 서열은 AAV2, 및 그의 변종의 것들이다. AAV 게놈은 전형적으로 또한, AAV 바이러스 입자에 대한 패키징 기능을 인코딩하는 패키징 유전자, 예컨대 rep 및/또는 cap 유전자를 포함한다. rep 유전자는 단백질 Rep78, Rep68, Rep52 및 Rep40 또는 이들의 변종 중 하나 이상을 인코딩한다. cap 유전자는 하나 이상의 캡시드 단백질, 예컨대 VP1, VP2 및 VP3 또는 이들의 변종을 인코딩한다. 이들 단백질은 AAV 바이러스 입자의 캡시드를 구성한다. 캡시드 변종은 하기에서 논의된다.
프로모터는 패키징 유전자 각각에 작동가능하게 연결될 것이다. 이러한 프로모터의 구체적 예는 p5, p19 및 p40 프로모터를 포함한다 (Laughlin 등, 1979, PNAS, 76:5567-5571). 예를 들어, p5 및 p19 프로모터는 일반적으로 rep 유전자의 발현을 위해 사용되며, p40 프로모터는 일반적으로 cap 유전자의 발현에 사용된다.
따라서, 상기에서 논의된 바와 같이, 본 발명의 벡터에서 사용되는 AAV 게놈은 자연 발생 AAV 바이러스의 전체 게놈일 수 있다. 예를 들어, 전체 AAV 게놈을 포함하는 벡터를 사용하여 시험관내에서 AAV 바이러스를 제조할 수 있다. 그러나, 이러한 벡터는 원칙적으로 환자에게 투여될 수 있지만, 이는 실용상 거의 수행되지 않을 것이다. 바람직하게는 AAV 게놈은 환자에 대한 투여를 위해 유도체화될 것이다. 이러한 유도체화는 당업계에서 표준이고, 본 발명은 AAV 게놈의 임의의 공지된 유도체, 및 당업계에 공지된 가술 적용에 의해 생성될 수 있는 유도체의 사용을 포함한다. AAV 게놈 및 AAV 캡시드의 유도체화는 Coura 및 Nardi (Virology Journal, 2007, 4:99), 및 상기에 언급된 최(Choi) 등 및 우(Wu) 등의 문헌에서 검토되어 있다.
AAV 게놈의 유도체는 생체내에서 본 발명의 벡터로부터의 ND4, ND6, 또는 ND1 트랜스진의 발현을 가능하게 하는 AAV 게놈의 임의의 절단된(truncated) 또는 수정된 형태를 포함한다. 전형적으로, 최소 바이러스 서열을 포함하면서도 상기 기능을 보유하도록 AAV 게놈을 상당히 절단할 수 있다. 이는 야생형 바이러스를 갖는 벡터의 재조합의 위험을 감소시키기 위해, 또한 표적 세포에서 바이러스 유전자 단백질의 존재에 의해 세포 면역 반응을 촉발시키는 것을 막기 위해 안전성의 이유로 바람직하다.
전형적으로, 유도체는 적어도 하나의 역위 말단 반복 서열 (ITR), 바람직하게는 하나 초과의 ITR, 예컨대 2개의 ITR 또는 그 초과를 포함할 것이다. ITR 중 하나 이상이 상이한 혈청형을 갖는 AAV 게놈으로부터 유래될 수 있거나, 키메라 또는 돌연변이 ITR일 수 있다. 바람직한 돌연변이 ITR은 trs (말단 분해 부위)의 결실을 갖는 것이다. 이 결실은 게놈의 연속된 복제가 코딩 및 상보적 서열 둘 다를 함유하는 단일-가닥 게놈, 즉 자가-상보적 AAV 게놈을 생성할 수 있게 한다. 이는 표적 세포에서 DNA 복제의 우회를 가능하게 하고, 따라서 가속화된 트랜스진 발현을 가능하게 한다.
하나 이상의 ITR은 바람직하게는 양 말단에서 ND4, ND6, ND1, 또는 그의 변종을 인코딩하는 폴리뉴클레오티드 서열을 플랭킹할 것이다. 하나 이상의 ITR의 포함은, 예를 들어 숙주 세포 DNA 폴리머라제의 작용에 의한 단일-가닥 벡터 DNA의 이중-가닥 DNA로의 전환에 따른, 숙주 세포의 핵에서의 본 발명의 벡터의 콘카테머(concatamer) 형성을 보조하기 위해 바람직하다. 이러한 에피솜 콘카테머의 형성은 숙주 세포의 수명 동안 벡터 작제물을 보호하고, 이로써 생체내에서 트랜스진의 연장된 발현을 가능하게 한다.
바람직한 구현예에서, ITR 요소는 유도체에서 네이티브 AAV 게놈으로부터 보유되는 유일한 서열일 것이다. 따라서, 유도체는 바람직하게는 네이티브 게놈의 rep 및/또는 cap 유전자 및 네이티브 게놈의 임의의 다른 서열을 포함하지 않을 것이다. 이는 상기에 기재된 이유로, 또한 벡터의 숙주 세포 게놈으로의 통합 가능성을 감소시키기 위해 바람직하다. 추가로, AAV 게놈의 크기 감소는 트랜스진에 추가로 벡터 내의 다른 서열 요소 (예컨대 조절 요소)의 혼입에서의 증가된 유연성을 가능하게 한다.
따라서, AAV2 게놈과 관련하여, 본 발명의 유도체에서 하기 부분이 제거될 수 있다: 하나의 역위 말단 반복 (ITR) 서열, 복제 (rep) 및 캡시드 (cap) 유전자 (주의: 야생형 AAV 게놈에서의 rep 유전자가 LHON에서 영향받은 인간 유전자, ND4, ND6, 또는 ND1와 혼동되어선 안됨). 그러나, 시험관내 구현예를 포함한 일부 구현예에서, 유도체는 추가로 AAV 게놈의 하나 이상의 rep 및/또는 cap 유전자 또는 다른 바이러스 서열을 포함할 수 있다. 자연 발생 AAV 바이러스는 인간 염색체 19 상의 특정 자리에서 높은 빈도수로 통합되고, 경미한 빈도수의 랜덤 통합을 나타내고, 그에 따라 벡터에서의 통합 능력의 보유는 치료적 셋팅에서 용인될 수 있다.
유도체 게놈이 캡시드 단백질, 즉 VP1, VP2 및/또는 VP3을 인코딩하는 유전자를 포함하는 경우, 상기 유도체는 하나 이상의 자연 발생 AAV 바이러스의 키메라, 셔플링(shuffling)된 또는 캡시드-수정된 유도체일 수 있다. 특히, 본 발명은 동일한 벡터 내의 AAV의 상이한 혈청형, 클레이드, 클론, 또는 단리물로부터의 캡시드 단백질 서열의 제공, 즉 위형화(pseudotyping)을 포함한다.
키메라, 셔플링된 또는 캡시드-수정된 유도체는 전형적으로 바이러스 벡터에 대한 하나 이상의 요망되는 기능성을 제공하기 위해 선택될 것이다. 따라서, 이들 유도체는 유전자 전달의 증가된 효율, 감소된 면역원성 (체액성 또는 세포성), 변경된 향성 범위 및/또는 AAV2의 것과 같은 자연 발생 AAV 게놈을 포함하는 AAV 바이러스 벡터에 비해 특정 세포 유형의 개선된 표적화를 나타낼 수 있다. 유전자 전달의 증가된 효율은 세포 표면에서의 개선된 수용체 또는 공동-수용체 결합, 개선된 내재화, 세포 내에서의, 또한 핵 내로의 개선된 트래픽킹(trafficking), 바이러스 입자의 개선된 언코팅(uncoating) 및 단일-가닥 게놈의 이중-가닥 형태로의 개선된 전환에 의해 달성될 수 있다. 증가된 효율은 또한, 벡터 용량이 이를 필요로 하지 않는 조직으로의 투여에 의해 희석되지 않도록 하는, 특정 세포 집단의 변경된 향성 범위 또는 표적화와 관련될 수 있다.
키메라 캡시드 단백질은 자연 발생 AAV 혈청형의 둘 이상의 캡시드 코딩 서열 사이의 재조합에 의해 생성된 것들을 포함한다. 이는 예를 들어 마커 레스큐 접근에 의해 수행될 수 있고, 여기서는 하나의 혈청형의 비-감염성 캡시드 서열이 상이한 혈청형의 캡시드 서열과 공동트랜스펙션되고, 요망되는 특성을 갖는 캡시드 서열에 대한 선택을 위해 지향 선택이 사용된다. 상이한 혈청형의 캡시드 서열은 세포 내의 상동 재조합에 의해 변경되어 신규한 키메라 캡시드 단백질을 생성할 수 있다.
키메라 캡시드 단백질은 또한, 둘 이상의 캡시드 단백질 사이, 예를 들어 상이한 혈청형의 둘 이상의 캡시드 단백질 사이의 특정 캡시드 단백질 도메인, 표면 루프 또는 특정 아미노산 잔기의 전달을 위해 캡시드 단백질 서열을 조작함으로써 생성된 것들을 포함한다.
셔플링된 또는 키메라 캡시드 단백질은 또한 DNA 셔플링 또는 에러-유발(error-prone) PCR에 의해 생성될 수 있다. 하이브리드 AAV 캡시드 유전자는 관련 AAV 유전자의 서열, 예를 들어 다수의 상이한 혈청형의 캡시드 단백질을 코딩하는 것들을 랜덤 단편화하고, 이어서 단편을 자가-프라이밍 폴리머라제 반응에서 후속 재어셈블링함으로써 생성될 수 있고, 이는 또한 서열 상동성의 영역에서의 교차를 일으킬 수 있다. 여러 혈청형의 캡시드 유전자의 셔플링에 의해 이러한 방식으로 생성된 하이브리드 AAV 유전자의 라이브러리를 스크리닝하여 요망되는 기능성을 갖는 바이러스 클론을 동정할 수 있다. 유사하게, 에러 유발 PCR을 사용하여 AAV 캡시드 유전자를 랜덤 돌연변이시켜 변종의 다양한 라이브러리를 생성하고, 이어서 이를 요망되는 특성에 대해 선택할 수 있다.
캡시드 유전자의 서열은 또한 네이티브 야생형 서열에 대하여 특정 결실, 치환 또는 삽입을 도입하도록 유전적으로 수정될 수 있다. 특히, 캡시드 유전자는 캡시드 코딩 서열의 개방 판독 프레임 내의, 또는 캡시드 코딩 서열의 N- 및/또는 C-말단에서의 비관련 단백질 또는 펩티드의 서열의 삽입에 의해 수정될 수 있다.
비관련 단백질 또는 펩티드는 유리하게는, 특정 세포 유형에 대한 리간드로서 작용하고, 이로써 표적 세포에 대한 개선된 결합을 부여하는 또는 특정 세포 집단에 대한 벡터의 표적화의 특이성을 개선시키는 것일 수 있다. 일례는 망막 색소 상피에서의 흡수를 차단하고 이로써 주변 망막 조직의 형질도입을 향상시키기 위한 RGD 펩티드의 사용을 포함할 수 있다 (Cronin 등, 2008 ARVO Abstract: D1048). 비관련 단백질은 또한, 생성 과정의 부분으로서의 바이러스 입자의 정제를 보조하는 것, 즉 에피토프 또는 친화성 택일 수 있다. 삽입 자리는 전형적으로, 바이러스 입자의 다른 기능, 예를 들어 바이러스 입자의 내재화, 트래픽킹을 방해하지 않도록 선택될 것이다. 당업자는 그들의 통상적 일반 지식에 기초하여 적합한 삽입 자리를 동정할 수 있다. 특정 자리는 상기에 언급된 최(Choi) 등의 문헌에 개시되어 있다.
본 발명은 추가로, 네이티브 AAV 게놈의 것과 상이한 순서 및 구성의 AAV 게놈의 서열 제공을 포함한다. 본 발명은 또한, 또 다른 바이러스로부터의 서열로의 또는 하나 초과의 바이러스로부터의 서열로 구성된 키메라 유전자로의 하나 이상의 AAV 서열 또는 유전자의 대체를 포함한다. 이러한 키메라 유전자는 상이한 바이러스 종의 둘 이상의 관련 바이러스 단백질로부터의 서열로 구성될 수 있다.
본 발명의 벡터는 AAV 게놈 또는 그의 유도체 및 ND4, ND6, ND1 또는 그의 변종을 인코딩하는 서열을 포함하는 폴리뉴클레오티드 서열의 형태를 취한다.
의심의 여지를 없애기 위해, 본 발명은 또한, 본 발명의 벡터를 포함하는 AAV 바이러스 입자를 제공한다. 본 발명의 AAV 입자는, 하나의 혈청형의 ITR을 갖는 AAV 게놈 또는 유도체가 상이한 혈청형의 캡시드 내에 패키징된 것인 캡시드전환 형태를 포함한다. 본 발명의 AAV 입자는 또한, 둘 이상의 상이한 혈청형으로부터의 수정되지 않은 캡시드 단백질의 혼합물이 바이러스 엔벨로프를 구성하는 것인 모자이크 형태를 포함한다. AAV 입자는 또한 캡시드 표면에 흡착된 리간드를 갖는 화학적으로 수정된 형태를 포함한다. 예를 들어, 이러한 리간드는 특정 세포 표면 수용체의 표적화를 위한 항체를 포함할 수 있다.
본 발명은 추가로 본 발명의 벡터 또는 AAV 바이러스 입자를 포함하는 숙주 세포를 제공한다.
재조합 핵산 서열
또한, NADH 데히드로게나제 서브유닛-4 (ND4), NADH 데히드로게나제 서브유닛-1 (ND1) 및 NADH 데히드로게나제 서브유닛-6 (ND6) 폴리펩티드 또는 그의 변종을 인코딩하는 폴리뉴클레오티드 서열을 포함하는 재조합 핵산 서열이 본원에 개시된다.
ND4에 대한 폴리뉴클레오티드 서열은 서열 번호: 6에 나타나 있고, 이는 서열 번호: 160에 나타낸 단백질을 인코딩한다. ND4에 대한 추가의 핵산 서열은 서열 번호: 7 및 8이다. ND6에 대한 폴리뉴클레오티드 서열은 서열 번호: 9에 나타나 있고, 이는 서열 번호: 161에 나타낸 단백질을 코딩한다. ND6에 대한 추가의 핵산 서열은 서열 번호: 10이다. ND1에 대한 폴리뉴클레오티드 서열은 서열 번호: 11에 나타나 있고, 이는 서열 번호: 162에 나타낸 단백질을 코딩한다. ND1에 대한 추가의 핵산 서열은 서열 번호: 12이다.
서열 번호: 160, 161, 또는 162 중 임의의 하나의 변종은 기능적 ND4, ND6, 또는 ND1 폴리펩티드를 인코딩하는 그의 절단물, 돌연변이체 또는 상동체, 및 그의 임의의 전사 변종을 포함할 수 있다. 본원에서 언급된 임의의 상동체는 전형적으로 ND4, ND6, 또는 ND1의 관련 영역과 적어도 70% 상동성을 갖고, 폴리펩티드 결핍을 기능적으로 보상할 수 있다.
상동성은 공지된 방법을 사용하여 측정될 수 있다. 예를 들어 UWGCG 패키지는 상동성 계산에 사용될 수 있는 BESTFIT 프로그램 (예를 들어 그의 디폴트 셋팅에서 사용됨)을 제공한다 (Devereux et at (1984) Nucleic Acids Research 12, 387-395). 예를 들어 Altschul S. F. (1993) J Mol Evol 36:290-300; Altschul, S, F et at (1990) J Mol Biol 215:403-10에 기재된 바와 같이, PILEUP 및 BLAST 알고리즘을 사용하여 상동성 또는 라인 업 서열을 계산할 수 있다 (전형적으로 그의 디폴트 셋팅에서 사용됨). BLAST 분석 수행을 위한 소프트웨어는 미국 국립 생물공학 정보 센터(National Center for Biotechnology Information) (http://www.ncbi.nlm.nih.gov/)를 통해 공개적으로 이용가능하다.
바람직한 구현예에서, 재조합 핵산 서열은, 적어도 20, 바람직하게는 적어도 30, 예를 들어 적어도 40, 60, 100, 200, 300, 400개 이상의 연속 아미노산에 걸쳐, 또는 심지어 재조합 핵산의 전체 서열에 걸쳐 ND4, ND6, 또는 ND1 (서열 번호: 160, 161, 또는 162)의 관련 영역과 적어도 55%, 65%, 70%, 75%, 80%, 85%, 90%, 또한 보다 바람직하게는 적어도 95%, 97%, 99%, 99.5%, 또는 100% 상동성을 갖는 폴리펩티드를 인코딩할 수 있다. 관련 영역은 ND4, ND6, 또는 ND1의 기능적 활성을 제공하는 영역일 것이다.
대안적으로, 또한 바람직하게는 재조합 핵산 서열은 그의 전체 서열에 걸쳐 전장 ND4, ND6, 또는 ND1 (서열 번호: 160, 161, 또는 162)와 적어도 70%, 75%, 80%, 85%, 90%, 또한 보다 바람직하게는 적어도 95%, 97%, 99%, 99.5%, 또는 100% 상동성을 갖는 폴리펩티드를 인코딩할 수 있다. 전형적으로 재조합 핵산 서열은 ND4, ND6, 또는 ND1 (서열 번호: 160, 161, 또는 162)의 관련 영역과 적어도 2, 5, 10, 20, 40, 50 또는 60개 또는 그 미만의 돌연변이 (이들 각각 치환, 삽입 또는 결실일 수 있음)에 의해 상이하다.
재조합 핵산 ND4, ND6, 또는 ND1 폴리펩티드는 상기에 언급된 서열의 길이 중 임의의 것에 걸쳐 특정 백분율 상동성 값 중 임의의 것 (즉, 이는 적어도 70%, 80% 또는 90%, 또한 보다 바람직하게는 적어도 95%, 97%, 99% 동일성일 수 있음)과 동일한 서열 번호: 160, 161, 또는 162의 특정 영역과의 백분율 동일성을 가질 수 있다.
ND4, ND6, 또는 ND1 (서열 번호: 160, 161, 또는 162)의 변종은 또한 절단물을 포함한다. 변종이 여전히 기능적인 한 임의의 절단물이 사용될 수 있다. 절단물은 전형적으로, 단백질 활성을 위해 비-필수적인 및/또는 폴딩된 단백질의 구조형태(conformation), 특히 활성 자리의 폴딩에 영향을 주지 않는 서열을 제거하기 위해 이루어질 것이다. 적절한 절단물은 N- 또는 C-말단으로부터의 다양한 길이의 서열의 체계적 절단에 의해 일상적으로 동정될 수 있다. 바람직한 절단물은 N-말단이고, 이는 촉매적 도메인을 제외한 모든 다른 서열을 제거할 수 있다.
ND4, ND6, 또는 ND1 (서열 번호: 160, 161, 또는 162)의 변종은 ND4, ND6, 또는 ND1 (서열 번호: 160, 161, 또는 162)의 특정 영역에 대하여, 하나 이상의, 예를 들어, 2, 3, 4, 5 내지 10개, 10 내지 20개, 20 내지 40개 이상의 아미노산 삽입, 치환 또는 결실을 갖는 돌연변이체를 추가로 포함한다. 결실 및 삽입은 바람직하게는 하기에 기재되는 바와 같이 촉매적 도메인의 외부에서 이루어진다. 치환은 또한 전형적으로, 프로테아제 활성을 위해 비-필수적인 및/또는 폴딩된 단백질의 구조형태에 영향을 주지 않는 영역에서 이루어진다.
치환은 바람직하게는, 아미노산을 유사한 화학적 구조, 유사한 화학적 특성 또는 유사한 측쇄 부피의 다른 아미노산으로 대체하는 하나 이상의 보존적 변화를 도입한다. 도입된 아미노산은 이들이 대체하는 아미노산과 유사한 극성, 친수성, 소수성, 염기성, 산성, 중성 또는 전하를 가질 수 있다. 대안적으로, 보존적 변화는 기존 방향족 또는 지방족 아미노산 대신에 방향족 또는 지방족인 또 다른 아미노산을 도입할 수 있다. 보존적 아미노산 변화는 당업계에 널리 공지되어 있고, 아미노산의 특성에 따라 선택될 수 있다.
유사하게, ND4, ND6, 또는 ND1 (서열 번호: 6, 9, 또는 11)의 폴리뉴클레오티드 서열의 바람직한 변종은 ND4, ND6, 또는 ND1 (서열 번호: 6, 9, 또는 11)의 관련 영역과 적어도 70%, 75%, 80%, 85%, 90%, 또한 보다 바람직하게는 적어도 95%, 96%, 97%, 98%, 99%, 또는 99.5% 상동성을 갖는 폴리뉴클레오티드를 포함한다. 바람직하게는 변종은 그의 전체 서열에 걸쳐 전장 ND4, ND6, 또는 ND1 (서열 번호: 6, 9, 또는 11)과 이들 수준의 상동성을 나타낸다.
미토콘드리아 표적화 서열 (MTS) 및 3 프라임 비번역 영역 (3'UTR)을 사용하여 미토콘드리아에 대하여 단백질 또는 mRNA를 표적화할 수 있다. MTS의 전하, 길이, 및 구조가 미토콘드리아에 대한 단백질 유입에 있어 중요할 수 있다. 특정 3'UTR은 미토콘드리아 표면에 대한 mRNA 국소화를 구동시키고 그에 따라 미토콘드리아에 대한 동시번역 단백질 유입을 용이하게 할 수 있다.
미토콘드리아 표적화 서열에 대한 폴리뉴클레오티드 서열은 hsCOX10, hsCOX8, scRPM2, lcSirt5, tbNDUS7, ncQCR2, hsATP5G2, hsLACTB, spilv1, gmCOX2, crATP6, hsOPA1, hsSDHD, hsADCK3, osP0644B06.24-2, 뉴로스포라 크라사 ATP9 (ncATP9), hsGHITM, hsNDUFAB1, hsATP5G3, crATP6 _hsADCK3, ncATP9_ncATP9, zmLOC100282174, ncATP9_zmLOC100282174_spilv1_ncATP9, zmLOC100282174_hsADCK3_crATP6 _hsATP5G3, zmLOC100282174_hsADCK3_hsATP5G3, ncATP9_zmLOC100282174, hsADCK3_zmLOC100282174_crATP6 _hsATP5G3, crATP6_hsADCK3_zmLOC100282174_hsATP5G3, hsADCK3_zmLOC100282174, hsADCK3_zmLOC100282174_crATP6, ncATP9_zmLOC100282174_spilv1_GNFP_ncATP9, 및 ncATP9_zmLOC100282174_spilv1_lcSirt5_osP0644B06.24-2_hsATP5G2_ncATP9 (서열 번호에 대하여 표 1 참조)로부터 선택된 폴리펩티드를 인코딩할 수 있다. 일례에서, 폴리뉴클레오티드 서열, COX10 (서열 번호: 1, 2, 또는 3)은 미토콘드리아 표적화 서열, MTS-COX10 (서열 번호: 126)을 인코딩할 수 있다. 또 다른 예에서, 폴리뉴클레오티드 서열, COX8 (서열 번호: 4)은 미토콘드리아 표적화 서열, MTS-COX8 (서열 번호: 127)을 인코딩할 수 있다. 또 다른 예에서, 폴리뉴클레오티드 서열, OPA1 (서열 번호: 5)은 미토콘드리아 표적화 서열, MTS-OPA1 (서열 번호: 128)을 인코딩할 수 있다.
3'UTR 핵산 서열은 hsACO2 (서열 번호: 111), hsATP5B (서열 번호: 112), hsAK2 (서열 번호: 113), hsALDH2 (서열 번호: 114), hsCOX10 (서열 번호: 115), hsUQCRFS1 (서열 번호: 116), hsNDUFV1 (서열 번호: 117), hsNDUFV2 (서열 번호: 118), hsSOD2 (서열 번호: 119), hsCOX6c (서열 번호: 120), hsIRP1 (서열 번호: 121), hsMRPS12 (서열 번호: 122), hsATP5J2 (서열 번호: 123), rnSOD2 (서열 번호: 124), 및 hsOXA1L (서열 번호: 125)로부터 선택될 수 있다. 3'UTR 핵산 서열은 또한, 본원에 열거된 임의의 3'UTR 핵산 서열과 적어도 70%, 75%, 80%, 85%, 90%, 또한 보다 바람직하게는 적어도 95%, 96%, 97%, 98%, 99%, 99.5%, 또는 100% 상동성을 갖는 변종일 수 있다. 예를 들어, 3'UTR 핵산 서열은 서열 번호: 13 또는 14일 수 있다.
또한, 미토콘드리아 표적화 서열, 미토콘드리아 단백질 코딩 서열, 및 3'UTR 핵산 서열을 포함하는 재조합 핵산 서열이 본원에 개시된다. 예를 들어, 재조합 핵산 서열은 서열 번호: 15-84로부터 선택될 수 있다. 재조합 핵산 서열은 또한, 본원에 열거된 임의의 재조합 핵산 서열과 적어도 70%, 75%, 80%, 85%, 90%, 또한 보다 바람직하게는 적어도 95%, 96%, 97%, 98%, 99%, 99.5%, 또는 100% 상동성을 갖는 변종일 수 있다.
프로모터 및 조절 서열
본 발명의 벡터는 또한 시험관내에서 또는 생체내에서 개시된 트랜스진의 발현을 가능하게 하는 요소를 포함한다. 따라서, 벡터는 전형적으로 ND4, ND6, 또는 ND1 트랜스진 또는 그의 변종을 인코딩하는 폴리뉴클레오티드 서열에 작동가능하게 연결된 프로모터 서열을 포함한다.
임의의 적합한 프로모터가 사용될 수 있다. 프로모터 서열은 임의의 숙주 세포 배경에서 구성적으로 활성, 즉 작동성일 수 있거나, 대안적으로 특정 숙주 세포 환경에서만 활성이고, 그에 따라 특정 세포 유형에서의 트랜스진의 표적화된 발현을 가능하게 할 수 있다. 프로모터는 또 다른 인자, 예를 들어 숙주 세포 내에 존재하는 인자의 존재에 반응하는 유도성 발현을 나타낼 수 있다. 어떤 경우에도, 벡터가 치료를 위해 투여되는 경우, 프로모터는 망막 세포 배경에서 기능적이어야 한다.
일부 구현예에서, 프로모터는 트랜스진이 단지 망막 세포 집단에서 발현될 수 있게 하기 위해 망막-세포 특이적 발현을 나타내는 것이 바람직하다. 따라서, 프로모터로부터의 발현은 망막-세포 특이적일 수 있고, 예를 들어 단지 감각신경 망막 및 망막 색소 상피의 세포로 국한될 수 있다.
ND4, ND6, 또는 ND1 트랜스진에 대한 바람직한 프로모터는, 임의로 시토메갈로바이러스 (CME) 인핸서 요소와 조합된, 치킨 베타-액틴 (CBA) 프로모터를 포함한다. 일부 경우에, ND4, ND6, 또는 ND1 트랜스진에 대한 바람직한 프로모터는 CAG 프로모터를 포함한다. 특히 바람직한 프로모터는 하이브리드 CBA/CAG 프로모터, 예를 들어 rAVE 발현 카세트에서 사용되는 프로모터이다. 망막 특이적 유전자 발현을 유도하는 인간 서열에 기초한 프로모터의 예는 간상체 및 추상체에 대한 로돕신 키나제 (Allocca 등, 2007, J Viol 81:11372-80), 단지 추상체에 대한 PR2.1 (Mancuso 등 2009, Nature) 및/또는 망막 색소 상피에 대한 RPE65 (Bainbridge 등, 2008, N Eng J Med)를 포함한다.
본 발명의 벡터는 또한 전사-전 또는 전사-후 작용할 수 있는 하나 이상의 추가의 조절 서열을 포함할 수 있다. 조절 서열은 네이티브 ND4, ND6, 또는 ND1 유전자좌의 부분일 수 있거나 비상동(heterologous) 조절 서열일 수 있다. 본 발명의 벡터는 네이티브 ND4, ND6, 또는 ND1 전사로부터의 5'UTR 또는 3'UTR의 부분을 포함할 수 있다.
조절 서열은 트랜스진의 발현을 용이하게 하는, 즉 전사의 발현을 증가시키거나 mRNA의 핵 유출을 개선시키거나 그의 안정성을 향상시키도록 작용하는 임의의 서열이다. 이러한 조절 서열은 예를 들어 인핸서 요소, 후조절 요소 및 폴리아데닐화 자리를 포함한다. 바람직한 폴리아데닐화 자리는 소 성장 호르몬 폴리-A 신호이다. 본 발명의 벡터와 관련하여, 이러한 조절 서열은 시스-작용성일 것이다. 그러나, 본 발명은 또한, 추가의 유전적 작제물 상에 위치하는 트랜스-작용 조절 서열의 사용을 포함한다.
본 발명의 벡터에서의 사용을 위해 바람직한 후조절 요소는 우드척 간염 후조절 요소 (WPRE) 또는 그의 변종이다. 본 발명의 벡터에서 사용될 수 있는 또 다른 조절 서열은 스캐폴드-부착 영역 (SAR)이다. 추가의 조절 서열은 당업자에 의해 이들의 통상적 일반 지식에 기초하여 선택될 수 있다.
벡터의 제조
본 발명의 벡터는 유전자 요법을 위한 벡터의 제공에 대하여 당업계에 공지된 표준 수단에 의해 제조될 수 있다. 따라서, 잘 확립된 공개적 도메인 트랜스펙션, 패키징 및 정제 방법을 적합한 벡터 조제물의 제조에 사용할 수 있다.
상기에서 논의된 바와 같이, 본 발명의 벡터는 ND4, ND6, 또는 ND1 또는 그의 변종을 인코딩하는 폴리뉴클레오티드 서열에 추가로 자연 발생 AAV 바이러스의 전체 게놈을 포함할 수 있다. 그러나, 통상적으로 유도체화된 게놈, 예를 들어 적어도 하나의 역위 말단 반복 서열 (ITR)을 갖는, 그러나 rep 또는 cap과 같은 임의의 AAV 유전자를 갖지 않을 수 있는 유도체가 사용될 것이다.
이러한 구현예에서, 유도체화된 게놈의 AAV 바이러스 입자로의 어셈블리를 제공하기 위해, AAV 및/또는 헬퍼 바이러스 기능을 제공하는 추가의 유전적 작제물이 유도체화된 게놈과 조합되어 숙주 세포에 제공될 것이다. 이들 추가의 작제물은 전형적으로 구조적 AAV 캡시드 단백질, 즉 cap, VP1, VP2, VP3을 인코딩하는 유전자, 및 rep과 같은 AAV 수명 주기를 위해 필요한 다른 기능을 인코딩하는 유전자를 함유할 것이다. 추가의 작제물 상에 제공되는 구조적 캡시드 단백질의 선택은 패키징된 바이러스 벡터의 혈청형을 결정할 것이다.
본 발명에서의 사용을 위한 특히 바람직한 패키징된 바이러스 벡터는 AAV5 또는 AAV8 캡시드 단백질과 조합된 AAV2의 유도체화된 게놈을 포함한다. 이 패키징된 바이러스 벡터는 전형적으로 하나 이상의 AAV2 ITR을 포함한다.
상기에 언급된 바와 같이, AAV 바이러스는 복제 능력이 없고, 따라서 AAV 복제를 가능하게 하도록 하나 이상의 추가의 작제물에 헬퍼 바이러스 기능, 바람직하게는 아데노바이러스 헬퍼 기능이 전형적으로 제공될 것이다.
상기 추가의 작제물 모두는 숙주 세포에서 플라스미드 또는 다른 에피솜 요소로서 제공될 수 있거나, 대안적으로 하나 이상의 작제물이 숙주 세포의 게놈으로 통합될 수 있다.
이들 양태에서, 본 발명은 본 발명의 벡터의 제조 방법을 제공한다. 상기 방법은 아데노-관련 바이러스 (AAV) 게놈 또는 그의 유도체 및 ND4, ND6, 또는 ND1 또는 그의 변종을 인코딩하는 폴리뉴클레오티드 서열을 포함하는 벡터를 숙주 세포에서 제공하고, 복제 및 AAV 바이러스 입자로의 벡터의 어셈블리를 위한 수단을 제공하는 것을 포함한다. 바람직하게는, 상기 방법은, AAV 및/또는 헬퍼 바이러스 기능을 인코딩하는 하나 이상의 추가의 유전적 작제물와 함께, ND4, ND6, 또는 ND1 또는 그의 변종을 인코딩하는 폴리뉴클레오티드 서열 및 AAV 게놈의 유도체를 포함하는 벡터를 제공하는 것을 포함한다. 전형적으로, AAV 게놈의 유도체는 적어도 하나의 ITR을 포함한다. 임의로, 상기 방법은 어셈블링된 바이러스 입자의 정제 단계를 추가로 포함한다. 추가로, 상기 방법은 치료적 사용을 위한 바이러스 입자의 제제화 단계를 포함할 수 있다.
치료 방법 및 의료적 용도
상기에서 논의된 바와 같이, 본 발명자들은 놀랍게도, 본 발명의 벡터를 사용하여 LHON의 기초가 되는 세포 기능장애를 해결할 수 있음을 입증하였다. 특히, 이들은 벡터의 사용이 LHON과 관련된 결함을 교정할 수 있음을 보여주었다. 이는 그에 의해 질환의 퇴행 과정이 치료되거나 저지되거나 완화되거나 방지될 수 있는 수단을 제공한다.
따라서, 본 발명은, 치료 유효량의 본 발명의 벡터를 환자에게 직접적 망막, 망막하 또는 유리체내 주사에 의해 투여하는 것을 포함하는, 그를 필요로 하는 환자에서의 LHON의 치료 또는 방지 방법을 제공한다. 따라서, LHON이 이로써 환자에서 치료되거나 방지된다.
관련 양태에서, 본 발명은, 본 발명의 벡터를 환자에게 직접적 망막, 망막하 또는 유리체내 주사에 의해 투여하는 것에 의한 LHON의 치료 또는 방지 방법에서의 본 발명의 벡터의 용도를 제공한다. 추가로, 본 발명은, 직접적 망막, 망막하 또는 유리체내 주사에 의한 LHON의 치료 또는 방지를 위한 의약 제조에서의 본 발명의 벡터의 용도를 제공한다.
모든 이들 구현예에서, 본 발명의 벡터는 LHON의 하나 이상의 증상의 발병을 막기 위해 투여될 수 있다. 환자는 무증상일 수 있다. 대상체는 질환에 대한 소인을 가질 수 있다. 방법 또는 용도는, 대상체가 LHON의 발달 위험에 있는지 또는 이를 갖는지의 여부를 동정하는 단계를 포함할 수 있다. 예방 유효량의 벡터가 이러한 대상체에게 투여된다. 예방 유효량은 질환의 하나 이상의 증상의 발병을 막는 양이다.
대안적으로, 상기 벡터는 질환의 증상이 대상체에서 나타나면, 즉 질환의 기존 증상을 치유하기 위해 투여될 수 있다. 치료 유효량의 길항제가 이러한 대상체에게 투여된다. 치료 유효량은 질환의 하나 이상의 증상을 개선시키기에 효과적인 양이다. 이러한 양은 또한 LHON과 관련된 주변 시력의 일부 손실을 저지시키거나 늦추거나 역전시킬 수 있다. 이러한 양은 또한 LHON의 발병을 저지시키거나 늦추거나 역전시킬 수 있다.
전형적인 단일 용량은 형질도입을 필요로 하는 남아있는 망막 조직의 양에 따라 1010 내지 1012개 게놈 입자이다. 게놈 입자는 본원에서 서열 특이적 방법 (예컨대 실시간 PCR)으로 정량화될 수 있는 단일 가닥 DNA 분자를 함유하는 AAV 캡시드로서 정의된다. 그 용량은 단일 용량으로서 제공될 수 있지만, 타안에 대해 또는 벡터가 어떠한 이유로든 (예컨대 수술 합병증) 망막의 정확한 영역을 표적화하지 않았을 수 있는 경우에 반복될 수 있다. 치료는 바람직하게는 각각의 눈에 대한 단일 영구 치료이지만, 예를 들어 향후 몇년 내의 및/또는 상이한 AAV 혈청형을 사용한 반복 주사가 고려될 수 있다.
본 발명은 또한, 직접적 망막, 망막하 또는 유리체내 주사에 의한 본 발명의 AAV 벡터의 투여 후 환자로부터 얻어진 망막 세포에서 생체외 활성을 측정하는 것을 포함하는, 상기 환자에서의 LHON의 치료 또는 방지를 모니터링하는 방법을 제공한다. 이 방법은 치료 효능의 결정을 가능하게 할 수 있다.
약제학적 조성물
본 발명의 벡터는 약제학적 조성물로 제제화될 수 있다. 이들 조성물은, 벡터에 추가로, 약제학적으로 허용가능한 부형제, 담체, 완충제, 안정화제 또는 당업자에게 널리 공지된 다른 물질을 포함할 수 있다. 이러한 물질은 비-독성이어야 하고, 활성 성분의 효능을 방해하지 않아야 한다. 담체 또는 다른 물질의 정확한 성질은 투여 경로, 즉 여기서는 직접적 망막, 망막하 또는 유리체내 주사에 따라 당업자에 의해 결정될 수 있다.
상기 약제학적 조성물은 전형적으로 액체 형태이다. 액체 약제학적 조성물은 일반적으로 액체 담체, 예컨대 물, 석유, 동물 또는 식물유, 미네랄 오일 또는 합성 오일을 포함한다. 생리 식염수, 염화마그네슘, 덱스트로스 또는 다른 사카라이드 용액 또는 글리콜, 예컨대 에틸렌 글리콜, 프로필렌 글리콜 또는 폴리에틸렌 글리콜이 포함될 수 있다. 일부 경우에, 계면활성제, 예컨대 플루로닉산 (PF68) 0.001%가 사용될 수 있다.
고통 부위에서의 주사를 위해, 활성 성분은 발열원이 없고 적합한 pH, 등장성 및 안정성을 갖는 수용액 형태일 것이다. 당업자는, 예를 들어, 등장성 비히클, 예컨대 염화나트륨 주사액, 링거 주사액, 락테이트 링거 주사액을 사용하여, 적합한 용액을 잘 제조할 수 있다. 보존제, 안정화제, 완충제, 산화방지제 및/또는 다른 첨가제가 필요에 따라 포함될 수 있다.
지연 방출을 위해, 벡터는 당업계에 공지된 방법에 따라 느린 방출을 위해 제제화된 약제학적 조성물 중에, 예컨대 생체적합성 중합체로부터 형성된 마이크로캡슐 내에 또는 리포솜 담체 시스템 내에 포함될 수 있다.
샘플
본원에 기재된 방법에서의 사용에 적합한 샘플은 대상체로부터의 핵산 샘플일 수 있다. 본원에서 사용되는 바와 같이 "핵산 샘플"은 RNA 또는 DNA, 또는 이들의 조합을 포함할 수 있다. 또 다른 구현예에서는, "폴리펩티드 샘플" (예: 펩티드 또는 단백질, 또는 이로부터의 단편)을 사용하여, 유전적 변종의 결과인 아미노산 변화가 일어난 정보를 확인할 수 있다. 핵산 및 폴리펩티드는 혈액, 타액, 소변, 구강 내벽의 점막 스크레이핑, 거담제, 혈청, 눈물, 피부, 조직, 또는 모발을 포함하나 이에 제한되지는 않는 하나 이상의 샘플로부터 추출될 수 있다. 핵산 샘플은 핵산 정보에 대해 검정될 수 있다. 본원에서 사용되는 바와 같이, "핵산 정보"는, 핵산 서열 자체, 핵산 서열에서의 유전적 변형의 존재/부재, 핵산 서열에 따라 달라지는 물리적 특성 (예: Tm), 및 핵산의 양 (예: mRNA 카피의 수)을 포함한다. "핵산"은 DNA, RNA, 인공적 뉴클레오티드를 포함한 DNA, 또는 인공적 뉴클레오티드를 포함한 RNA 중 임의의 하나를 의미한다. 본원에서 사용되는 바와 같이, "정제된 핵산"은 cDNA, 게놈 핵산의 단편, 폴리머라제 사슬 반응 (PCR)을 사용하여 생성된 핵산, 게놈 핵산의 제한 효소 처리에 의해 형성된 핵산, 재조합 핵산, 및 화학적으로 합성된 핵산 분자를 포함한다. "재조합" 핵산 분자는 서열의 2개의 다른 방식으로 분리된 세그먼트의 인공적 조합에 의해, 예를 들어 화학적 합성에 의해 또는 유전적 조작 기술에 의한 핵산의 단리된 세그먼트의 조종에 의해 형성된 핵산 분자를 포함한다. 본원에서 사용되는 바와 같이, "폴리펩티드"는, 천연 공급원으로부터 단리된 것이든, 재조합 기술에 의해 생성된 것이든, 화학적으로 합성된 것이든, 단백질, 단백질의 단편, 및 펩티드를 포함한다. 폴리펩티드는 하나 이상의 수정, 예컨대 번역-후 수정 (예: 글리코실화, 인산화 등) 또는 임의의 다른 수정 (예: 페길화(pegylation) 등)을 가질 수 있다. 폴리펩티드는 하나 이상의 비-천연-발생 아미노산 (예: 측쇄 수정을 갖는 아미노산 등)을 함유할 수 있다.
일부 구현예에서, 핵산 샘플은 세포 또는 조직, 예를 들어 세포 라인을 포함할 수 있다. 본원에 기재된 방법을 사용하여 핵산이 얻어질 수 있는 예시적 세포 유형은 하기를 포함하나, 이에 제한되지는 않는다: 혈액 세포, 예컨대 B 림프구, T 림프구, 백혈구, 적혈구, 대식세포, 또는 호중구; 근육 세포, 예컨대 골격 세포, 평활근 세포 또는 심근 세포; 생식 세포, 예컨대 정자 또는 난자; 상피 세포; 결합 조직 세포, 예컨대 지방세포, 연골세포; 섬유아세포 또는 골아세포; 뉴런; 성상세포; 간질 세포; 기관 특이적 세포, 예컨대 신장 세포, 췌장 세포, 간 세포, 또는 케라티노사이트; 줄기 세포; 또는 이로부터 발달하는 임의의 세포. 핵산이 얻어질 수 있는 세포는 혈액 세포 또는 하기를 포함하는 특정 유형의 혈액 세포: 예를 들어, 조혈 줄기 세포 또는 조혈 줄기 세포로부터 유래되는 세포, 예컨대 적혈구, B 림프구, T 림프구, 자연 살해 세포, 호중구, 호염기구, 호산구, 단핵구, 대식세포, 또는 혈소판일 수 있다. 일반적으로, 배아 줄기 세포, 성체 줄기 세포, 또는 만능 줄기 세포를 포함하나 이에 제한되지는 않는 임의의 유형의 줄기 세포가 사용될 수 있다.
일부 구현예에서, 핵산 샘플은 RNA 또는 DNA 단리에 대해 프로세싱될 수 있고, 예를 들어, 세포 또는 조직 샘플 내의 RNA 또는 DNA가 핵산 샘플의 다른 성분으로부터 분리될 수 있다. 세포는, 표준 기술을 사용하여, 예를 들어, 세포 샘플의 원심분리 및 예를 들어 완충 용액, 예를 들어 인산염 완충 식염수 (PBS) 중의 펠릿화된 세포의 재현탁에 의해, 핵산 샘플로부터 수확될 수 있다. 일부 구현예에서는, 세포 현탁액을 원심분리하여 세포 펠릿을 얻은 후, 세포를 용균시켜 DNA를 추출할 수 있다. 일부 구현예에서는, 핵산 샘플을 농축시키고/거나 정제하여 DNA를 단리할 수 있다. 임의의 부류의 추가의 프로세싱에 적용된 것들을 포함한, 대상체로부터 얻어진 모든 핵산 샘플이 대상체로부터 얻어진 것으로 고려된다. 일부 구현예에서는, 당업계에 공지된 표준 기술 및 키트를 사용하여 핵산 샘플로부터 RNA 또는 DNA를 추출할 수 있고, 이는 예를 들어 페놀 추출, QIAAMP® 조직 키트 (Qiagen, 미국 캘리포니아주 챗스워스), WIZARD® 게놈 DNA 정제 키트 (Promega), 또는 아카이빙(archiving)을 위한 잘 적합화된 고도로 안정적인 DNA의 정제를 가능하게 할 수 있는 Puregene 화학을 사용한 Qiagen Autopure 방법을 포함한다.
일부 구현예에서, 대립유전자의 동일성 결정 또는 카피 수의 결정은, 대상체로부터 RNA 및/또는 DNA를 포함하는 핵산 샘플을 얻고/거나 동일성, 카피 수, 하나 이상의 유전적 변형의 존재 또는 부재 및 핵산 샘플로부터 유래된 게놈 DNA (즉, 대상체의 게놈) 내의 이들의 염색체 위치를 평가하는 것을 포함할 수 있으나 이것이 반드시 필요한 것은 아니다.
결정을 수행하는 개인 또는 조직이 실제로 대상체로부터의 핵산 샘플의 물리적 분석을 수행할 필요는 없다. 일부 구현예에서, 방법은 제3자에 의해 핵산 샘플의 분석에 의해 얻어진 정보를 사용하는 것을 포함할 수 있다. 일부 구현예에서, 방법은 하나 초과의 장소에서 수행되는 단계를 포함할 수 있다. 예를 들어, 핵산 샘플을 제1 장소, 예컨대 의료 제공 기관에서 또는 자가-시험 키트의 경우에는 대상체의 가정에서 대상체로부터 얻을 수 있다. 핵산 샘플을 동일한 또는 제2 장소에서, 예를 들어, 실험실 또는 다른 시험 시설에서 분석할 수 있다.
핵산
본원에 기재된 핵산 및 폴리펩티드가 본 개시내용의 방법 및 키트에서 사용될 수 있다. 일부 구현예에서는, 본원에 기재된 핵산 및 폴리펩티드에 특이적으로 결합하는 앱타머가 본 개시내용의 방법 및 키트에서 사용될 수 있다. 본원에서 사용되는 바와 같이, 핵산은, 단일형이든 중합체이든, 자연 발생이든 비-자연 발생이든, 이중-가닥이든 단일-가닥이든, 코딩, 예를 들어 번역 유전자이든 비-코딩, 예를 들어 조절 영역이든, 데옥시리보뉴클레오티드 (DNA) 또는 리보뉴클레오티드 (RNA), 또는 이들의 임의의 단편, 유도체, 모방체 또는 상보물을 포함할 수 있다. 일부 구현예에서, 핵산은 올리고뉴클레오티드, 뉴클레오티드, 폴리뉴클레오티드, 핵산 서열, 게놈 서열, 상보적 DNA (cDNA), 안티센스 핵산, DNA 영역, 프로브, 프라이머, 유전자, 조절 영역, 인트론, 엑손, 개방-판독 프레임, 결합 자리, 표적 핵산 및 대립유전자-특이적 핵산을 포함할 수 있다.
본원에서 사용되는 바와 같이, "프로브"는, 핵산의 상보성에 기초한 하이브리드화 반응을 사용한 시험편에서의 핵산의 검사를 위한 핵산 단편을 포함한다.
본원에서 사용되는 바와 같이, "하이브리드"는, DNA-DNA, DNA-RNA, RNA-RNA 등을 포함한, 상기 언급된 핵산 중 임의의 하나 사이에, 동일한 유형 내에, 또는 상이한 유형에 걸쳐 형성된 이중 가닥을 포함한다.
본원에서 사용되는 바와 같이, "단리된" 핵산은, 통상적으로 (게놈 서열에서와 같이) 유전자 또는 뉴클레오티드 서열을 플랭킹하는 핵산으로부터 분리되고/거나 (예를 들어 RNA 라이브러리에서와 같이) 다른 전사된 서열로부터 완전히 또는 부분적으로 정제된 것이다. 예를 들어, 본 개시내용의 단리된 핵산은, 그것이 자연 발생된 복잡한 세포 환경, 또는 재조합 기술에 의해 생성시 배양 배지, 또는 화학적으로 합성시 화학적 전구체 또는 다른 화학물질에 대하여 실질적으로 단리될 수 있다. 일부 예에서, 단리된 물질은 조성물, 예를 들어, 다른 물질, 완충 시스템 또는 시약 혼합물을 함유하는 미정제(crude) 추출물의 부분을 형성할 수 있다. 일부 구현예에서, 물질은 당업계에 공지된 방법을 사용하여, 예를 들어, 폴리아크릴아미드 겔 전기영동 (PAGE) 또는 컬럼 크로마토그래피 (예: HPLC)에 의해 필수적 균질성으로 정제될 수 있다. 게놈 DNA (gDNA)에 대하여, 용어 "단리된"은 또한, 게놈 DNA가 자연적으로 회합되는 염색체로부터 분리된 핵산을 지칭할 수 있다. 예를 들어, 단리된 핵산 분자는, 핵산 분자가 유래되는 세포의 gDNA에서 핵산 분자를 플랭킹하는 약 250 kb, 200 kb, 150 kb, 100 kb, 75 kb, 50 kb, 25 kb, 10 kb, 5 kb, 4 kb, 3 kb, 2kb, 1 kb, 0.5 kb 또는 0.1 kb 미만의 뉴클레오티드를 함유할 수 있다.
핵산은 다른 코딩 또는 조절 서열에 융합될 수 있고, 이는 단리된 것으로 고려될 수 있다. 예를 들어, 벡터 내에 함유된 재조합 DNA는 본원에서 사용되는 바와 같은 "단리된"의 정의 내에 포함된다. 일부 구현예에서, 단리된 핵산은 비상동 숙주 세포 또는 비상동 유기체 내의 재조합 DNA 분자, 뿐만 아니라 용액 중의 부분적으로 또는 실질적으로 정제된 DNA 분자를 포함할 수 있다. 단리된 핵산은 또한 본 개시내용의 DNA 분자의 생체내 및 시험관내 RNA 전사물을 포함한다. 단리된 핵산 분자 또는 뉴클레오티드 서열은 화학적으로 또는 재조합 수단에 의해 합성될 수 있다. 이러한 단리된 뉴클레오티드 서열은, 예를 들어, 인코딩된 폴리펩티드의 제조에서, 상동 서열 (예: 다른 포유류 종으로부터의 것)의 단리를 위해, 유전자 맵핑 (예: 염색체와의 계내 하이브리드화에 의한 것)을 위해, 또는 노던 블롯 분석 또는 본원에 개시된 다른 하이브리드화 기술 등에 의해, 조직 (예: 인간 조직) 내의 유전자의 발현 검출을 위해 유용할 수 있다. 본 개시내용은 또한, 본원에 기재된 뉴클레오티드 서열에 대하여, 선택적 하이브리드화에 대한 것과 같은 고 엄격성 하이브리드화 조건 하에 하이브리드화되는 핵산 서열에 관한 것이다. 이러한 핵산 서열은 대립유전자- 또는 서열-특이적 하이브리드화 (예: 고 엄격성 조건 하)에 의해 검출 및/또는 단리될 수 있다. 핵산 하이브리드화에 대한 엄격성 조건 및 방법은 당업자에게 널리 공지되어 있다 (예를 들어 Current Protocols in Molecular Biology, Ausubel, F. 등, John Wiley & Sons, (1998), 및 Kraus, M. 및 Aaronson, S., Methods Enzymol., 200:546-556 (1991) 참조, 이들의 전체 교시내용은 본원에 참조로 포함됨).
둘 이상의 뉴클레오티드 또는 아미노산 서열 사이의 "동일성" 또는 "퍼센트 동일성"의 계산은, 최적 비교를 위해 서열을 정렬시킴으로써 결정될 수 있다 (예를 들어, 제1 서열의 서열 내에 갭이 도입될 수 있음). 이어서, 상응하는 위치의 뉴클레오티드를 비교하고, 두 서열 사이의 퍼센트 동일성은 서열에 의해 공유되는 동일한 위치의 수의 함수이다 (즉, % 동일성 = 동일한 위치의 #/위치의 총 # x 100). 예를 들어, 제1 서열에서의 위치가 제2 서열에서의 상응하는 위치와 동일한 뉴클레오티드에 의해 점유되면, 분자는 그 위치에서 동일하다. 두 서열 사이의 퍼센트 동일성은, 두 서열의 최적 정렬을 위해 도입되어야 하는 갭의 수, 및 각각의 갭의 길이를 고려한, 서열에 의해 공유되는 동일한 위치의 수의 함수이다.
일부 구현예에서, 비교 목적을 위해 정렬되는 서열의 길이는 참조 서열의 길이의 적어도 30%, 적어도 40%, 적어도 50%, 적어도 60%, 적어도 70%, 적어도 80%, 적어도 90%, 또는 적어도 95%이다. 두 서열의 실제 비교는 널리 공지된 방법에 의해, 예를 들어 수학적 알고리즘을 사용하여 달성될 수 있다. 이러한 수학적 알고리즘의 비-제한적 예는 Karlin, S. 및 Altschul, S., Proc. Natl. Acad. Sci. USA, 90- 5873-5877 (1993)에 기재되어 있다. 이러한 알고리즘은 Altschul, S. 등, Nucleic Acids Res., 25:3389-3402 (1997)에 기재된 바와 같이 NBLAST 및 XBLAST 프로그램 (버전 2.0) 내로 혼입된다. BLAST 및 갭트(Gapped) BLAST 프로그램 활용시, 각각의 프로그램 (예: NBLAST)의 임의의 관련 파라미터가 사용될 수 있다. 예를 들어, 서열 비교에 대한 파라미터는 스코어= 100, 워드 길이= 12로 셋팅될 수 있거나, 또는 달라질 수 있다 (예: W=5 또는 W=20). 다른 예는 마이어 앤 밀러(Myers and Miller)의 알고리즘, CABIOS (1989), ADVANCE, ADAM, BLAT, 및 FASTA를 포함한다. 일부 구현예에서, 두 아미노산 서열 사이의 퍼센트 동일성은, 예를 들어, GCG 소프트웨어 패키지 (Accelrys, 영국 캠브릿지) 내의 GAP 프로그램을 사용하여 달성될 수 있다.
"프로브" 또는 "프라이머"는 염기-특이적 방식으로 핵산 분자의 상보적 가닥에 대해 하이브리드화되는 올리고뉴클레오티드일 수 있다. 프로브는, 표적 서열의 증폭을 위한 폴리머라제 사슬 반응 (PCR) 및 리가제 사슬 반응 (LCR)을 포함하나 이에 제한되지는 않는 방법을 사용한 템플레이트-지향 DNA 합성의 개시점으로서 작용할 수 있는 단일-가닥 올리고뉴클레오티드 프로브일 수 있는 프라이머를 포함할 수 있다. 본원에 기재된 바와 같은 올리고뉴클레오티드는 핵산 서열의 세그먼트 또는 단편, 또는 그의 상보물을 포함할 수 있다. 일부 구현예에서, DNA 세그먼트는 5 내지 10,000개 연속 염기일 수 있고, 5, 10, 12, 15, 20, 또는 25개 뉴클레오티드 내지 10, 15, 20, 25, 30, 40, 50, 100, 200, 500, 1000 또는 10,000개 뉴클레오티드의 범위일 수 있다. DNA 및 RNA에 추가로, 프로브 및 프라이머는 Nielsen, P. 등, Science 254: 1497-1500 (1991)에 기재된 바와 같이 폴리펩티드 핵산 (PNA)을 포함할 수 있다. 프로브 또는 프라이머는 핵산 분자의 적어도 약 15, 전형적으로 약 20-25, 또한 특정 구현예에서 약 40, 50, 60 또는 75개의 연속 뉴클레오티드에 대해 하이브리드화되는 뉴클레오티드 서열의 영역을 포함할 수 있다.
본 개시내용은 또한, 뉴클레오티드 서열을 포함하거나 이것으로 이루어지거는 핵산에 대하여 선택적으로 하이브리드화될 수 있는 단편 또는 부분을 함유하며, 여기서 뉴클레오티드 서열은 본원에 기재된 유전적 변형물에 함유된 적어도 하나의 다형성(polymorphism) 또는 다형성 대립유전자 또는 동일한 위치에 위치하는 야생형 뉴클레오티드, 또는 그의 상보물을 포함할 수 있는 것인, 단리된 핵산, 예를 들어, 프로브 또는 프라이머를 제공한다. 일부 구현예에서, 프로브 또는 프라이머는 연속 뉴클레오티드 서열 또는 연속 뉴클레오티드 서열의 상보물과 적어도 70% 동일, 적어도 80% 동일, 적어도 85% 동일, 적어도 90% 동일, 또는 적어도 95% 동일할 수 있다.
일부 구현예에서, 핵산 프로브는, 본원에 기재된 유전적 변형을 함유하는 병태 (예: LHON)와 관련된 유전자의 상보적 영역과 하이브리드화될 수 있는 올리고뉴클레오티드일 수 있다. 본 개시내용의 핵산 단편은 본원에 기재된 것들과 같은 검정에서 프로브 또는 프라이머로서 사용될 수 있다.
상기에 기재된 것들과 같은 본 개시내용의 핵산은 당업자에게 널리 공지된 표준 분자 생물학 기술을 사용하여 동정 및 단리될 수 있다. 일부 구현예에서, DNA는 증폭될 수 있고/거나 라벨링 (예: 방사선라벨링, 형광 라벨링)되고 스크리닝을 위한 프로브로서 사용될 수 있고, 이는 예를 들어 유기체로부터 유래된 cDNA 라이브러리이다. cDNA는 mRNA로부터 유래될 수 있고 적합한 벡터 내에 함유될 수 있다. 예를 들어, 상응하는 클론은 생체내 절제에 따라 얻어진 단리된 DNA일 수 있고, 클로닝된 삽입물을 업계-인식 방법에 의해 한쪽 또는 양쪽 배향으로 시퀀싱하여 적절한 분자량의 폴리펩티드를 인코딩하는 정확한 판독 프레임을 동정할 수 있다. 이들 또는 유사한 방법을 사용하여, 폴리펩티드 및 폴리펩티드를 인코딩하는 DNA를 단리하고, 시퀀싱하고 추가로 특성화할 수 있다.
일부 구현예에서, 핵산은 하나 이상의 다형성, 변형, 또는 돌연변이, 예를 들어, 단일 뉴클레오티드 다형성 (SNP), 단일 뉴클레오티드 변형 (SNV), 카피 수 변형 (CNV), 예를 들어, 삽입, 결실, 반전, 및 전좌를 포함할 수 있다. 일부 구현예에서, 핵산은 유사체, 예를 들어, 포스포로티오에이트, 포스포르아미데이트, 메틸 포스포네이트, 키랄메틸 포스포네이트, 2-0-메틸 리보뉴클레오티드, 또는 변형된 핵산, 예를 들어, 변형된 백본 잔기 또는 연결, 또는 탄수화물, 지질, 폴리펩티드 또는 다른 물질과 조합된 핵산, 또는 펩티드 핵산 (PNA), 예를 들어, 크로마틴, 리보솜, 및 트랜스크립토솜(transcriptosome)을 포함할 수 있다. 일부 구현예에서 핵산은 다양한 구조의 핵산, 예를 들어, A DNA, B DNA, Z형 DNA, siRNA, tRNA, 및 리보자임을 포함할 수 있다. 일부 구현예에서, 핵산은, 예를 들어, 참조 서열에 비해 하나 이상의 서열 차이, 예를 들어, 부가, 결실 및/또는 치환을 갖는, 자연적으로 또는 비-자연적으로 다형성일 수 있다. 일부 구현예에서, 참조 서열은 공개적으로 이용가능한 정보, 예를 들어, U.C. 산타 크루즈 인간 게놈 브라우저 게이트웨이 (genome.ucsc.edu/cgi-bin/hgGateway) 또는 NCBI 웹사이트 (www.ncbi.nlm.nih.gov)에 기초할 수 있다. 일부 구현예에서, 참조 서열은 당업계에 널리 공지된 방법을 사용하여, 예를 들어 참조 핵산의 시퀀싱에 의해, 본 개시내용의 실무자에 의해 결정될 수 있다.
일부 구현예에서, 프로브는 본원에 기재된 바와 같은 대립유전자, SNP, SNV, 또는 CNV에 대해 하이브리드화될 수 있다. 일부 구현예에서, 프로브는 본원에 기재된 바와 같은 LHON과 관련된 또 다른 마커 서열에 결합할 수 있다.
당업자는, 특정 대립유전자가 시험 핵산 샘플로부터의 게놈 서열에 존재하는 경우에만 서열 특이적 하이브리드화가 일어날 수 있도록 프로브를 디자인하는 방법을 알 것이다. 본 개시내용은 또한, 특정 유전적 변형을 유전형 분석하기 위한 상업적으로 이용가능한 기술 및 방법을 포함한 임의의 편리한 유전형 분석 방법을 사용하여 실행하도록 축소될 수 있다.
또한 대조군 프로브, 예를 들어, 보다 덜 가변적인 서열, 예를 들어, 염색체의 동원체와 관련된 반복 DNA에 결합하는 프로브가 사용될 수 있고, 이는 대조군으로서 사용될 수 있다. 일부 구현예에서, 프로브는 상업적 공급원으로부터 얻어질 수 있다. 일부 구현예에서, 프로브는, 예를 들어, 화학적으로 또는 시험관내에서 합성될 수 있거나, 표준 기술을 통해 염색체 또는 게놈 DNA로부터 제조될 수 있다. 일부 구현예에서, 사용될 수 있는 DNA의 공급원은 게놈 DNA, 클로닝된 DNA 서열, 숙주의 정상적 염색체 상보물과 함께 인간 염색체 중 하나 또는 하나의 일부를 함유하는 체세포 하이브리드, 및 유동 세포계측법 또는 현미해부에 의해 정제된 염색체를 포함한다. 관심 영역이 클로닝을 통해, 또는 PCR을 사용한 자리-특이적 증폭에 의해 단리될 수 있다.
하나 이상의 핵산, 예를 들어, 프로브 또는 프라이머는 또한, 예를 들어 직접 라벨링에 의해, 검출가능한 라벨을 포함하도록 라벨링될 수 있다. 검출가능 라벨은 물리적, 화학적, 또는 생물학적 방법에 의해 검출이 가능한 임의의 라벨, 예를 들어 방사성 라벨, 예컨대 32P 또는 3H, 형광 라벨, 예컨대 FITC, 발색단 라벨, 친화성-리간드 라벨, 효소 라벨, 예컨대 알칼리 포스파타제, 호스래디쉬 퍼옥시다제, 또는 I2 갈락토시다제, 효소 공동인자 라벨, 햅텐 컨쥬게이트 라벨, 예컨대 디곡시게닌 또는 디니트로페닐, 라만 신호 생성 라벨, 자성 라벨, 스핀 라벨, 에피토프 라벨, 예컨대 FLAG 또는 HA 에피토프, 발광성 라벨, 중원자 라벨, 나노입자 라벨, 전기화학적 라벨, 광 산란 라벨, 구형 쉘 라벨, 반도체 나노결정 라벨, 예컨대 양자점 (미국 특허 번호 6,207,392에 기재됨), 및 당업자에게 공지된 임의의 다른 신호 생성 라벨로 라벨링된 프로브를 포함할 수 있으며, 여기서 라벨은 프로브가 2차 검출 분자와 함께 또는 이것 없이 가시화될 수 있게 할 수 있다. 뉴클레오티드는 표준 기술, 예를 들어, 닉 번역, 랜덤 프라이밍, 및 PCR 라벨링에 의해 프로브 내로 직접 혼입될 수 있다. 본원에서 사용되는 바와 같이, "신호"는, 형광, 방사능, 화학발광 등을 포함한 적절한 수단에 의해 적합하게 검출가능 및 측정가능한 신호를 포함한다.
검출에 유용한 라벨 모이어티의 비-제한적 예는, 적합한 효소, 예컨대 호스래디쉬 퍼옥시다제, 알칼리 포스파타제, 베타-갈락토시다제, 또는 아세틸콜린에스테라제; 예를 들어, 토끼 IgG 및 항-토끼 IgG를 포함한 항원/항체 복합체, 스트렙타비딘/비오틴 또는 아비딘/비오틴 등의 복합체를 형성할 수 있는 결합 쌍의 구성원; 형광단, 예컨대 움벨리페론, 플루오레세인, 플루오레세인 이소티오시아네이트, 로다민, 테트라메틸 로다민, 에오신, 녹색 형광 단백질, 에리트로신, 쿠마린, 메틸 쿠마린, 피렌, 말라카이트 그린, 스틸벤, 루시퍼 옐로우, 캐스캐이드 블루, 텍사스 레드, 디클로로트리아지닐아민 플루오레세인, 단실 클로라이드, 피코에리트린, 유로퓸 및 테르븀을 포함한 것들과 같은 형광 란타나이드 복합체, 시아닌 염료 패밀리 구성원, 예컨대 Cy3 및 Cy5, 분자 비콘 및 그의 형광 유도체, 뿐만 아니라, 예를 들어, Principles of Fluorescence Spectroscopy, Joseph R. Lakowicz (Editor), Plenum Pub Corp, 2nd edition (July 1999) and the 6th Edition of the Molecular Probes Handbook by Richard P. Hoagland에 기재된 바와 같은 당업계에 공지된 다른 것들; 루미놀 등의 발광성 물질; 광 산란 또는 플라스몬 공명 물질, 예컨대 금 또는 은 입자 또는 양자점; 또는 14C, 123I, 124I, 125I, Tc99m, 32P, 33P, 35S 또는 3H를 포함한 방사성 물질을 포함하나, 이에 제한되지는 않는다.
다른 라벨, 예를 들어, 백본 라벨이 또한 본 개시내용의 방법에서 사용될 수 있다. 백본 라벨은 서열 독립적 방식으로 핵산에 결합하는 핵산 염색을 포함한다. 비-제한적 예는 개재 염료, 예컨대 페난트리딘 및 아크리딘 (예: 에티듐 브로마이드, 프로피듐 아이오다이드, 헥시듐 아이오다이드, 디히드로에티듐, 에티듐 호모다이머-1 및 -2, 에티듐 모노아지드, 및 ACMA); 일부 작은 홈 결합제, 예컨대 인돌 및 이미다졸 (예: Hoechst 33258, Hoechst 33342, Hoechst 34580 및 DAPI); 및 기타 핵산 염색, 예컨대 아크리딘 오렌지 (또한 개재가 가능함), 7-AAD, 액티노마이신 D, LDS751, 및 히드록시스틸바미딘을 포함한다. 상기 언급된 모든 핵산 염색은 Molecular Probes, Inc. 등의 공급업체로부터 상업적으로 입수가능하다. 핵산 염색의 또한 다른 예는 Molecular Probes로부터의 하기 염료를 포함한다: 시아닌 염료, 예컨대 SYTOX 블루, SYTOX 그린, SYTOX 오렌지, POPO-1, POPO-3, YOYO-1, YOYO-3, TOTO-1, TOTO-3, JOJO-1, LOLO-1, BOBO-1, BOBO-3, PO-PRO-1, PO-PRO-3, BO-PRO-1, BO-PRO-3, TO-PRO-1, TO-PRO-3, TO-PRO-5, JO-PRO-1, LO-PRO-1, YO-PRO-1, YO-PRO-3, 피코그린(PicoGreen), 올리그린(OliGreen), 리보그린(RiboGreen), SYBR 골드, SYBR 그린 I, SYBR 그린 II, SYBR DX, SYTO-40, -41, -42, -43, -44, -45 (청색), SYTO-13, -16, -24, -21, -23, -12, -11, -20, -22, -15, -14, -25 (녹색), SYTO-81, -80, -82, -83, -84, -85 (오렌지색), SYTO-64, -17, -59, -61, -62, -60, -63 (적색).
일부 구현예에서, 상이한 색의 형광단이 선택될 수 있고, 이는, 예를 들어, 7-아미노-4-메틸쿠마린-3-아세트산 (AMCA), 5-(및-6)-카르복시-X-로다민, 리사민 로다민 B, 5-(및-6)-카르복시플루오레세인, 플루오레세인-5-이소티오시아네이트 (FITC), 7-디에틸아미노쿠마린-3-카르복실산, 테트라메틸로다민-5-(및-6)-이소티오시아네이트, 5-(및-6)-카르복시테트라메틸로다민, 7-히드록시쿠마린-3-카르복실산, 6-[플루오레세인 5-(및-6)-카르복사미도]헥산산, N-(4,4-디플루오로-5,7-디메틸-4-보라-3a,4a 디아자-3-인다센프로피온산, 에오신-5-이소티오시아네이트, 에리트로신-5- 이소티오시아네이트, TRITC, 로다민, 테트라메틸로다민, R-피코에리트린, Cy-3, Cy-5, Cy-7, 텍사스 레드, Phar-Red, 알로피코시아닌 (APC), 및 CASCADETM 블루 아세틸아지드이고, 이에 따라 세트 내에 있거나 세트 내에 있지 않은 각각의 프로브가 뚜렷하게 시각화될 수 있다. 일부 구현예에서, 형광 라벨링된 프로브는 형광 현미경 및 각각의 형광단에 대한 적절한 필터로, 또는 다수의 형광단을 관찰하기 위한 이중 또는 삼중 대역-통과 필터 세트에 의해 볼 수 있다. 일부 구현예에서는, 유동 세포계측법 등의 기술을 사용하여 프로브의 하이브리드화 패턴을 검사할 수 있다.
다른 구현예에서, 프로브는 간접적으로, 예를 들어 비오틴 또는 디곡시게닌으로 라벨링되거나, 32P 및/또는 3H 등의 방사성 동위원소로 라벨링될 수 있다. 비-제한적 예로서, 비오틴으로 간접적으로 라벨링된 프로브는 검출가능 마커에 컨쥬게이션된 아비딘에 의해 검출될 수 있다. 예를 들어, 아비딘은 알칼리 포스파타제 또는 호스래디쉬 퍼옥시다제 등의 효소 마커에 컨쥬게이션될 수 있다. 일부 구현예에서, 효소 마커는 효소에 대한 기질 및/또는 촉매를 사용하여 비색 반응을 사용하여 검출될 수 있다. 일부 구현예에서, 알칼리 포스파타제에 대한 촉매가 사용될 수 있고, 이는 예를 들어 5-브로모-4-클로로-3-인돌릴포스페이트 및 니트로 블루 테트라졸륨이다. 일부 구현예에서, 호스래디쉬 퍼옥시다제에 대한 촉매, 예를 들어, 디아미노벤조에이트가 사용될 수 있다.
제제, 투여 경로, 및 유효 용량
본 개시내용의 또한 또 다른 양태는 본 개시내용의 작용제 또는 작용제의 조합을 포함하는 약제학적 조성물에 대한 제제, 투여 경로 및 유효 용량에 관한 것이다. 이러한 약제학적 조성물을 사용하여 상기에 기재된 바와 같은 병태 (예: LHON)를 치료할 수 있다.
본 개시내용의 화합물은 경구 (협측 및 설하 포함), 직장, 비강, 국소, 경피 패치, 폐, 질, 좌제, 또는 비경구 (안내, 유리체내, 근육내, 동맥내, 경막내, 피내, 복강내, 피하 및 정맥내) 투여에 적합한 것들을 포함한 또는 에어로졸화, 흡입 또는 취입에 의한 투여에 적합한 형태의 약제학적 제제로서 투여될 수 있다. 약물 전달 시스템에 대한 일반적 정보는 Ansel 등, Pharmaceutical Dosage Forms and Drug Delivery Systems (Lippencott Williams & Wilkins, Baltimore Md. (1999)에서 찾아볼 수 있다.
다양한 구현예에서, 약제학적 조성물은 담체 및 부형제 (완충제, 탄수화물, 만니톨, 폴리펩티드, 아미노산, 산화방지제, 정균제, 킬레이팅제, 현탁제, 증점제 및/또는 보존제를 포함하나 이에 제한되지는 않음), 물, 석유, 동물, 식물 또는 합성 기원의 것들을 포함한 오일, 예컨대 땅콩유, 대두유, 미네랄 오일, 참깨유 등, 식염수, 수성 덱스트로스 및 글리세롤 용액, 착향제, 착색제, 점착제거제 및 다른 허용가능한 첨가제, 아주반트, 또는 결합제, 생리적 조건에 근접하기 위한 다른 약제학적으로 허용가능한 보조제 성분, 예컨대 pH 완충제, 긴장성 조정제, 유화제, 습윤제 등을 포함한다. 부형제의 예는 전분, 글루코스, 락토스, 수크로스, 젤라틴, 맥아, 쌀, 밀가루, 백악, 실리카 겔, 스테아르산나트륨, 글리세롤 모노스테아레이트, 활석, 염화나트륨, 건조 탈지 우유, 글리세롤, 프로필렌, 글리콜, 물, 에탄올 등을 포함한다. 일부 구현예에서, 약제학적 조제물은 보존제를 실질적으로 갖지 않는다. 다른 구현예에서, 약제학적 조제물은 적어도 하나의 보존제를 함유할 수 있다. 제약 투여 형태에 대한 일반적 방법론은 Ansel 등, Pharmaceutical Dosage Forms and Drug Delivery Systems (Lippencott, Williams, & Wilkins, Baltimore Md. (1999)에 나타나 있다. 당업자에게 공지된 임의의 적합한 담체를 사용하여 본 개시내용의 조성물을 투여할 수 있지만, 담체의 유형은 투여 방식에 따라 달라질 수 있음을 인식할 수 있다.
화합물은 또한 널리 공지된 기술을 사용하여 리포솜 내에 캡슐화될 수 있다. 생분해성 마이크로스피어가 또한 본 개시내용의 약제학적 조성물에 대한 담체로서 사용될 수 있다. 적합한 생분해성 마이크로스피어는, 예를 들어, 미국 특허 번호 4,897,268, 5,075,109, 5,928,647, 5,811,128, 5,820,883, 5,853,763, 5,814,344 및 5,942,252에 개시되어 있다.
상기 화합물은 리포솜 또는 마이크로스피어 (또는 마이크로입자)로 투여될 수 있다. 대상체에 대한 투여를 위한 리포솜 및 마이크로스피어의 제조 방법은 당업자에게 널리 공지되어 있다. 그 내용이 본원에 참조로 포함되는 미국 특허 번호 4,789,734는, 리포솜 내의 생물학적 물질의 캡슐화 방법을 기재한다. 필수적으로, 물질을 수용액 중에 용해시키고, 적절한 인지질 및 지질을, 또한 필요한 경우 계면활성제와 함께 첨가하고, 물질을 필요에 따라 투석 또는 음파처리한다. 공지된 방법의 검토는 G. Gregoriadis, Chapter 14, "Liposomes," Drug Carriers in Biology and Medicine, pp. 2.sup.87-341 (Academic Press, 1979)에 의해 제공된다.
중합체 또는 폴리펩티드로 형성된 마이크로스피어가 당업자에게 널리 공지되어 있고, 위장관을 통해 직접 혈류로의 통과에 대해 맞춤화될 수 있다. 대안적으로, 화합물은 혼입될 수 있고, 마이크로스피어, 또는 마이크로스피어의 복합체는 수일 내지 수개월의 시간 기간에 걸친 느린 방출을 위해 임플란팅될 수 있다. 예를 들어, 미국 특허 번호 4,906,474, 4,925,673 및 3,625,214, 및 Jein, TIPS 19:155-157 (1998)을 참조하며, 이들의 내용은 본원에 참조로 포함된다.
약물의 농도는 조정될 수 있고, 용액의 pH는 완충될 수 있고, 등장성은 안내 또는 유리체내 주사와 상용성이 되도록 조정될 수 있다.
본 개시내용의 화합물은 적합한 비히클 중에서 멸균 용액 또는 현탁액으로서 제제화될 수 있다. 약제학적 조성물은 종래의 널리 공지된 멸균 기술에 의해 멸균될 수 있거나, 멸균 여과될 수 있다. 생성된 수용액은 그 자체로의 사용을 위해 패키징되거나, 동결건조될 수 있고, 동결건조된 조제물은 투여 전에 멸균 용액과 조합된다. 적합한 제제 및 추가의 담체는 Remington "The Science and Practice of Pharmacy" (20th Ed., Lippincott Williams & Wilkins, Baltimore MD)에 기재되어 있고, 그의 교시 내용은 그 전체가 본원에 참조로 포함된다.
작용제 또는 그의 약제학적으로 허용가능한 염은 단독으로 또는 하나 이상의 다른 작용제와 또는 하나 이상의 다른 형태와 조합되어 제공될 수 있다. 예를 들어, 제제는 하나 이상의 작용제를, 각각의 작용제의 상대적 효력 및 의도된 지시에 따라, 특정 비율로 포함할 수 있다. 예를 들어, 2개의 상이한 숙주 표적을 표적화하기 위한 조성물에서, 또한 효력이 유사한 경우, 약 1:1 비율의 작용제가 사용될 수 있다. 두 형태가 동일한 투여량 단위, 예를 들어 하나의 크림, 좌제, 정제, 캡슐, 에어로졸 스프레이, 또는 음료 중에 용해시킬 분말의 패킷 내에서 함께 제제화될 수 있거나; 또는 각각의 형태가 별도의 단위, 예를 들어 2개의 크림, 2개의 좌제, 2개의 정제, 2개의 캡슐, 정제 및 정제 용해를 위한 액체, 2개의 에어로졸 스프레이, 또는 분말 및 분말 용해를 위한 액체의 패킷 내에서 제제화될 수 있다.
용어 "약제학적으로 허용가능한 염"은 본 개시내용에서 사용되는 작용제의 생물학적 유효성 및 특성을 보유하고, 생물학적으로 또는 다른 방식으로 바람직하지 않은 것이 아닌 염을 의미한다.
전형적인 염은, 예를 들어, 나트륨, 칼륨, 칼슘, 마그네슘 등과 같은 무기 이온의 것들이다. 이러한 염은 염산, 브로민화수소산, 인산, 질산, 황산, 메탄술폰산, p 톨루엔술폰산, 아세트산, 푸마르산, 숙신산, 락트산, 만델산, 말산, 시트르산, 타르타르산 또는 말레산 등의 무기 또는 유기 산과의 염을 포함한다. 추가로, 작용제(들)가 카르복실 기 또는 다른 산성 기를 함유하는 경우, 이는 무기 또는 유기 염기와의 약제학적으로 허용가능한 부가 염으로 전환될 수 있다. 적합한 염기의 예는 수산화나트륨, 수산화칼륨, 암모니아, 시클로헥실아민, 디시클로헥실-아민, 에탄올아민, 디에탄올아민, 트리에탄올아민 등을 포함한다.
약제학적으로 허용가능한 에스테르 또는 아미드는 본 개시내용에서 사용되는 작용제의 생물학적 유효성 및 특성을 보유하고, 생물학적으로 또는 다른 방식으로 바람직하지 않은 것이 아닌 것들을 지칭한다. 전형적인 에스테르는 에틸, 메틸, 이소부틸, 에틸렌 글리콜 등을 포함한다. 전형적인 아미드는 비치환된 아미드, 알킬 아미드, 디알킬 아미드 등을 포함한다.
일부 구현예에서, 작용제는, 예를 들어 상기에 기재된 바와 같이, 하나 이상의 다른 화합물, 형태, 및/또는 작용제와 조합하여 투여될 수 있다. 하나 이상의 다른 활성제를 갖는 약제학적 조성물은 특정 몰비를 포함하도록 제제화될 수 있다. 예를 들어, 약 99:1 내지 약 1:99의 제1 활성제 대 다른 활성제의 몰비가 사용될 수 있다. 구현예의 일부 서브세트에서, 제1 활성제: 다른 활성제의 몰비의 범위는 약 80:20 내지 약 20:80; 약 75:25 내지 약 25:75, 약 70:30 내지 약 30:70, 약 66:33 내지 약 33:66, 약 60:40 내지 약 40:60; 약 50:50; 및 약 90:10 내지 약 10:90으로부터 선택된다. 제1 활성제: 다른 활성제의 몰비는 약 1:9일 수 있고, 일부 구현예에서 약 1:1일 수 있다. 두 작용제, 형태 및/또는 화합물이 동일한 투여량 단위, 예를 들어 하나의 크림, 좌제, 정제, 캡슐, 또는 음료 중에 용해시킬 분말의 패킷 내에서 함께 제제화될 수 있거나; 또는 각각의 작용제, 형태 및/또는 화합물이 별도의 단위, 예를 들어 2개의 크림, 좌제, 정제, 2개의 캡슐, 정제 및 정제 용해를 위한 액체, 에어로졸 스프레이, 또는 분말 및 분말 용해를 위한 액체의 패킷 내에서 제제화될 수 있다.
필요시 또는 바람직한 경우, 작용제 및/또는 작용제의 조합을 또한 다른 작용제와 투여할 수 있다. 본 개시내용의 작용제 및/또는 작용제의 조합과 공동-투여될 수 있는 작용제의 선택은, 적어도 부분적으로, 치료되는 병태에 따라 달라질 수 있다.
작용제(들) (또는 그의 약제학적으로 허용가능한 염, 에스테르 또는 아미드)는 그 자체로 또는 약제학적 조성물의 형태로 투여될 수 있고, 여기서 활성제(들)는 하나 이상의 약제학적으로 허용가능한 담체와의 혼합체 또는 혼합물로 존재한다. 본원에서 사용되는 바와 같이, 약제학적 조성물은 대상체에 대한 투여를 위해 제조된 임의의 조성물일 수 있다. 본 개시내용에 따른 사용을 위한 약제학적 조성물은, 예를 들어 투여될 수 있는 조제물로의 활성제의 프로세싱을 용이하게 하는 부형제, 희석제, 및/또는 보조제를 포함하는, 하나 이상의 생리적으로 허용가능한 담체를 사용하여 종래의 방식으로 제제화될 수 있다. 적당한 제제는 적어도 부분적으로 선택된 투여 경로에 따라 달라질 수 있다. 본 개시내용에서 유용한 작용제(들), 또는 그의 약제학적으로 허용가능한 염, 에스테르, 또는 아미드는, 흡입에 의한 것 뿐만 아니라 경구, 협측, 국소, 직장, 경피, 경점막, 피하, 정맥내, 안내, 유리체내, 및 근육내 적용을 포함한 많은 투여 경로 또는 방식을 사용하여 대상체에게 전달될 수 있다.
일부 구현예에서는, 예를 들어, 큰 친유성 모이어티의 존재로 인해, 작용제를 용액으로 만들기 위해 오일 또는 비-수성 용매 오일 또는 비-수성 용매가 사용될 수 있다. 대안적으로, 에멀젼, 현탁액, 또는 다른 조제물, 예를 들어 리포솜 조제물이 사용될 수 있다. 리포솜 조제물과 관련하여, 병태 치료를 위한 리포솜의 제조를 위한 임의의 공지된 방법이 사용될 수 있다. 예를 들어, 본원에 참조로 포함되는 Bangham 등, J. Mol. Biol. 23: 238-252 (1965) 및 Szoka 등, Proc. Natl Acad. Sci. USA 75: 4194-4198 (1978)을 참조한다. 특정 작용 자리로 이들 조성물을 지향시키기 위해 리포솜에 리간드가 부착될 수 있다. 본 개시내용의 작용제는 또한 특정 대상체 집단에서의 가용화, 투여, 및/또는 순응을 용이하게 하기 위해 식품, 예를 들어 크림 치즈, 버터, 샐러드 드레싱, 또는 아이스크림으로 통합될 수 있다.
본 개시내용의 화합물은 비경구 투여 (예: 주사, 예를 들어, 안내 또는 유리체내 주사에 의한)를 위해 제제화될 수 있고, 앰풀, 예비-충전 시린지, 작은 부피의 주입물 내에서 또는 첨가된 보존제와 함께 다용량 용기 내에서 단위 용량으로 존재할 수 있다. 조성물은 현탁액, 용액, 또는 유성 또는 수성 비히클 내의 에멀젼, 예를 들어, 수성 폴리에틸렌 글리콜 중의 용액 등의 형태를 가질 수 있다.
주사가능 제제의 경우, 비히클은 수용액 또는 유성 현탁액, 또는 에멀젼과, 참깨유, 옥수수유, 면실유, 또는 땅콩유, 뿐만 아니라 엘릭시르, 만니톨, 덱스트로스, 또는 멸균 수용액, 및 유사한 제약 비히클을 포함한, 적합한 것으로 당업계에 공지된 것들로부터 선택될 수 있다. 제제는 또한, 폴리(락틱-코-글리콜)산 등의 생체적합성, 생분해성인 중합체 조성물을 포함할 수 있다. 이들 물질은 약물이 로딩된, 또한 우수한 지속 방출 성능을 제공하기 위해 추가로 코팅되거나 유도체화된 마이크로 또는 나노스피어로 제조될 수 있다. 안구주위 또는 안내 주사에 적합한 비히클은, 예를 들어, 주사 등급 물, 리포솜 및 친유성 물질에 적합한 비히클 중의 치료제의 현탁액을 포함한다. 안구주위 또는 안내 주사를 위한 다른 비히클은 당업계에 널리 공지되어 있다.
일부 구현예에서, 조성물은 인간에 대한 정맥내 투여를 위해 적합화된 약제학적 조성물로서 일상적 절차에 따라 제제화된다. 전형적으로, 정맥내 투여를 위한 조성물은 멸균 등장성 수성 완충제 중의 용액이다. 필요한 경우, 조성물은 또한 가용화제 및 주사 부위에서의 통증 완화를 위해 국소 마취제, 예컨대 리도카인을 포함할 수 있다. 일반적으로, 성분들은, 예를 들어 활성제의 양을 지시하는 앰풀 또는 사쉐 등의 기밀 밀봉된 용기 내의 건조 동결건조 분말 또는 무수 농축물로서, 단위 투여 형태 중에서 함께 혼합되어 또는 별도로 공급된다. 조성물이 주입에 의해 투여되어야 하는 경우, 이는 멸균 제약 등급 물 또는 식염수를 함유하는 주입병으로 분배될 수 있다. 조성물이 주사에 의해 투여되는 경우, 성분들이 투여 전에 혼합될 수 있도록 주사용 멸균수 또는 식염수의 앰풀이 제공될 수 있다.
투여가 주사에 의해 수행되는 경우, 활성 화합물은 수용액 중에서, 구체적으로 생리적으로 상용성인 완충제, 예컨대 행크스(Hanks) 용액, 링거액, 또는 생리 식염 완충제 중에서 제제화될 수 있다. 용액은 제제 작용제, 예컨대 현탁제, 안정화제 및/또는 분산제를 함유할 수 있다. 대안적으로, 활성 화합물은, 사용 전에, 적합한 비히클, 예를 들어 멸균 무발열원 물과의 구성을 위한 분말 형태로 존재할 수 있다. 일부 구현예에서, 약제학적 조성물은 아주반트 또는 펩티드에 의해 자극되는 면역 반응 향상을 위해 첨가되는 임의의 다른 물질을 포함하지 않는다. 일부 구현예에서, 약제학적 조성물은 펩티드에 대한 면역 반응을 억제하는 물질을 포함한다. 제제화 방법은, 예를 들어, Remington's Pharmaceutical Sciences, latest edition, Mack Publishing Co., Easton P에 개시된 바와 같이, 당업계에 공지되어 있다.
일부 구현예에서, 눈 장애는 본 개시내용의 작용제 또는 작용제의 조합을 포함하는 안과용 용액, 현탁액, 연고 또는 삽입물로 효과적으로 치료될 수 있다. 점안액은 멸균 수용액, 예컨대 생리 식염수, 완충액 중에 활성 성분을 용해시킴으로써, 또는 사용 전에 용해되도록 분말 조성물을 조합함으로써 제조될 수 있다. 당업계에 공지된 바와 같은 다른 비히클이 선택될 수 있고, 이는 하기를 포함하나 이에 제한되지는 않는다: 밸런스 염 용액, 식염수, 수용성 폴리에테르, 예컨대 폴리에틸렌 글리콜, 폴리비닐, 예컨대 폴리비닐 알콜 및 포비돈, 셀룰로스 유도체, 예컨대 메틸셀룰로스 및 히드록시프로필 메틸셀룰로스, 석유 유도체, 예컨대 미네랄 오일 및 백색 바셀린, 동물 지방, 예컨대 라놀린, 아크릴산의 중합체, 예컨대 카르복시폴리메틸렌 겔, 식물 지방, 예컨대 땅콩유 및 폴리사카라이드, 예컨대 덱스트란, 및 글리코사미노글리칸, 예컨대 나트륨 히알루로네이트. 요망되는 경우, 점안액에서 통상적으로 사용되는 첨가제가 첨가될 수 있다. 이러한 첨가제는 등장화제 (예: 염화나트륨 등), 완충제 (예: 붕산, 나트륨 일수소 인산염, 나트륨 이수소 인산염 등), 보존제 (예: 벤즈알코늄 클로라이드, 벤즈에토늄 클로라이드, 클로로부탄올 등), 증점제 (예: 사카라이드, 예컨대 락토스, 만니톨, 말토스 등; 예: 히알루론산 또는 그의 염, 예컨대 나트륨 히알루로네이트, 칼륨 히알루로네이트 등; 예: 무코폴리사카라이드, 예컨대 콘드로이틴 술페이트 등; 예: 나트륨 폴리아크릴레이트, 카르복시비닐 중합체, 가교 폴리아크릴레이트, 폴리비닐 알콜, 폴리비닐 피롤리돈, 메틸 셀룰로스, 히드록시 프로필 메틸셀룰로스, 히드록시에틸 셀룰로스, 카르복시메틸 셀룰로스, 히드록시 프로필 셀룰로스 또는 당업자에게 공지된 다른 작용제)를 포함한다.
본 발명의 조성물의 성분의 용해도는 조성물 중의 계면활성제 또는 다른 적절한 공용매에 의해 향상될 수 있다. 이러한 공용매는 폴리소르베이트 20, 60, 및 80, 플루로닉(Pluronic) F68, F-84 및 P-103, 시클로덱스트린, 또는 당업자에게 공지된 다른 제제를 포함한다. 이러한 공용매는 약 0.01 중량% 내지 2 중량%의 수준으로 사용될 수 있다.
본 개시내용의 조성물은 다용량 형태로 패키징될 수 있다. 사용 동안 미생물 오염을 막기 위해 보존제가 바람직할 수 있다. 적합한 보존제는 하기를 포함한다: 벤즈알코늄 클로라이드, 티메로살, 클로로부탄올, 메틸 파라벤, 프로필 파라벤, 페닐에틸 알콜, 에데테이트 이나트륨, 소르브산, Onamer M, 또는 당업자에게 공지된 다른 작용제. 선행 기술 안과용 생성물에서, 이러한 보존제는 0.004% 내지 0.02%의 수준으로 사용될 수 있다. 본 출원의 조성물에서, 보존제, 바람직하게는 벤즈알코늄 클로라이드는, 0.001% 내지 0.01% 미만, 예를 들어 0.001% 내지 0.008%, 바람직하게는 약 0.005 중량%의 수준으로 사용될 수 있다. 본 개시내용의 조성물을 미생물 공격으로부터 보존하기 위해 0.005%의 벤즈알코늄 클로라이드 농도가 충분할 수 있음이 확인되었다.
일부 구현예에서, 본 개시내용의 작용제는 현탁액보다는 가용성 형태로 전달되고, 이는 작용 부위로의 보다 빠르고 정량적인 흡수를 가능하게 한다. 일반적으로, 젤리, 크림, 로션, 좌제 및 연고 등의 제제는 본 개시내용의 작용제로의 보다 연장된 노출을 갖는 영역을 제공할 수 있으며, 용액 중의 제제, 예를 들어 스프레이는 보다 즉각적인 단기간 노출을 제공한다.
추가로, 본 개시내용의 화합물은 국소, 안내, 안구주위, 또는 전신 투여를 위한 삽입물 상의, 그 안의 또는 그에 부착된 지속 방출 제제에서의 사용을 위해 생체적합성 중합체에 탈착가능하게 부착될 수 있음이 고려된다. 생체적합성 중합체로부터의 제어 방출을 수용성 중합체와 함께 활용하여 점적가능(instillable) 제제를 형성할 수도 있다. 예를 들어, PLGA 마이크로스피어 또는 나노스피어 등의 생체적합성 중합체로부터의 제어 방출이 지연 방출 투여를 위한 안내 임플란테이션 또는 주사에 적합한 제제에서 활용될 수 있고, 또한 임의의 적합한 생분해성 및 생체적합성 중합체가 사용될 수 있다.
실시예
하기 예시적 구현예는 본 발명을 추가로 설명한다. 이들 실시예는 단지 본 발명을 예시하도록 의도되며, 본 발명의 범위를 제한하도록 의도되지는 않음을 이해하여야 한다. 달리 지시되지 않는 한, 예를 들어 sambrook 등, molecular cloning: a laboratory manual (New York: cold spring harbor laboratory press, 1989)에 개시된 방법 및 조건 또는 제조업자에 의해 권고되는 조건이 하기 실시예에서 사용될 수 있다.
실시예 1 - ND4 플라스미드 및 바이러스 제조
1.1 플라스미드 제조
인간 ND4에 대한 뉴클레오티드 서열 (서열 번호: 6)을 미국 국립 생물공학 정보 센터(US National Center for Biotechnology Information) 참조 서열 yp_003024035.1에 기초하여 얻었다. 비-최적화된 미토콘드리아 표적화 서열 COX10에 대한 서열은 서열 번호: 1이다. 전사 효율 및 번역 효율을 향상시키기 위해 하기 서열에 대한 최적화된 서열: 미토콘드리아 표적화 서열 COX10 (opt_COX10, 서열 번호: 2) 및 인간 ND4의 코딩 서열 (opt_ND4, 서열 번호: 7)을 디자인하였다. 비-최적화된 COX10-ND4와 약 75.89% 상동성을 갖는 최적화된 COX10-ND4 서열에 3 프라임 비번역 영역 (즉, 3'UTR, 서열 번호: 13)을 후속시켜 재조합 핵산, opt_COX10-opt_ND4-3'UTR (서열 번호: 31에 나타냄)을 형성하였다.
합성된 재조합 핵산, opt_COX10-opt_ND4-3'UTR을 PCR 증폭에 의해 아데노-관련 바이러스 (AAV) 벡터 내로 혼입하였다 (도 1). opt_COX10-opt_ND4-3'UTR을 EcoRI/SalI 제한 효소에 의해 절단하여 응집성 말단을 형성하고, 이어서 pSNaV 벡터와 같은 EcoRI/SalI 제한 자리를 갖는 AAV 벡터 내로 내포시켜 pSNaV/rAAV2/2-ND4 플라스미드 (즉, pAAV2-최적화된 ND4 플라스미드)를 생성하였다. pAAV2-opt_ND4 플라스미드를 비-최적화된 pAAV2-ND4 플라스미드와 비교하였다.
레콘(recon) 스크리닝 및 동정 단계는 CN102634527B와 유사하였다: 플라스미드를 37℃에서 LB 플레이트 내에서 배양하였다. 청색 콜로니 및 백색 콜로니가 나타났고, 여기서 백색 콜로니가 재조합 클론이었다. 백색 콜로니를 선택하고, 100 mg/L 앰피실린-함유 LB 배양 배지에 첨가하고, 37℃에서 200 rpm으로 8시간 동안 배양하고, 이어서 Biomiga 플라스미드 추출 프로토콜에 기초하여 배양된 박테리아 배지로부터 플라스미드를 추출하였다. EcoRI/SalI 제한 효소를 사용하여 플라스미드의 동정을 확인하였다.
1.2 세포 트랜스펙션
트랜스펙션 하루 전에, HEK293 세포를 225 cm2 세포 배양병에 접종하였다: 3.0 × 107개 세포/mL의 접종 밀도, 10% 소혈청을 갖는 둘베코 수정 이글 배지 (DMEM)의 배양 배지, 37℃에서, 5% CO2 인큐베이터 내에서, 밤새. 트랜스펙션 당일에 배양 배지를 10% 소혈청을 갖는 신선한 DMEM으로 교체하였다.
세포가 80-90%까지 성장한 후, 배양 배지를 폐기하고, PlasmidTrans (VGTC) 트랜스펙션 키트를 사용하여, 세포를 pAAV2-ND4 및 pAAV2-opt_ND4 플라스미드로 트랜스펙션시킨다. 상세한 트랜스펙션 프로토콜은 CN102634527B 실시예 1에 기재되어 있다. 세포를 트랜스펙션 후 48 h에 수집하였다.
1.3 재조합 아데노-관련 바이러스의 수집, 농축 및 정제
바이러스 수집: 1) 드라이 아이스 에탄올 배쓰 (또는 액체 질소) 및 37℃ 수조를 준비하고; 2) 배지와 함께 트랜스펙션된 세포를 15 ml 원심분리 튜브 내에서 수집하고; 3) 세포를 1000 rpm/min으로 3분 동안 원심분리하고; 세포 및 상청액을 분리하고; 상청액을 별도로 저장하고; 세포를 1 mL의 PBS 중에 재현탁시키고; 4) 세포 현탁액을 드라이 아이스-에탄올 배쓰와 37℃ 수조 사이에 반복적으로 전달하고, 각각 10분 동안 4회 동결 해동시키고, 각각의 해동 후 약하게 진탕시켰다.
바이러스 농축: 1) 세포 잔사를 10,000 g 원심분리로 제거하고; 원심분리 상청액을 새로운 원심분리 튜브로 전달하고; 2) 0.45 μm 필터로의 여과에 의해 불순물을 제거하고; 3) 각각 1/2 부피의 1M NaCl 및 10% PEG 8000 용액을 샘플 중에 첨가하고, 균일하게 혼합하고, 4℃에서 밤새 저장하고; 4) 2 h 동안 12,000 rpm 원심분리 후 상청액을 폐기하고; 바이러스 침전물을 적절한 양의 PBS 용액 중에 완전히 용해시킨 후, 샘플을 0.22 μm 필터로 멸균시키고; 5) 벤조나제 뉴클레아제를 첨가하여 잔류 플라스미드 DNA를 제거하였다 (50 U/ml의 최종 농도). 튜브를 수회 뒤집어 철저히 혼합하고, 이어서 37℃에서 30분 동안 인큐베이션하고; 6) 샘플을 0.45 μm 여과 헤드로 여과하였고; 여액이 농축된 rAAV2 바이러스이다.
바이러스 정제 : 1) CsCl을 1.41 g/ml의 밀도까지 농축된 바이러스 용액에 첨가하고 (1.372의 굴절률); 2) 샘플을 원심분리 튜브 내에 첨가하고, 튜브를 예비-제조된 1.41 g/ml CsCl 용액으로 충전시키고; 3) 175,000 g로 24시간 동안 원심분리하여 밀도 구배를 형성하였다. 상이한 밀도의 샘플의 순차적 수집을 수행하였다. 풍부화된 rAAV2 입자를 수집하고; 4) 과정을 1회 더 반복하였다. 바이러스를 100 kDa 투석 백에 로딩하고, 4℃에서 밤새 투석/탈염하였다. 농축 및 정제된 재조합 아데노-관련 바이러스는 rAAV2-ND4 및 rAAV2-최적화된 ND4였다.
유사하게, 다른 미토콘드리아 표적화 서열 (MTS), 예컨대 OPA1 (서열 번호: 5)을 사용하여 상기 실시예에서의 COX10을 대체하고 재조합 플라스미드로 AAV를 생성할 수 있다.
실시예 2 - 토끼 눈에서의 rAAV2의 유리체내 주사
12마리의 토끼를 2개 그룹으로 분할하였다: rAAV2-ND4 및 rAAV2-최적화된 ND4. 바이러스 용액 (1 × 1010 vg/0.05 mL)을 편평부(pars plana)에서 각막 연부 3 mm 외부로부터 유리체강 내로 천공투입하였다. 유리체내 주사 후, 세극등 검사 및 안저부 사진 검사를 사용하여 눈을 검사하였다. 30일 동안 주사. 각각의 그룹에서 각각 RT-PCR 검출 및 면역블롯팅을 수행하였다.
실시예 3 - ND4의 발현에 대한 실시간 PCR
TRIZOL 총 RNA 추출 키트를 사용하여 트랜스펙션된 rAAV2-ND4 및 rAAV2-최적화된 ND4 토끼 시신경 세포로부터의 RNA를 추출하였다. cDNA 템플레이트를 추출된 RNA의 역전사에 의해 합성하였다.
NCBI 보존 구조 도메인 분석 소프트웨어를 사용하여 ND4의 보존적 구조를 분석하여, 디자인된 프라이머 증폭 단편이 비-보존 영역에 위치함을 확인하고; 이어서 프라이머를 형광 정량 PCR 프라이머 디자인 원리에 따라 디자인하였다:
β-액틴-S:CGAGATCGTGCGGGACAT (서열 번호: 85);
β-액틴-A:CAGGAAGGAGGGCTGGAAC (서열 번호: 86);
ND4-S:CTGCCTACGACAAACAGAC (서열 번호: 87);
ND4-A:AGTGCGTTCGTAGTTTGAG (서열 번호: 88);
형광 정량 PCR 반응 및 프로토콜: 형광 정량 PCR을 실시간 PCR 검출 시스템에서 측정하였다. 0.2 ml PCR 반응 튜브 내에서, SYBR 그린 믹스 12.5 μl, ddH2O 8 μl, 1 μl의 각각의 프라이머, 및 cDNA 샘플 2.5 μl를 25 μl의 전체 부피까지 첨가하였다. 각각의 샘플을 표적 유전자의 증폭 및 참조 유전자 β-액틴의 증폭을 위해 사용하고, 각각의 증폭을 3회 반복하였다. 공통의 시약을 함께 첨가하고, 이어서 별도로 분할하여 취급 변동을 최소화하였다. 형광 정량 PCR을 수행하였다: 95℃에서 1 초동안 예비-변성, 94℃에서 15 초동안 변성, 55℃에서 15 초동안 어닐링, 72℃에서 45 초동안 확장. 총 40 사이클의 증폭 반응을 수행하고, 형광 신호 획득을 각각의 사이클의 확장기에서 수행하였다. 반응 후, 94℃ 내지 55℃ 용융 곡선 분석을 수행하였다. 유전자 발현 수준의 상대적 정량 방법 연구를 채택하여 내부 기준 유전자로서 베타-액틴과의 차이를 사용하였다.
도 2에 나타낸 바와 같이, rAAV2-ND4 및 rAAV2-최적화된 ND4의 상대적 발현 수준 (mRNA 수준)은 각각 0.42 ± 0.23 및 0.57 ± 0.62였다 (p < 0.05, 도 2). 결과는 예상외로, 최적화된 ND4 (opt_ND4, 서열 번호: 7) 코딩 핵산 서열 및 상응하는 재조합 핵산 (opt_COX10-opt_ND4-3'UTR, 서열 번호: 31)이 놀랍게도 전사 효율을 증가시켜, rAAV2-최적화된 ND4의 발현을 약 36%만큼 증가시켰음을 보여준다. 결과는 rAAV2-최적화된 ND4의 전사 효율이 현저히 더 높음을 보여주었다.
실시예 4 - ND4 발현의 면역블롯팅 검출
ND4 단백질을 각각 rAAV2-최적화된 ND4 및 rAAV2-ND4에 의해 트랜스펙션된 토끼 신경 세포로부터 정제하였다. 10% 폴리아크릴아미드 겔 전기영동 후, 면역 검출을 위해 폴리비닐리덴 디플루오라이드 멤브레인 (Bio-Rad, HER-hercules, 미국 캘리포니아주)으로 전달하였다. β-액틴을 내부 기준 유전자로서 사용하였다. 필름 스트립을 자동 이미지 분석 기기 (Li-Cor; 미국 네브래스카주 링컨)에서 관찰하고, 적분 정규화 방법으로 단백질 밴드의 적분된 광학 밀도를 사용하여 분석하여, 광학 밀도 값에 상응하는 동일한 샘플을 얻었다. 통계 분석 소프트웨어 SPSS 19.0을 데이터 분석에 사용하였다.
결과를 도 3에 나타내었다. rAAV2-최적화된 ND4 (좌측 흑색 컬럼) 및 rAAV2-ND4에 대한 ND4의 평균 상대적 단백질 발현 수준은 각각 0.32 ± 0.11 및 0.68 ± 0.20이었다 (p < 0.01, 도 3). 결과는 예상외로, 최적화된 ND4 코딩 핵산 서열 (opt_ND4, 서열 번호: 7) 및 상응하는 재조합 핵산 (opt_COX10-opt_ND4-3'UTR, 서열 번호: 31)이 놀랍게도 번역 효율을 증가시켜, rAAV2-최적화된 ND4의 발현을 약 112%만큼 증가시켰음을 보여준다. 결과는 rAAV2-최적화된 ND4의 전사 효율이 또한 현저히 더 높음을 보여주었다.
실시예 5 - 토끼 안내압 및 안저 사진
수술 후 1, 3, 7, 및 30일에 토끼의 2개 그룹 모두에 대하여 세극등 검사 및 안내압 측정을 수행하였다. 명백한 비정상, 결막 울혈, 분비, 또는 안구내염이 관찰되지 않았고, 안내압이 모든 토끼에서 상승되지 않았다.
안저부 사진 결과를 도 4에 나타내었다. 토끼의 시신경 및 망막 혈관에 대한 명백한 손상 또는 합병증이 없고, 이는 표준 유리체내 주사가 뚜렷한 염증 반응 또는 다른 합병증 없이 안전함을 나타낸다.
실시예 6 - 인간 임상 실험
2개 그룹의 환자를 시험하였다: 1) 대조군으로서, 2011년과 2012년 사이에, 9명의 환자가 단일 눈에 1 × 1010 vg/0.05 mL rAAV2-ND4의 유리체내 주사를 수용하였고; 2) 실험군으로서, 2017년과 2018년 1월 사이에, 20명의 환자가 단일 눈에 1 × 1010 vg/0.05 mL rAAV2-최적화된 ND4의 유리체내 주사를 수용하였다. 통계 분석 SPSS 19.0을 사용하여 임상 실험 결과를 분석하였다.
2개 그룹의 비교가 표 2에 나타나 있다. 가장 빠른 시각 개선 시간은 실험군에서 1개월이었고, 이는 3개월의 대조군보다 현저히 빨랐고 (p < 0.01); 실험군에 대한 시력의 최적 회복은 1.0이었고, 이는 0.8의 대조군보다 명백히 더 높았고 (p < 0.01); 실험군에서의 시력의 평균 회복은 0.582 ± 0.086이었고, 이는 0.344 ± 0.062의 대조군보다 명백히 더 높았다 (p < 0.01). 안저부 사진 결과를 도 5에 나타내었다. 실험군 및 대조군에서 환자의 시신경 및 망막 혈관에 대한 명백한 손상 또는 합병증이 없고, 이는 rAAV2-최적화된 ND4 및 rAAV2-ND4의 유리체내 주사의 안전성을 나타낸다.
표 2: LHON 유전자 요법에서 rAAV2-최적화된 ND4 및 rAAV2-ND4의 비교
실시예 7 - 미토콘드리아 표적화 서열로서의 OPA1
실시예 1-6에서의 재조합 핵산의 COX10 및 3'UTR 서열 (opt_COX10-opt_ND4-3'UTR, 서열 번호: 31)을 각각 또 다른 미토콘드리아 표적화 서열, OPA1 (서열 번호: 5) 및 또 다른 3'UTR 서열, 3'UTR* (서열 번호: 14)로 대체하여, 새로운 재조합 핵산, OPA1-opt_ND4-3'UTR* (서열 번호: 74)을 생성하였다.
실험 방법은 실시예 1-6과 동일하였고, 여기서는 재조합 핵산 opt_COX10-opt_ND4-3'UTR (서열 번호: 31)을 OPA1-opt_ND4-3'UTR* (서열 번호: 74)로 대체하였다. 최적화된 ND4 서열은, 비-최적화된 ND4 (COX10-ND4-3'UTR, 서열 번호: 15)와 비교시 현저히 개선된 전사 및 번역 효율, 발현 수준, 뿐만 아니라 LHON 치료에 있어 보다 높은 효능 및 안전성을 가짐이 확인되었다.
실시예 8 - 최적화된 ND4 서열 opt_ND4
*
핵산, opt_COX10*-opt_ND4*-3'UTR (서열 번호: 47)을 사용하여 실시예 1-6에서의 유사한 실험 방법을 수행하였다. 실시예 1에서와 유사한 절차를 따라, 형광 단백질, EGFP로 태깅된 바이러스를 rAAV2-ND4-EGFP 및 rAAV2-opt_ND4*-EGFP로서 제조하였다.
동결된 293T 세포를 소생시키고, 약 90%까지 T75 플라스크에서 성장시켰다. 세포를 침전시키고, DMEM 완전 배지 중에 5 × 104개 세포/mL의 세포 밀도로 재현탁시켰다. 세포를 재현탁시켰다. 약 100 μl의 세포 현탁액 (약 5000개 세포)을 96 웰 플레이트의 각각의 웰에 첨가하였다. 세포를 배양하고 37℃ 및 5% CO2 하에 50%까지 성장시켰다. 약 0.02 μl PBS를 각각 2 × 1010 vg/0.02 μl의 바이러스 rAAV2-ND4-EGFP 및 rAAV2-opt_ND4*-EGFP와 혼합하였다. 48시간 후, 형광 현미경분석 및 RT-PCR 검출 및 면역블롯팅 실험을 수행하였다. 도 6에 나타낸 바와 같이, EGFP가 성공적으로 발현되었고, 이는 EGFP 유전자를 갖는 rAAV가 293T 세포에서 성공적으로 트랜스펙션되었고, rAAV2-ND4-EGFP 및 rAAV2-opt_ND4*-EGFP가 성공적으로 발현되었음을 나타낸다.
하기 프라이머를 사용하여 실시예 3과 유사한 실시간 PCR 시험을 수행하였다:
β-액틴-S:CGAGATCGTGCGGGACAT (서열 번호: 85);
β-액틴-A:CAGGAAGGAGGGCTGGAAC (서열 번호: 86);
ND4-S: GCCAACAGCAACTACGAGC (서열 번호: 107);
ND4-A: TGATGTTGCTCCAGCTGAAG (서열 번호: 108);
결과는 예상외로, 최적화된 ND4* (opt_ND4, 서열 번호: 8) 코딩 핵산 서열 및 상응하는 재조합 핵산 (opt_COX10*-opt_ND4*-3'UTR, 서열 번호: 47)이 놀랍게도 전사 효율을 증가시켜, rAAV2-opt_ND4의 발현을 약 20%만큼 증가시켰음을 보여준다. 결과는 rAAV2-opt_ND4의 전사 효율이 현저히 더 높음을 보여주었다.
도 7은 293T 세포에서의 ND4 발현을 나타낸다. rAAV2-ND4에 대한 ND4 단백질의 평균 발현은 0.36이며, rAAV2-opt_ND4*에 대한 ND4 단백질의 평균 발현은 1.65이고, 이는 rAAV2-ND4 그룹에 비해 약 4.6배 더 높은 것이다 (p < 0.01) (도 8 참조).
도 9는 토끼 시신경 세포에서의 ND4 발현을 나타낸다. rAAV2-ND4에 대한 ND4 단백질의 평균 발현은 0.16이며, rAAV2-opt_ND4*에 대한 ND4 단백질의 평균 발현은 0.48이고, 이는 rAAV2-ND4 그룹에 비해 약 3배 더 높은 것이다 (p < 0.01) (도 10 참조).
1, 3, 7, 및 30일에 토끼의 2개 그룹 모두에 대하여 세극등 검사 및 안내압 측정을 수행하였다. 명백한 비정상, 결막 울혈, 분비, 또는 안구내염이 관찰되지 않았고, 안내압이 모든 토끼에서 상승되지 않았다.
rAAV2-ND4 및 rAAV2-opt_ND4*에 대한 안저부 사진 결과를 도 11에 나타내었다. 토끼의 시신경 및 망막 혈관에 대한 명백한 손상 또는 합병증이 없고, 이는 표준 유리체내 주사가 뚜렷한 염증 반응 또는 다른 합병증 없이 안전함을 나타낸다.
세극등 검사 및 안내압 측정 후 2개 토끼 그룹 모두로부터의 안구를 제거하였다. 안구를 고정시키고, 파라핀을 사용하여 탈수시켰다. 시신경의 방향을 따라 조직을 병리학적으로 절개하였다. 추가의 탈수 후, 헤마톡실린 및 에오신을 사용하여 조직 샘플을 염색하였다. 현미경 검사 결과는 도 12를 참조한다. HE 염색 결과에서 나타난 바와 같이, 토끼 망막 신경절 섬유 층이 손상되지 않았고, 신경절 세포의 수가 감소하지 않았으며, 이는 유리체내 주사가 망막 독성 또는 신경 손상을 생성하지 않고, 안전하게 사용될 수 있음을 나타낸다.
실험 방법은 실시예 8과 동일하였고, 여기서는 재조합 핵산 opt_COX10*-opt_ND4*-3'UTR (서열 번호: 47)을 OPA1-opt_ND4*-3'UTR* (서열 번호: 76)로 대체하였다. 최적화된 ND4 서열은, 비-최적화된 ND4 (COX10-ND4-3'UTR, 서열 번호: 15)와 비교시 현저히 개선된 전사 및 번역 효율, 발현 수준, 뿐만 아니라 LHON 치료에 있어 보다 높은 효능 및 안전성을 가짐이 확인되었다.
실시예 9 - ND6 서열
COX10 (서열 번호: 1), ND6 (서열 번호: 9), 및 3'UTR (서열 번호: 13)의 조합 (5'에서 3'으로)인, 핵산, COX10-ND6-3'UTR (서열 번호: 21)을 사용하여 실시예 1-6에서의 유사한 실험 방법을 수행하였다.
COX10-ND6-3'UTR (서열 번호: 21)에 대한 플라스미드 스크리닝에서 하기 프라이머를 사용하였다:
ND6-F: ATGATGTATGCTTTGTTTCTG (서열 번호: 89),
ND6-R: CTAATTCCCCCGAGCAATCTC (서열 번호: 90),
트랜스펙션 및 스크리닝된 바이러스 rAAV2-ND6은 2.0 × 1011 vg/mL의 바이러스 역가를 가졌다. 실시예 5와 유사하게, 수술 후 1, 7, 및 30일에 토끼의 3개 그룹 (A: rAAV2-ND6; B: rAAV-GFP; C: PBS)에 대하여 세극등 검사 및 안내압 측정을 수행하였다(도 13). 명백한 비정상, 결막 울혈, 분비, 또는 안구내염이 관찰되지 않았고, 안내압이 모든 토끼에서 상승되지 않았다.
하기 프라이머를 사용하여 실시예 3과 유사한 실시간 PCR 시험을 수행하였다:
β-액틴-S:CGAGATCGTGCGGGACAT (서열 번호: 85);
β-액틴-A:CAGGAAGGAGGGCTGGAAC (서열 번호: 86);
ND6-S: AGTGTGGGTTTAGTAATG (서열 번호: 91);
ND4-A: TGCCTCAGGATACTCCTC (서열 번호: 92);
결과는 rAAV2-ND6 및 대조군 (PBS)에 대한 ND6의 발현이 각각 0.59 ± 0.06 및 0.41 ± 0.03이었음을 보여준다. 결과는 rAAV2-ND6의 전사 효율이 대조군보다 높음을 보여주었다 (p<0.01).
실시예 10 - 최적화된 opt_ND6 서열
opt_COX10* (서열 번호: 3), opt_ND6 (서열 번호: 10), 및 3'UTR (서열 번호: 13)의 조합 (5'에서 3'으로)인, 핵산, opt_COX10*-opt_ND6-3'UTR (서열 번호: 51)을 사용하여 실시예 1-6에서의 유사한 실험 방법을 수행하였다.
토끼의 3개 그룹에 주사하였다: A: 1010 vg/50 μl의 rAAV2-opt_ND6, B: 1010 vg/50 μl의 rAAV2-ND6 (실시예 9), 및 C: 1010 vg/50 μl의 rAAV2-EGFP. 도 14는 각각 rAAV2-opt_ND6 (A), rAAV2-ND6 (B), rAAV-EGFP (C)가 주사된 토끼에 대한 안저부 사진 결과를 나타낸다. 명백한 비정상, 결막 울혈, 분비, 또는 안구내염이 관찰되지 않았고, 안내압이 모든 토끼에서 상승되지 않았다.
하기 프라이머를 사용하여 실시예 3과 유사한 실시간 PCR 시험을 수행하였다:
β-액틴-F:CTCCATCCTGGCCTCGCTGT (서열 번호: 93);
β-액틴-R:GCTGTCACCTTCACCGTTCC (서열 번호: 94);
ND6-F: GGGTTTTCTTCTAAGCCTTCTCC (서열 번호: 95);
ND6-R: CCATCATACTCTTTCACCCACAG (서열 번호: 96);
opt_ND6-F: CGCCTGCTGACCGGCTGCGT (서열 번호: 97);
opt_ND6-R: CCAGGCCTCGGGGTACTCCT (서열 번호: 98);
도 15에 나타낸 바와 같이, rAAV2-opt_ND6 (A) 및 rAAV2-ND6 (B) 둘 다 대조군 (C)에 비해 더 높은 (p<0.05) 상대적 ND6 발현 수준을 가졌다. rAAV2-opt_ND6 (A)은 rAAV2-ND6 (B)에 비해 약간 더 높은 상대적 ND6 발현 수준을 가졌다. 도 16의 웨스턴 블롯에서 나타난 바와 같이, rAAV2-opt_ND6 (A)은 rAAV2-ND6 (B)에 비해 3배 초과로 더 높은 상대적 ND6 발현 수준을 가졌다.
실험 방법은 실시예 8과 동일하였고, 여기서는 재조합 핵산, COX10-ND6-3'UTR (서열 번호: 21) 및 opt_COX10*-opt_ND6-3'UTR (서열 번호: 51)을 OPA1-ND6-3'UTR (서열 번호: 77) 및 OPA1-opt_ND6-3'UTR (서열 번호: 79)로 대체하였다. 최적화된 ND6 서열은 현저히 개선된 전사 및 번역 효율, 발현 수준, 뿐만 아니라 LHON 치료에 있어 보다 높은 효능 및 안전성을 가짐이 확인되었다.
실시예 11 - ND1 및 opt_ND1 서열
COX10 (서열 번호: 1), ND1 (서열 번호: 11), 및 3'UTR (서열 번호: 13)의 조합 (5'에서 3'으로)인 rAAV2-ND1, COX10-ND1-3'UTR (서열 번호: 25); 또한 opt_COX10* (서열 번호: 3), opt_ND1 (서열 번호: 12), 및 3'UTR (서열 번호: 13)의 조합 (5'에서 3'으로)인 rAAV2-opt_ND1, opt_COX10*-opt_ND1-3'UTR (서열 번호: 55)을 사용하여 실시예 1-6에서의 유사한 실험 방법을 수행하였다.
COX10-ND1-3'UTR (서열 번호: 25)에 대한 플라스미드 스크리닝에서 하기 프라이머를 사용하였다:
ND1-F: ATGGCCGCATCTCCGCACACT (서열 번호: 99),
ND1-R: TTAGGTTTGAGGGGGAATGCT (서열 번호: 100),
opt_COX10*-opt_ND1-3'UTR (서열 번호: 55)에 대한 플라스미드 스크리닝에서 하기 프라이머를 사용하였다:
ND1-F: AACCTCAACCTAGGCCTCCTA (서열 번호: 101),
ND1-R: TGGCAGGAGTAACCAGAGGTG (서열 번호: 102),
토끼의 3개 그룹에 주사하였다: A: 1010 vg/50 μl의 rAAV2-opt_ND1, B: 1010 vg/50 μl의 rAAV2-ND1 (실시예 9), 및 C: 1010 vg/50 μl의 rAAV2-EGFP. 명백한 비정상, 결막 울혈, 분비, 또는 안구내염이 관찰되지 않았고, 안내압이 모든 토끼에서 상승되지 않았다.
하기 프라이머를 사용하여 실시예 3과 유사한 실시간 PCR 시험을 수행하였다:
ND1-F: AGGAGGCTCTGTCTGGTATCTTG (서열 번호: 103);
ND1-R: TTTTAGGGGCTCTTTGGTGAA (서열 번호: 104);
opt_ND1-F: GCCGCCTGCTGACCGGCTGCGT (서열 번호: 105);
opt_ND1-R: TGATGTACAGGGTGATGGTGCTGG (서열 번호: 106);
도 17에 나타낸 바와 같이, rAAV2-opt_ND1 (A) 및 rAAV2-ND1 (B) 둘 다 대조군 (C)에 비해 더 높은 (p<0.05) 상대적 ND1 발현 수준을 가졌다. 도 18의 웨스턴 블롯에서 나타난 바와 같이, rAAV2-opt_ND1 (A)은 rAAV2-ND1 (B)에 비해 2배 초과로 더 높은 상대적 ND6 발현 수준을 가졌다.
실험 방법은 실시예 8과 동일하였고, 여기서는 재조합 핵산, COX10-ND1-3'UTR (서열 번호: 25) 및 opt_COX10*-opt_ND1-3'UTR (서열 번호: 55)을 OPA1-ND1-3'UTR (서열 번호: 81) 및 OPA1-opt_ND1-3'UTR (서열 번호: 83)로 대체하였다. 최적화된 ND1 서열은 현저히 개선된 전사 및 번역 효율, 발현 수준, 뿐만 아니라 LHON 치료에 있어 보다 높은 효능 및 안전성을 가짐이 확인되었다.
실시예 12 - 다른 융합 단백질
서열 번호: 15-84에 기재된 바와 같은 다른 융합 단백질을 사용하여 실시예 1-6에서의 유사한 실험 방법을 수행할 수 있다. 또한 유사한 결과가 달성될 것으로 예상된다.
실시예 13 - 제제 개발
AAV2 바이러스 샘플을 사용하여 상이한 AAV 제제를 스크리닝하였다. StepOnePlus 실시간 PCR 시스템을 사용하여 상이한 AAV 제제의 안정성을 평가하였다. 동결/해동 사이클 조건 하에 각각의 제제의 바이러스 역가를 측정하였다.
첫번째로, 3종의 상이한 제제를 1, 2, 3, 4, 및 5회의 동결/해동 사이클 하에 시험하였고, 바이러스 역가를 측정하고, 표 3에 요약하였다. 시험된 3종의 제제는 하기와 같았다: A: 인산염 완충 식염수 (PBS); B: 1% α,α-트레할로스 탈수화물, 1% L-히스티딘 모노히드로클로라이드 일수화물, 및 1% 폴리소르베이트 20; 및 C: 180 mM NaCl, 10 mM NaH2PO4/Na2HPO4, 및 0.001% 폴록사머 188, pH 7.3. 표 3에 나타낸 바와 같이, 제제 C는 5회의 동결/해동 사이클 후에 최저 상대 표준 편차 (RSD)를 갖고, 이는 AAV 제제로서 우수한 안정성을 나타낸다.
표 3 - 제제 A, B, 및 C의 바이러스 역가
표 3에 나타낸 바와 같이, 제제 C는 5개 동결/해동 사이클 후에 최저 상대 표준 편차 (RSD)를 갖고, 이는 AAV 제제로서 우수한 안정성을 나타낸다.
두번째로, 3종의 상이한 제제의 또 다른 그룹을 1, 2, 3, 4, 및 5개 동결/해동 사이클 하에 시험하였고, 바이러스 역가를 측정하고, 표 4에 요약하였다. 시험된 3종의 제제는 하기와 같았다: D: 인산염 완충 식염수 (PBS), pH 7.2-7.4; E: PBS 및 0.001% 폴록사머 188, pH 7.2-7.4; 및 F: 80 mM NaCl, 5 mM NaH2PO4, 40 mM Na2HPO4, 5 mM KH2PO4 및 0.001% 폴록사머 188, 7.2-7.4.
표 4 - 제제 D, E, 및 F의 바이러스 역가
표 4에 나타낸 바와 같이, 제제 F는 5개 동결/해동 사이클 후에 최저 상대 표준 편차 (RSD)를 갖고, 이는 AAV 제제로서 우수한 안정성을 나타낸다. 전체적으로, 제제 F는 또한 모든 시험된 제제 중에서 최저 RSD를 갖고, 차후 개발을 위한 AAV 제제로서 사용될 수 있다.
본 발명의 바람직한 구현예를 본원에서 나타내고 기재하였지만, 이러한 구현예는 단지 예로서 제공되는 것임이 당업자에게 명백할 것이다. 이제 수많은 변형, 변화, 및 치환이 본 발명으로부터 벗어나지 않으면서 당업자에게 나타날 것이다. 본원에 기재된 본 발명의 구현예에 대한 다양한 대안이 본 발명의 실행에서 사용될 수 있음을 이해하여야 한다. 하기 청구범위가 본 발명의 범위를 정의하고, 이로써 이들 청구범위의 범위 내의 방법 및 구조 및 그의 등가물이 포함됨이 의도된다.
<110> WUHAN NEUROPHTH BIOLOGICAL TECHNOLOGY LIMITED COMPANY
<120> COMPOSITIONS AND METHODS FOR TREATING LEBER'S HEREDITARY OPTIC
NEUROPATHY
<130> WNBT-002/03WO 336356-2007
<150> PCT/CN2019/070461
<151> 2019-01-04
<150> PCT/CN2018/113799
<151> 2018-11-30
<150> PCT/CN2018/118662
<151> 2018-11-02
<150> CN 201811230856.2
<151> 2018-10-22
<150> CN 201811221305.X
<151> 2018-10-19
<150> PCT/CN2018/103937
<151> 2018-09-04
<150> CN 201810948193.1
<151> 2018-08-20
<150> PCT/CN2018/095023
<151> 2018-07-09
<150> CN 201810703168.7
<151> 2018-06-29
<150> CN 201810702492.7
<151> 2018-06-29
<160> 162
<170> KoPatentIn 3.0
<210> 1
<211> 84
<212> DNA
<213> Homo sapiens
<400> 1
atggccgcat ctccgcacac tctctcctca cgcctcctga caggttgcgt aggaggctct 60
gtctggtatc ttgaaagaag aact 84
<210> 2
<211> 84
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10
<400> 2
atggccgcct ctccacacac actgagtagc agactgctga ccggctgtgt tggcggctct 60
gtgtggtatc tggaacggcg gaca 84
<210> 3
<211> 84
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10*
<400> 3
atggccgcca gcccccacac cctgagcagc cgcctgctga ccggctgcgt gggcggcagc 60
gtgtggtacc tggagcgccg cacc 84
<210> 4
<211> 87
<212> DNA
<213> Artificial Sequence
<220>
<223> COX8
<400> 4
atgtccgtcc tgacgcgcct gctgctgcgg ggcttgacac ggctcggctc ggcggctcca 60
gtgcggcgcg ccagaatcca ttcgttg 87
<210> 5
<211> 266
<212> DNA
<213> Homo sapiens
<400> 5
gtgctgcccg cctagaaagg gtgaagtggt tgtttccgtg acggactgag tacgggtgcc 60
tgtcaggctc ttgcggaagt ccatgcgcca ttgggagggc ctcggccgcg gctctgtgcc 120
cttgctgctg agggccactt cctgggtcat tcctggaccg ggagccgggc tggggctcac 180
acgggggctc ccgcgtggcc gtctcggcgc ctgcgtgacc tccccgccgg cgggatgtgg 240
cgactacgtc gggccgctgt ggcctg 266
<210> 6
<211> 1380
<212> DNA
<213> Homo sapiens
<400> 6
atgctaaaac taatcgtccc aacaattatg ttactaccac tgacatggct ttccaaaaaa 60
cacatgattt ggatcaacac aaccacccac agcctaatta ttagcatcat ccctctacta 120
ttttttaacc aaatcaacaa caacctattt agctgttccc caaccttttc ctccgacccc 180
ctaacaaccc ccctcctaat gctaactacc tggctcctac ccctcacaat catggcaagc 240
caacgccact tatccagtga accactatca cgaaaaaaac tctacctctc tatgctaatc 300
tccctacaaa tctccttaat tatgacattc acagccacag aactaatcat gttttatatc 360
ttcttcgaaa ccacacttat ccccaccttg gctatcatca cccgatgggg caaccagcca 420
gaacgcctga acgcaggcac atacttccta ttctacaccc tagtaggctc ccttccccta 480
ctcatcgcac taatttacac tcacaacacc ctaggctcac taaacattct actactcact 540
ctcactgccc aagaactatc aaactcctgg gccaacaact taatgtggct agcttacaca 600
atggctttta tggtaaagat gcctctttac ggactccact tatggctccc taaagcccat 660
gtcgaagccc ccatcgctgg gtcaatggta cttgccgcag tactcttaaa actaggcggc 720
tatggtatga tgcgcctcac actcattctc aaccccctga caaaacacat ggcctacccc 780
ttccttgtac tatccctatg gggcatgatt atgacaagct ccatctgcct acgacaaaca 840
gacctaaaat cgctcattgc atactcttca atcagccaca tggccctcgt agtaacagcc 900
attctcatcc aaaccccctg gagcttcacc ggcgcagtca ttctcatgat cgcccacggg 960
cttacatcct cattactatt ctgcctagca aactcaaact acgaacgcac tcacagtcgc 1020
atcatgatcc tctctcaagg acttcaaact ctactcccac taatggcttt ttggtggctt 1080
ctagcaagcc tcgctaacct cgccttaccc cccactatta acctactggg agaactctct 1140
gtgctagtaa ccacgttctc ctggtcaaat atcactctcc tacttacagg actcaacatg 1200
ctagtcacag ccctatactc cctctacatg tttaccacaa cacaatgggg ctcactcacc 1260
caccacatta acaacatgaa accctcattc acacgagaaa acaccctcat gttcatgcac 1320
ctatccccca ttctcctcct atccctcaac cccgacatca ttaccgggtt ttcctcttaa 1380
1380
<210> 7
<211> 1380
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_ND4
<400> 7
atgctgaagc tgatcgtgcc caccatcatg ctgctgcctc tgacctggct gagcaagaaa 60
cacatgatct ggatcaacac caccacgcac agcctgatca tcagcatcat ccctctgctg 120
ttcttcaacc agatcaacaa caacctgttc agctgcagcc ccaccttcag cagcgaccct 180
ctgacaacac ctctgctgat gctgaccacc tggctgctgc ccctcacaat catggcctct 240
cagagacacc tgagcagcga gcccctgagc cggaagaaac tgtacctgag catgctgatc 300
tccctgcaga tctctctgat catgaccttc accgccaccg agctgatcat gttctacatc 360
tttttcgaga caacgctgat ccccacactg gccatcatca ccagatgggg caaccagcct 420
gagagactga acgccggcac ctactttctg ttctacaccc tcgtgggcag cctgccactg 480
ctgattgccc tgatctacac ccacaacacc ctgggctccc tgaacatcct gctgctgaca 540
ctgacagccc aagagctgag caacagctgg gccaacaatc tgatgtggct ggcctacaca 600
atggccttca tggtcaagat gcccctgtac ggcctgcacc tgtggctgcc taaagctcat 660
gtggaagccc ctatcgccgg ctctatggtg ctggctgcag tgctgctgaa actcggcggc 720
tacggcatga tgcggctgac cctgattctg aatcccctga ccaagcacat ggcctatcca 780
tttctggtgc tgagcctgtg gggcatgatt atgaccagca gcatctgcct gcggcagacc 840
gatctgaagt ccctgatcgc ctacagctcc atcagccaca tggccctggt ggtcaccgcc 900
atcctgattc agaccccttg gagctttaca ggcgccgtga tcctgatgat tgcccacggc 960
ctgacaagca gcctgctgtt ttgtctggcc aacagcaact acgagcggac ccacagcaga 1020
atcatgatcc tgtctcaggg cctgcagacc ctcctgcctc ttatggcttt ttggtggctg 1080
ctggcctctc tggccaatct ggcactgcct cctaccatca atctgctggg cgagctgagc 1140
gtgctggtca ccacattcag ctggtccaat atcaccctgc tgctcaccgg cctgaacatg 1200
ctggttacag ccctgtactc cctgtacatg ttcaccacca cacagtgggg aagcctgaca 1260
caccacatca acaatatgaa gcccagcttc acccgcgaga acaccctgat gttcatgcat 1320
ctgagcccca ttctgctgct gtccctgaat cctgatatca tcaccggctt ctccagctga 1380
1380
<210> 8
<211> 1380
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_ND4*
<400> 8
atgctgaagc tgatcgtgcc caccatcatg ctgctgcccc tgacctggct gagcaagaag 60
cacatgatct ggatcaacac caccacccac agcctgatca tcagcatcat ccccctgctg 120
ttcttcaacc agatcaacaa caacctgttc agctgcagcc ccaccttcag cagcgacccc 180
ctgaccaccc ccctgctgat gctgaccacc tggctgctgc ccctgaccat catggccagc 240
cagcgccacc tgagcagcga gcccctgagc cgcaagaagc tgtacctgag catgctgatc 300
agcctgcaga tcagcctgat catgaccttc accgccaccg agctgatcat gttctacatc 360
ttcttcgaga ccaccctgat ccccaccctg gccatcatca cccgctgggg caaccagccc 420
gagcgcctga acgccggcac ctacttcctg ttctacaccc tggtgggcag cctgcccctg 480
ctgatcgccc tgatctacac ccacaacacc ctgggcagcc tgaacatcct gctgctgacc 540
ctgaccgccc aggagctgag caacagctgg gccaacaacc tgatgtggct ggcctacacc 600
atggccttca tggtgaagat gcccctgtac ggcctgcacc tgtggctgcc caaggcccac 660
gtggaggccc ccatcgccgg cagcatggtg ctggccgccg tgctgctgaa gctgggcggc 720
tacggcatga tgcgcctgac cctgatcctg aaccccctga ccaagcacat ggcctacccc 780
ttcctggtgc tgagcctgtg gggcatgatc atgaccagca gcatctgcct gcgccagacc 840
gacctgaaga gcctgatcgc ctacagcagc atcagccaca tggccctggt ggtgaccgcc 900
atcctgatcc agaccccctg gagcttcacc ggcgccgtga tcctgatgat cgcccacggc 960
ctgaccagca gcctgctgtt ctgcctggcc aacagcaact acgagcgcac ccacagccgc 1020
atcatgatcc tgagccaggg cctgcagacc ctgctgcccc tgatggcctt ctggtggctg 1080
ctggccagcc tggccaacct ggccctgccc cccaccatca acctgctggg cgagctgagc 1140
gtgctggtga ccaccttcag ctggagcaac atcaccctgc tgctgaccgg cctgaacatg 1200
ctggtgaccg ccctgtacag cctgtacatg ttcaccacca cccagtgggg cagcctgacc 1260
caccacatca acaacatgaa gcccagcttc acccgcgaga acaccctgat gttcatgcac 1320
ctgagcccca tcctgctgct gagcctgaac cccgacatca tcaccggctt cagcagctaa 1380
1380
<210> 9
<211> 525
<212> DNA
<213> Homo sapiens
<400> 9
atgatgtatg ctttgtttct gttgagtgtg ggtttagtaa tggggtttgt ggggttttct 60
tctaagcctt ctcctattta tgggggttta gtattgattg ttagcggtgt ggtcgggtgt 120
gttattattc tgaattttgg gggaggttat atgggtttaa tggttttttt aatttattta 180
gggggaatga tggttgtctt tggatatact acagcgatgg ctattgagga gtatcctgag 240
gcatgggggt caggggttga ggtcttggtg agtgttttag tggggttagc gatggaggta 300
ggattggtgc tgtgggtgaa agagtatgat ggggtggtgg ttgtggtaaa ctttaatagt 360
gtaggaagct ggatgattta tgaaggagag gggtcagggt tgattcggga ggatcctatt 420
ggtgcggggg ctttgtatga ttatgggcgt tggttagtag tagttactgg ttggacattg 480
tttgttggtg tatatattgt aattgagatt gctcggggga attag 525
<210> 10
<211> 525
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_ND6
<400> 10
atgatgtacg ccctgttcct gctgagcgtg ggcctggtga tgggcttcgt gggcttcagc 60
agcaagccca gccccatcta cggcggcctg gtgctgatcg tgagcggcgt ggtgggctgc 120
gtgatcatcc tgaacttcgg cggcggctac atgggcctga tggtgttcct gatctacctg 180
ggcggcatga tggtggtgtt cggctacacc accgccatgg ccatcgagga gtaccccgag 240
gcctggggca gcggcgtgga ggtgctggtg agcgtgctgg tgggcctggc catggaggtg 300
ggcctggtgc tgtgggtgaa ggagtacgac ggcgtggtgg tggtggtgaa cttcaacagc 360
gtgggcagct ggatgatcta cgagggcgag ggcagcggcc tgatccgcga ggaccccatc 420
ggcgccggcg ccctgtacga ctacggccgc tggctggtgg tggtgaccgg ctggaccctg 480
ttcgtgggcg tgtacatcgt gatcgagatc gcccgcggca actaa 525
<210> 11
<211> 951
<212> DNA
<213> Homo sapiens
<400> 11
atggccaacc tcctactcct cattgtaccc attctaatcg caatggcatt cctaatgctt 60
accgaacgaa aaattctagg ctatatgcaa ctacgcaaag gccccaacgt tgtaggcccc 120
tacgggctac tacaaccctt cgctgacgcc ataaaactct tcaccaaaga gcccctaaaa 180
cccgccacat ctaccatcac cctctacatc accgccccga ccttagctct caccatcgct 240
cttctactat ggacccccct ccccatgccc aaccccctgg tcaacctcaa cctaggcctc 300
ctatttattc tagccacctc tagcctagcc gtttactcaa tcctctggtc agggtgggca 360
tcaaactcaa actacgccct gatcggcgca ctgcgagcag tagcccaaac aatctcatat 420
gaagtcaccc tagccatcat tctactatca acattactaa tgagtggctc ctttaacctc 480
tccaccctta tcacaacaca agaacacctc tggttactcc tgccatcatg gcccttggcc 540
atgatgtggt ttatctccac actagcagag accaaccgaa cccccttcga ccttgccgaa 600
ggggagtccg aactagtctc aggcttcaac atcgaatacg ccgcaggccc cttcgcccta 660
ttcttcatgg ccgaatacac aaacattatt atgatgaaca ccctcaccac tacaatcttc 720
ctaggaacaa catatgacgc actctcccct gaactctaca caacatattt tgtcaccaag 780
accctacttc taacctccct gttcttatgg attcgaacag catacccccg attccgctac 840
gaccaactca tgcacctcct atggaaaaac ttcctaccac tcaccctagc attacttatg 900
tggtatgtct ccatgcccat tacaatctcc agcattcccc ctcaaaccta a 951
<210> 12
<211> 951
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_ND1
<400> 12
atggccaacc tgctgctgct gatcgtgccc atcctgatcg ccatggcctt cctgatgctg 60
accgagcgca agatcctggg ctacatgcag ctgcgcaagg gccccaacgt ggtgggcccc 120
tacggcctgc tgcagccctt cgccgacgcc atcaagctgt tcaccaagga gcccctgaag 180
cccgccacca gcaccatcac cctgtacatc accgccccca ccctggccct gaccatcgcc 240
ctgctgctgt ggacccccct gcccatgccc aaccccctgg tgaacctgaa cctgggcctg 300
ctgttcatcc tggccaccag cagcctggcc gtgtacagca tcctgtggag cggctgggcc 360
agcaacagca actacgccct gatcggcgcc ctgcgcgccg tggcccagac catcagctac 420
gaggtgaccc tggccatcat cctgctgagc accctgctga tgagcggcag cttcaacctg 480
agcaccctga tcaccaccca ggagcacctg tggctgctgc tgcccagctg gcccctggcc 540
atgatgtggt tcatcagcac cctggccgag accaaccgca cccccttcga cctggccgag 600
ggcgagagcg agctggtgag cggcttcaac atcgagtacg ccgccggccc cttcgccctg 660
ttcttcatgg ccgagtacac caacatcatc atgatgaaca ccctgaccac caccatcttc 720
ctgggcacca cctacgacgc cctgagcccc gagctgtaca ccacctactt cgtgaccaag 780
accctgctgc tgaccagcct gttcctgtgg atccgcaccg cctacccccg cttccgctac 840
gaccagctga tgcacctgct gtggaagaac ttcctgcccc tgaccctggc cctgctgatg 900
tggtacgtga gcatgcccat caccatcagc agcatccccc cccagaccta a 951
<210> 13
<211> 1425
<212> DNA
<213> Homo sapiens
<400> 13
gagcactggg acgcccaccg cccctttccc tccgctgcca ggcgagcatg ttgtggtaat 60
tctggaacac aagaagagaa attgctgggt ttagaacaag attataaacg aattcggtgc 120
tcagtgatca cttgacagtt tttttttttt ttaaatatta cccaaaatgc tccccaaata 180
agaaatgcat cagctcagtc agtgaataca aaaaaggaat tatttttccc tttgagggtc 240
ttttatacat ctctcctcca accccaccct ctattctgtt tcttcctcct cacatggggg 300
tacacataca cagcttcctc ttttggttcc atccttacca ccacaccaca cgcacactcc 360
acatgcccag cagagtggca cttggtggcc agaaagtgtg agcctcatga tctgctgtct 420
gtagttctgt gagctcaggt ccctcaaagg cctcggagca cccccttcct tgtgactgag 480
ccagggcctg catttttggt tttccccacc ccacacattc tcaaccatag tccttctaac 540
aataccaata gctaggaccc ggctgctgtg cactgggact ggggattcca catgtttgcc 600
ttgggagtct caagctggac tgccagcccc tgtcctccct tcacccccat tgcgtatgag 660
catttcagaa ctccaaggag tcacaggcat ctttatagtt cacgttaaca tatagacact 720
gttggaagca gttccttcta aaagggtagc cctggactta ataccagccg gatacctctg 780
gcccccaccc cattactgta cctctggagt cactactgtg ggtcgccact cctctgctac 840
acagcacggc tttttcaagg ctgtattgag aagggaagtt aggaagaagg gtgtgctggg 900
ctaaccagcc cacagagctc acattcctgt cccttgggtg aaaaatacat gtccatcctg 960
atatctcctg aattcagaaa ttagcctcca catgtgcaat ggctttaaga gccagaagca 1020
gggttctggg aattttgcaa gttacctgtg gccaggtgtg gtctcggtta ccaaatacgg 1080
ttacctgcag ctttttagtc ctttgtgctc ccacgggtct acagagtccc atctgcccaa 1140
aggtcttgaa gcttgacagg atgttttcga ttactcagtc tcccagggca ctactggtcc 1200
gtaggattcg attggtcggg gtaggagagt taaacaacat ttaaacagag ttctctcaaa 1260
aatgtctaaa gggattgtag gtagataaca tccaatcact gtttgcactt atctgaaatc 1320
ttccctcttg gctgccccca ggtatttact gtggagaaca ttgcatagga atgtctggaa 1380
aaagcttcta caacttgtta cagccttcac atttgtagaa gcttt 1425
<210> 14
<211> 625
<212> DNA
<213> Homo sapiens
<400> 14
gagcactggg acgcccaccg cccctttccc tccgctgcca ggcgagcatg ttgtggtaat 60
tctggaacac aagaagagaa attgctgggt ttagaacaag attataaacg aattcggtgc 120
tcagtgatca cttgacagtt tttttttttt ttaaatatta cccaaaatgc tccccaaata 180
agaaatgcat cagctcagtc agtgaataca aaaaaggaat tatttttccc tttgagggtc 240
ttttatacat ctctcctcca accccaccct ctattctgtt tcttcctcct cacatggggg 300
tacacataca cagcttcctc ttttggttcc atccttacca ccacaccaca cgcacactcc 360
acatgcccag cagagtggca cttggtggcc agaaagtgtg agcctcatga tctgctgtct 420
gtagttctgt gagctcaggt ccctcaaagg cctcggagca cccccttcct tgtgactgag 480
ccagggcctg catttttggt tttccccacc ccacacattc tcaaccatag tccttctaac 540
aataccaata gctaggaccc ggctgctgtg cactgggact ggggattcca catgtttgcc 600
ttgggagtct caagctggac tgcca 625
<210> 15
<211> 2889
<212> DNA
<213> Artificial Sequence
<220>
<223> COX10-ND4-3'UTR
<400> 15
atggccgcat ctccgcacac tctctcctca cgcctcctga caggttgcgt aggaggctct 60
gtctggtatc ttgaaagaag aactatgcta aaactaatcg tcccaacaat tatgttacta 120
ccactgacat ggctttccaa aaaacacatg atttggatca acacaaccac ccacagccta 180
attattagca tcatccctct actatttttt aaccaaatca acaacaacct atttagctgt 240
tccccaacct tttcctccga ccccctaaca acccccctcc taatgctaac tacctggctc 300
ctacccctca caatcatggc aagccaacgc cacttatcca gtgaaccact atcacgaaaa 360
aaactctacc tctctatgct aatctcccta caaatctcct taattatgac attcacagcc 420
acagaactaa tcatgtttta tatcttcttc gaaaccacac ttatccccac cttggctatc 480
atcacccgat ggggcaacca gccagaacgc ctgaacgcag gcacatactt cctattctac 540
accctagtag gctcccttcc cctactcatc gcactaattt acactcacaa caccctaggc 600
tcactaaaca ttctactact cactctcact gcccaagaac tatcaaactc ctgggccaac 660
aacttaatgt ggctagctta cacaatggct tttatggtaa agatgcctct ttacggactc 720
cacttatggc tccctaaagc ccatgtcgaa gcccccatcg ctgggtcaat ggtacttgcc 780
gcagtactct taaaactagg cggctatggt atgatgcgcc tcacactcat tctcaacccc 840
ctgacaaaac acatggccta ccccttcctt gtactatccc tatggggcat gattatgaca 900
agctccatct gcctacgaca aacagaccta aaatcgctca ttgcatactc ttcaatcagc 960
cacatggccc tcgtagtaac agccattctc atccaaaccc cctggagctt caccggcgca 1020
gtcattctca tgatcgccca cgggcttaca tcctcattac tattctgcct agcaaactca 1080
aactacgaac gcactcacag tcgcatcatg atcctctctc aaggacttca aactctactc 1140
ccactaatgg ctttttggtg gcttctagca agcctcgcta acctcgcctt accccccact 1200
attaacctac tgggagaact ctctgtgcta gtaaccacgt tctcctggtc aaatatcact 1260
ctcctactta caggactcaa catgctagtc acagccctat actccctcta catgtttacc 1320
acaacacaat ggggctcact cacccaccac attaacaaca tgaaaccctc attcacacga 1380
gaaaacaccc tcatgttcat gcacctatcc cccattctcc tcctatccct caaccccgac 1440
atcattaccg ggttttcctc ttaagagcac tgggacgccc accgcccctt tccctccgct 1500
gccaggcgag catgttgtgg taattctgga acacaagaag agaaattgct gggtttagaa 1560
caagattata aacgaattcg gtgctcagtg atcacttgac agtttttttt ttttttaaat 1620
attacccaaa atgctcccca aataagaaat gcatcagctc agtcagtgaa tacaaaaaag 1680
gaattatttt tccctttgag ggtcttttat acatctctcc tccaacccca ccctctattc 1740
tgtttcttcc tcctcacatg ggggtacaca tacacagctt cctcttttgg ttccatcctt 1800
accaccacac cacacgcaca ctccacatgc ccagcagagt ggcacttggt ggccagaaag 1860
tgtgagcctc atgatctgct gtctgtagtt ctgtgagctc aggtccctca aaggcctcgg 1920
agcaccccct tccttgtgac tgagccaggg cctgcatttt tggttttccc caccccacac 1980
attctcaacc atagtccttc taacaatacc aatagctagg acccggctgc tgtgcactgg 2040
gactggggat tccacatgtt tgccttggga gtctcaagct ggactgccag cccctgtcct 2100
cccttcaccc ccattgcgta tgagcatttc agaactccaa ggagtcacag gcatctttat 2160
agttcacgtt aacatataga cactgttgga agcagttcct tctaaaaggg tagccctgga 2220
cttaatacca gccggatacc tctggccccc accccattac tgtacctctg gagtcactac 2280
tgtgggtcgc cactcctctg ctacacagca cggctttttc aaggctgtat tgagaaggga 2340
agttaggaag aagggtgtgc tgggctaacc agcccacaga gctcacattc ctgtcccttg 2400
ggtgaaaaat acatgtccat cctgatatct cctgaattca gaaattagcc tccacatgtg 2460
caatggcttt aagagccaga agcagggttc tgggaatttt gcaagttacc tgtggccagg 2520
tgtggtctcg gttaccaaat acggttacct gcagcttttt agtcctttgt gctcccacgg 2580
gtctacagag tcccatctgc ccaaaggtct tgaagcttga caggatgttt tcgattactc 2640
agtctcccag ggcactactg gtccgtagga ttcgattggt cggggtagga gagttaaaca 2700
acatttaaac agagttctct caaaaatgtc taaagggatt gtaggtagat aacatccaat 2760
cactgtttgc acttatctga aatcttccct cttggctgcc cccaggtatt tactgtggag 2820
aacattgcat aggaatgtct ggaaaaagct tctacaactt gttacagcct tcacatttgt 2880
agaagcttt 2889
<210> 16
<211> 2089
<212> DNA
<213> Artificial Sequence
<220>
<223> COX10-ND4-3'UTR*
<400> 16
atggccgcat ctccgcacac tctctcctca cgcctcctga caggttgcgt aggaggctct 60
gtctggtatc ttgaaagaag aactatgcta aaactaatcg tcccaacaat tatgttacta 120
ccactgacat ggctttccaa aaaacacatg atttggatca acacaaccac ccacagccta 180
attattagca tcatccctct actatttttt aaccaaatca acaacaacct atttagctgt 240
tccccaacct tttcctccga ccccctaaca acccccctcc taatgctaac tacctggctc 300
ctacccctca caatcatggc aagccaacgc cacttatcca gtgaaccact atcacgaaaa 360
aaactctacc tctctatgct aatctcccta caaatctcct taattatgac attcacagcc 420
acagaactaa tcatgtttta tatcttcttc gaaaccacac ttatccccac cttggctatc 480
atcacccgat ggggcaacca gccagaacgc ctgaacgcag gcacatactt cctattctac 540
accctagtag gctcccttcc cctactcatc gcactaattt acactcacaa caccctaggc 600
tcactaaaca ttctactact cactctcact gcccaagaac tatcaaactc ctgggccaac 660
aacttaatgt ggctagctta cacaatggct tttatggtaa agatgcctct ttacggactc 720
cacttatggc tccctaaagc ccatgtcgaa gcccccatcg ctgggtcaat ggtacttgcc 780
gcagtactct taaaactagg cggctatggt atgatgcgcc tcacactcat tctcaacccc 840
ctgacaaaac acatggccta ccccttcctt gtactatccc tatggggcat gattatgaca 900
agctccatct gcctacgaca aacagaccta aaatcgctca ttgcatactc ttcaatcagc 960
cacatggccc tcgtagtaac agccattctc atccaaaccc cctggagctt caccggcgca 1020
gtcattctca tgatcgccca cgggcttaca tcctcattac tattctgcct agcaaactca 1080
aactacgaac gcactcacag tcgcatcatg atcctctctc aaggacttca aactctactc 1140
ccactaatgg ctttttggtg gcttctagca agcctcgcta acctcgcctt accccccact 1200
attaacctac tgggagaact ctctgtgcta gtaaccacgt tctcctggtc aaatatcact 1260
ctcctactta caggactcaa catgctagtc acagccctat actccctcta catgtttacc 1320
acaacacaat ggggctcact cacccaccac attaacaaca tgaaaccctc attcacacga 1380
gaaaacaccc tcatgttcat gcacctatcc cccattctcc tcctatccct caaccccgac 1440
atcattaccg ggttttcctc ttaagagcac tgggacgccc accgcccctt tccctccgct 1500
gccaggcgag catgttgtgg taattctgga acacaagaag agaaattgct gggtttagaa 1560
caagattata aacgaattcg gtgctcagtg atcacttgac agtttttttt ttttttaaat 1620
attacccaaa atgctcccca aataagaaat gcatcagctc agtcagtgaa tacaaaaaag 1680
gaattatttt tccctttgag ggtcttttat acatctctcc tccaacccca ccctctattc 1740
tgtttcttcc tcctcacatg ggggtacaca tacacagctt cctcttttgg ttccatcctt 1800
accaccacac cacacgcaca ctccacatgc ccagcagagt ggcacttggt ggccagaaag 1860
tgtgagcctc atgatctgct gtctgtagtt ctgtgagctc aggtccctca aaggcctcgg 1920
agcaccccct tccttgtgac tgagccaggg cctgcatttt tggttttccc caccccacac 1980
attctcaacc atagtccttc taacaatacc aatagctagg acccggctgc tgtgcactgg 2040
gactggggat tccacatgtt tgccttggga gtctcaagct ggactgcca 2089
<210> 17
<211> 2889
<212> DNA
<213> Artificial Sequence
<220>
<223> COX10-opt_ND4-3'UTR
<400> 17
atggccgcat ctccgcacac tctctcctca cgcctcctga caggttgcgt aggaggctct 60
gtctggtatc ttgaaagaag aactatgctg aagctgatcg tgcccaccat catgctgctg 120
cctctgacct ggctgagcaa gaaacacatg atctggatca acaccaccac gcacagcctg 180
atcatcagca tcatccctct gctgttcttc aaccagatca acaacaacct gttcagctgc 240
agccccacct tcagcagcga ccctctgaca acacctctgc tgatgctgac cacctggctg 300
ctgcccctca caatcatggc ctctcagaga cacctgagca gcgagcccct gagccggaag 360
aaactgtacc tgagcatgct gatctccctg cagatctctc tgatcatgac cttcaccgcc 420
accgagctga tcatgttcta catctttttc gagacaacgc tgatccccac actggccatc 480
atcaccagat ggggcaacca gcctgagaga ctgaacgccg gcacctactt tctgttctac 540
accctcgtgg gcagcctgcc actgctgatt gccctgatct acacccacaa caccctgggc 600
tccctgaaca tcctgctgct gacactgaca gcccaagagc tgagcaacag ctgggccaac 660
aatctgatgt ggctggccta cacaatggcc ttcatggtca agatgcccct gtacggcctg 720
cacctgtggc tgcctaaagc tcatgtggaa gcccctatcg ccggctctat ggtgctggct 780
gcagtgctgc tgaaactcgg cggctacggc atgatgcggc tgaccctgat tctgaatccc 840
ctgaccaagc acatggccta tccatttctg gtgctgagcc tgtggggcat gattatgacc 900
agcagcatct gcctgcggca gaccgatctg aagtccctga tcgcctacag ctccatcagc 960
cacatggccc tggtggtcac cgccatcctg attcagaccc cttggagctt tacaggcgcc 1020
gtgatcctga tgattgccca cggcctgaca agcagcctgc tgttttgtct ggccaacagc 1080
aactacgagc ggacccacag cagaatcatg atcctgtctc agggcctgca gaccctcctg 1140
cctcttatgg ctttttggtg gctgctggcc tctctggcca atctggcact gcctcctacc 1200
atcaatctgc tgggcgagct gagcgtgctg gtcaccacat tcagctggtc caatatcacc 1260
ctgctgctca ccggcctgaa catgctggtt acagccctgt actccctgta catgttcacc 1320
accacacagt ggggaagcct gacacaccac atcaacaata tgaagcccag cttcacccgc 1380
gagaacaccc tgatgttcat gcatctgagc cccattctgc tgctgtccct gaatcctgat 1440
atcatcaccg gcttctccag ctgagagcac tgggacgccc accgcccctt tccctccgct 1500
gccaggcgag catgttgtgg taattctgga acacaagaag agaaattgct gggtttagaa 1560
caagattata aacgaattcg gtgctcagtg atcacttgac agtttttttt ttttttaaat 1620
attacccaaa atgctcccca aataagaaat gcatcagctc agtcagtgaa tacaaaaaag 1680
gaattatttt tccctttgag ggtcttttat acatctctcc tccaacccca ccctctattc 1740
tgtttcttcc tcctcacatg ggggtacaca tacacagctt cctcttttgg ttccatcctt 1800
accaccacac cacacgcaca ctccacatgc ccagcagagt ggcacttggt ggccagaaag 1860
tgtgagcctc atgatctgct gtctgtagtt ctgtgagctc aggtccctca aaggcctcgg 1920
agcaccccct tccttgtgac tgagccaggg cctgcatttt tggttttccc caccccacac 1980
attctcaacc atagtccttc taacaatacc aatagctagg acccggctgc tgtgcactgg 2040
gactggggat tccacatgtt tgccttggga gtctcaagct ggactgccag cccctgtcct 2100
cccttcaccc ccattgcgta tgagcatttc agaactccaa ggagtcacag gcatctttat 2160
agttcacgtt aacatataga cactgttgga agcagttcct tctaaaaggg tagccctgga 2220
cttaatacca gccggatacc tctggccccc accccattac tgtacctctg gagtcactac 2280
tgtgggtcgc cactcctctg ctacacagca cggctttttc aaggctgtat tgagaaggga 2340
agttaggaag aagggtgtgc tgggctaacc agcccacaga gctcacattc ctgtcccttg 2400
ggtgaaaaat acatgtccat cctgatatct cctgaattca gaaattagcc tccacatgtg 2460
caatggcttt aagagccaga agcagggttc tgggaatttt gcaagttacc tgtggccagg 2520
tgtggtctcg gttaccaaat acggttacct gcagcttttt agtcctttgt gctcccacgg 2580
gtctacagag tcccatctgc ccaaaggtct tgaagcttga caggatgttt tcgattactc 2640
agtctcccag ggcactactg gtccgtagga ttcgattggt cggggtagga gagttaaaca 2700
acatttaaac agagttctct caaaaatgtc taaagggatt gtaggtagat aacatccaat 2760
cactgtttgc acttatctga aatcttccct cttggctgcc cccaggtatt tactgtggag 2820
aacattgcat aggaatgtct ggaaaaagct tctacaactt gttacagcct tcacatttgt 2880
agaagcttt 2889
<210> 18
<211> 2089
<212> DNA
<213> Artificial Sequence
<220>
<223> COX10-opt_ND4-3'UTR*
<400> 18
atggccgcat ctccgcacac tctctcctca cgcctcctga caggttgcgt aggaggctct 60
gtctggtatc ttgaaagaag aactatgctg aagctgatcg tgcccaccat catgctgctg 120
cctctgacct ggctgagcaa gaaacacatg atctggatca acaccaccac gcacagcctg 180
atcatcagca tcatccctct gctgttcttc aaccagatca acaacaacct gttcagctgc 240
agccccacct tcagcagcga ccctctgaca acacctctgc tgatgctgac cacctggctg 300
ctgcccctca caatcatggc ctctcagaga cacctgagca gcgagcccct gagccggaag 360
aaactgtacc tgagcatgct gatctccctg cagatctctc tgatcatgac cttcaccgcc 420
accgagctga tcatgttcta catctttttc gagacaacgc tgatccccac actggccatc 480
atcaccagat ggggcaacca gcctgagaga ctgaacgccg gcacctactt tctgttctac 540
accctcgtgg gcagcctgcc actgctgatt gccctgatct acacccacaa caccctgggc 600
tccctgaaca tcctgctgct gacactgaca gcccaagagc tgagcaacag ctgggccaac 660
aatctgatgt ggctggccta cacaatggcc ttcatggtca agatgcccct gtacggcctg 720
cacctgtggc tgcctaaagc tcatgtggaa gcccctatcg ccggctctat ggtgctggct 780
gcagtgctgc tgaaactcgg cggctacggc atgatgcggc tgaccctgat tctgaatccc 840
ctgaccaagc acatggccta tccatttctg gtgctgagcc tgtggggcat gattatgacc 900
agcagcatct gcctgcggca gaccgatctg aagtccctga tcgcctacag ctccatcagc 960
cacatggccc tggtggtcac cgccatcctg attcagaccc cttggagctt tacaggcgcc 1020
gtgatcctga tgattgccca cggcctgaca agcagcctgc tgttttgtct ggccaacagc 1080
aactacgagc ggacccacag cagaatcatg atcctgtctc agggcctgca gaccctcctg 1140
cctcttatgg ctttttggtg gctgctggcc tctctggcca atctggcact gcctcctacc 1200
atcaatctgc tgggcgagct gagcgtgctg gtcaccacat tcagctggtc caatatcacc 1260
ctgctgctca ccggcctgaa catgctggtt acagccctgt actccctgta catgttcacc 1320
accacacagt ggggaagcct gacacaccac atcaacaata tgaagcccag cttcacccgc 1380
gagaacaccc tgatgttcat gcatctgagc cccattctgc tgctgtccct gaatcctgat 1440
atcatcaccg gcttctccag ctgagagcac tgggacgccc accgcccctt tccctccgct 1500
gccaggcgag catgttgtgg taattctgga acacaagaag agaaattgct gggtttagaa 1560
caagattata aacgaattcg gtgctcagtg atcacttgac agtttttttt ttttttaaat 1620
attacccaaa atgctcccca aataagaaat gcatcagctc agtcagtgaa tacaaaaaag 1680
gaattatttt tccctttgag ggtcttttat acatctctcc tccaacccca ccctctattc 1740
tgtttcttcc tcctcacatg ggggtacaca tacacagctt cctcttttgg ttccatcctt 1800
accaccacac cacacgcaca ctccacatgc ccagcagagt ggcacttggt ggccagaaag 1860
tgtgagcctc atgatctgct gtctgtagtt ctgtgagctc aggtccctca aaggcctcgg 1920
agcaccccct tccttgtgac tgagccaggg cctgcatttt tggttttccc caccccacac 1980
attctcaacc atagtccttc taacaatacc aatagctagg acccggctgc tgtgcactgg 2040
gactggggat tccacatgtt tgccttggga gtctcaagct ggactgcca 2089
<210> 19
<211> 2889
<212> DNA
<213> Artificial Sequence
<220>
<223> COX10-opt_ND4*-3'UTR
<400> 19
atggccgcat ctccgcacac tctctcctca cgcctcctga caggttgcgt aggaggctct 60
gtctggtatc ttgaaagaag aactatgctg aagctgatcg tgcccaccat catgctgctg 120
cccctgacct ggctgagcaa gaagcacatg atctggatca acaccaccac ccacagcctg 180
atcatcagca tcatccccct gctgttcttc aaccagatca acaacaacct gttcagctgc 240
agccccacct tcagcagcga ccccctgacc acccccctgc tgatgctgac cacctggctg 300
ctgcccctga ccatcatggc cagccagcgc cacctgagca gcgagcccct gagccgcaag 360
aagctgtacc tgagcatgct gatcagcctg cagatcagcc tgatcatgac cttcaccgcc 420
accgagctga tcatgttcta catcttcttc gagaccaccc tgatccccac cctggccatc 480
atcacccgct ggggcaacca gcccgagcgc ctgaacgccg gcacctactt cctgttctac 540
accctggtgg gcagcctgcc cctgctgatc gccctgatct acacccacaa caccctgggc 600
agcctgaaca tcctgctgct gaccctgacc gcccaggagc tgagcaacag ctgggccaac 660
aacctgatgt ggctggccta caccatggcc ttcatggtga agatgcccct gtacggcctg 720
cacctgtggc tgcccaaggc ccacgtggag gcccccatcg ccggcagcat ggtgctggcc 780
gccgtgctgc tgaagctggg cggctacggc atgatgcgcc tgaccctgat cctgaacccc 840
ctgaccaagc acatggccta ccccttcctg gtgctgagcc tgtggggcat gatcatgacc 900
agcagcatct gcctgcgcca gaccgacctg aagagcctga tcgcctacag cagcatcagc 960
cacatggccc tggtggtgac cgccatcctg atccagaccc cctggagctt caccggcgcc 1020
gtgatcctga tgatcgccca cggcctgacc agcagcctgc tgttctgcct ggccaacagc 1080
aactacgagc gcacccacag ccgcatcatg atcctgagcc agggcctgca gaccctgctg 1140
cccctgatgg ccttctggtg gctgctggcc agcctggcca acctggccct gccccccacc 1200
atcaacctgc tgggcgagct gagcgtgctg gtgaccacct tcagctggag caacatcacc 1260
ctgctgctga ccggcctgaa catgctggtg accgccctgt acagcctgta catgttcacc 1320
accacccagt ggggcagcct gacccaccac atcaacaaca tgaagcccag cttcacccgc 1380
gagaacaccc tgatgttcat gcacctgagc cccatcctgc tgctgagcct gaaccccgac 1440
atcatcaccg gcttcagcag ctaagagcac tgggacgccc accgcccctt tccctccgct 1500
gccaggcgag catgttgtgg taattctgga acacaagaag agaaattgct gggtttagaa 1560
caagattata aacgaattcg gtgctcagtg atcacttgac agtttttttt ttttttaaat 1620
attacccaaa atgctcccca aataagaaat gcatcagctc agtcagtgaa tacaaaaaag 1680
gaattatttt tccctttgag ggtcttttat acatctctcc tccaacccca ccctctattc 1740
tgtttcttcc tcctcacatg ggggtacaca tacacagctt cctcttttgg ttccatcctt 1800
accaccacac cacacgcaca ctccacatgc ccagcagagt ggcacttggt ggccagaaag 1860
tgtgagcctc atgatctgct gtctgtagtt ctgtgagctc aggtccctca aaggcctcgg 1920
agcaccccct tccttgtgac tgagccaggg cctgcatttt tggttttccc caccccacac 1980
attctcaacc atagtccttc taacaatacc aatagctagg acccggctgc tgtgcactgg 2040
gactggggat tccacatgtt tgccttggga gtctcaagct ggactgccag cccctgtcct 2100
cccttcaccc ccattgcgta tgagcatttc agaactccaa ggagtcacag gcatctttat 2160
agttcacgtt aacatataga cactgttgga agcagttcct tctaaaaggg tagccctgga 2220
cttaatacca gccggatacc tctggccccc accccattac tgtacctctg gagtcactac 2280
tgtgggtcgc cactcctctg ctacacagca cggctttttc aaggctgtat tgagaaggga 2340
agttaggaag aagggtgtgc tgggctaacc agcccacaga gctcacattc ctgtcccttg 2400
ggtgaaaaat acatgtccat cctgatatct cctgaattca gaaattagcc tccacatgtg 2460
caatggcttt aagagccaga agcagggttc tgggaatttt gcaagttacc tgtggccagg 2520
tgtggtctcg gttaccaaat acggttacct gcagcttttt agtcctttgt gctcccacgg 2580
gtctacagag tcccatctgc ccaaaggtct tgaagcttga caggatgttt tcgattactc 2640
agtctcccag ggcactactg gtccgtagga ttcgattggt cggggtagga gagttaaaca 2700
acatttaaac agagttctct caaaaatgtc taaagggatt gtaggtagat aacatccaat 2760
cactgtttgc acttatctga aatcttccct cttggctgcc cccaggtatt tactgtggag 2820
aacattgcat aggaatgtct ggaaaaagct tctacaactt gttacagcct tcacatttgt 2880
agaagcttt 2889
<210> 20
<211> 2089
<212> DNA
<213> Artificial Sequence
<220>
<223> COX10-opt_ND4*-3'UTR*
<400> 20
atggccgcat ctccgcacac tctctcctca cgcctcctga caggttgcgt aggaggctct 60
gtctggtatc ttgaaagaag aactatgctg aagctgatcg tgcccaccat catgctgctg 120
cccctgacct ggctgagcaa gaagcacatg atctggatca acaccaccac ccacagcctg 180
atcatcagca tcatccccct gctgttcttc aaccagatca acaacaacct gttcagctgc 240
agccccacct tcagcagcga ccccctgacc acccccctgc tgatgctgac cacctggctg 300
ctgcccctga ccatcatggc cagccagcgc cacctgagca gcgagcccct gagccgcaag 360
aagctgtacc tgagcatgct gatcagcctg cagatcagcc tgatcatgac cttcaccgcc 420
accgagctga tcatgttcta catcttcttc gagaccaccc tgatccccac cctggccatc 480
atcacccgct ggggcaacca gcccgagcgc ctgaacgccg gcacctactt cctgttctac 540
accctggtgg gcagcctgcc cctgctgatc gccctgatct acacccacaa caccctgggc 600
agcctgaaca tcctgctgct gaccctgacc gcccaggagc tgagcaacag ctgggccaac 660
aacctgatgt ggctggccta caccatggcc ttcatggtga agatgcccct gtacggcctg 720
cacctgtggc tgcccaaggc ccacgtggag gcccccatcg ccggcagcat ggtgctggcc 780
gccgtgctgc tgaagctggg cggctacggc atgatgcgcc tgaccctgat cctgaacccc 840
ctgaccaagc acatggccta ccccttcctg gtgctgagcc tgtggggcat gatcatgacc 900
agcagcatct gcctgcgcca gaccgacctg aagagcctga tcgcctacag cagcatcagc 960
cacatggccc tggtggtgac cgccatcctg atccagaccc cctggagctt caccggcgcc 1020
gtgatcctga tgatcgccca cggcctgacc agcagcctgc tgttctgcct ggccaacagc 1080
aactacgagc gcacccacag ccgcatcatg atcctgagcc agggcctgca gaccctgctg 1140
cccctgatgg ccttctggtg gctgctggcc agcctggcca acctggccct gccccccacc 1200
atcaacctgc tgggcgagct gagcgtgctg gtgaccacct tcagctggag caacatcacc 1260
ctgctgctga ccggcctgaa catgctggtg accgccctgt acagcctgta catgttcacc 1320
accacccagt ggggcagcct gacccaccac atcaacaaca tgaagcccag cttcacccgc 1380
gagaacaccc tgatgttcat gcacctgagc cccatcctgc tgctgagcct gaaccccgac 1440
atcatcaccg gcttcagcag ctaagagcac tgggacgccc accgcccctt tccctccgct 1500
gccaggcgag catgttgtgg taattctgga acacaagaag agaaattgct gggtttagaa 1560
caagattata aacgaattcg gtgctcagtg atcacttgac agtttttttt ttttttaaat 1620
attacccaaa atgctcccca aataagaaat gcatcagctc agtcagtgaa tacaaaaaag 1680
gaattatttt tccctttgag ggtcttttat acatctctcc tccaacccca ccctctattc 1740
tgtttcttcc tcctcacatg ggggtacaca tacacagctt cctcttttgg ttccatcctt 1800
accaccacac cacacgcaca ctccacatgc ccagcagagt ggcacttggt ggccagaaag 1860
tgtgagcctc atgatctgct gtctgtagtt ctgtgagctc aggtccctca aaggcctcgg 1920
agcaccccct tccttgtgac tgagccaggg cctgcatttt tggttttccc caccccacac 1980
attctcaacc atagtccttc taacaatacc aatagctagg acccggctgc tgtgcactgg 2040
gactggggat tccacatgtt tgccttggga gtctcaagct ggactgcca 2089
<210> 21
<211> 2034
<212> DNA
<213> Artificial Sequence
<220>
<223> COX10-ND6-3'UTR
<400> 21
atggccgcat ctccgcacac tctctcctca cgcctcctga caggttgcgt aggaggctct 60
gtctggtatc ttgaaagaag aactatgatg tatgctttgt ttctgttgag tgtgggttta 120
gtaatggggt ttgtggggtt ttcttctaag ccttctccta tttatggggg tttagtattg 180
attgttagcg gtgtggtcgg gtgtgttatt attctgaatt ttgggggagg ttatatgggt 240
ttaatggttt ttttaattta tttaggggga atgatggttg tctttggata tactacagcg 300
atggctattg aggagtatcc tgaggcatgg gggtcagggg ttgaggtctt ggtgagtgtt 360
ttagtggggt tagcgatgga ggtaggattg gtgctgtggg tgaaagagta tgatggggtg 420
gtggttgtgg taaactttaa tagtgtagga agctggatga tttatgaagg agaggggtca 480
gggttgattc gggaggatcc tattggtgcg ggggctttgt atgattatgg gcgttggtta 540
gtagtagtta ctggttggac attgtttgtt ggtgtatata ttgtaattga gattgctcgg 600
gggaattagg agcactggga cgcccaccgc ccctttccct ccgctgccag gcgagcatgt 660
tgtggtaatt ctggaacaca agaagagaaa ttgctgggtt tagaacaaga ttataaacga 720
attcggtgct cagtgatcac ttgacagttt tttttttttt taaatattac ccaaaatgct 780
ccccaaataa gaaatgcatc agctcagtca gtgaatacaa aaaaggaatt atttttccct 840
ttgagggtct tttatacatc tctcctccaa ccccaccctc tattctgttt cttcctcctc 900
acatgggggt acacatacac agcttcctct tttggttcca tccttaccac cacaccacac 960
gcacactcca catgcccagc agagtggcac ttggtggcca gaaagtgtga gcctcatgat 1020
ctgctgtctg tagttctgtg agctcaggtc cctcaaaggc ctcggagcac ccccttcctt 1080
gtgactgagc cagggcctgc atttttggtt ttccccaccc cacacattct caaccatagt 1140
ccttctaaca ataccaatag ctaggacccg gctgctgtgc actgggactg gggattccac 1200
atgtttgcct tgggagtctc aagctggact gccagcccct gtcctccctt cacccccatt 1260
gcgtatgagc atttcagaac tccaaggagt cacaggcatc tttatagttc acgttaacat 1320
atagacactg ttggaagcag ttccttctaa aagggtagcc ctggacttaa taccagccgg 1380
atacctctgg cccccacccc attactgtac ctctggagtc actactgtgg gtcgccactc 1440
ctctgctaca cagcacggct ttttcaaggc tgtattgaga agggaagtta ggaagaaggg 1500
tgtgctgggc taaccagccc acagagctca cattcctgtc ccttgggtga aaaatacatg 1560
tccatcctga tatctcctga attcagaaat tagcctccac atgtgcaatg gctttaagag 1620
ccagaagcag ggttctggga attttgcaag ttacctgtgg ccaggtgtgg tctcggttac 1680
caaatacggt tacctgcagc tttttagtcc tttgtgctcc cacgggtcta cagagtccca 1740
tctgcccaaa ggtcttgaag cttgacagga tgttttcgat tactcagtct cccagggcac 1800
tactggtccg taggattcga ttggtcgggg taggagagtt aaacaacatt taaacagagt 1860
tctctcaaaa atgtctaaag ggattgtagg tagataacat ccaatcactg tttgcactta 1920
tctgaaatct tccctcttgg ctgcccccag gtatttactg tggagaacat tgcataggaa 1980
tgtctggaaa aagcttctac aacttgttac agccttcaca tttgtagaag cttt 2034
<210> 22
<211> 1234
<212> DNA
<213> Artificial Sequence
<220>
<223> COX10-ND6-3'UTR*
<400> 22
atggccgcat ctccgcacac tctctcctca cgcctcctga caggttgcgt aggaggctct 60
gtctggtatc ttgaaagaag aactatgatg tatgctttgt ttctgttgag tgtgggttta 120
gtaatggggt ttgtggggtt ttcttctaag ccttctccta tttatggggg tttagtattg 180
attgttagcg gtgtggtcgg gtgtgttatt attctgaatt ttgggggagg ttatatgggt 240
ttaatggttt ttttaattta tttaggggga atgatggttg tctttggata tactacagcg 300
atggctattg aggagtatcc tgaggcatgg gggtcagggg ttgaggtctt ggtgagtgtt 360
ttagtggggt tagcgatgga ggtaggattg gtgctgtggg tgaaagagta tgatggggtg 420
gtggttgtgg taaactttaa tagtgtagga agctggatga tttatgaagg agaggggtca 480
gggttgattc gggaggatcc tattggtgcg ggggctttgt atgattatgg gcgttggtta 540
gtagtagtta ctggttggac attgtttgtt ggtgtatata ttgtaattga gattgctcgg 600
gggaattagg agcactggga cgcccaccgc ccctttccct ccgctgccag gcgagcatgt 660
tgtggtaatt ctggaacaca agaagagaaa ttgctgggtt tagaacaaga ttataaacga 720
attcggtgct cagtgatcac ttgacagttt tttttttttt taaatattac ccaaaatgct 780
ccccaaataa gaaatgcatc agctcagtca gtgaatacaa aaaaggaatt atttttccct 840
ttgagggtct tttatacatc tctcctccaa ccccaccctc tattctgttt cttcctcctc 900
acatgggggt acacatacac agcttcctct tttggttcca tccttaccac cacaccacac 960
gcacactcca catgcccagc agagtggcac ttggtggcca gaaagtgtga gcctcatgat 1020
ctgctgtctg tagttctgtg agctcaggtc cctcaaaggc ctcggagcac ccccttcctt 1080
gtgactgagc cagggcctgc atttttggtt ttccccaccc cacacattct caaccatagt 1140
ccttctaaca ataccaatag ctaggacccg gctgctgtgc actgggactg gggattccac 1200
atgtttgcct tgggagtctc aagctggact gcca 1234
<210> 23
<211> 2034
<212> DNA
<213> Artificial Sequence
<220>
<223> COX10-opt_ND6-3'UTR
<400> 23
atggccgcat ctccgcacac tctctcctca cgcctcctga caggttgcgt aggaggctct 60
gtctggtatc ttgaaagaag aactatgatg tacgccctgt tcctgctgag cgtgggcctg 120
gtgatgggct tcgtgggctt cagcagcaag cccagcccca tctacggcgg cctggtgctg 180
atcgtgagcg gcgtggtggg ctgcgtgatc atcctgaact tcggcggcgg ctacatgggc 240
ctgatggtgt tcctgatcta cctgggcggc atgatggtgg tgttcggcta caccaccgcc 300
atggccatcg aggagtaccc cgaggcctgg ggcagcggcg tggaggtgct ggtgagcgtg 360
ctggtgggcc tggccatgga ggtgggcctg gtgctgtggg tgaaggagta cgacggcgtg 420
gtggtggtgg tgaacttcaa cagcgtgggc agctggatga tctacgaggg cgagggcagc 480
ggcctgatcc gcgaggaccc catcggcgcc ggcgccctgt acgactacgg ccgctggctg 540
gtggtggtga ccggctggac cctgttcgtg ggcgtgtaca tcgtgatcga gatcgcccgc 600
ggcaactaag agcactggga cgcccaccgc ccctttccct ccgctgccag gcgagcatgt 660
tgtggtaatt ctggaacaca agaagagaaa ttgctgggtt tagaacaaga ttataaacga 720
attcggtgct cagtgatcac ttgacagttt tttttttttt taaatattac ccaaaatgct 780
ccccaaataa gaaatgcatc agctcagtca gtgaatacaa aaaaggaatt atttttccct 840
ttgagggtct tttatacatc tctcctccaa ccccaccctc tattctgttt cttcctcctc 900
acatgggggt acacatacac agcttcctct tttggttcca tccttaccac cacaccacac 960
gcacactcca catgcccagc agagtggcac ttggtggcca gaaagtgtga gcctcatgat 1020
ctgctgtctg tagttctgtg agctcaggtc cctcaaaggc ctcggagcac ccccttcctt 1080
gtgactgagc cagggcctgc atttttggtt ttccccaccc cacacattct caaccatagt 1140
ccttctaaca ataccaatag ctaggacccg gctgctgtgc actgggactg gggattccac 1200
atgtttgcct tgggagtctc aagctggact gccagcccct gtcctccctt cacccccatt 1260
gcgtatgagc atttcagaac tccaaggagt cacaggcatc tttatagttc acgttaacat 1320
atagacactg ttggaagcag ttccttctaa aagggtagcc ctggacttaa taccagccgg 1380
atacctctgg cccccacccc attactgtac ctctggagtc actactgtgg gtcgccactc 1440
ctctgctaca cagcacggct ttttcaaggc tgtattgaga agggaagtta ggaagaaggg 1500
tgtgctgggc taaccagccc acagagctca cattcctgtc ccttgggtga aaaatacatg 1560
tccatcctga tatctcctga attcagaaat tagcctccac atgtgcaatg gctttaagag 1620
ccagaagcag ggttctggga attttgcaag ttacctgtgg ccaggtgtgg tctcggttac 1680
caaatacggt tacctgcagc tttttagtcc tttgtgctcc cacgggtcta cagagtccca 1740
tctgcccaaa ggtcttgaag cttgacagga tgttttcgat tactcagtct cccagggcac 1800
tactggtccg taggattcga ttggtcgggg taggagagtt aaacaacatt taaacagagt 1860
tctctcaaaa atgtctaaag ggattgtagg tagataacat ccaatcactg tttgcactta 1920
tctgaaatct tccctcttgg ctgcccccag gtatttactg tggagaacat tgcataggaa 1980
tgtctggaaa aagcttctac aacttgttac agccttcaca tttgtagaag cttt 2034
<210> 24
<211> 1234
<212> DNA
<213> Artificial Sequence
<220>
<223> COX10-opt_ND6-3'UTR*
<400> 24
atggccgcat ctccgcacac tctctcctca cgcctcctga caggttgcgt aggaggctct 60
gtctggtatc ttgaaagaag aactatgatg tacgccctgt tcctgctgag cgtgggcctg 120
gtgatgggct tcgtgggctt cagcagcaag cccagcccca tctacggcgg cctggtgctg 180
atcgtgagcg gcgtggtggg ctgcgtgatc atcctgaact tcggcggcgg ctacatgggc 240
ctgatggtgt tcctgatcta cctgggcggc atgatggtgg tgttcggcta caccaccgcc 300
atggccatcg aggagtaccc cgaggcctgg ggcagcggcg tggaggtgct ggtgagcgtg 360
ctggtgggcc tggccatgga ggtgggcctg gtgctgtggg tgaaggagta cgacggcgtg 420
gtggtggtgg tgaacttcaa cagcgtgggc agctggatga tctacgaggg cgagggcagc 480
ggcctgatcc gcgaggaccc catcggcgcc ggcgccctgt acgactacgg ccgctggctg 540
gtggtggtga ccggctggac cctgttcgtg ggcgtgtaca tcgtgatcga gatcgcccgc 600
ggcaactaag agcactggga cgcccaccgc ccctttccct ccgctgccag gcgagcatgt 660
tgtggtaatt ctggaacaca agaagagaaa ttgctgggtt tagaacaaga ttataaacga 720
attcggtgct cagtgatcac ttgacagttt tttttttttt taaatattac ccaaaatgct 780
ccccaaataa gaaatgcatc agctcagtca gtgaatacaa aaaaggaatt atttttccct 840
ttgagggtct tttatacatc tctcctccaa ccccaccctc tattctgttt cttcctcctc 900
acatgggggt acacatacac agcttcctct tttggttcca tccttaccac cacaccacac 960
gcacactcca catgcccagc agagtggcac ttggtggcca gaaagtgtga gcctcatgat 1020
ctgctgtctg tagttctgtg agctcaggtc cctcaaaggc ctcggagcac ccccttcctt 1080
gtgactgagc cagggcctgc atttttggtt ttccccaccc cacacattct caaccatagt 1140
ccttctaaca ataccaatag ctaggacccg gctgctgtgc actgggactg gggattccac 1200
atgtttgcct tgggagtctc aagctggact gcca 1234
<210> 25
<211> 2460
<212> DNA
<213> Artificial Sequence
<220>
<223> COX10-ND1-3'UTR
<400> 25
atggccgcat ctccgcacac tctctcctca cgcctcctga caggttgcgt aggaggctct 60
gtctggtatc ttgaaagaag aactatggcc aacctcctac tcctcattgt acccattcta 120
atcgcaatgg cattcctaat gcttaccgaa cgaaaaattc taggctatat gcaactacgc 180
aaaggcccca acgttgtagg cccctacggg ctactacaac ccttcgctga cgccataaaa 240
ctcttcacca aagagcccct aaaacccgcc acatctacca tcaccctcta catcaccgcc 300
ccgaccttag ctctcaccat cgctcttcta ctatggaccc ccctccccat gcccaacccc 360
ctggtcaacc tcaacctagg cctcctattt attctagcca cctctagcct agccgtttac 420
tcaatcctct ggtcagggtg ggcatcaaac tcaaactacg ccctgatcgg cgcactgcga 480
gcagtagccc aaacaatctc atatgaagtc accctagcca tcattctact atcaacatta 540
ctaatgagtg gctcctttaa cctctccacc cttatcacaa cacaagaaca cctctggtta 600
ctcctgccat catggccctt ggccatgatg tggtttatct ccacactagc agagaccaac 660
cgaaccccct tcgaccttgc cgaaggggag tccgaactag tctcaggctt caacatcgaa 720
tacgccgcag gccccttcgc cctattcttc atggccgaat acacaaacat tattatgatg 780
aacaccctca ccactacaat cttcctagga acaacatatg acgcactctc ccctgaactc 840
tacacaacat attttgtcac caagacccta cttctaacct ccctgttctt atggattcga 900
acagcatacc cccgattccg ctacgaccaa ctcatgcacc tcctatggaa aaacttccta 960
ccactcaccc tagcattact tatgtggtat gtctccatgc ccattacaat ctccagcatt 1020
ccccctcaaa cctaagagca ctgggacgcc caccgcccct ttccctccgc tgccaggcga 1080
gcatgttgtg gtaattctgg aacacaagaa gagaaattgc tgggtttaga acaagattat 1140
aaacgaattc ggtgctcagt gatcacttga cagttttttt tttttttaaa tattacccaa 1200
aatgctcccc aaataagaaa tgcatcagct cagtcagtga atacaaaaaa ggaattattt 1260
ttccctttga gggtctttta tacatctctc ctccaacccc accctctatt ctgtttcttc 1320
ctcctcacat gggggtacac atacacagct tcctcttttg gttccatcct taccaccaca 1380
ccacacgcac actccacatg cccagcagag tggcacttgg tggccagaaa gtgtgagcct 1440
catgatctgc tgtctgtagt tctgtgagct caggtccctc aaaggcctcg gagcaccccc 1500
ttccttgtga ctgagccagg gcctgcattt ttggttttcc ccaccccaca cattctcaac 1560
catagtcctt ctaacaatac caatagctag gacccggctg ctgtgcactg ggactgggga 1620
ttccacatgt ttgccttggg agtctcaagc tggactgcca gcccctgtcc tcccttcacc 1680
cccattgcgt atgagcattt cagaactcca aggagtcaca ggcatcttta tagttcacgt 1740
taacatatag acactgttgg aagcagttcc ttctaaaagg gtagccctgg acttaatacc 1800
agccggatac ctctggcccc caccccatta ctgtacctct ggagtcacta ctgtgggtcg 1860
ccactcctct gctacacagc acggcttttt caaggctgta ttgagaaggg aagttaggaa 1920
gaagggtgtg ctgggctaac cagcccacag agctcacatt cctgtccctt gggtgaaaaa 1980
tacatgtcca tcctgatatc tcctgaattc agaaattagc ctccacatgt gcaatggctt 2040
taagagccag aagcagggtt ctgggaattt tgcaagttac ctgtggccag gtgtggtctc 2100
ggttaccaaa tacggttacc tgcagctttt tagtcctttg tgctcccacg ggtctacaga 2160
gtcccatctg cccaaaggtc ttgaagcttg acaggatgtt ttcgattact cagtctccca 2220
gggcactact ggtccgtagg attcgattgg tcggggtagg agagttaaac aacatttaaa 2280
cagagttctc tcaaaaatgt ctaaagggat tgtaggtaga taacatccaa tcactgtttg 2340
cacttatctg aaatcttccc tcttggctgc ccccaggtat ttactgtgga gaacattgca 2400
taggaatgtc tggaaaaagc ttctacaact tgttacagcc ttcacatttg tagaagcttt 2460
2460
<210> 26
<211> 1660
<212> DNA
<213> Artificial Sequence
<220>
<223> COX10-ND1-3'UTR*
<400> 26
atggccgcat ctccgcacac tctctcctca cgcctcctga caggttgcgt aggaggctct 60
gtctggtatc ttgaaagaag aactatggcc aacctcctac tcctcattgt acccattcta 120
atcgcaatgg cattcctaat gcttaccgaa cgaaaaattc taggctatat gcaactacgc 180
aaaggcccca acgttgtagg cccctacggg ctactacaac ccttcgctga cgccataaaa 240
ctcttcacca aagagcccct aaaacccgcc acatctacca tcaccctcta catcaccgcc 300
ccgaccttag ctctcaccat cgctcttcta ctatggaccc ccctccccat gcccaacccc 360
ctggtcaacc tcaacctagg cctcctattt attctagcca cctctagcct agccgtttac 420
tcaatcctct ggtcagggtg ggcatcaaac tcaaactacg ccctgatcgg cgcactgcga 480
gcagtagccc aaacaatctc atatgaagtc accctagcca tcattctact atcaacatta 540
ctaatgagtg gctcctttaa cctctccacc cttatcacaa cacaagaaca cctctggtta 600
ctcctgccat catggccctt ggccatgatg tggtttatct ccacactagc agagaccaac 660
cgaaccccct tcgaccttgc cgaaggggag tccgaactag tctcaggctt caacatcgaa 720
tacgccgcag gccccttcgc cctattcttc atggccgaat acacaaacat tattatgatg 780
aacaccctca ccactacaat cttcctagga acaacatatg acgcactctc ccctgaactc 840
tacacaacat attttgtcac caagacccta cttctaacct ccctgttctt atggattcga 900
acagcatacc cccgattccg ctacgaccaa ctcatgcacc tcctatggaa aaacttccta 960
ccactcaccc tagcattact tatgtggtat gtctccatgc ccattacaat ctccagcatt 1020
ccccctcaaa cctaagagca ctgggacgcc caccgcccct ttccctccgc tgccaggcga 1080
gcatgttgtg gtaattctgg aacacaagaa gagaaattgc tgggtttaga acaagattat 1140
aaacgaattc ggtgctcagt gatcacttga cagttttttt tttttttaaa tattacccaa 1200
aatgctcccc aaataagaaa tgcatcagct cagtcagtga atacaaaaaa ggaattattt 1260
ttccctttga gggtctttta tacatctctc ctccaacccc accctctatt ctgtttcttc 1320
ctcctcacat gggggtacac atacacagct tcctcttttg gttccatcct taccaccaca 1380
ccacacgcac actccacatg cccagcagag tggcacttgg tggccagaaa gtgtgagcct 1440
catgatctgc tgtctgtagt tctgtgagct caggtccctc aaaggcctcg gagcaccccc 1500
ttccttgtga ctgagccagg gcctgcattt ttggttttcc ccaccccaca cattctcaac 1560
catagtcctt ctaacaatac caatagctag gacccggctg ctgtgcactg ggactgggga 1620
ttccacatgt ttgccttggg agtctcaagc tggactgcca 1660
<210> 27
<211> 2460
<212> DNA
<213> Artificial Sequence
<220>
<223> COX10-opt_ND1-3'UTR
<400> 27
atggccgcat ctccgcacac tctctcctca cgcctcctga caggttgcgt aggaggctct 60
gtctggtatc ttgaaagaag aactatggcc aacctgctgc tgctgatcgt gcccatcctg 120
atcgccatgg ccttcctgat gctgaccgag cgcaagatcc tgggctacat gcagctgcgc 180
aagggcccca acgtggtggg cccctacggc ctgctgcagc ccttcgccga cgccatcaag 240
ctgttcacca aggagcccct gaagcccgcc accagcacca tcaccctgta catcaccgcc 300
cccaccctgg ccctgaccat cgccctgctg ctgtggaccc ccctgcccat gcccaacccc 360
ctggtgaacc tgaacctggg cctgctgttc atcctggcca ccagcagcct ggccgtgtac 420
agcatcctgt ggagcggctg ggccagcaac agcaactacg ccctgatcgg cgccctgcgc 480
gccgtggccc agaccatcag ctacgaggtg accctggcca tcatcctgct gagcaccctg 540
ctgatgagcg gcagcttcaa cctgagcacc ctgatcacca cccaggagca cctgtggctg 600
ctgctgccca gctggcccct ggccatgatg tggttcatca gcaccctggc cgagaccaac 660
cgcaccccct tcgacctggc cgagggcgag agcgagctgg tgagcggctt caacatcgag 720
tacgccgccg gccccttcgc cctgttcttc atggccgagt acaccaacat catcatgatg 780
aacaccctga ccaccaccat cttcctgggc accacctacg acgccctgag ccccgagctg 840
tacaccacct acttcgtgac caagaccctg ctgctgacca gcctgttcct gtggatccgc 900
accgcctacc cccgcttccg ctacgaccag ctgatgcacc tgctgtggaa gaacttcctg 960
cccctgaccc tggccctgct gatgtggtac gtgagcatgc ccatcaccat cagcagcatc 1020
cccccccaga cctaagagca ctgggacgcc caccgcccct ttccctccgc tgccaggcga 1080
gcatgttgtg gtaattctgg aacacaagaa gagaaattgc tgggtttaga acaagattat 1140
aaacgaattc ggtgctcagt gatcacttga cagttttttt tttttttaaa tattacccaa 1200
aatgctcccc aaataagaaa tgcatcagct cagtcagtga atacaaaaaa ggaattattt 1260
ttccctttga gggtctttta tacatctctc ctccaacccc accctctatt ctgtttcttc 1320
ctcctcacat gggggtacac atacacagct tcctcttttg gttccatcct taccaccaca 1380
ccacacgcac actccacatg cccagcagag tggcacttgg tggccagaaa gtgtgagcct 1440
catgatctgc tgtctgtagt tctgtgagct caggtccctc aaaggcctcg gagcaccccc 1500
ttccttgtga ctgagccagg gcctgcattt ttggttttcc ccaccccaca cattctcaac 1560
catagtcctt ctaacaatac caatagctag gacccggctg ctgtgcactg ggactgggga 1620
ttccacatgt ttgccttggg agtctcaagc tggactgcca gcccctgtcc tcccttcacc 1680
cccattgcgt atgagcattt cagaactcca aggagtcaca ggcatcttta tagttcacgt 1740
taacatatag acactgttgg aagcagttcc ttctaaaagg gtagccctgg acttaatacc 1800
agccggatac ctctggcccc caccccatta ctgtacctct ggagtcacta ctgtgggtcg 1860
ccactcctct gctacacagc acggcttttt caaggctgta ttgagaaggg aagttaggaa 1920
gaagggtgtg ctgggctaac cagcccacag agctcacatt cctgtccctt gggtgaaaaa 1980
tacatgtcca tcctgatatc tcctgaattc agaaattagc ctccacatgt gcaatggctt 2040
taagagccag aagcagggtt ctgggaattt tgcaagttac ctgtggccag gtgtggtctc 2100
ggttaccaaa tacggttacc tgcagctttt tagtcctttg tgctcccacg ggtctacaga 2160
gtcccatctg cccaaaggtc ttgaagcttg acaggatgtt ttcgattact cagtctccca 2220
gggcactact ggtccgtagg attcgattgg tcggggtagg agagttaaac aacatttaaa 2280
cagagttctc tcaaaaatgt ctaaagggat tgtaggtaga taacatccaa tcactgtttg 2340
cacttatctg aaatcttccc tcttggctgc ccccaggtat ttactgtgga gaacattgca 2400
taggaatgtc tggaaaaagc ttctacaact tgttacagcc ttcacatttg tagaagcttt 2460
2460
<210> 28
<211> 1660
<212> DNA
<213> Artificial Sequence
<220>
<223> COX10-opt_ND1-3'UTR*
<400> 28
atggccgcat ctccgcacac tctctcctca cgcctcctga caggttgcgt aggaggctct 60
gtctggtatc ttgaaagaag aactatggcc aacctgctgc tgctgatcgt gcccatcctg 120
atcgccatgg ccttcctgat gctgaccgag cgcaagatcc tgggctacat gcagctgcgc 180
aagggcccca acgtggtggg cccctacggc ctgctgcagc ccttcgccga cgccatcaag 240
ctgttcacca aggagcccct gaagcccgcc accagcacca tcaccctgta catcaccgcc 300
cccaccctgg ccctgaccat cgccctgctg ctgtggaccc ccctgcccat gcccaacccc 360
ctggtgaacc tgaacctggg cctgctgttc atcctggcca ccagcagcct ggccgtgtac 420
agcatcctgt ggagcggctg ggccagcaac agcaactacg ccctgatcgg cgccctgcgc 480
gccgtggccc agaccatcag ctacgaggtg accctggcca tcatcctgct gagcaccctg 540
ctgatgagcg gcagcttcaa cctgagcacc ctgatcacca cccaggagca cctgtggctg 600
ctgctgccca gctggcccct ggccatgatg tggttcatca gcaccctggc cgagaccaac 660
cgcaccccct tcgacctggc cgagggcgag agcgagctgg tgagcggctt caacatcgag 720
tacgccgccg gccccttcgc cctgttcttc atggccgagt acaccaacat catcatgatg 780
aacaccctga ccaccaccat cttcctgggc accacctacg acgccctgag ccccgagctg 840
tacaccacct acttcgtgac caagaccctg ctgctgacca gcctgttcct gtggatccgc 900
accgcctacc cccgcttccg ctacgaccag ctgatgcacc tgctgtggaa gaacttcctg 960
cccctgaccc tggccctgct gatgtggtac gtgagcatgc ccatcaccat cagcagcatc 1020
cccccccaga cctaagagca ctgggacgcc caccgcccct ttccctccgc tgccaggcga 1080
gcatgttgtg gtaattctgg aacacaagaa gagaaattgc tgggtttaga acaagattat 1140
aaacgaattc ggtgctcagt gatcacttga cagttttttt tttttttaaa tattacccaa 1200
aatgctcccc aaataagaaa tgcatcagct cagtcagtga atacaaaaaa ggaattattt 1260
ttccctttga gggtctttta tacatctctc ctccaacccc accctctatt ctgtttcttc 1320
ctcctcacat gggggtacac atacacagct tcctcttttg gttccatcct taccaccaca 1380
ccacacgcac actccacatg cccagcagag tggcacttgg tggccagaaa gtgtgagcct 1440
catgatctgc tgtctgtagt tctgtgagct caggtccctc aaaggcctcg gagcaccccc 1500
ttccttgtga ctgagccagg gcctgcattt ttggttttcc ccaccccaca cattctcaac 1560
catagtcctt ctaacaatac caatagctag gacccggctg ctgtgcactg ggactgggga 1620
ttccacatgt ttgccttggg agtctcaagc tggactgcca 1660
<210> 29
<211> 2889
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10-ND4-3'UTR
<400> 29
atggccgcct ctccacacac actgagtagc agactgctga ccggctgtgt tggcggctct 60
gtgtggtatc tggaacggcg gacaatgcta aaactaatcg tcccaacaat tatgttacta 120
ccactgacat ggctttccaa aaaacacatg atttggatca acacaaccac ccacagccta 180
attattagca tcatccctct actatttttt aaccaaatca acaacaacct atttagctgt 240
tccccaacct tttcctccga ccccctaaca acccccctcc taatgctaac tacctggctc 300
ctacccctca caatcatggc aagccaacgc cacttatcca gtgaaccact atcacgaaaa 360
aaactctacc tctctatgct aatctcccta caaatctcct taattatgac attcacagcc 420
acagaactaa tcatgtttta tatcttcttc gaaaccacac ttatccccac cttggctatc 480
atcacccgat ggggcaacca gccagaacgc ctgaacgcag gcacatactt cctattctac 540
accctagtag gctcccttcc cctactcatc gcactaattt acactcacaa caccctaggc 600
tcactaaaca ttctactact cactctcact gcccaagaac tatcaaactc ctgggccaac 660
aacttaatgt ggctagctta cacaatggct tttatggtaa agatgcctct ttacggactc 720
cacttatggc tccctaaagc ccatgtcgaa gcccccatcg ctgggtcaat ggtacttgcc 780
gcagtactct taaaactagg cggctatggt atgatgcgcc tcacactcat tctcaacccc 840
ctgacaaaac acatggccta ccccttcctt gtactatccc tatggggcat gattatgaca 900
agctccatct gcctacgaca aacagaccta aaatcgctca ttgcatactc ttcaatcagc 960
cacatggccc tcgtagtaac agccattctc atccaaaccc cctggagctt caccggcgca 1020
gtcattctca tgatcgccca cgggcttaca tcctcattac tattctgcct agcaaactca 1080
aactacgaac gcactcacag tcgcatcatg atcctctctc aaggacttca aactctactc 1140
ccactaatgg ctttttggtg gcttctagca agcctcgcta acctcgcctt accccccact 1200
attaacctac tgggagaact ctctgtgcta gtaaccacgt tctcctggtc aaatatcact 1260
ctcctactta caggactcaa catgctagtc acagccctat actccctcta catgtttacc 1320
acaacacaat ggggctcact cacccaccac attaacaaca tgaaaccctc attcacacga 1380
gaaaacaccc tcatgttcat gcacctatcc cccattctcc tcctatccct caaccccgac 1440
atcattaccg ggttttcctc ttaagagcac tgggacgccc accgcccctt tccctccgct 1500
gccaggcgag catgttgtgg taattctgga acacaagaag agaaattgct gggtttagaa 1560
caagattata aacgaattcg gtgctcagtg atcacttgac agtttttttt ttttttaaat 1620
attacccaaa atgctcccca aataagaaat gcatcagctc agtcagtgaa tacaaaaaag 1680
gaattatttt tccctttgag ggtcttttat acatctctcc tccaacccca ccctctattc 1740
tgtttcttcc tcctcacatg ggggtacaca tacacagctt cctcttttgg ttccatcctt 1800
accaccacac cacacgcaca ctccacatgc ccagcagagt ggcacttggt ggccagaaag 1860
tgtgagcctc atgatctgct gtctgtagtt ctgtgagctc aggtccctca aaggcctcgg 1920
agcaccccct tccttgtgac tgagccaggg cctgcatttt tggttttccc caccccacac 1980
attctcaacc atagtccttc taacaatacc aatagctagg acccggctgc tgtgcactgg 2040
gactggggat tccacatgtt tgccttggga gtctcaagct ggactgccag cccctgtcct 2100
cccttcaccc ccattgcgta tgagcatttc agaactccaa ggagtcacag gcatctttat 2160
agttcacgtt aacatataga cactgttgga agcagttcct tctaaaaggg tagccctgga 2220
cttaatacca gccggatacc tctggccccc accccattac tgtacctctg gagtcactac 2280
tgtgggtcgc cactcctctg ctacacagca cggctttttc aaggctgtat tgagaaggga 2340
agttaggaag aagggtgtgc tgggctaacc agcccacaga gctcacattc ctgtcccttg 2400
ggtgaaaaat acatgtccat cctgatatct cctgaattca gaaattagcc tccacatgtg 2460
caatggcttt aagagccaga agcagggttc tgggaatttt gcaagttacc tgtggccagg 2520
tgtggtctcg gttaccaaat acggttacct gcagcttttt agtcctttgt gctcccacgg 2580
gtctacagag tcccatctgc ccaaaggtct tgaagcttga caggatgttt tcgattactc 2640
agtctcccag ggcactactg gtccgtagga ttcgattggt cggggtagga gagttaaaca 2700
acatttaaac agagttctct caaaaatgtc taaagggatt gtaggtagat aacatccaat 2760
cactgtttgc acttatctga aatcttccct cttggctgcc cccaggtatt tactgtggag 2820
aacattgcat aggaatgtct ggaaaaagct tctacaactt gttacagcct tcacatttgt 2880
agaagcttt 2889
<210> 30
<211> 2089
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10-ND4-3'UTR*
<400> 30
atggccgcct ctccacacac actgagtagc agactgctga ccggctgtgt tggcggctct 60
gtgtggtatc tggaacggcg gacaatgcta aaactaatcg tcccaacaat tatgttacta 120
ccactgacat ggctttccaa aaaacacatg atttggatca acacaaccac ccacagccta 180
attattagca tcatccctct actatttttt aaccaaatca acaacaacct atttagctgt 240
tccccaacct tttcctccga ccccctaaca acccccctcc taatgctaac tacctggctc 300
ctacccctca caatcatggc aagccaacgc cacttatcca gtgaaccact atcacgaaaa 360
aaactctacc tctctatgct aatctcccta caaatctcct taattatgac attcacagcc 420
acagaactaa tcatgtttta tatcttcttc gaaaccacac ttatccccac cttggctatc 480
atcacccgat ggggcaacca gccagaacgc ctgaacgcag gcacatactt cctattctac 540
accctagtag gctcccttcc cctactcatc gcactaattt acactcacaa caccctaggc 600
tcactaaaca ttctactact cactctcact gcccaagaac tatcaaactc ctgggccaac 660
aacttaatgt ggctagctta cacaatggct tttatggtaa agatgcctct ttacggactc 720
cacttatggc tccctaaagc ccatgtcgaa gcccccatcg ctgggtcaat ggtacttgcc 780
gcagtactct taaaactagg cggctatggt atgatgcgcc tcacactcat tctcaacccc 840
ctgacaaaac acatggccta ccccttcctt gtactatccc tatggggcat gattatgaca 900
agctccatct gcctacgaca aacagaccta aaatcgctca ttgcatactc ttcaatcagc 960
cacatggccc tcgtagtaac agccattctc atccaaaccc cctggagctt caccggcgca 1020
gtcattctca tgatcgccca cgggcttaca tcctcattac tattctgcct agcaaactca 1080
aactacgaac gcactcacag tcgcatcatg atcctctctc aaggacttca aactctactc 1140
ccactaatgg ctttttggtg gcttctagca agcctcgcta acctcgcctt accccccact 1200
attaacctac tgggagaact ctctgtgcta gtaaccacgt tctcctggtc aaatatcact 1260
ctcctactta caggactcaa catgctagtc acagccctat actccctcta catgtttacc 1320
acaacacaat ggggctcact cacccaccac attaacaaca tgaaaccctc attcacacga 1380
gaaaacaccc tcatgttcat gcacctatcc cccattctcc tcctatccct caaccccgac 1440
atcattaccg ggttttcctc ttaagagcac tgggacgccc accgcccctt tccctccgct 1500
gccaggcgag catgttgtgg taattctgga acacaagaag agaaattgct gggtttagaa 1560
caagattata aacgaattcg gtgctcagtg atcacttgac agtttttttt ttttttaaat 1620
attacccaaa atgctcccca aataagaaat gcatcagctc agtcagtgaa tacaaaaaag 1680
gaattatttt tccctttgag ggtcttttat acatctctcc tccaacccca ccctctattc 1740
tgtttcttcc tcctcacatg ggggtacaca tacacagctt cctcttttgg ttccatcctt 1800
accaccacac cacacgcaca ctccacatgc ccagcagagt ggcacttggt ggccagaaag 1860
tgtgagcctc atgatctgct gtctgtagtt ctgtgagctc aggtccctca aaggcctcgg 1920
agcaccccct tccttgtgac tgagccaggg cctgcatttt tggttttccc caccccacac 1980
attctcaacc atagtccttc taacaatacc aatagctagg acccggctgc tgtgcactgg 2040
gactggggat tccacatgtt tgccttggga gtctcaagct ggactgcca 2089
<210> 31
<211> 2889
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10-opt_ND4-3'UTR
<400> 31
atggccgcct ctccacacac actgagtagc agactgctga ccggctgtgt tggcggctct 60
gtgtggtatc tggaacggcg gacaatgctg aagctgatcg tgcccaccat catgctgctg 120
cctctgacct ggctgagcaa gaaacacatg atctggatca acaccaccac gcacagcctg 180
atcatcagca tcatccctct gctgttcttc aaccagatca acaacaacct gttcagctgc 240
agccccacct tcagcagcga ccctctgaca acacctctgc tgatgctgac cacctggctg 300
ctgcccctca caatcatggc ctctcagaga cacctgagca gcgagcccct gagccggaag 360
aaactgtacc tgagcatgct gatctccctg cagatctctc tgatcatgac cttcaccgcc 420
accgagctga tcatgttcta catctttttc gagacaacgc tgatccccac actggccatc 480
atcaccagat ggggcaacca gcctgagaga ctgaacgccg gcacctactt tctgttctac 540
accctcgtgg gcagcctgcc actgctgatt gccctgatct acacccacaa caccctgggc 600
tccctgaaca tcctgctgct gacactgaca gcccaagagc tgagcaacag ctgggccaac 660
aatctgatgt ggctggccta cacaatggcc ttcatggtca agatgcccct gtacggcctg 720
cacctgtggc tgcctaaagc tcatgtggaa gcccctatcg ccggctctat ggtgctggct 780
gcagtgctgc tgaaactcgg cggctacggc atgatgcggc tgaccctgat tctgaatccc 840
ctgaccaagc acatggccta tccatttctg gtgctgagcc tgtggggcat gattatgacc 900
agcagcatct gcctgcggca gaccgatctg aagtccctga tcgcctacag ctccatcagc 960
cacatggccc tggtggtcac cgccatcctg attcagaccc cttggagctt tacaggcgcc 1020
gtgatcctga tgattgccca cggcctgaca agcagcctgc tgttttgtct ggccaacagc 1080
aactacgagc ggacccacag cagaatcatg atcctgtctc agggcctgca gaccctcctg 1140
cctcttatgg ctttttggtg gctgctggcc tctctggcca atctggcact gcctcctacc 1200
atcaatctgc tgggcgagct gagcgtgctg gtcaccacat tcagctggtc caatatcacc 1260
ctgctgctca ccggcctgaa catgctggtt acagccctgt actccctgta catgttcacc 1320
accacacagt ggggaagcct gacacaccac atcaacaata tgaagcccag cttcacccgc 1380
gagaacaccc tgatgttcat gcatctgagc cccattctgc tgctgtccct gaatcctgat 1440
atcatcaccg gcttctccag ctgagagcac tgggacgccc accgcccctt tccctccgct 1500
gccaggcgag catgttgtgg taattctgga acacaagaag agaaattgct gggtttagaa 1560
caagattata aacgaattcg gtgctcagtg atcacttgac agtttttttt ttttttaaat 1620
attacccaaa atgctcccca aataagaaat gcatcagctc agtcagtgaa tacaaaaaag 1680
gaattatttt tccctttgag ggtcttttat acatctctcc tccaacccca ccctctattc 1740
tgtttcttcc tcctcacatg ggggtacaca tacacagctt cctcttttgg ttccatcctt 1800
accaccacac cacacgcaca ctccacatgc ccagcagagt ggcacttggt ggccagaaag 1860
tgtgagcctc atgatctgct gtctgtagtt ctgtgagctc aggtccctca aaggcctcgg 1920
agcaccccct tccttgtgac tgagccaggg cctgcatttt tggttttccc caccccacac 1980
attctcaacc atagtccttc taacaatacc aatagctagg acccggctgc tgtgcactgg 2040
gactggggat tccacatgtt tgccttggga gtctcaagct ggactgccag cccctgtcct 2100
cccttcaccc ccattgcgta tgagcatttc agaactccaa ggagtcacag gcatctttat 2160
agttcacgtt aacatataga cactgttgga agcagttcct tctaaaaggg tagccctgga 2220
cttaatacca gccggatacc tctggccccc accccattac tgtacctctg gagtcactac 2280
tgtgggtcgc cactcctctg ctacacagca cggctttttc aaggctgtat tgagaaggga 2340
agttaggaag aagggtgtgc tgggctaacc agcccacaga gctcacattc ctgtcccttg 2400
ggtgaaaaat acatgtccat cctgatatct cctgaattca gaaattagcc tccacatgtg 2460
caatggcttt aagagccaga agcagggttc tgggaatttt gcaagttacc tgtggccagg 2520
tgtggtctcg gttaccaaat acggttacct gcagcttttt agtcctttgt gctcccacgg 2580
gtctacagag tcccatctgc ccaaaggtct tgaagcttga caggatgttt tcgattactc 2640
agtctcccag ggcactactg gtccgtagga ttcgattggt cggggtagga gagttaaaca 2700
acatttaaac agagttctct caaaaatgtc taaagggatt gtaggtagat aacatccaat 2760
cactgtttgc acttatctga aatcttccct cttggctgcc cccaggtatt tactgtggag 2820
aacattgcat aggaatgtct ggaaaaagct tctacaactt gttacagcct tcacatttgt 2880
agaagcttt 2889
<210> 32
<211> 2089
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10-opt_ND4-3'UTR*
<400> 32
atggccgcct ctccacacac actgagtagc agactgctga ccggctgtgt tggcggctct 60
gtgtggtatc tggaacggcg gacaatgctg aagctgatcg tgcccaccat catgctgctg 120
cctctgacct ggctgagcaa gaaacacatg atctggatca acaccaccac gcacagcctg 180
atcatcagca tcatccctct gctgttcttc aaccagatca acaacaacct gttcagctgc 240
agccccacct tcagcagcga ccctctgaca acacctctgc tgatgctgac cacctggctg 300
ctgcccctca caatcatggc ctctcagaga cacctgagca gcgagcccct gagccggaag 360
aaactgtacc tgagcatgct gatctccctg cagatctctc tgatcatgac cttcaccgcc 420
accgagctga tcatgttcta catctttttc gagacaacgc tgatccccac actggccatc 480
atcaccagat ggggcaacca gcctgagaga ctgaacgccg gcacctactt tctgttctac 540
accctcgtgg gcagcctgcc actgctgatt gccctgatct acacccacaa caccctgggc 600
tccctgaaca tcctgctgct gacactgaca gcccaagagc tgagcaacag ctgggccaac 660
aatctgatgt ggctggccta cacaatggcc ttcatggtca agatgcccct gtacggcctg 720
cacctgtggc tgcctaaagc tcatgtggaa gcccctatcg ccggctctat ggtgctggct 780
gcagtgctgc tgaaactcgg cggctacggc atgatgcggc tgaccctgat tctgaatccc 840
ctgaccaagc acatggccta tccatttctg gtgctgagcc tgtggggcat gattatgacc 900
agcagcatct gcctgcggca gaccgatctg aagtccctga tcgcctacag ctccatcagc 960
cacatggccc tggtggtcac cgccatcctg attcagaccc cttggagctt tacaggcgcc 1020
gtgatcctga tgattgccca cggcctgaca agcagcctgc tgttttgtct ggccaacagc 1080
aactacgagc ggacccacag cagaatcatg atcctgtctc agggcctgca gaccctcctg 1140
cctcttatgg ctttttggtg gctgctggcc tctctggcca atctggcact gcctcctacc 1200
atcaatctgc tgggcgagct gagcgtgctg gtcaccacat tcagctggtc caatatcacc 1260
ctgctgctca ccggcctgaa catgctggtt acagccctgt actccctgta catgttcacc 1320
accacacagt ggggaagcct gacacaccac atcaacaata tgaagcccag cttcacccgc 1380
gagaacaccc tgatgttcat gcatctgagc cccattctgc tgctgtccct gaatcctgat 1440
atcatcaccg gcttctccag ctgagagcac tgggacgccc accgcccctt tccctccgct 1500
gccaggcgag catgttgtgg taattctgga acacaagaag agaaattgct gggtttagaa 1560
caagattata aacgaattcg gtgctcagtg atcacttgac agtttttttt ttttttaaat 1620
attacccaaa atgctcccca aataagaaat gcatcagctc agtcagtgaa tacaaaaaag 1680
gaattatttt tccctttgag ggtcttttat acatctctcc tccaacccca ccctctattc 1740
tgtttcttcc tcctcacatg ggggtacaca tacacagctt cctcttttgg ttccatcctt 1800
accaccacac cacacgcaca ctccacatgc ccagcagagt ggcacttggt ggccagaaag 1860
tgtgagcctc atgatctgct gtctgtagtt ctgtgagctc aggtccctca aaggcctcgg 1920
agcaccccct tccttgtgac tgagccaggg cctgcatttt tggttttccc caccccacac 1980
attctcaacc atagtccttc taacaatacc aatagctagg acccggctgc tgtgcactgg 2040
gactggggat tccacatgtt tgccttggga gtctcaagct ggactgcca 2089
<210> 33
<211> 2889
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10-opt_ND4*-3'UTR
<400> 33
atggccgcct ctccacacac actgagtagc agactgctga ccggctgtgt tggcggctct 60
gtgtggtatc tggaacggcg gacaatgctg aagctgatcg tgcccaccat catgctgctg 120
cccctgacct ggctgagcaa gaagcacatg atctggatca acaccaccac ccacagcctg 180
atcatcagca tcatccccct gctgttcttc aaccagatca acaacaacct gttcagctgc 240
agccccacct tcagcagcga ccccctgacc acccccctgc tgatgctgac cacctggctg 300
ctgcccctga ccatcatggc cagccagcgc cacctgagca gcgagcccct gagccgcaag 360
aagctgtacc tgagcatgct gatcagcctg cagatcagcc tgatcatgac cttcaccgcc 420
accgagctga tcatgttcta catcttcttc gagaccaccc tgatccccac cctggccatc 480
atcacccgct ggggcaacca gcccgagcgc ctgaacgccg gcacctactt cctgttctac 540
accctggtgg gcagcctgcc cctgctgatc gccctgatct acacccacaa caccctgggc 600
agcctgaaca tcctgctgct gaccctgacc gcccaggagc tgagcaacag ctgggccaac 660
aacctgatgt ggctggccta caccatggcc ttcatggtga agatgcccct gtacggcctg 720
cacctgtggc tgcccaaggc ccacgtggag gcccccatcg ccggcagcat ggtgctggcc 780
gccgtgctgc tgaagctggg cggctacggc atgatgcgcc tgaccctgat cctgaacccc 840
ctgaccaagc acatggccta ccccttcctg gtgctgagcc tgtggggcat gatcatgacc 900
agcagcatct gcctgcgcca gaccgacctg aagagcctga tcgcctacag cagcatcagc 960
cacatggccc tggtggtgac cgccatcctg atccagaccc cctggagctt caccggcgcc 1020
gtgatcctga tgatcgccca cggcctgacc agcagcctgc tgttctgcct ggccaacagc 1080
aactacgagc gcacccacag ccgcatcatg atcctgagcc agggcctgca gaccctgctg 1140
cccctgatgg ccttctggtg gctgctggcc agcctggcca acctggccct gccccccacc 1200
atcaacctgc tgggcgagct gagcgtgctg gtgaccacct tcagctggag caacatcacc 1260
ctgctgctga ccggcctgaa catgctggtg accgccctgt acagcctgta catgttcacc 1320
accacccagt ggggcagcct gacccaccac atcaacaaca tgaagcccag cttcacccgc 1380
gagaacaccc tgatgttcat gcacctgagc cccatcctgc tgctgagcct gaaccccgac 1440
atcatcaccg gcttcagcag ctaagagcac tgggacgccc accgcccctt tccctccgct 1500
gccaggcgag catgttgtgg taattctgga acacaagaag agaaattgct gggtttagaa 1560
caagattata aacgaattcg gtgctcagtg atcacttgac agtttttttt ttttttaaat 1620
attacccaaa atgctcccca aataagaaat gcatcagctc agtcagtgaa tacaaaaaag 1680
gaattatttt tccctttgag ggtcttttat acatctctcc tccaacccca ccctctattc 1740
tgtttcttcc tcctcacatg ggggtacaca tacacagctt cctcttttgg ttccatcctt 1800
accaccacac cacacgcaca ctccacatgc ccagcagagt ggcacttggt ggccagaaag 1860
tgtgagcctc atgatctgct gtctgtagtt ctgtgagctc aggtccctca aaggcctcgg 1920
agcaccccct tccttgtgac tgagccaggg cctgcatttt tggttttccc caccccacac 1980
attctcaacc atagtccttc taacaatacc aatagctagg acccggctgc tgtgcactgg 2040
gactggggat tccacatgtt tgccttggga gtctcaagct ggactgccag cccctgtcct 2100
cccttcaccc ccattgcgta tgagcatttc agaactccaa ggagtcacag gcatctttat 2160
agttcacgtt aacatataga cactgttgga agcagttcct tctaaaaggg tagccctgga 2220
cttaatacca gccggatacc tctggccccc accccattac tgtacctctg gagtcactac 2280
tgtgggtcgc cactcctctg ctacacagca cggctttttc aaggctgtat tgagaaggga 2340
agttaggaag aagggtgtgc tgggctaacc agcccacaga gctcacattc ctgtcccttg 2400
ggtgaaaaat acatgtccat cctgatatct cctgaattca gaaattagcc tccacatgtg 2460
caatggcttt aagagccaga agcagggttc tgggaatttt gcaagttacc tgtggccagg 2520
tgtggtctcg gttaccaaat acggttacct gcagcttttt agtcctttgt gctcccacgg 2580
gtctacagag tcccatctgc ccaaaggtct tgaagcttga caggatgttt tcgattactc 2640
agtctcccag ggcactactg gtccgtagga ttcgattggt cggggtagga gagttaaaca 2700
acatttaaac agagttctct caaaaatgtc taaagggatt gtaggtagat aacatccaat 2760
cactgtttgc acttatctga aatcttccct cttggctgcc cccaggtatt tactgtggag 2820
aacattgcat aggaatgtct ggaaaaagct tctacaactt gttacagcct tcacatttgt 2880
agaagcttt 2889
<210> 34
<211> 2089
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10-opt_ND4*-3'UTR*
<400> 34
atggccgcct ctccacacac actgagtagc agactgctga ccggctgtgt tggcggctct 60
gtgtggtatc tggaacggcg gacaatgctg aagctgatcg tgcccaccat catgctgctg 120
cccctgacct ggctgagcaa gaagcacatg atctggatca acaccaccac ccacagcctg 180
atcatcagca tcatccccct gctgttcttc aaccagatca acaacaacct gttcagctgc 240
agccccacct tcagcagcga ccccctgacc acccccctgc tgatgctgac cacctggctg 300
ctgcccctga ccatcatggc cagccagcgc cacctgagca gcgagcccct gagccgcaag 360
aagctgtacc tgagcatgct gatcagcctg cagatcagcc tgatcatgac cttcaccgcc 420
accgagctga tcatgttcta catcttcttc gagaccaccc tgatccccac cctggccatc 480
atcacccgct ggggcaacca gcccgagcgc ctgaacgccg gcacctactt cctgttctac 540
accctggtgg gcagcctgcc cctgctgatc gccctgatct acacccacaa caccctgggc 600
agcctgaaca tcctgctgct gaccctgacc gcccaggagc tgagcaacag ctgggccaac 660
aacctgatgt ggctggccta caccatggcc ttcatggtga agatgcccct gtacggcctg 720
cacctgtggc tgcccaaggc ccacgtggag gcccccatcg ccggcagcat ggtgctggcc 780
gccgtgctgc tgaagctggg cggctacggc atgatgcgcc tgaccctgat cctgaacccc 840
ctgaccaagc acatggccta ccccttcctg gtgctgagcc tgtggggcat gatcatgacc 900
agcagcatct gcctgcgcca gaccgacctg aagagcctga tcgcctacag cagcatcagc 960
cacatggccc tggtggtgac cgccatcctg atccagaccc cctggagctt caccggcgcc 1020
gtgatcctga tgatcgccca cggcctgacc agcagcctgc tgttctgcct ggccaacagc 1080
aactacgagc gcacccacag ccgcatcatg atcctgagcc agggcctgca gaccctgctg 1140
cccctgatgg ccttctggtg gctgctggcc agcctggcca acctggccct gccccccacc 1200
atcaacctgc tgggcgagct gagcgtgctg gtgaccacct tcagctggag caacatcacc 1260
ctgctgctga ccggcctgaa catgctggtg accgccctgt acagcctgta catgttcacc 1320
accacccagt ggggcagcct gacccaccac atcaacaaca tgaagcccag cttcacccgc 1380
gagaacaccc tgatgttcat gcacctgagc cccatcctgc tgctgagcct gaaccccgac 1440
atcatcaccg gcttcagcag ctaagagcac tgggacgccc accgcccctt tccctccgct 1500
gccaggcgag catgttgtgg taattctgga acacaagaag agaaattgct gggtttagaa 1560
caagattata aacgaattcg gtgctcagtg atcacttgac agtttttttt ttttttaaat 1620
attacccaaa atgctcccca aataagaaat gcatcagctc agtcagtgaa tacaaaaaag 1680
gaattatttt tccctttgag ggtcttttat acatctctcc tccaacccca ccctctattc 1740
tgtttcttcc tcctcacatg ggggtacaca tacacagctt cctcttttgg ttccatcctt 1800
accaccacac cacacgcaca ctccacatgc ccagcagagt ggcacttggt ggccagaaag 1860
tgtgagcctc atgatctgct gtctgtagtt ctgtgagctc aggtccctca aaggcctcgg 1920
agcaccccct tccttgtgac tgagccaggg cctgcatttt tggttttccc caccccacac 1980
attctcaacc atagtccttc taacaatacc aatagctagg acccggctgc tgtgcactgg 2040
gactggggat tccacatgtt tgccttggga gtctcaagct ggactgcca 2089
<210> 35
<211> 2034
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10-ND6-3'UTR
<400> 35
atggccgcct ctccacacac actgagtagc agactgctga ccggctgtgt tggcggctct 60
gtgtggtatc tggaacggcg gacaatgatg tatgctttgt ttctgttgag tgtgggttta 120
gtaatggggt ttgtggggtt ttcttctaag ccttctccta tttatggggg tttagtattg 180
attgttagcg gtgtggtcgg gtgtgttatt attctgaatt ttgggggagg ttatatgggt 240
ttaatggttt ttttaattta tttaggggga atgatggttg tctttggata tactacagcg 300
atggctattg aggagtatcc tgaggcatgg gggtcagggg ttgaggtctt ggtgagtgtt 360
ttagtggggt tagcgatgga ggtaggattg gtgctgtggg tgaaagagta tgatggggtg 420
gtggttgtgg taaactttaa tagtgtagga agctggatga tttatgaagg agaggggtca 480
gggttgattc gggaggatcc tattggtgcg ggggctttgt atgattatgg gcgttggtta 540
gtagtagtta ctggttggac attgtttgtt ggtgtatata ttgtaattga gattgctcgg 600
gggaattagg agcactggga cgcccaccgc ccctttccct ccgctgccag gcgagcatgt 660
tgtggtaatt ctggaacaca agaagagaaa ttgctgggtt tagaacaaga ttataaacga 720
attcggtgct cagtgatcac ttgacagttt tttttttttt taaatattac ccaaaatgct 780
ccccaaataa gaaatgcatc agctcagtca gtgaatacaa aaaaggaatt atttttccct 840
ttgagggtct tttatacatc tctcctccaa ccccaccctc tattctgttt cttcctcctc 900
acatgggggt acacatacac agcttcctct tttggttcca tccttaccac cacaccacac 960
gcacactcca catgcccagc agagtggcac ttggtggcca gaaagtgtga gcctcatgat 1020
ctgctgtctg tagttctgtg agctcaggtc cctcaaaggc ctcggagcac ccccttcctt 1080
gtgactgagc cagggcctgc atttttggtt ttccccaccc cacacattct caaccatagt 1140
ccttctaaca ataccaatag ctaggacccg gctgctgtgc actgggactg gggattccac 1200
atgtttgcct tgggagtctc aagctggact gccagcccct gtcctccctt cacccccatt 1260
gcgtatgagc atttcagaac tccaaggagt cacaggcatc tttatagttc acgttaacat 1320
atagacactg ttggaagcag ttccttctaa aagggtagcc ctggacttaa taccagccgg 1380
atacctctgg cccccacccc attactgtac ctctggagtc actactgtgg gtcgccactc 1440
ctctgctaca cagcacggct ttttcaaggc tgtattgaga agggaagtta ggaagaaggg 1500
tgtgctgggc taaccagccc acagagctca cattcctgtc ccttgggtga aaaatacatg 1560
tccatcctga tatctcctga attcagaaat tagcctccac atgtgcaatg gctttaagag 1620
ccagaagcag ggttctggga attttgcaag ttacctgtgg ccaggtgtgg tctcggttac 1680
caaatacggt tacctgcagc tttttagtcc tttgtgctcc cacgggtcta cagagtccca 1740
tctgcccaaa ggtcttgaag cttgacagga tgttttcgat tactcagtct cccagggcac 1800
tactggtccg taggattcga ttggtcgggg taggagagtt aaacaacatt taaacagagt 1860
tctctcaaaa atgtctaaag ggattgtagg tagataacat ccaatcactg tttgcactta 1920
tctgaaatct tccctcttgg ctgcccccag gtatttactg tggagaacat tgcataggaa 1980
tgtctggaaa aagcttctac aacttgttac agccttcaca tttgtagaag cttt 2034
<210> 36
<211> 1234
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10-ND6-3'UTR*
<400> 36
atggccgcct ctccacacac actgagtagc agactgctga ccggctgtgt tggcggctct 60
gtgtggtatc tggaacggcg gacaatgatg tatgctttgt ttctgttgag tgtgggttta 120
gtaatggggt ttgtggggtt ttcttctaag ccttctccta tttatggggg tttagtattg 180
attgttagcg gtgtggtcgg gtgtgttatt attctgaatt ttgggggagg ttatatgggt 240
ttaatggttt ttttaattta tttaggggga atgatggttg tctttggata tactacagcg 300
atggctattg aggagtatcc tgaggcatgg gggtcagggg ttgaggtctt ggtgagtgtt 360
ttagtggggt tagcgatgga ggtaggattg gtgctgtggg tgaaagagta tgatggggtg 420
gtggttgtgg taaactttaa tagtgtagga agctggatga tttatgaagg agaggggtca 480
gggttgattc gggaggatcc tattggtgcg ggggctttgt atgattatgg gcgttggtta 540
gtagtagtta ctggttggac attgtttgtt ggtgtatata ttgtaattga gattgctcgg 600
gggaattagg agcactggga cgcccaccgc ccctttccct ccgctgccag gcgagcatgt 660
tgtggtaatt ctggaacaca agaagagaaa ttgctgggtt tagaacaaga ttataaacga 720
attcggtgct cagtgatcac ttgacagttt tttttttttt taaatattac ccaaaatgct 780
ccccaaataa gaaatgcatc agctcagtca gtgaatacaa aaaaggaatt atttttccct 840
ttgagggtct tttatacatc tctcctccaa ccccaccctc tattctgttt cttcctcctc 900
acatgggggt acacatacac agcttcctct tttggttcca tccttaccac cacaccacac 960
gcacactcca catgcccagc agagtggcac ttggtggcca gaaagtgtga gcctcatgat 1020
ctgctgtctg tagttctgtg agctcaggtc cctcaaaggc ctcggagcac ccccttcctt 1080
gtgactgagc cagggcctgc atttttggtt ttccccaccc cacacattct caaccatagt 1140
ccttctaaca ataccaatag ctaggacccg gctgctgtgc actgggactg gggattccac 1200
atgtttgcct tgggagtctc aagctggact gcca 1234
<210> 37
<211> 2034
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10-opt_ND6-3'UTR
<400> 37
atggccgcct ctccacacac actgagtagc agactgctga ccggctgtgt tggcggctct 60
gtgtggtatc tggaacggcg gacaatgatg tacgccctgt tcctgctgag cgtgggcctg 120
gtgatgggct tcgtgggctt cagcagcaag cccagcccca tctacggcgg cctggtgctg 180
atcgtgagcg gcgtggtggg ctgcgtgatc atcctgaact tcggcggcgg ctacatgggc 240
ctgatggtgt tcctgatcta cctgggcggc atgatggtgg tgttcggcta caccaccgcc 300
atggccatcg aggagtaccc cgaggcctgg ggcagcggcg tggaggtgct ggtgagcgtg 360
ctggtgggcc tggccatgga ggtgggcctg gtgctgtggg tgaaggagta cgacggcgtg 420
gtggtggtgg tgaacttcaa cagcgtgggc agctggatga tctacgaggg cgagggcagc 480
ggcctgatcc gcgaggaccc catcggcgcc ggcgccctgt acgactacgg ccgctggctg 540
gtggtggtga ccggctggac cctgttcgtg ggcgtgtaca tcgtgatcga gatcgcccgc 600
ggcaactaag agcactggga cgcccaccgc ccctttccct ccgctgccag gcgagcatgt 660
tgtggtaatt ctggaacaca agaagagaaa ttgctgggtt tagaacaaga ttataaacga 720
attcggtgct cagtgatcac ttgacagttt tttttttttt taaatattac ccaaaatgct 780
ccccaaataa gaaatgcatc agctcagtca gtgaatacaa aaaaggaatt atttttccct 840
ttgagggtct tttatacatc tctcctccaa ccccaccctc tattctgttt cttcctcctc 900
acatgggggt acacatacac agcttcctct tttggttcca tccttaccac cacaccacac 960
gcacactcca catgcccagc agagtggcac ttggtggcca gaaagtgtga gcctcatgat 1020
ctgctgtctg tagttctgtg agctcaggtc cctcaaaggc ctcggagcac ccccttcctt 1080
gtgactgagc cagggcctgc atttttggtt ttccccaccc cacacattct caaccatagt 1140
ccttctaaca ataccaatag ctaggacccg gctgctgtgc actgggactg gggattccac 1200
atgtttgcct tgggagtctc aagctggact gccagcccct gtcctccctt cacccccatt 1260
gcgtatgagc atttcagaac tccaaggagt cacaggcatc tttatagttc acgttaacat 1320
atagacactg ttggaagcag ttccttctaa aagggtagcc ctggacttaa taccagccgg 1380
atacctctgg cccccacccc attactgtac ctctggagtc actactgtgg gtcgccactc 1440
ctctgctaca cagcacggct ttttcaaggc tgtattgaga agggaagtta ggaagaaggg 1500
tgtgctgggc taaccagccc acagagctca cattcctgtc ccttgggtga aaaatacatg 1560
tccatcctga tatctcctga attcagaaat tagcctccac atgtgcaatg gctttaagag 1620
ccagaagcag ggttctggga attttgcaag ttacctgtgg ccaggtgtgg tctcggttac 1680
caaatacggt tacctgcagc tttttagtcc tttgtgctcc cacgggtcta cagagtccca 1740
tctgcccaaa ggtcttgaag cttgacagga tgttttcgat tactcagtct cccagggcac 1800
tactggtccg taggattcga ttggtcgggg taggagagtt aaacaacatt taaacagagt 1860
tctctcaaaa atgtctaaag ggattgtagg tagataacat ccaatcactg tttgcactta 1920
tctgaaatct tccctcttgg ctgcccccag gtatttactg tggagaacat tgcataggaa 1980
tgtctggaaa aagcttctac aacttgttac agccttcaca tttgtagaag cttt 2034
<210> 38
<211> 1234
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10-opt_ND6-3'UTR*
<400> 38
atggccgcct ctccacacac actgagtagc agactgctga ccggctgtgt tggcggctct 60
gtgtggtatc tggaacggcg gacaatgatg tacgccctgt tcctgctgag cgtgggcctg 120
gtgatgggct tcgtgggctt cagcagcaag cccagcccca tctacggcgg cctggtgctg 180
atcgtgagcg gcgtggtggg ctgcgtgatc atcctgaact tcggcggcgg ctacatgggc 240
ctgatggtgt tcctgatcta cctgggcggc atgatggtgg tgttcggcta caccaccgcc 300
atggccatcg aggagtaccc cgaggcctgg ggcagcggcg tggaggtgct ggtgagcgtg 360
ctggtgggcc tggccatgga ggtgggcctg gtgctgtggg tgaaggagta cgacggcgtg 420
gtggtggtgg tgaacttcaa cagcgtgggc agctggatga tctacgaggg cgagggcagc 480
ggcctgatcc gcgaggaccc catcggcgcc ggcgccctgt acgactacgg ccgctggctg 540
gtggtggtga ccggctggac cctgttcgtg ggcgtgtaca tcgtgatcga gatcgcccgc 600
ggcaactaag agcactggga cgcccaccgc ccctttccct ccgctgccag gcgagcatgt 660
tgtggtaatt ctggaacaca agaagagaaa ttgctgggtt tagaacaaga ttataaacga 720
attcggtgct cagtgatcac ttgacagttt tttttttttt taaatattac ccaaaatgct 780
ccccaaataa gaaatgcatc agctcagtca gtgaatacaa aaaaggaatt atttttccct 840
ttgagggtct tttatacatc tctcctccaa ccccaccctc tattctgttt cttcctcctc 900
acatgggggt acacatacac agcttcctct tttggttcca tccttaccac cacaccacac 960
gcacactcca catgcccagc agagtggcac ttggtggcca gaaagtgtga gcctcatgat 1020
ctgctgtctg tagttctgtg agctcaggtc cctcaaaggc ctcggagcac ccccttcctt 1080
gtgactgagc cagggcctgc atttttggtt ttccccaccc cacacattct caaccatagt 1140
ccttctaaca ataccaatag ctaggacccg gctgctgtgc actgggactg gggattccac 1200
atgtttgcct tgggagtctc aagctggact gcca 1234
<210> 39
<211> 2460
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10-ND1-3'UTR
<400> 39
atggccgcct ctccacacac actgagtagc agactgctga ccggctgtgt tggcggctct 60
gtgtggtatc tggaacggcg gacaatggcc aacctcctac tcctcattgt acccattcta 120
atcgcaatgg cattcctaat gcttaccgaa cgaaaaattc taggctatat gcaactacgc 180
aaaggcccca acgttgtagg cccctacggg ctactacaac ccttcgctga cgccataaaa 240
ctcttcacca aagagcccct aaaacccgcc acatctacca tcaccctcta catcaccgcc 300
ccgaccttag ctctcaccat cgctcttcta ctatggaccc ccctccccat gcccaacccc 360
ctggtcaacc tcaacctagg cctcctattt attctagcca cctctagcct agccgtttac 420
tcaatcctct ggtcagggtg ggcatcaaac tcaaactacg ccctgatcgg cgcactgcga 480
gcagtagccc aaacaatctc atatgaagtc accctagcca tcattctact atcaacatta 540
ctaatgagtg gctcctttaa cctctccacc cttatcacaa cacaagaaca cctctggtta 600
ctcctgccat catggccctt ggccatgatg tggtttatct ccacactagc agagaccaac 660
cgaaccccct tcgaccttgc cgaaggggag tccgaactag tctcaggctt caacatcgaa 720
tacgccgcag gccccttcgc cctattcttc atggccgaat acacaaacat tattatgatg 780
aacaccctca ccactacaat cttcctagga acaacatatg acgcactctc ccctgaactc 840
tacacaacat attttgtcac caagacccta cttctaacct ccctgttctt atggattcga 900
acagcatacc cccgattccg ctacgaccaa ctcatgcacc tcctatggaa aaacttccta 960
ccactcaccc tagcattact tatgtggtat gtctccatgc ccattacaat ctccagcatt 1020
ccccctcaaa cctaagagca ctgggacgcc caccgcccct ttccctccgc tgccaggcga 1080
gcatgttgtg gtaattctgg aacacaagaa gagaaattgc tgggtttaga acaagattat 1140
aaacgaattc ggtgctcagt gatcacttga cagttttttt tttttttaaa tattacccaa 1200
aatgctcccc aaataagaaa tgcatcagct cagtcagtga atacaaaaaa ggaattattt 1260
ttccctttga gggtctttta tacatctctc ctccaacccc accctctatt ctgtttcttc 1320
ctcctcacat gggggtacac atacacagct tcctcttttg gttccatcct taccaccaca 1380
ccacacgcac actccacatg cccagcagag tggcacttgg tggccagaaa gtgtgagcct 1440
catgatctgc tgtctgtagt tctgtgagct caggtccctc aaaggcctcg gagcaccccc 1500
ttccttgtga ctgagccagg gcctgcattt ttggttttcc ccaccccaca cattctcaac 1560
catagtcctt ctaacaatac caatagctag gacccggctg ctgtgcactg ggactgggga 1620
ttccacatgt ttgccttggg agtctcaagc tggactgcca gcccctgtcc tcccttcacc 1680
cccattgcgt atgagcattt cagaactcca aggagtcaca ggcatcttta tagttcacgt 1740
taacatatag acactgttgg aagcagttcc ttctaaaagg gtagccctgg acttaatacc 1800
agccggatac ctctggcccc caccccatta ctgtacctct ggagtcacta ctgtgggtcg 1860
ccactcctct gctacacagc acggcttttt caaggctgta ttgagaaggg aagttaggaa 1920
gaagggtgtg ctgggctaac cagcccacag agctcacatt cctgtccctt gggtgaaaaa 1980
tacatgtcca tcctgatatc tcctgaattc agaaattagc ctccacatgt gcaatggctt 2040
taagagccag aagcagggtt ctgggaattt tgcaagttac ctgtggccag gtgtggtctc 2100
ggttaccaaa tacggttacc tgcagctttt tagtcctttg tgctcccacg ggtctacaga 2160
gtcccatctg cccaaaggtc ttgaagcttg acaggatgtt ttcgattact cagtctccca 2220
gggcactact ggtccgtagg attcgattgg tcggggtagg agagttaaac aacatttaaa 2280
cagagttctc tcaaaaatgt ctaaagggat tgtaggtaga taacatccaa tcactgtttg 2340
cacttatctg aaatcttccc tcttggctgc ccccaggtat ttactgtgga gaacattgca 2400
taggaatgtc tggaaaaagc ttctacaact tgttacagcc ttcacatttg tagaagcttt 2460
2460
<210> 40
<211> 1660
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10-ND1-3'UTR*
<400> 40
atggccgcct ctccacacac actgagtagc agactgctga ccggctgtgt tggcggctct 60
gtgtggtatc tggaacggcg gacaatggcc aacctcctac tcctcattgt acccattcta 120
atcgcaatgg cattcctaat gcttaccgaa cgaaaaattc taggctatat gcaactacgc 180
aaaggcccca acgttgtagg cccctacggg ctactacaac ccttcgctga cgccataaaa 240
ctcttcacca aagagcccct aaaacccgcc acatctacca tcaccctcta catcaccgcc 300
ccgaccttag ctctcaccat cgctcttcta ctatggaccc ccctccccat gcccaacccc 360
ctggtcaacc tcaacctagg cctcctattt attctagcca cctctagcct agccgtttac 420
tcaatcctct ggtcagggtg ggcatcaaac tcaaactacg ccctgatcgg cgcactgcga 480
gcagtagccc aaacaatctc atatgaagtc accctagcca tcattctact atcaacatta 540
ctaatgagtg gctcctttaa cctctccacc cttatcacaa cacaagaaca cctctggtta 600
ctcctgccat catggccctt ggccatgatg tggtttatct ccacactagc agagaccaac 660
cgaaccccct tcgaccttgc cgaaggggag tccgaactag tctcaggctt caacatcgaa 720
tacgccgcag gccccttcgc cctattcttc atggccgaat acacaaacat tattatgatg 780
aacaccctca ccactacaat cttcctagga acaacatatg acgcactctc ccctgaactc 840
tacacaacat attttgtcac caagacccta cttctaacct ccctgttctt atggattcga 900
acagcatacc cccgattccg ctacgaccaa ctcatgcacc tcctatggaa aaacttccta 960
ccactcaccc tagcattact tatgtggtat gtctccatgc ccattacaat ctccagcatt 1020
ccccctcaaa cctaagagca ctgggacgcc caccgcccct ttccctccgc tgccaggcga 1080
gcatgttgtg gtaattctgg aacacaagaa gagaaattgc tgggtttaga acaagattat 1140
aaacgaattc ggtgctcagt gatcacttga cagttttttt tttttttaaa tattacccaa 1200
aatgctcccc aaataagaaa tgcatcagct cagtcagtga atacaaaaaa ggaattattt 1260
ttccctttga gggtctttta tacatctctc ctccaacccc accctctatt ctgtttcttc 1320
ctcctcacat gggggtacac atacacagct tcctcttttg gttccatcct taccaccaca 1380
ccacacgcac actccacatg cccagcagag tggcacttgg tggccagaaa gtgtgagcct 1440
catgatctgc tgtctgtagt tctgtgagct caggtccctc aaaggcctcg gagcaccccc 1500
ttccttgtga ctgagccagg gcctgcattt ttggttttcc ccaccccaca cattctcaac 1560
catagtcctt ctaacaatac caatagctag gacccggctg ctgtgcactg ggactgggga 1620
ttccacatgt ttgccttggg agtctcaagc tggactgcca 1660
<210> 41
<211> 2460
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10-opt_ND1-3'UTR
<400> 41
atggccgcct ctccacacac actgagtagc agactgctga ccggctgtgt tggcggctct 60
gtgtggtatc tggaacggcg gacaatggcc aacctgctgc tgctgatcgt gcccatcctg 120
atcgccatgg ccttcctgat gctgaccgag cgcaagatcc tgggctacat gcagctgcgc 180
aagggcccca acgtggtggg cccctacggc ctgctgcagc ccttcgccga cgccatcaag 240
ctgttcacca aggagcccct gaagcccgcc accagcacca tcaccctgta catcaccgcc 300
cccaccctgg ccctgaccat cgccctgctg ctgtggaccc ccctgcccat gcccaacccc 360
ctggtgaacc tgaacctggg cctgctgttc atcctggcca ccagcagcct ggccgtgtac 420
agcatcctgt ggagcggctg ggccagcaac agcaactacg ccctgatcgg cgccctgcgc 480
gccgtggccc agaccatcag ctacgaggtg accctggcca tcatcctgct gagcaccctg 540
ctgatgagcg gcagcttcaa cctgagcacc ctgatcacca cccaggagca cctgtggctg 600
ctgctgccca gctggcccct ggccatgatg tggttcatca gcaccctggc cgagaccaac 660
cgcaccccct tcgacctggc cgagggcgag agcgagctgg tgagcggctt caacatcgag 720
tacgccgccg gccccttcgc cctgttcttc atggccgagt acaccaacat catcatgatg 780
aacaccctga ccaccaccat cttcctgggc accacctacg acgccctgag ccccgagctg 840
tacaccacct acttcgtgac caagaccctg ctgctgacca gcctgttcct gtggatccgc 900
accgcctacc cccgcttccg ctacgaccag ctgatgcacc tgctgtggaa gaacttcctg 960
cccctgaccc tggccctgct gatgtggtac gtgagcatgc ccatcaccat cagcagcatc 1020
cccccccaga cctaagagca ctgggacgcc caccgcccct ttccctccgc tgccaggcga 1080
gcatgttgtg gtaattctgg aacacaagaa gagaaattgc tgggtttaga acaagattat 1140
aaacgaattc ggtgctcagt gatcacttga cagttttttt tttttttaaa tattacccaa 1200
aatgctcccc aaataagaaa tgcatcagct cagtcagtga atacaaaaaa ggaattattt 1260
ttccctttga gggtctttta tacatctctc ctccaacccc accctctatt ctgtttcttc 1320
ctcctcacat gggggtacac atacacagct tcctcttttg gttccatcct taccaccaca 1380
ccacacgcac actccacatg cccagcagag tggcacttgg tggccagaaa gtgtgagcct 1440
catgatctgc tgtctgtagt tctgtgagct caggtccctc aaaggcctcg gagcaccccc 1500
ttccttgtga ctgagccagg gcctgcattt ttggttttcc ccaccccaca cattctcaac 1560
catagtcctt ctaacaatac caatagctag gacccggctg ctgtgcactg ggactgggga 1620
ttccacatgt ttgccttggg agtctcaagc tggactgcca gcccctgtcc tcccttcacc 1680
cccattgcgt atgagcattt cagaactcca aggagtcaca ggcatcttta tagttcacgt 1740
taacatatag acactgttgg aagcagttcc ttctaaaagg gtagccctgg acttaatacc 1800
agccggatac ctctggcccc caccccatta ctgtacctct ggagtcacta ctgtgggtcg 1860
ccactcctct gctacacagc acggcttttt caaggctgta ttgagaaggg aagttaggaa 1920
gaagggtgtg ctgggctaac cagcccacag agctcacatt cctgtccctt gggtgaaaaa 1980
tacatgtcca tcctgatatc tcctgaattc agaaattagc ctccacatgt gcaatggctt 2040
taagagccag aagcagggtt ctgggaattt tgcaagttac ctgtggccag gtgtggtctc 2100
ggttaccaaa tacggttacc tgcagctttt tagtcctttg tgctcccacg ggtctacaga 2160
gtcccatctg cccaaaggtc ttgaagcttg acaggatgtt ttcgattact cagtctccca 2220
gggcactact ggtccgtagg attcgattgg tcggggtagg agagttaaac aacatttaaa 2280
cagagttctc tcaaaaatgt ctaaagggat tgtaggtaga taacatccaa tcactgtttg 2340
cacttatctg aaatcttccc tcttggctgc ccccaggtat ttactgtgga gaacattgca 2400
taggaatgtc tggaaaaagc ttctacaact tgttacagcc ttcacatttg tagaagcttt 2460
2460
<210> 42
<211> 1660
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10-opt_ND1-3'UTR*
<400> 42
atggccgcct ctccacacac actgagtagc agactgctga ccggctgtgt tggcggctct 60
gtgtggtatc tggaacggcg gacaatggcc aacctgctgc tgctgatcgt gcccatcctg 120
atcgccatgg ccttcctgat gctgaccgag cgcaagatcc tgggctacat gcagctgcgc 180
aagggcccca acgtggtggg cccctacggc ctgctgcagc ccttcgccga cgccatcaag 240
ctgttcacca aggagcccct gaagcccgcc accagcacca tcaccctgta catcaccgcc 300
cccaccctgg ccctgaccat cgccctgctg ctgtggaccc ccctgcccat gcccaacccc 360
ctggtgaacc tgaacctggg cctgctgttc atcctggcca ccagcagcct ggccgtgtac 420
agcatcctgt ggagcggctg ggccagcaac agcaactacg ccctgatcgg cgccctgcgc 480
gccgtggccc agaccatcag ctacgaggtg accctggcca tcatcctgct gagcaccctg 540
ctgatgagcg gcagcttcaa cctgagcacc ctgatcacca cccaggagca cctgtggctg 600
ctgctgccca gctggcccct ggccatgatg tggttcatca gcaccctggc cgagaccaac 660
cgcaccccct tcgacctggc cgagggcgag agcgagctgg tgagcggctt caacatcgag 720
tacgccgccg gccccttcgc cctgttcttc atggccgagt acaccaacat catcatgatg 780
aacaccctga ccaccaccat cttcctgggc accacctacg acgccctgag ccccgagctg 840
tacaccacct acttcgtgac caagaccctg ctgctgacca gcctgttcct gtggatccgc 900
accgcctacc cccgcttccg ctacgaccag ctgatgcacc tgctgtggaa gaacttcctg 960
cccctgaccc tggccctgct gatgtggtac gtgagcatgc ccatcaccat cagcagcatc 1020
cccccccaga cctaagagca ctgggacgcc caccgcccct ttccctccgc tgccaggcga 1080
gcatgttgtg gtaattctgg aacacaagaa gagaaattgc tgggtttaga acaagattat 1140
aaacgaattc ggtgctcagt gatcacttga cagttttttt tttttttaaa tattacccaa 1200
aatgctcccc aaataagaaa tgcatcagct cagtcagtga atacaaaaaa ggaattattt 1260
ttccctttga gggtctttta tacatctctc ctccaacccc accctctatt ctgtttcttc 1320
ctcctcacat gggggtacac atacacagct tcctcttttg gttccatcct taccaccaca 1380
ccacacgcac actccacatg cccagcagag tggcacttgg tggccagaaa gtgtgagcct 1440
catgatctgc tgtctgtagt tctgtgagct caggtccctc aaaggcctcg gagcaccccc 1500
ttccttgtga ctgagccagg gcctgcattt ttggttttcc ccaccccaca cattctcaac 1560
catagtcctt ctaacaatac caatagctag gacccggctg ctgtgcactg ggactgggga 1620
ttccacatgt ttgccttggg agtctcaagc tggactgcca 1660
<210> 43
<211> 2889
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10*-ND4-3'UTR
<400> 43
atggccgcca gcccccacac cctgagcagc cgcctgctga ccggctgcgt gggcggcagc 60
gtgtggtacc tggagcgccg caccatgcta aaactaatcg tcccaacaat tatgttacta 120
ccactgacat ggctttccaa aaaacacatg atttggatca acacaaccac ccacagccta 180
attattagca tcatccctct actatttttt aaccaaatca acaacaacct atttagctgt 240
tccccaacct tttcctccga ccccctaaca acccccctcc taatgctaac tacctggctc 300
ctacccctca caatcatggc aagccaacgc cacttatcca gtgaaccact atcacgaaaa 360
aaactctacc tctctatgct aatctcccta caaatctcct taattatgac attcacagcc 420
acagaactaa tcatgtttta tatcttcttc gaaaccacac ttatccccac cttggctatc 480
atcacccgat ggggcaacca gccagaacgc ctgaacgcag gcacatactt cctattctac 540
accctagtag gctcccttcc cctactcatc gcactaattt acactcacaa caccctaggc 600
tcactaaaca ttctactact cactctcact gcccaagaac tatcaaactc ctgggccaac 660
aacttaatgt ggctagctta cacaatggct tttatggtaa agatgcctct ttacggactc 720
cacttatggc tccctaaagc ccatgtcgaa gcccccatcg ctgggtcaat ggtacttgcc 780
gcagtactct taaaactagg cggctatggt atgatgcgcc tcacactcat tctcaacccc 840
ctgacaaaac acatggccta ccccttcctt gtactatccc tatggggcat gattatgaca 900
agctccatct gcctacgaca aacagaccta aaatcgctca ttgcatactc ttcaatcagc 960
cacatggccc tcgtagtaac agccattctc atccaaaccc cctggagctt caccggcgca 1020
gtcattctca tgatcgccca cgggcttaca tcctcattac tattctgcct agcaaactca 1080
aactacgaac gcactcacag tcgcatcatg atcctctctc aaggacttca aactctactc 1140
ccactaatgg ctttttggtg gcttctagca agcctcgcta acctcgcctt accccccact 1200
attaacctac tgggagaact ctctgtgcta gtaaccacgt tctcctggtc aaatatcact 1260
ctcctactta caggactcaa catgctagtc acagccctat actccctcta catgtttacc 1320
acaacacaat ggggctcact cacccaccac attaacaaca tgaaaccctc attcacacga 1380
gaaaacaccc tcatgttcat gcacctatcc cccattctcc tcctatccct caaccccgac 1440
atcattaccg ggttttcctc ttaagagcac tgggacgccc accgcccctt tccctccgct 1500
gccaggcgag catgttgtgg taattctgga acacaagaag agaaattgct gggtttagaa 1560
caagattata aacgaattcg gtgctcagtg atcacttgac agtttttttt ttttttaaat 1620
attacccaaa atgctcccca aataagaaat gcatcagctc agtcagtgaa tacaaaaaag 1680
gaattatttt tccctttgag ggtcttttat acatctctcc tccaacccca ccctctattc 1740
tgtttcttcc tcctcacatg ggggtacaca tacacagctt cctcttttgg ttccatcctt 1800
accaccacac cacacgcaca ctccacatgc ccagcagagt ggcacttggt ggccagaaag 1860
tgtgagcctc atgatctgct gtctgtagtt ctgtgagctc aggtccctca aaggcctcgg 1920
agcaccccct tccttgtgac tgagccaggg cctgcatttt tggttttccc caccccacac 1980
attctcaacc atagtccttc taacaatacc aatagctagg acccggctgc tgtgcactgg 2040
gactggggat tccacatgtt tgccttggga gtctcaagct ggactgccag cccctgtcct 2100
cccttcaccc ccattgcgta tgagcatttc agaactccaa ggagtcacag gcatctttat 2160
agttcacgtt aacatataga cactgttgga agcagttcct tctaaaaggg tagccctgga 2220
cttaatacca gccggatacc tctggccccc accccattac tgtacctctg gagtcactac 2280
tgtgggtcgc cactcctctg ctacacagca cggctttttc aaggctgtat tgagaaggga 2340
agttaggaag aagggtgtgc tgggctaacc agcccacaga gctcacattc ctgtcccttg 2400
ggtgaaaaat acatgtccat cctgatatct cctgaattca gaaattagcc tccacatgtg 2460
caatggcttt aagagccaga agcagggttc tgggaatttt gcaagttacc tgtggccagg 2520
tgtggtctcg gttaccaaat acggttacct gcagcttttt agtcctttgt gctcccacgg 2580
gtctacagag tcccatctgc ccaaaggtct tgaagcttga caggatgttt tcgattactc 2640
agtctcccag ggcactactg gtccgtagga ttcgattggt cggggtagga gagttaaaca 2700
acatttaaac agagttctct caaaaatgtc taaagggatt gtaggtagat aacatccaat 2760
cactgtttgc acttatctga aatcttccct cttggctgcc cccaggtatt tactgtggag 2820
aacattgcat aggaatgtct ggaaaaagct tctacaactt gttacagcct tcacatttgt 2880
agaagcttt 2889
<210> 44
<211> 2089
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10*-ND4-3'UTR*
<400> 44
atggccgcca gcccccacac cctgagcagc cgcctgctga ccggctgcgt gggcggcagc 60
gtgtggtacc tggagcgccg caccatgcta aaactaatcg tcccaacaat tatgttacta 120
ccactgacat ggctttccaa aaaacacatg atttggatca acacaaccac ccacagccta 180
attattagca tcatccctct actatttttt aaccaaatca acaacaacct atttagctgt 240
tccccaacct tttcctccga ccccctaaca acccccctcc taatgctaac tacctggctc 300
ctacccctca caatcatggc aagccaacgc cacttatcca gtgaaccact atcacgaaaa 360
aaactctacc tctctatgct aatctcccta caaatctcct taattatgac attcacagcc 420
acagaactaa tcatgtttta tatcttcttc gaaaccacac ttatccccac cttggctatc 480
atcacccgat ggggcaacca gccagaacgc ctgaacgcag gcacatactt cctattctac 540
accctagtag gctcccttcc cctactcatc gcactaattt acactcacaa caccctaggc 600
tcactaaaca ttctactact cactctcact gcccaagaac tatcaaactc ctgggccaac 660
aacttaatgt ggctagctta cacaatggct tttatggtaa agatgcctct ttacggactc 720
cacttatggc tccctaaagc ccatgtcgaa gcccccatcg ctgggtcaat ggtacttgcc 780
gcagtactct taaaactagg cggctatggt atgatgcgcc tcacactcat tctcaacccc 840
ctgacaaaac acatggccta ccccttcctt gtactatccc tatggggcat gattatgaca 900
agctccatct gcctacgaca aacagaccta aaatcgctca ttgcatactc ttcaatcagc 960
cacatggccc tcgtagtaac agccattctc atccaaaccc cctggagctt caccggcgca 1020
gtcattctca tgatcgccca cgggcttaca tcctcattac tattctgcct agcaaactca 1080
aactacgaac gcactcacag tcgcatcatg atcctctctc aaggacttca aactctactc 1140
ccactaatgg ctttttggtg gcttctagca agcctcgcta acctcgcctt accccccact 1200
attaacctac tgggagaact ctctgtgcta gtaaccacgt tctcctggtc aaatatcact 1260
ctcctactta caggactcaa catgctagtc acagccctat actccctcta catgtttacc 1320
acaacacaat ggggctcact cacccaccac attaacaaca tgaaaccctc attcacacga 1380
gaaaacaccc tcatgttcat gcacctatcc cccattctcc tcctatccct caaccccgac 1440
atcattaccg ggttttcctc ttaagagcac tgggacgccc accgcccctt tccctccgct 1500
gccaggcgag catgttgtgg taattctgga acacaagaag agaaattgct gggtttagaa 1560
caagattata aacgaattcg gtgctcagtg atcacttgac agtttttttt ttttttaaat 1620
attacccaaa atgctcccca aataagaaat gcatcagctc agtcagtgaa tacaaaaaag 1680
gaattatttt tccctttgag ggtcttttat acatctctcc tccaacccca ccctctattc 1740
tgtttcttcc tcctcacatg ggggtacaca tacacagctt cctcttttgg ttccatcctt 1800
accaccacac cacacgcaca ctccacatgc ccagcagagt ggcacttggt ggccagaaag 1860
tgtgagcctc atgatctgct gtctgtagtt ctgtgagctc aggtccctca aaggcctcgg 1920
agcaccccct tccttgtgac tgagccaggg cctgcatttt tggttttccc caccccacac 1980
attctcaacc atagtccttc taacaatacc aatagctagg acccggctgc tgtgcactgg 2040
gactggggat tccacatgtt tgccttggga gtctcaagct ggactgcca 2089
<210> 45
<211> 2889
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10*-opt_ND4-3'UTR
<400> 45
atggccgcca gcccccacac cctgagcagc cgcctgctga ccggctgcgt gggcggcagc 60
gtgtggtacc tggagcgccg caccatgctg aagctgatcg tgcccaccat catgctgctg 120
cctctgacct ggctgagcaa gaaacacatg atctggatca acaccaccac gcacagcctg 180
atcatcagca tcatccctct gctgttcttc aaccagatca acaacaacct gttcagctgc 240
agccccacct tcagcagcga ccctctgaca acacctctgc tgatgctgac cacctggctg 300
ctgcccctca caatcatggc ctctcagaga cacctgagca gcgagcccct gagccggaag 360
aaactgtacc tgagcatgct gatctccctg cagatctctc tgatcatgac cttcaccgcc 420
accgagctga tcatgttcta catctttttc gagacaacgc tgatccccac actggccatc 480
atcaccagat ggggcaacca gcctgagaga ctgaacgccg gcacctactt tctgttctac 540
accctcgtgg gcagcctgcc actgctgatt gccctgatct acacccacaa caccctgggc 600
tccctgaaca tcctgctgct gacactgaca gcccaagagc tgagcaacag ctgggccaac 660
aatctgatgt ggctggccta cacaatggcc ttcatggtca agatgcccct gtacggcctg 720
cacctgtggc tgcctaaagc tcatgtggaa gcccctatcg ccggctctat ggtgctggct 780
gcagtgctgc tgaaactcgg cggctacggc atgatgcggc tgaccctgat tctgaatccc 840
ctgaccaagc acatggccta tccatttctg gtgctgagcc tgtggggcat gattatgacc 900
agcagcatct gcctgcggca gaccgatctg aagtccctga tcgcctacag ctccatcagc 960
cacatggccc tggtggtcac cgccatcctg attcagaccc cttggagctt tacaggcgcc 1020
gtgatcctga tgattgccca cggcctgaca agcagcctgc tgttttgtct ggccaacagc 1080
aactacgagc ggacccacag cagaatcatg atcctgtctc agggcctgca gaccctcctg 1140
cctcttatgg ctttttggtg gctgctggcc tctctggcca atctggcact gcctcctacc 1200
atcaatctgc tgggcgagct gagcgtgctg gtcaccacat tcagctggtc caatatcacc 1260
ctgctgctca ccggcctgaa catgctggtt acagccctgt actccctgta catgttcacc 1320
accacacagt ggggaagcct gacacaccac atcaacaata tgaagcccag cttcacccgc 1380
gagaacaccc tgatgttcat gcatctgagc cccattctgc tgctgtccct gaatcctgat 1440
atcatcaccg gcttctccag ctgagagcac tgggacgccc accgcccctt tccctccgct 1500
gccaggcgag catgttgtgg taattctgga acacaagaag agaaattgct gggtttagaa 1560
caagattata aacgaattcg gtgctcagtg atcacttgac agtttttttt ttttttaaat 1620
attacccaaa atgctcccca aataagaaat gcatcagctc agtcagtgaa tacaaaaaag 1680
gaattatttt tccctttgag ggtcttttat acatctctcc tccaacccca ccctctattc 1740
tgtttcttcc tcctcacatg ggggtacaca tacacagctt cctcttttgg ttccatcctt 1800
accaccacac cacacgcaca ctccacatgc ccagcagagt ggcacttggt ggccagaaag 1860
tgtgagcctc atgatctgct gtctgtagtt ctgtgagctc aggtccctca aaggcctcgg 1920
agcaccccct tccttgtgac tgagccaggg cctgcatttt tggttttccc caccccacac 1980
attctcaacc atagtccttc taacaatacc aatagctagg acccggctgc tgtgcactgg 2040
gactggggat tccacatgtt tgccttggga gtctcaagct ggactgccag cccctgtcct 2100
cccttcaccc ccattgcgta tgagcatttc agaactccaa ggagtcacag gcatctttat 2160
agttcacgtt aacatataga cactgttgga agcagttcct tctaaaaggg tagccctgga 2220
cttaatacca gccggatacc tctggccccc accccattac tgtacctctg gagtcactac 2280
tgtgggtcgc cactcctctg ctacacagca cggctttttc aaggctgtat tgagaaggga 2340
agttaggaag aagggtgtgc tgggctaacc agcccacaga gctcacattc ctgtcccttg 2400
ggtgaaaaat acatgtccat cctgatatct cctgaattca gaaattagcc tccacatgtg 2460
caatggcttt aagagccaga agcagggttc tgggaatttt gcaagttacc tgtggccagg 2520
tgtggtctcg gttaccaaat acggttacct gcagcttttt agtcctttgt gctcccacgg 2580
gtctacagag tcccatctgc ccaaaggtct tgaagcttga caggatgttt tcgattactc 2640
agtctcccag ggcactactg gtccgtagga ttcgattggt cggggtagga gagttaaaca 2700
acatttaaac agagttctct caaaaatgtc taaagggatt gtaggtagat aacatccaat 2760
cactgtttgc acttatctga aatcttccct cttggctgcc cccaggtatt tactgtggag 2820
aacattgcat aggaatgtct ggaaaaagct tctacaactt gttacagcct tcacatttgt 2880
agaagcttt 2889
<210> 46
<211> 2089
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10*-opt_ND4-3'UTR*
<400> 46
atggccgcca gcccccacac cctgagcagc cgcctgctga ccggctgcgt gggcggcagc 60
gtgtggtacc tggagcgccg caccatgctg aagctgatcg tgcccaccat catgctgctg 120
cctctgacct ggctgagcaa gaaacacatg atctggatca acaccaccac gcacagcctg 180
atcatcagca tcatccctct gctgttcttc aaccagatca acaacaacct gttcagctgc 240
agccccacct tcagcagcga ccctctgaca acacctctgc tgatgctgac cacctggctg 300
ctgcccctca caatcatggc ctctcagaga cacctgagca gcgagcccct gagccggaag 360
aaactgtacc tgagcatgct gatctccctg cagatctctc tgatcatgac cttcaccgcc 420
accgagctga tcatgttcta catctttttc gagacaacgc tgatccccac actggccatc 480
atcaccagat ggggcaacca gcctgagaga ctgaacgccg gcacctactt tctgttctac 540
accctcgtgg gcagcctgcc actgctgatt gccctgatct acacccacaa caccctgggc 600
tccctgaaca tcctgctgct gacactgaca gcccaagagc tgagcaacag ctgggccaac 660
aatctgatgt ggctggccta cacaatggcc ttcatggtca agatgcccct gtacggcctg 720
cacctgtggc tgcctaaagc tcatgtggaa gcccctatcg ccggctctat ggtgctggct 780
gcagtgctgc tgaaactcgg cggctacggc atgatgcggc tgaccctgat tctgaatccc 840
ctgaccaagc acatggccta tccatttctg gtgctgagcc tgtggggcat gattatgacc 900
agcagcatct gcctgcggca gaccgatctg aagtccctga tcgcctacag ctccatcagc 960
cacatggccc tggtggtcac cgccatcctg attcagaccc cttggagctt tacaggcgcc 1020
gtgatcctga tgattgccca cggcctgaca agcagcctgc tgttttgtct ggccaacagc 1080
aactacgagc ggacccacag cagaatcatg atcctgtctc agggcctgca gaccctcctg 1140
cctcttatgg ctttttggtg gctgctggcc tctctggcca atctggcact gcctcctacc 1200
atcaatctgc tgggcgagct gagcgtgctg gtcaccacat tcagctggtc caatatcacc 1260
ctgctgctca ccggcctgaa catgctggtt acagccctgt actccctgta catgttcacc 1320
accacacagt ggggaagcct gacacaccac atcaacaata tgaagcccag cttcacccgc 1380
gagaacaccc tgatgttcat gcatctgagc cccattctgc tgctgtccct gaatcctgat 1440
atcatcaccg gcttctccag ctgagagcac tgggacgccc accgcccctt tccctccgct 1500
gccaggcgag catgttgtgg taattctgga acacaagaag agaaattgct gggtttagaa 1560
caagattata aacgaattcg gtgctcagtg atcacttgac agtttttttt ttttttaaat 1620
attacccaaa atgctcccca aataagaaat gcatcagctc agtcagtgaa tacaaaaaag 1680
gaattatttt tccctttgag ggtcttttat acatctctcc tccaacccca ccctctattc 1740
tgtttcttcc tcctcacatg ggggtacaca tacacagctt cctcttttgg ttccatcctt 1800
accaccacac cacacgcaca ctccacatgc ccagcagagt ggcacttggt ggccagaaag 1860
tgtgagcctc atgatctgct gtctgtagtt ctgtgagctc aggtccctca aaggcctcgg 1920
agcaccccct tccttgtgac tgagccaggg cctgcatttt tggttttccc caccccacac 1980
attctcaacc atagtccttc taacaatacc aatagctagg acccggctgc tgtgcactgg 2040
gactggggat tccacatgtt tgccttggga gtctcaagct ggactgcca 2089
<210> 47
<211> 2889
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10*-opt_ND4*-3'UTR
<400> 47
atggccgcca gcccccacac cctgagcagc cgcctgctga ccggctgcgt gggcggcagc 60
gtgtggtacc tggagcgccg caccatgctg aagctgatcg tgcccaccat catgctgctg 120
cccctgacct ggctgagcaa gaagcacatg atctggatca acaccaccac ccacagcctg 180
atcatcagca tcatccccct gctgttcttc aaccagatca acaacaacct gttcagctgc 240
agccccacct tcagcagcga ccccctgacc acccccctgc tgatgctgac cacctggctg 300
ctgcccctga ccatcatggc cagccagcgc cacctgagca gcgagcccct gagccgcaag 360
aagctgtacc tgagcatgct gatcagcctg cagatcagcc tgatcatgac cttcaccgcc 420
accgagctga tcatgttcta catcttcttc gagaccaccc tgatccccac cctggccatc 480
atcacccgct ggggcaacca gcccgagcgc ctgaacgccg gcacctactt cctgttctac 540
accctggtgg gcagcctgcc cctgctgatc gccctgatct acacccacaa caccctgggc 600
agcctgaaca tcctgctgct gaccctgacc gcccaggagc tgagcaacag ctgggccaac 660
aacctgatgt ggctggccta caccatggcc ttcatggtga agatgcccct gtacggcctg 720
cacctgtggc tgcccaaggc ccacgtggag gcccccatcg ccggcagcat ggtgctggcc 780
gccgtgctgc tgaagctggg cggctacggc atgatgcgcc tgaccctgat cctgaacccc 840
ctgaccaagc acatggccta ccccttcctg gtgctgagcc tgtggggcat gatcatgacc 900
agcagcatct gcctgcgcca gaccgacctg aagagcctga tcgcctacag cagcatcagc 960
cacatggccc tggtggtgac cgccatcctg atccagaccc cctggagctt caccggcgcc 1020
gtgatcctga tgatcgccca cggcctgacc agcagcctgc tgttctgcct ggccaacagc 1080
aactacgagc gcacccacag ccgcatcatg atcctgagcc agggcctgca gaccctgctg 1140
cccctgatgg ccttctggtg gctgctggcc agcctggcca acctggccct gccccccacc 1200
atcaacctgc tgggcgagct gagcgtgctg gtgaccacct tcagctggag caacatcacc 1260
ctgctgctga ccggcctgaa catgctggtg accgccctgt acagcctgta catgttcacc 1320
accacccagt ggggcagcct gacccaccac atcaacaaca tgaagcccag cttcacccgc 1380
gagaacaccc tgatgttcat gcacctgagc cccatcctgc tgctgagcct gaaccccgac 1440
atcatcaccg gcttcagcag ctaagagcac tgggacgccc accgcccctt tccctccgct 1500
gccaggcgag catgttgtgg taattctgga acacaagaag agaaattgct gggtttagaa 1560
caagattata aacgaattcg gtgctcagtg atcacttgac agtttttttt ttttttaaat 1620
attacccaaa atgctcccca aataagaaat gcatcagctc agtcagtgaa tacaaaaaag 1680
gaattatttt tccctttgag ggtcttttat acatctctcc tccaacccca ccctctattc 1740
tgtttcttcc tcctcacatg ggggtacaca tacacagctt cctcttttgg ttccatcctt 1800
accaccacac cacacgcaca ctccacatgc ccagcagagt ggcacttggt ggccagaaag 1860
tgtgagcctc atgatctgct gtctgtagtt ctgtgagctc aggtccctca aaggcctcgg 1920
agcaccccct tccttgtgac tgagccaggg cctgcatttt tggttttccc caccccacac 1980
attctcaacc atagtccttc taacaatacc aatagctagg acccggctgc tgtgcactgg 2040
gactggggat tccacatgtt tgccttggga gtctcaagct ggactgccag cccctgtcct 2100
cccttcaccc ccattgcgta tgagcatttc agaactccaa ggagtcacag gcatctttat 2160
agttcacgtt aacatataga cactgttgga agcagttcct tctaaaaggg tagccctgga 2220
cttaatacca gccggatacc tctggccccc accccattac tgtacctctg gagtcactac 2280
tgtgggtcgc cactcctctg ctacacagca cggctttttc aaggctgtat tgagaaggga 2340
agttaggaag aagggtgtgc tgggctaacc agcccacaga gctcacattc ctgtcccttg 2400
ggtgaaaaat acatgtccat cctgatatct cctgaattca gaaattagcc tccacatgtg 2460
caatggcttt aagagccaga agcagggttc tgggaatttt gcaagttacc tgtggccagg 2520
tgtggtctcg gttaccaaat acggttacct gcagcttttt agtcctttgt gctcccacgg 2580
gtctacagag tcccatctgc ccaaaggtct tgaagcttga caggatgttt tcgattactc 2640
agtctcccag ggcactactg gtccgtagga ttcgattggt cggggtagga gagttaaaca 2700
acatttaaac agagttctct caaaaatgtc taaagggatt gtaggtagat aacatccaat 2760
cactgtttgc acttatctga aatcttccct cttggctgcc cccaggtatt tactgtggag 2820
aacattgcat aggaatgtct ggaaaaagct tctacaactt gttacagcct tcacatttgt 2880
agaagcttt 2889
<210> 48
<211> 2089
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10*-opt_ND4*-3'UTR*
<400> 48
atggccgcca gcccccacac cctgagcagc cgcctgctga ccggctgcgt gggcggcagc 60
gtgtggtacc tggagcgccg caccatgctg aagctgatcg tgcccaccat catgctgctg 120
cccctgacct ggctgagcaa gaagcacatg atctggatca acaccaccac ccacagcctg 180
atcatcagca tcatccccct gctgttcttc aaccagatca acaacaacct gttcagctgc 240
agccccacct tcagcagcga ccccctgacc acccccctgc tgatgctgac cacctggctg 300
ctgcccctga ccatcatggc cagccagcgc cacctgagca gcgagcccct gagccgcaag 360
aagctgtacc tgagcatgct gatcagcctg cagatcagcc tgatcatgac cttcaccgcc 420
accgagctga tcatgttcta catcttcttc gagaccaccc tgatccccac cctggccatc 480
atcacccgct ggggcaacca gcccgagcgc ctgaacgccg gcacctactt cctgttctac 540
accctggtgg gcagcctgcc cctgctgatc gccctgatct acacccacaa caccctgggc 600
agcctgaaca tcctgctgct gaccctgacc gcccaggagc tgagcaacag ctgggccaac 660
aacctgatgt ggctggccta caccatggcc ttcatggtga agatgcccct gtacggcctg 720
cacctgtggc tgcccaaggc ccacgtggag gcccccatcg ccggcagcat ggtgctggcc 780
gccgtgctgc tgaagctggg cggctacggc atgatgcgcc tgaccctgat cctgaacccc 840
ctgaccaagc acatggccta ccccttcctg gtgctgagcc tgtggggcat gatcatgacc 900
agcagcatct gcctgcgcca gaccgacctg aagagcctga tcgcctacag cagcatcagc 960
cacatggccc tggtggtgac cgccatcctg atccagaccc cctggagctt caccggcgcc 1020
gtgatcctga tgatcgccca cggcctgacc agcagcctgc tgttctgcct ggccaacagc 1080
aactacgagc gcacccacag ccgcatcatg atcctgagcc agggcctgca gaccctgctg 1140
cccctgatgg ccttctggtg gctgctggcc agcctggcca acctggccct gccccccacc 1200
atcaacctgc tgggcgagct gagcgtgctg gtgaccacct tcagctggag caacatcacc 1260
ctgctgctga ccggcctgaa catgctggtg accgccctgt acagcctgta catgttcacc 1320
accacccagt ggggcagcct gacccaccac atcaacaaca tgaagcccag cttcacccgc 1380
gagaacaccc tgatgttcat gcacctgagc cccatcctgc tgctgagcct gaaccccgac 1440
atcatcaccg gcttcagcag ctaagagcac tgggacgccc accgcccctt tccctccgct 1500
gccaggcgag catgttgtgg taattctgga acacaagaag agaaattgct gggtttagaa 1560
caagattata aacgaattcg gtgctcagtg atcacttgac agtttttttt ttttttaaat 1620
attacccaaa atgctcccca aataagaaat gcatcagctc agtcagtgaa tacaaaaaag 1680
gaattatttt tccctttgag ggtcttttat acatctctcc tccaacccca ccctctattc 1740
tgtttcttcc tcctcacatg ggggtacaca tacacagctt cctcttttgg ttccatcctt 1800
accaccacac cacacgcaca ctccacatgc ccagcagagt ggcacttggt ggccagaaag 1860
tgtgagcctc atgatctgct gtctgtagtt ctgtgagctc aggtccctca aaggcctcgg 1920
agcaccccct tccttgtgac tgagccaggg cctgcatttt tggttttccc caccccacac 1980
attctcaacc atagtccttc taacaatacc aatagctagg acccggctgc tgtgcactgg 2040
gactggggat tccacatgtt tgccttggga gtctcaagct ggactgcca 2089
<210> 49
<211> 2034
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10*-ND6-3'UTR
<400> 49
atggccgcca gcccccacac cctgagcagc cgcctgctga ccggctgcgt gggcggcagc 60
gtgtggtacc tggagcgccg caccatgatg tatgctttgt ttctgttgag tgtgggttta 120
gtaatggggt ttgtggggtt ttcttctaag ccttctccta tttatggggg tttagtattg 180
attgttagcg gtgtggtcgg gtgtgttatt attctgaatt ttgggggagg ttatatgggt 240
ttaatggttt ttttaattta tttaggggga atgatggttg tctttggata tactacagcg 300
atggctattg aggagtatcc tgaggcatgg gggtcagggg ttgaggtctt ggtgagtgtt 360
ttagtggggt tagcgatgga ggtaggattg gtgctgtggg tgaaagagta tgatggggtg 420
gtggttgtgg taaactttaa tagtgtagga agctggatga tttatgaagg agaggggtca 480
gggttgattc gggaggatcc tattggtgcg ggggctttgt atgattatgg gcgttggtta 540
gtagtagtta ctggttggac attgtttgtt ggtgtatata ttgtaattga gattgctcgg 600
gggaattagg agcactggga cgcccaccgc ccctttccct ccgctgccag gcgagcatgt 660
tgtggtaatt ctggaacaca agaagagaaa ttgctgggtt tagaacaaga ttataaacga 720
attcggtgct cagtgatcac ttgacagttt tttttttttt taaatattac ccaaaatgct 780
ccccaaataa gaaatgcatc agctcagtca gtgaatacaa aaaaggaatt atttttccct 840
ttgagggtct tttatacatc tctcctccaa ccccaccctc tattctgttt cttcctcctc 900
acatgggggt acacatacac agcttcctct tttggttcca tccttaccac cacaccacac 960
gcacactcca catgcccagc agagtggcac ttggtggcca gaaagtgtga gcctcatgat 1020
ctgctgtctg tagttctgtg agctcaggtc cctcaaaggc ctcggagcac ccccttcctt 1080
gtgactgagc cagggcctgc atttttggtt ttccccaccc cacacattct caaccatagt 1140
ccttctaaca ataccaatag ctaggacccg gctgctgtgc actgggactg gggattccac 1200
atgtttgcct tgggagtctc aagctggact gccagcccct gtcctccctt cacccccatt 1260
gcgtatgagc atttcagaac tccaaggagt cacaggcatc tttatagttc acgttaacat 1320
atagacactg ttggaagcag ttccttctaa aagggtagcc ctggacttaa taccagccgg 1380
atacctctgg cccccacccc attactgtac ctctggagtc actactgtgg gtcgccactc 1440
ctctgctaca cagcacggct ttttcaaggc tgtattgaga agggaagtta ggaagaaggg 1500
tgtgctgggc taaccagccc acagagctca cattcctgtc ccttgggtga aaaatacatg 1560
tccatcctga tatctcctga attcagaaat tagcctccac atgtgcaatg gctttaagag 1620
ccagaagcag ggttctggga attttgcaag ttacctgtgg ccaggtgtgg tctcggttac 1680
caaatacggt tacctgcagc tttttagtcc tttgtgctcc cacgggtcta cagagtccca 1740
tctgcccaaa ggtcttgaag cttgacagga tgttttcgat tactcagtct cccagggcac 1800
tactggtccg taggattcga ttggtcgggg taggagagtt aaacaacatt taaacagagt 1860
tctctcaaaa atgtctaaag ggattgtagg tagataacat ccaatcactg tttgcactta 1920
tctgaaatct tccctcttgg ctgcccccag gtatttactg tggagaacat tgcataggaa 1980
tgtctggaaa aagcttctac aacttgttac agccttcaca tttgtagaag cttt 2034
<210> 50
<211> 1234
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10*-ND6-3'UTR*
<400> 50
atggccgcca gcccccacac cctgagcagc cgcctgctga ccggctgcgt gggcggcagc 60
gtgtggtacc tggagcgccg caccatgatg tatgctttgt ttctgttgag tgtgggttta 120
gtaatggggt ttgtggggtt ttcttctaag ccttctccta tttatggggg tttagtattg 180
attgttagcg gtgtggtcgg gtgtgttatt attctgaatt ttgggggagg ttatatgggt 240
ttaatggttt ttttaattta tttaggggga atgatggttg tctttggata tactacagcg 300
atggctattg aggagtatcc tgaggcatgg gggtcagggg ttgaggtctt ggtgagtgtt 360
ttagtggggt tagcgatgga ggtaggattg gtgctgtggg tgaaagagta tgatggggtg 420
gtggttgtgg taaactttaa tagtgtagga agctggatga tttatgaagg agaggggtca 480
gggttgattc gggaggatcc tattggtgcg ggggctttgt atgattatgg gcgttggtta 540
gtagtagtta ctggttggac attgtttgtt ggtgtatata ttgtaattga gattgctcgg 600
gggaattagg agcactggga cgcccaccgc ccctttccct ccgctgccag gcgagcatgt 660
tgtggtaatt ctggaacaca agaagagaaa ttgctgggtt tagaacaaga ttataaacga 720
attcggtgct cagtgatcac ttgacagttt tttttttttt taaatattac ccaaaatgct 780
ccccaaataa gaaatgcatc agctcagtca gtgaatacaa aaaaggaatt atttttccct 840
ttgagggtct tttatacatc tctcctccaa ccccaccctc tattctgttt cttcctcctc 900
acatgggggt acacatacac agcttcctct tttggttcca tccttaccac cacaccacac 960
gcacactcca catgcccagc agagtggcac ttggtggcca gaaagtgtga gcctcatgat 1020
ctgctgtctg tagttctgtg agctcaggtc cctcaaaggc ctcggagcac ccccttcctt 1080
gtgactgagc cagggcctgc atttttggtt ttccccaccc cacacattct caaccatagt 1140
ccttctaaca ataccaatag ctaggacccg gctgctgtgc actgggactg gggattccac 1200
atgtttgcct tgggagtctc aagctggact gcca 1234
<210> 51
<211> 2034
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10*-opt_ND6-3'UTR
<400> 51
atggccgcca gcccccacac cctgagcagc cgcctgctga ccggctgcgt gggcggcagc 60
gtgtggtacc tggagcgccg caccatgatg tacgccctgt tcctgctgag cgtgggcctg 120
gtgatgggct tcgtgggctt cagcagcaag cccagcccca tctacggcgg cctggtgctg 180
atcgtgagcg gcgtggtggg ctgcgtgatc atcctgaact tcggcggcgg ctacatgggc 240
ctgatggtgt tcctgatcta cctgggcggc atgatggtgg tgttcggcta caccaccgcc 300
atggccatcg aggagtaccc cgaggcctgg ggcagcggcg tggaggtgct ggtgagcgtg 360
ctggtgggcc tggccatgga ggtgggcctg gtgctgtggg tgaaggagta cgacggcgtg 420
gtggtggtgg tgaacttcaa cagcgtgggc agctggatga tctacgaggg cgagggcagc 480
ggcctgatcc gcgaggaccc catcggcgcc ggcgccctgt acgactacgg ccgctggctg 540
gtggtggtga ccggctggac cctgttcgtg ggcgtgtaca tcgtgatcga gatcgcccgc 600
ggcaactaag agcactggga cgcccaccgc ccctttccct ccgctgccag gcgagcatgt 660
tgtggtaatt ctggaacaca agaagagaaa ttgctgggtt tagaacaaga ttataaacga 720
attcggtgct cagtgatcac ttgacagttt tttttttttt taaatattac ccaaaatgct 780
ccccaaataa gaaatgcatc agctcagtca gtgaatacaa aaaaggaatt atttttccct 840
ttgagggtct tttatacatc tctcctccaa ccccaccctc tattctgttt cttcctcctc 900
acatgggggt acacatacac agcttcctct tttggttcca tccttaccac cacaccacac 960
gcacactcca catgcccagc agagtggcac ttggtggcca gaaagtgtga gcctcatgat 1020
ctgctgtctg tagttctgtg agctcaggtc cctcaaaggc ctcggagcac ccccttcctt 1080
gtgactgagc cagggcctgc atttttggtt ttccccaccc cacacattct caaccatagt 1140
ccttctaaca ataccaatag ctaggacccg gctgctgtgc actgggactg gggattccac 1200
atgtttgcct tgggagtctc aagctggact gccagcccct gtcctccctt cacccccatt 1260
gcgtatgagc atttcagaac tccaaggagt cacaggcatc tttatagttc acgttaacat 1320
atagacactg ttggaagcag ttccttctaa aagggtagcc ctggacttaa taccagccgg 1380
atacctctgg cccccacccc attactgtac ctctggagtc actactgtgg gtcgccactc 1440
ctctgctaca cagcacggct ttttcaaggc tgtattgaga agggaagtta ggaagaaggg 1500
tgtgctgggc taaccagccc acagagctca cattcctgtc ccttgggtga aaaatacatg 1560
tccatcctga tatctcctga attcagaaat tagcctccac atgtgcaatg gctttaagag 1620
ccagaagcag ggttctggga attttgcaag ttacctgtgg ccaggtgtgg tctcggttac 1680
caaatacggt tacctgcagc tttttagtcc tttgtgctcc cacgggtcta cagagtccca 1740
tctgcccaaa ggtcttgaag cttgacagga tgttttcgat tactcagtct cccagggcac 1800
tactggtccg taggattcga ttggtcgggg taggagagtt aaacaacatt taaacagagt 1860
tctctcaaaa atgtctaaag ggattgtagg tagataacat ccaatcactg tttgcactta 1920
tctgaaatct tccctcttgg ctgcccccag gtatttactg tggagaacat tgcataggaa 1980
tgtctggaaa aagcttctac aacttgttac agccttcaca tttgtagaag cttt 2034
<210> 52
<211> 1234
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10*-opt_ND6-3'UTR*
<400> 52
atggccgcca gcccccacac cctgagcagc cgcctgctga ccggctgcgt gggcggcagc 60
gtgtggtacc tggagcgccg caccatgatg tacgccctgt tcctgctgag cgtgggcctg 120
gtgatgggct tcgtgggctt cagcagcaag cccagcccca tctacggcgg cctggtgctg 180
atcgtgagcg gcgtggtggg ctgcgtgatc atcctgaact tcggcggcgg ctacatgggc 240
ctgatggtgt tcctgatcta cctgggcggc atgatggtgg tgttcggcta caccaccgcc 300
atggccatcg aggagtaccc cgaggcctgg ggcagcggcg tggaggtgct ggtgagcgtg 360
ctggtgggcc tggccatgga ggtgggcctg gtgctgtggg tgaaggagta cgacggcgtg 420
gtggtggtgg tgaacttcaa cagcgtgggc agctggatga tctacgaggg cgagggcagc 480
ggcctgatcc gcgaggaccc catcggcgcc ggcgccctgt acgactacgg ccgctggctg 540
gtggtggtga ccggctggac cctgttcgtg ggcgtgtaca tcgtgatcga gatcgcccgc 600
ggcaactaag agcactggga cgcccaccgc ccctttccct ccgctgccag gcgagcatgt 660
tgtggtaatt ctggaacaca agaagagaaa ttgctgggtt tagaacaaga ttataaacga 720
attcggtgct cagtgatcac ttgacagttt tttttttttt taaatattac ccaaaatgct 780
ccccaaataa gaaatgcatc agctcagtca gtgaatacaa aaaaggaatt atttttccct 840
ttgagggtct tttatacatc tctcctccaa ccccaccctc tattctgttt cttcctcctc 900
acatgggggt acacatacac agcttcctct tttggttcca tccttaccac cacaccacac 960
gcacactcca catgcccagc agagtggcac ttggtggcca gaaagtgtga gcctcatgat 1020
ctgctgtctg tagttctgtg agctcaggtc cctcaaaggc ctcggagcac ccccttcctt 1080
gtgactgagc cagggcctgc atttttggtt ttccccaccc cacacattct caaccatagt 1140
ccttctaaca ataccaatag ctaggacccg gctgctgtgc actgggactg gggattccac 1200
atgtttgcct tgggagtctc aagctggact gcca 1234
<210> 53
<211> 2460
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10*-ND1-3'UTR
<400> 53
atggccgcca gcccccacac cctgagcagc cgcctgctga ccggctgcgt gggcggcagc 60
gtgtggtacc tggagcgccg caccatggcc aacctcctac tcctcattgt acccattcta 120
atcgcaatgg cattcctaat gcttaccgaa cgaaaaattc taggctatat gcaactacgc 180
aaaggcccca acgttgtagg cccctacggg ctactacaac ccttcgctga cgccataaaa 240
ctcttcacca aagagcccct aaaacccgcc acatctacca tcaccctcta catcaccgcc 300
ccgaccttag ctctcaccat cgctcttcta ctatggaccc ccctccccat gcccaacccc 360
ctggtcaacc tcaacctagg cctcctattt attctagcca cctctagcct agccgtttac 420
tcaatcctct ggtcagggtg ggcatcaaac tcaaactacg ccctgatcgg cgcactgcga 480
gcagtagccc aaacaatctc atatgaagtc accctagcca tcattctact atcaacatta 540
ctaatgagtg gctcctttaa cctctccacc cttatcacaa cacaagaaca cctctggtta 600
ctcctgccat catggccctt ggccatgatg tggtttatct ccacactagc agagaccaac 660
cgaaccccct tcgaccttgc cgaaggggag tccgaactag tctcaggctt caacatcgaa 720
tacgccgcag gccccttcgc cctattcttc atggccgaat acacaaacat tattatgatg 780
aacaccctca ccactacaat cttcctagga acaacatatg acgcactctc ccctgaactc 840
tacacaacat attttgtcac caagacccta cttctaacct ccctgttctt atggattcga 900
acagcatacc cccgattccg ctacgaccaa ctcatgcacc tcctatggaa aaacttccta 960
ccactcaccc tagcattact tatgtggtat gtctccatgc ccattacaat ctccagcatt 1020
ccccctcaaa cctaagagca ctgggacgcc caccgcccct ttccctccgc tgccaggcga 1080
gcatgttgtg gtaattctgg aacacaagaa gagaaattgc tgggtttaga acaagattat 1140
aaacgaattc ggtgctcagt gatcacttga cagttttttt tttttttaaa tattacccaa 1200
aatgctcccc aaataagaaa tgcatcagct cagtcagtga atacaaaaaa ggaattattt 1260
ttccctttga gggtctttta tacatctctc ctccaacccc accctctatt ctgtttcttc 1320
ctcctcacat gggggtacac atacacagct tcctcttttg gttccatcct taccaccaca 1380
ccacacgcac actccacatg cccagcagag tggcacttgg tggccagaaa gtgtgagcct 1440
catgatctgc tgtctgtagt tctgtgagct caggtccctc aaaggcctcg gagcaccccc 1500
ttccttgtga ctgagccagg gcctgcattt ttggttttcc ccaccccaca cattctcaac 1560
catagtcctt ctaacaatac caatagctag gacccggctg ctgtgcactg ggactgggga 1620
ttccacatgt ttgccttggg agtctcaagc tggactgcca gcccctgtcc tcccttcacc 1680
cccattgcgt atgagcattt cagaactcca aggagtcaca ggcatcttta tagttcacgt 1740
taacatatag acactgttgg aagcagttcc ttctaaaagg gtagccctgg acttaatacc 1800
agccggatac ctctggcccc caccccatta ctgtacctct ggagtcacta ctgtgggtcg 1860
ccactcctct gctacacagc acggcttttt caaggctgta ttgagaaggg aagttaggaa 1920
gaagggtgtg ctgggctaac cagcccacag agctcacatt cctgtccctt gggtgaaaaa 1980
tacatgtcca tcctgatatc tcctgaattc agaaattagc ctccacatgt gcaatggctt 2040
taagagccag aagcagggtt ctgggaattt tgcaagttac ctgtggccag gtgtggtctc 2100
ggttaccaaa tacggttacc tgcagctttt tagtcctttg tgctcccacg ggtctacaga 2160
gtcccatctg cccaaaggtc ttgaagcttg acaggatgtt ttcgattact cagtctccca 2220
gggcactact ggtccgtagg attcgattgg tcggggtagg agagttaaac aacatttaaa 2280
cagagttctc tcaaaaatgt ctaaagggat tgtaggtaga taacatccaa tcactgtttg 2340
cacttatctg aaatcttccc tcttggctgc ccccaggtat ttactgtgga gaacattgca 2400
taggaatgtc tggaaaaagc ttctacaact tgttacagcc ttcacatttg tagaagcttt 2460
2460
<210> 54
<211> 1660
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10*-ND1-3'UTR*
<400> 54
atggccgcca gcccccacac cctgagcagc cgcctgctga ccggctgcgt gggcggcagc 60
gtgtggtacc tggagcgccg caccatggcc aacctcctac tcctcattgt acccattcta 120
atcgcaatgg cattcctaat gcttaccgaa cgaaaaattc taggctatat gcaactacgc 180
aaaggcccca acgttgtagg cccctacggg ctactacaac ccttcgctga cgccataaaa 240
ctcttcacca aagagcccct aaaacccgcc acatctacca tcaccctcta catcaccgcc 300
ccgaccttag ctctcaccat cgctcttcta ctatggaccc ccctccccat gcccaacccc 360
ctggtcaacc tcaacctagg cctcctattt attctagcca cctctagcct agccgtttac 420
tcaatcctct ggtcagggtg ggcatcaaac tcaaactacg ccctgatcgg cgcactgcga 480
gcagtagccc aaacaatctc atatgaagtc accctagcca tcattctact atcaacatta 540
ctaatgagtg gctcctttaa cctctccacc cttatcacaa cacaagaaca cctctggtta 600
ctcctgccat catggccctt ggccatgatg tggtttatct ccacactagc agagaccaac 660
cgaaccccct tcgaccttgc cgaaggggag tccgaactag tctcaggctt caacatcgaa 720
tacgccgcag gccccttcgc cctattcttc atggccgaat acacaaacat tattatgatg 780
aacaccctca ccactacaat cttcctagga acaacatatg acgcactctc ccctgaactc 840
tacacaacat attttgtcac caagacccta cttctaacct ccctgttctt atggattcga 900
acagcatacc cccgattccg ctacgaccaa ctcatgcacc tcctatggaa aaacttccta 960
ccactcaccc tagcattact tatgtggtat gtctccatgc ccattacaat ctccagcatt 1020
ccccctcaaa cctaagagca ctgggacgcc caccgcccct ttccctccgc tgccaggcga 1080
gcatgttgtg gtaattctgg aacacaagaa gagaaattgc tgggtttaga acaagattat 1140
aaacgaattc ggtgctcagt gatcacttga cagttttttt tttttttaaa tattacccaa 1200
aatgctcccc aaataagaaa tgcatcagct cagtcagtga atacaaaaaa ggaattattt 1260
ttccctttga gggtctttta tacatctctc ctccaacccc accctctatt ctgtttcttc 1320
ctcctcacat gggggtacac atacacagct tcctcttttg gttccatcct taccaccaca 1380
ccacacgcac actccacatg cccagcagag tggcacttgg tggccagaaa gtgtgagcct 1440
catgatctgc tgtctgtagt tctgtgagct caggtccctc aaaggcctcg gagcaccccc 1500
ttccttgtga ctgagccagg gcctgcattt ttggttttcc ccaccccaca cattctcaac 1560
catagtcctt ctaacaatac caatagctag gacccggctg ctgtgcactg ggactgggga 1620
ttccacatgt ttgccttggg agtctcaagc tggactgcca 1660
<210> 55
<211> 2460
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10*-opt_ND1-3'UTR
<400> 55
atggccgcca gcccccacac cctgagcagc cgcctgctga ccggctgcgt gggcggcagc 60
gtgtggtacc tggagcgccg caccatggcc aacctgctgc tgctgatcgt gcccatcctg 120
atcgccatgg ccttcctgat gctgaccgag cgcaagatcc tgggctacat gcagctgcgc 180
aagggcccca acgtggtggg cccctacggc ctgctgcagc ccttcgccga cgccatcaag 240
ctgttcacca aggagcccct gaagcccgcc accagcacca tcaccctgta catcaccgcc 300
cccaccctgg ccctgaccat cgccctgctg ctgtggaccc ccctgcccat gcccaacccc 360
ctggtgaacc tgaacctggg cctgctgttc atcctggcca ccagcagcct ggccgtgtac 420
agcatcctgt ggagcggctg ggccagcaac agcaactacg ccctgatcgg cgccctgcgc 480
gccgtggccc agaccatcag ctacgaggtg accctggcca tcatcctgct gagcaccctg 540
ctgatgagcg gcagcttcaa cctgagcacc ctgatcacca cccaggagca cctgtggctg 600
ctgctgccca gctggcccct ggccatgatg tggttcatca gcaccctggc cgagaccaac 660
cgcaccccct tcgacctggc cgagggcgag agcgagctgg tgagcggctt caacatcgag 720
tacgccgccg gccccttcgc cctgttcttc atggccgagt acaccaacat catcatgatg 780
aacaccctga ccaccaccat cttcctgggc accacctacg acgccctgag ccccgagctg 840
tacaccacct acttcgtgac caagaccctg ctgctgacca gcctgttcct gtggatccgc 900
accgcctacc cccgcttccg ctacgaccag ctgatgcacc tgctgtggaa gaacttcctg 960
cccctgaccc tggccctgct gatgtggtac gtgagcatgc ccatcaccat cagcagcatc 1020
cccccccaga cctaagagca ctgggacgcc caccgcccct ttccctccgc tgccaggcga 1080
gcatgttgtg gtaattctgg aacacaagaa gagaaattgc tgggtttaga acaagattat 1140
aaacgaattc ggtgctcagt gatcacttga cagttttttt tttttttaaa tattacccaa 1200
aatgctcccc aaataagaaa tgcatcagct cagtcagtga atacaaaaaa ggaattattt 1260
ttccctttga gggtctttta tacatctctc ctccaacccc accctctatt ctgtttcttc 1320
ctcctcacat gggggtacac atacacagct tcctcttttg gttccatcct taccaccaca 1380
ccacacgcac actccacatg cccagcagag tggcacttgg tggccagaaa gtgtgagcct 1440
catgatctgc tgtctgtagt tctgtgagct caggtccctc aaaggcctcg gagcaccccc 1500
ttccttgtga ctgagccagg gcctgcattt ttggttttcc ccaccccaca cattctcaac 1560
catagtcctt ctaacaatac caatagctag gacccggctg ctgtgcactg ggactgggga 1620
ttccacatgt ttgccttggg agtctcaagc tggactgcca gcccctgtcc tcccttcacc 1680
cccattgcgt atgagcattt cagaactcca aggagtcaca ggcatcttta tagttcacgt 1740
taacatatag acactgttgg aagcagttcc ttctaaaagg gtagccctgg acttaatacc 1800
agccggatac ctctggcccc caccccatta ctgtacctct ggagtcacta ctgtgggtcg 1860
ccactcctct gctacacagc acggcttttt caaggctgta ttgagaaggg aagttaggaa 1920
gaagggtgtg ctgggctaac cagcccacag agctcacatt cctgtccctt gggtgaaaaa 1980
tacatgtcca tcctgatatc tcctgaattc agaaattagc ctccacatgt gcaatggctt 2040
taagagccag aagcagggtt ctgggaattt tgcaagttac ctgtggccag gtgtggtctc 2100
ggttaccaaa tacggttacc tgcagctttt tagtcctttg tgctcccacg ggtctacaga 2160
gtcccatctg cccaaaggtc ttgaagcttg acaggatgtt ttcgattact cagtctccca 2220
gggcactact ggtccgtagg attcgattgg tcggggtagg agagttaaac aacatttaaa 2280
cagagttctc tcaaaaatgt ctaaagggat tgtaggtaga taacatccaa tcactgtttg 2340
cacttatctg aaatcttccc tcttggctgc ccccaggtat ttactgtgga gaacattgca 2400
taggaatgtc tggaaaaagc ttctacaact tgttacagcc ttcacatttg tagaagcttt 2460
2460
<210> 56
<211> 1660
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_COX10*-opt_ND1-3'UTR*
<400> 56
atggccgcca gcccccacac cctgagcagc cgcctgctga ccggctgcgt gggcggcagc 60
gtgtggtacc tggagcgccg caccatggcc aacctgctgc tgctgatcgt gcccatcctg 120
atcgccatgg ccttcctgat gctgaccgag cgcaagatcc tgggctacat gcagctgcgc 180
aagggcccca acgtggtggg cccctacggc ctgctgcagc ccttcgccga cgccatcaag 240
ctgttcacca aggagcccct gaagcccgcc accagcacca tcaccctgta catcaccgcc 300
cccaccctgg ccctgaccat cgccctgctg ctgtggaccc ccctgcccat gcccaacccc 360
ctggtgaacc tgaacctggg cctgctgttc atcctggcca ccagcagcct ggccgtgtac 420
agcatcctgt ggagcggctg ggccagcaac agcaactacg ccctgatcgg cgccctgcgc 480
gccgtggccc agaccatcag ctacgaggtg accctggcca tcatcctgct gagcaccctg 540
ctgatgagcg gcagcttcaa cctgagcacc ctgatcacca cccaggagca cctgtggctg 600
ctgctgccca gctggcccct ggccatgatg tggttcatca gcaccctggc cgagaccaac 660
cgcaccccct tcgacctggc cgagggcgag agcgagctgg tgagcggctt caacatcgag 720
tacgccgccg gccccttcgc cctgttcttc atggccgagt acaccaacat catcatgatg 780
aacaccctga ccaccaccat cttcctgggc accacctacg acgccctgag ccccgagctg 840
tacaccacct acttcgtgac caagaccctg ctgctgacca gcctgttcct gtggatccgc 900
accgcctacc cccgcttccg ctacgaccag ctgatgcacc tgctgtggaa gaacttcctg 960
cccctgaccc tggccctgct gatgtggtac gtgagcatgc ccatcaccat cagcagcatc 1020
cccccccaga cctaagagca ctgggacgcc caccgcccct ttccctccgc tgccaggcga 1080
gcatgttgtg gtaattctgg aacacaagaa gagaaattgc tgggtttaga acaagattat 1140
aaacgaattc ggtgctcagt gatcacttga cagttttttt tttttttaaa tattacccaa 1200
aatgctcccc aaataagaaa tgcatcagct cagtcagtga atacaaaaaa ggaattattt 1260
ttccctttga gggtctttta tacatctctc ctccaacccc accctctatt ctgtttcttc 1320
ctcctcacat gggggtacac atacacagct tcctcttttg gttccatcct taccaccaca 1380
ccacacgcac actccacatg cccagcagag tggcacttgg tggccagaaa gtgtgagcct 1440
catgatctgc tgtctgtagt tctgtgagct caggtccctc aaaggcctcg gagcaccccc 1500
ttccttgtga ctgagccagg gcctgcattt ttggttttcc ccaccccaca cattctcaac 1560
catagtcctt ctaacaatac caatagctag gacccggctg ctgtgcactg ggactgggga 1620
ttccacatgt ttgccttggg agtctcaagc tggactgcca 1660
<210> 57
<211> 2892
<212> DNA
<213> Artificial Sequence
<220>
<223> COX8-ND4-3'UTR
<400> 57
atgtccgtcc tgacgcgcct gctgctgcgg ggcttgacac ggctcggctc ggcggctcca 60
gtgcggcgcg ccagaatcca ttcgttgatg ctaaaactaa tcgtcccaac aattatgtta 120
ctaccactga catggctttc caaaaaacac atgatttgga tcaacacaac cacccacagc 180
ctaattatta gcatcatccc tctactattt tttaaccaaa tcaacaacaa cctatttagc 240
tgttccccaa ccttttcctc cgacccccta acaacccccc tcctaatgct aactacctgg 300
ctcctacccc tcacaatcat ggcaagccaa cgccacttat ccagtgaacc actatcacga 360
aaaaaactct acctctctat gctaatctcc ctacaaatct ccttaattat gacattcaca 420
gccacagaac taatcatgtt ttatatcttc ttcgaaacca cacttatccc caccttggct 480
atcatcaccc gatggggcaa ccagccagaa cgcctgaacg caggcacata cttcctattc 540
tacaccctag taggctccct tcccctactc atcgcactaa tttacactca caacacccta 600
ggctcactaa acattctact actcactctc actgcccaag aactatcaaa ctcctgggcc 660
aacaacttaa tgtggctagc ttacacaatg gcttttatgg taaagatgcc tctttacgga 720
ctccacttat ggctccctaa agcccatgtc gaagccccca tcgctgggtc aatggtactt 780
gccgcagtac tcttaaaact aggcggctat ggtatgatgc gcctcacact cattctcaac 840
cccctgacaa aacacatggc ctaccccttc cttgtactat ccctatgggg catgattatg 900
acaagctcca tctgcctacg acaaacagac ctaaaatcgc tcattgcata ctcttcaatc 960
agccacatgg ccctcgtagt aacagccatt ctcatccaaa ccccctggag cttcaccggc 1020
gcagtcattc tcatgatcgc ccacgggctt acatcctcat tactattctg cctagcaaac 1080
tcaaactacg aacgcactca cagtcgcatc atgatcctct ctcaaggact tcaaactcta 1140
ctcccactaa tggctttttg gtggcttcta gcaagcctcg ctaacctcgc cttacccccc 1200
actattaacc tactgggaga actctctgtg ctagtaacca cgttctcctg gtcaaatatc 1260
actctcctac ttacaggact caacatgcta gtcacagccc tatactccct ctacatgttt 1320
accacaacac aatggggctc actcacccac cacattaaca acatgaaacc ctcattcaca 1380
cgagaaaaca ccctcatgtt catgcaccta tcccccattc tcctcctatc cctcaacccc 1440
gacatcatta ccgggttttc ctcttaagag cactgggacg cccaccgccc ctttccctcc 1500
gctgccaggc gagcatgttg tggtaattct ggaacacaag aagagaaatt gctgggttta 1560
gaacaagatt ataaacgaat tcggtgctca gtgatcactt gacagttttt ttttttttta 1620
aatattaccc aaaatgctcc ccaaataaga aatgcatcag ctcagtcagt gaatacaaaa 1680
aaggaattat ttttcccttt gagggtcttt tatacatctc tcctccaacc ccaccctcta 1740
ttctgtttct tcctcctcac atgggggtac acatacacag cttcctcttt tggttccatc 1800
cttaccacca caccacacgc acactccaca tgcccagcag agtggcactt ggtggccaga 1860
aagtgtgagc ctcatgatct gctgtctgta gttctgtgag ctcaggtccc tcaaaggcct 1920
cggagcaccc ccttccttgt gactgagcca gggcctgcat ttttggtttt ccccacccca 1980
cacattctca accatagtcc ttctaacaat accaatagct aggacccggc tgctgtgcac 2040
tgggactggg gattccacat gtttgccttg ggagtctcaa gctggactgc cagcccctgt 2100
cctcccttca cccccattgc gtatgagcat ttcagaactc caaggagtca caggcatctt 2160
tatagttcac gttaacatat agacactgtt ggaagcagtt ccttctaaaa gggtagccct 2220
ggacttaata ccagccggat acctctggcc cccaccccat tactgtacct ctggagtcac 2280
tactgtgggt cgccactcct ctgctacaca gcacggcttt ttcaaggctg tattgagaag 2340
ggaagttagg aagaagggtg tgctgggcta accagcccac agagctcaca ttcctgtccc 2400
ttgggtgaaa aatacatgtc catcctgata tctcctgaat tcagaaatta gcctccacat 2460
gtgcaatggc tttaagagcc agaagcaggg ttctgggaat tttgcaagtt acctgtggcc 2520
aggtgtggtc tcggttacca aatacggtta cctgcagctt tttagtcctt tgtgctccca 2580
cgggtctaca gagtcccatc tgcccaaagg tcttgaagct tgacaggatg ttttcgatta 2640
ctcagtctcc cagggcacta ctggtccgta ggattcgatt ggtcggggta ggagagttaa 2700
acaacattta aacagagttc tctcaaaaat gtctaaaggg attgtaggta gataacatcc 2760
aatcactgtt tgcacttatc tgaaatcttc cctcttggct gcccccaggt atttactgtg 2820
gagaacattg cataggaatg tctggaaaaa gcttctacaa cttgttacag ccttcacatt 2880
tgtagaagct tt 2892
<210> 58
<211> 2092
<212> DNA
<213> Artificial Sequence
<220>
<223> COX8-ND4-3'UTR*
<400> 58
atgtccgtcc tgacgcgcct gctgctgcgg ggcttgacac ggctcggctc ggcggctcca 60
gtgcggcgcg ccagaatcca ttcgttgatg ctaaaactaa tcgtcccaac aattatgtta 120
ctaccactga catggctttc caaaaaacac atgatttgga tcaacacaac cacccacagc 180
ctaattatta gcatcatccc tctactattt tttaaccaaa tcaacaacaa cctatttagc 240
tgttccccaa ccttttcctc cgacccccta acaacccccc tcctaatgct aactacctgg 300
ctcctacccc tcacaatcat ggcaagccaa cgccacttat ccagtgaacc actatcacga 360
aaaaaactct acctctctat gctaatctcc ctacaaatct ccttaattat gacattcaca 420
gccacagaac taatcatgtt ttatatcttc ttcgaaacca cacttatccc caccttggct 480
atcatcaccc gatggggcaa ccagccagaa cgcctgaacg caggcacata cttcctattc 540
tacaccctag taggctccct tcccctactc atcgcactaa tttacactca caacacccta 600
ggctcactaa acattctact actcactctc actgcccaag aactatcaaa ctcctgggcc 660
aacaacttaa tgtggctagc ttacacaatg gcttttatgg taaagatgcc tctttacgga 720
ctccacttat ggctccctaa agcccatgtc gaagccccca tcgctgggtc aatggtactt 780
gccgcagtac tcttaaaact aggcggctat ggtatgatgc gcctcacact cattctcaac 840
cccctgacaa aacacatggc ctaccccttc cttgtactat ccctatgggg catgattatg 900
acaagctcca tctgcctacg acaaacagac ctaaaatcgc tcattgcata ctcttcaatc 960
agccacatgg ccctcgtagt aacagccatt ctcatccaaa ccccctggag cttcaccggc 1020
gcagtcattc tcatgatcgc ccacgggctt acatcctcat tactattctg cctagcaaac 1080
tcaaactacg aacgcactca cagtcgcatc atgatcctct ctcaaggact tcaaactcta 1140
ctcccactaa tggctttttg gtggcttcta gcaagcctcg ctaacctcgc cttacccccc 1200
actattaacc tactgggaga actctctgtg ctagtaacca cgttctcctg gtcaaatatc 1260
actctcctac ttacaggact caacatgcta gtcacagccc tatactccct ctacatgttt 1320
accacaacac aatggggctc actcacccac cacattaaca acatgaaacc ctcattcaca 1380
cgagaaaaca ccctcatgtt catgcaccta tcccccattc tcctcctatc cctcaacccc 1440
gacatcatta ccgggttttc ctcttaagag cactgggacg cccaccgccc ctttccctcc 1500
gctgccaggc gagcatgttg tggtaattct ggaacacaag aagagaaatt gctgggttta 1560
gaacaagatt ataaacgaat tcggtgctca gtgatcactt gacagttttt ttttttttta 1620
aatattaccc aaaatgctcc ccaaataaga aatgcatcag ctcagtcagt gaatacaaaa 1680
aaggaattat ttttcccttt gagggtcttt tatacatctc tcctccaacc ccaccctcta 1740
ttctgtttct tcctcctcac atgggggtac acatacacag cttcctcttt tggttccatc 1800
cttaccacca caccacacgc acactccaca tgcccagcag agtggcactt ggtggccaga 1860
aagtgtgagc ctcatgatct gctgtctgta gttctgtgag ctcaggtccc tcaaaggcct 1920
cggagcaccc ccttccttgt gactgagcca gggcctgcat ttttggtttt ccccacccca 1980
cacattctca accatagtcc ttctaacaat accaatagct aggacccggc tgctgtgcac 2040
tgggactggg gattccacat gtttgccttg ggagtctcaa gctggactgc ca 2092
<210> 59
<211> 2892
<212> DNA
<213> Artificial Sequence
<220>
<223> COX8-opt_ND4-3'UTR
<400> 59
atgtccgtcc tgacgcgcct gctgctgcgg ggcttgacac ggctcggctc ggcggctcca 60
gtgcggcgcg ccagaatcca ttcgttgatg ctgaagctga tcgtgcccac catcatgctg 120
ctgcctctga cctggctgag caagaaacac atgatctgga tcaacaccac cacgcacagc 180
ctgatcatca gcatcatccc tctgctgttc ttcaaccaga tcaacaacaa cctgttcagc 240
tgcagcccca ccttcagcag cgaccctctg acaacacctc tgctgatgct gaccacctgg 300
ctgctgcccc tcacaatcat ggcctctcag agacacctga gcagcgagcc cctgagccgg 360
aagaaactgt acctgagcat gctgatctcc ctgcagatct ctctgatcat gaccttcacc 420
gccaccgagc tgatcatgtt ctacatcttt ttcgagacaa cgctgatccc cacactggcc 480
atcatcacca gatggggcaa ccagcctgag agactgaacg ccggcaccta ctttctgttc 540
tacaccctcg tgggcagcct gccactgctg attgccctga tctacaccca caacaccctg 600
ggctccctga acatcctgct gctgacactg acagcccaag agctgagcaa cagctgggcc 660
aacaatctga tgtggctggc ctacacaatg gccttcatgg tcaagatgcc cctgtacggc 720
ctgcacctgt ggctgcctaa agctcatgtg gaagccccta tcgccggctc tatggtgctg 780
gctgcagtgc tgctgaaact cggcggctac ggcatgatgc ggctgaccct gattctgaat 840
cccctgacca agcacatggc ctatccattt ctggtgctga gcctgtgggg catgattatg 900
accagcagca tctgcctgcg gcagaccgat ctgaagtccc tgatcgccta cagctccatc 960
agccacatgg ccctggtggt caccgccatc ctgattcaga ccccttggag ctttacaggc 1020
gccgtgatcc tgatgattgc ccacggcctg acaagcagcc tgctgttttg tctggccaac 1080
agcaactacg agcggaccca cagcagaatc atgatcctgt ctcagggcct gcagaccctc 1140
ctgcctctta tggctttttg gtggctgctg gcctctctgg ccaatctggc actgcctcct 1200
accatcaatc tgctgggcga gctgagcgtg ctggtcacca cattcagctg gtccaatatc 1260
accctgctgc tcaccggcct gaacatgctg gttacagccc tgtactccct gtacatgttc 1320
accaccacac agtggggaag cctgacacac cacatcaaca atatgaagcc cagcttcacc 1380
cgcgagaaca ccctgatgtt catgcatctg agccccattc tgctgctgtc cctgaatcct 1440
gatatcatca ccggcttctc cagctgagag cactgggacg cccaccgccc ctttccctcc 1500
gctgccaggc gagcatgttg tggtaattct ggaacacaag aagagaaatt gctgggttta 1560
gaacaagatt ataaacgaat tcggtgctca gtgatcactt gacagttttt ttttttttta 1620
aatattaccc aaaatgctcc ccaaataaga aatgcatcag ctcagtcagt gaatacaaaa 1680
aaggaattat ttttcccttt gagggtcttt tatacatctc tcctccaacc ccaccctcta 1740
ttctgtttct tcctcctcac atgggggtac acatacacag cttcctcttt tggttccatc 1800
cttaccacca caccacacgc acactccaca tgcccagcag agtggcactt ggtggccaga 1860
aagtgtgagc ctcatgatct gctgtctgta gttctgtgag ctcaggtccc tcaaaggcct 1920
cggagcaccc ccttccttgt gactgagcca gggcctgcat ttttggtttt ccccacccca 1980
cacattctca accatagtcc ttctaacaat accaatagct aggacccggc tgctgtgcac 2040
tgggactggg gattccacat gtttgccttg ggagtctcaa gctggactgc cagcccctgt 2100
cctcccttca cccccattgc gtatgagcat ttcagaactc caaggagtca caggcatctt 2160
tatagttcac gttaacatat agacactgtt ggaagcagtt ccttctaaaa gggtagccct 2220
ggacttaata ccagccggat acctctggcc cccaccccat tactgtacct ctggagtcac 2280
tactgtgggt cgccactcct ctgctacaca gcacggcttt ttcaaggctg tattgagaag 2340
ggaagttagg aagaagggtg tgctgggcta accagcccac agagctcaca ttcctgtccc 2400
ttgggtgaaa aatacatgtc catcctgata tctcctgaat tcagaaatta gcctccacat 2460
gtgcaatggc tttaagagcc agaagcaggg ttctgggaat tttgcaagtt acctgtggcc 2520
aggtgtggtc tcggttacca aatacggtta cctgcagctt tttagtcctt tgtgctccca 2580
cgggtctaca gagtcccatc tgcccaaagg tcttgaagct tgacaggatg ttttcgatta 2640
ctcagtctcc cagggcacta ctggtccgta ggattcgatt ggtcggggta ggagagttaa 2700
acaacattta aacagagttc tctcaaaaat gtctaaaggg attgtaggta gataacatcc 2760
aatcactgtt tgcacttatc tgaaatcttc cctcttggct gcccccaggt atttactgtg 2820
gagaacattg cataggaatg tctggaaaaa gcttctacaa cttgttacag ccttcacatt 2880
tgtagaagct tt 2892
<210> 60
<211> 2092
<212> DNA
<213> Artificial Sequence
<220>
<223> COX8-opt_ND4-3'UTR*
<400> 60
atgtccgtcc tgacgcgcct gctgctgcgg ggcttgacac ggctcggctc ggcggctcca 60
gtgcggcgcg ccagaatcca ttcgttgatg ctgaagctga tcgtgcccac catcatgctg 120
ctgcctctga cctggctgag caagaaacac atgatctgga tcaacaccac cacgcacagc 180
ctgatcatca gcatcatccc tctgctgttc ttcaaccaga tcaacaacaa cctgttcagc 240
tgcagcccca ccttcagcag cgaccctctg acaacacctc tgctgatgct gaccacctgg 300
ctgctgcccc tcacaatcat ggcctctcag agacacctga gcagcgagcc cctgagccgg 360
aagaaactgt acctgagcat gctgatctcc ctgcagatct ctctgatcat gaccttcacc 420
gccaccgagc tgatcatgtt ctacatcttt ttcgagacaa cgctgatccc cacactggcc 480
atcatcacca gatggggcaa ccagcctgag agactgaacg ccggcaccta ctttctgttc 540
tacaccctcg tgggcagcct gccactgctg attgccctga tctacaccca caacaccctg 600
ggctccctga acatcctgct gctgacactg acagcccaag agctgagcaa cagctgggcc 660
aacaatctga tgtggctggc ctacacaatg gccttcatgg tcaagatgcc cctgtacggc 720
ctgcacctgt ggctgcctaa agctcatgtg gaagccccta tcgccggctc tatggtgctg 780
gctgcagtgc tgctgaaact cggcggctac ggcatgatgc ggctgaccct gattctgaat 840
cccctgacca agcacatggc ctatccattt ctggtgctga gcctgtgggg catgattatg 900
accagcagca tctgcctgcg gcagaccgat ctgaagtccc tgatcgccta cagctccatc 960
agccacatgg ccctggtggt caccgccatc ctgattcaga ccccttggag ctttacaggc 1020
gccgtgatcc tgatgattgc ccacggcctg acaagcagcc tgctgttttg tctggccaac 1080
agcaactacg agcggaccca cagcagaatc atgatcctgt ctcagggcct gcagaccctc 1140
ctgcctctta tggctttttg gtggctgctg gcctctctgg ccaatctggc actgcctcct 1200
accatcaatc tgctgggcga gctgagcgtg ctggtcacca cattcagctg gtccaatatc 1260
accctgctgc tcaccggcct gaacatgctg gttacagccc tgtactccct gtacatgttc 1320
accaccacac agtggggaag cctgacacac cacatcaaca atatgaagcc cagcttcacc 1380
cgcgagaaca ccctgatgtt catgcatctg agccccattc tgctgctgtc cctgaatcct 1440
gatatcatca ccggcttctc cagctgagag cactgggacg cccaccgccc ctttccctcc 1500
gctgccaggc gagcatgttg tggtaattct ggaacacaag aagagaaatt gctgggttta 1560
gaacaagatt ataaacgaat tcggtgctca gtgatcactt gacagttttt ttttttttta 1620
aatattaccc aaaatgctcc ccaaataaga aatgcatcag ctcagtcagt gaatacaaaa 1680
aaggaattat ttttcccttt gagggtcttt tatacatctc tcctccaacc ccaccctcta 1740
ttctgtttct tcctcctcac atgggggtac acatacacag cttcctcttt tggttccatc 1800
cttaccacca caccacacgc acactccaca tgcccagcag agtggcactt ggtggccaga 1860
aagtgtgagc ctcatgatct gctgtctgta gttctgtgag ctcaggtccc tcaaaggcct 1920
cggagcaccc ccttccttgt gactgagcca gggcctgcat ttttggtttt ccccacccca 1980
cacattctca accatagtcc ttctaacaat accaatagct aggacccggc tgctgtgcac 2040
tgggactggg gattccacat gtttgccttg ggagtctcaa gctggactgc ca 2092
<210> 61
<211> 2892
<212> DNA
<213> Artificial Sequence
<220>
<223> COX8-opt_ND4*-3'UTR
<400> 61
atgtccgtcc tgacgcgcct gctgctgcgg ggcttgacac ggctcggctc ggcggctcca 60
gtgcggcgcg ccagaatcca ttcgttgatg ctgaagctga tcgtgcccac catcatgctg 120
ctgcccctga cctggctgag caagaagcac atgatctgga tcaacaccac cacccacagc 180
ctgatcatca gcatcatccc cctgctgttc ttcaaccaga tcaacaacaa cctgttcagc 240
tgcagcccca ccttcagcag cgaccccctg accacccccc tgctgatgct gaccacctgg 300
ctgctgcccc tgaccatcat ggccagccag cgccacctga gcagcgagcc cctgagccgc 360
aagaagctgt acctgagcat gctgatcagc ctgcagatca gcctgatcat gaccttcacc 420
gccaccgagc tgatcatgtt ctacatcttc ttcgagacca ccctgatccc caccctggcc 480
atcatcaccc gctggggcaa ccagcccgag cgcctgaacg ccggcaccta cttcctgttc 540
tacaccctgg tgggcagcct gcccctgctg atcgccctga tctacaccca caacaccctg 600
ggcagcctga acatcctgct gctgaccctg accgcccagg agctgagcaa cagctgggcc 660
aacaacctga tgtggctggc ctacaccatg gccttcatgg tgaagatgcc cctgtacggc 720
ctgcacctgt ggctgcccaa ggcccacgtg gaggccccca tcgccggcag catggtgctg 780
gccgccgtgc tgctgaagct gggcggctac ggcatgatgc gcctgaccct gatcctgaac 840
cccctgacca agcacatggc ctaccccttc ctggtgctga gcctgtgggg catgatcatg 900
accagcagca tctgcctgcg ccagaccgac ctgaagagcc tgatcgccta cagcagcatc 960
agccacatgg ccctggtggt gaccgccatc ctgatccaga ccccctggag cttcaccggc 1020
gccgtgatcc tgatgatcgc ccacggcctg accagcagcc tgctgttctg cctggccaac 1080
agcaactacg agcgcaccca cagccgcatc atgatcctga gccagggcct gcagaccctg 1140
ctgcccctga tggccttctg gtggctgctg gccagcctgg ccaacctggc cctgcccccc 1200
accatcaacc tgctgggcga gctgagcgtg ctggtgacca ccttcagctg gagcaacatc 1260
accctgctgc tgaccggcct gaacatgctg gtgaccgccc tgtacagcct gtacatgttc 1320
accaccaccc agtggggcag cctgacccac cacatcaaca acatgaagcc cagcttcacc 1380
cgcgagaaca ccctgatgtt catgcacctg agccccatcc tgctgctgag cctgaacccc 1440
gacatcatca ccggcttcag cagctaagag cactgggacg cccaccgccc ctttccctcc 1500
gctgccaggc gagcatgttg tggtaattct ggaacacaag aagagaaatt gctgggttta 1560
gaacaagatt ataaacgaat tcggtgctca gtgatcactt gacagttttt ttttttttta 1620
aatattaccc aaaatgctcc ccaaataaga aatgcatcag ctcagtcagt gaatacaaaa 1680
aaggaattat ttttcccttt gagggtcttt tatacatctc tcctccaacc ccaccctcta 1740
ttctgtttct tcctcctcac atgggggtac acatacacag cttcctcttt tggttccatc 1800
cttaccacca caccacacgc acactccaca tgcccagcag agtggcactt ggtggccaga 1860
aagtgtgagc ctcatgatct gctgtctgta gttctgtgag ctcaggtccc tcaaaggcct 1920
cggagcaccc ccttccttgt gactgagcca gggcctgcat ttttggtttt ccccacccca 1980
cacattctca accatagtcc ttctaacaat accaatagct aggacccggc tgctgtgcac 2040
tgggactggg gattccacat gtttgccttg ggagtctcaa gctggactgc cagcccctgt 2100
cctcccttca cccccattgc gtatgagcat ttcagaactc caaggagtca caggcatctt 2160
tatagttcac gttaacatat agacactgtt ggaagcagtt ccttctaaaa gggtagccct 2220
ggacttaata ccagccggat acctctggcc cccaccccat tactgtacct ctggagtcac 2280
tactgtgggt cgccactcct ctgctacaca gcacggcttt ttcaaggctg tattgagaag 2340
ggaagttagg aagaagggtg tgctgggcta accagcccac agagctcaca ttcctgtccc 2400
ttgggtgaaa aatacatgtc catcctgata tctcctgaat tcagaaatta gcctccacat 2460
gtgcaatggc tttaagagcc agaagcaggg ttctgggaat tttgcaagtt acctgtggcc 2520
aggtgtggtc tcggttacca aatacggtta cctgcagctt tttagtcctt tgtgctccca 2580
cgggtctaca gagtcccatc tgcccaaagg tcttgaagct tgacaggatg ttttcgatta 2640
ctcagtctcc cagggcacta ctggtccgta ggattcgatt ggtcggggta ggagagttaa 2700
acaacattta aacagagttc tctcaaaaat gtctaaaggg attgtaggta gataacatcc 2760
aatcactgtt tgcacttatc tgaaatcttc cctcttggct gcccccaggt atttactgtg 2820
gagaacattg cataggaatg tctggaaaaa gcttctacaa cttgttacag ccttcacatt 2880
tgtagaagct tt 2892
<210> 62
<211> 2092
<212> DNA
<213> Artificial Sequence
<220>
<223> COX8-opt_ND4*-3'UTR*
<400> 62
atgtccgtcc tgacgcgcct gctgctgcgg ggcttgacac ggctcggctc ggcggctcca 60
gtgcggcgcg ccagaatcca ttcgttgatg ctgaagctga tcgtgcccac catcatgctg 120
ctgcccctga cctggctgag caagaagcac atgatctgga tcaacaccac cacccacagc 180
ctgatcatca gcatcatccc cctgctgttc ttcaaccaga tcaacaacaa cctgttcagc 240
tgcagcccca ccttcagcag cgaccccctg accacccccc tgctgatgct gaccacctgg 300
ctgctgcccc tgaccatcat ggccagccag cgccacctga gcagcgagcc cctgagccgc 360
aagaagctgt acctgagcat gctgatcagc ctgcagatca gcctgatcat gaccttcacc 420
gccaccgagc tgatcatgtt ctacatcttc ttcgagacca ccctgatccc caccctggcc 480
atcatcaccc gctggggcaa ccagcccgag cgcctgaacg ccggcaccta cttcctgttc 540
tacaccctgg tgggcagcct gcccctgctg atcgccctga tctacaccca caacaccctg 600
ggcagcctga acatcctgct gctgaccctg accgcccagg agctgagcaa cagctgggcc 660
aacaacctga tgtggctggc ctacaccatg gccttcatgg tgaagatgcc cctgtacggc 720
ctgcacctgt ggctgcccaa ggcccacgtg gaggccccca tcgccggcag catggtgctg 780
gccgccgtgc tgctgaagct gggcggctac ggcatgatgc gcctgaccct gatcctgaac 840
cccctgacca agcacatggc ctaccccttc ctggtgctga gcctgtgggg catgatcatg 900
accagcagca tctgcctgcg ccagaccgac ctgaagagcc tgatcgccta cagcagcatc 960
agccacatgg ccctggtggt gaccgccatc ctgatccaga ccccctggag cttcaccggc 1020
gccgtgatcc tgatgatcgc ccacggcctg accagcagcc tgctgttctg cctggccaac 1080
agcaactacg agcgcaccca cagccgcatc atgatcctga gccagggcct gcagaccctg 1140
ctgcccctga tggccttctg gtggctgctg gccagcctgg ccaacctggc cctgcccccc 1200
accatcaacc tgctgggcga gctgagcgtg ctggtgacca ccttcagctg gagcaacatc 1260
accctgctgc tgaccggcct gaacatgctg gtgaccgccc tgtacagcct gtacatgttc 1320
accaccaccc agtggggcag cctgacccac cacatcaaca acatgaagcc cagcttcacc 1380
cgcgagaaca ccctgatgtt catgcacctg agccccatcc tgctgctgag cctgaacccc 1440
gacatcatca ccggcttcag cagctaagag cactgggacg cccaccgccc ctttccctcc 1500
gctgccaggc gagcatgttg tggtaattct ggaacacaag aagagaaatt gctgggttta 1560
gaacaagatt ataaacgaat tcggtgctca gtgatcactt gacagttttt ttttttttta 1620
aatattaccc aaaatgctcc ccaaataaga aatgcatcag ctcagtcagt gaatacaaaa 1680
aaggaattat ttttcccttt gagggtcttt tatacatctc tcctccaacc ccaccctcta 1740
ttctgtttct tcctcctcac atgggggtac acatacacag cttcctcttt tggttccatc 1800
cttaccacca caccacacgc acactccaca tgcccagcag agtggcactt ggtggccaga 1860
aagtgtgagc ctcatgatct gctgtctgta gttctgtgag ctcaggtccc tcaaaggcct 1920
cggagcaccc ccttccttgt gactgagcca gggcctgcat ttttggtttt ccccacccca 1980
cacattctca accatagtcc ttctaacaat accaatagct aggacccggc tgctgtgcac 2040
tgggactggg gattccacat gtttgccttg ggagtctcaa gctggactgc ca 2092
<210> 63
<211> 2037
<212> DNA
<213> Artificial Sequence
<220>
<223> COX8-ND6-3'UTR
<400> 63
atgtccgtcc tgacgcgcct gctgctgcgg ggcttgacac ggctcggctc ggcggctcca 60
gtgcggcgcg ccagaatcca ttcgttgatg atgtatgctt tgtttctgtt gagtgtgggt 120
ttagtaatgg ggtttgtggg gttttcttct aagccttctc ctatttatgg gggtttagta 180
ttgattgtta gcggtgtggt cgggtgtgtt attattctga attttggggg aggttatatg 240
ggtttaatgg tttttttaat ttatttaggg ggaatgatgg ttgtctttgg atatactaca 300
gcgatggcta ttgaggagta tcctgaggca tgggggtcag gggttgaggt cttggtgagt 360
gttttagtgg ggttagcgat ggaggtagga ttggtgctgt gggtgaaaga gtatgatggg 420
gtggtggttg tggtaaactt taatagtgta ggaagctgga tgatttatga aggagagggg 480
tcagggttga ttcgggagga tcctattggt gcgggggctt tgtatgatta tgggcgttgg 540
ttagtagtag ttactggttg gacattgttt gttggtgtat atattgtaat tgagattgct 600
cgggggaatt aggagcactg ggacgcccac cgcccctttc cctccgctgc caggcgagca 660
tgttgtggta attctggaac acaagaagag aaattgctgg gtttagaaca agattataaa 720
cgaattcggt gctcagtgat cacttgacag tttttttttt ttttaaatat tacccaaaat 780
gctccccaaa taagaaatgc atcagctcag tcagtgaata caaaaaagga attatttttc 840
cctttgaggg tcttttatac atctctcctc caaccccacc ctctattctg tttcttcctc 900
ctcacatggg ggtacacata cacagcttcc tcttttggtt ccatccttac caccacacca 960
cacgcacact ccacatgccc agcagagtgg cacttggtgg ccagaaagtg tgagcctcat 1020
gatctgctgt ctgtagttct gtgagctcag gtccctcaaa ggcctcggag cacccccttc 1080
cttgtgactg agccagggcc tgcatttttg gttttcccca ccccacacat tctcaaccat 1140
agtccttcta acaataccaa tagctaggac ccggctgctg tgcactggga ctggggattc 1200
cacatgtttg ccttgggagt ctcaagctgg actgccagcc cctgtcctcc cttcaccccc 1260
attgcgtatg agcatttcag aactccaagg agtcacaggc atctttatag ttcacgttaa 1320
catatagaca ctgttggaag cagttccttc taaaagggta gccctggact taataccagc 1380
cggatacctc tggcccccac cccattactg tacctctgga gtcactactg tgggtcgcca 1440
ctcctctgct acacagcacg gctttttcaa ggctgtattg agaagggaag ttaggaagaa 1500
gggtgtgctg ggctaaccag cccacagagc tcacattcct gtcccttggg tgaaaaatac 1560
atgtccatcc tgatatctcc tgaattcaga aattagcctc cacatgtgca atggctttaa 1620
gagccagaag cagggttctg ggaattttgc aagttacctg tggccaggtg tggtctcggt 1680
taccaaatac ggttacctgc agctttttag tcctttgtgc tcccacgggt ctacagagtc 1740
ccatctgccc aaaggtcttg aagcttgaca ggatgttttc gattactcag tctcccaggg 1800
cactactggt ccgtaggatt cgattggtcg gggtaggaga gttaaacaac atttaaacag 1860
agttctctca aaaatgtcta aagggattgt aggtagataa catccaatca ctgtttgcac 1920
ttatctgaaa tcttccctct tggctgcccc caggtattta ctgtggagaa cattgcatag 1980
gaatgtctgg aaaaagcttc tacaacttgt tacagccttc acatttgtag aagcttt 2037
<210> 64
<211> 1237
<212> DNA
<213> Artificial Sequence
<220>
<223> COX8-ND6-3'UTR*
<400> 64
atgtccgtcc tgacgcgcct gctgctgcgg ggcttgacac ggctcggctc ggcggctcca 60
gtgcggcgcg ccagaatcca ttcgttgatg atgtatgctt tgtttctgtt gagtgtgggt 120
ttagtaatgg ggtttgtggg gttttcttct aagccttctc ctatttatgg gggtttagta 180
ttgattgtta gcggtgtggt cgggtgtgtt attattctga attttggggg aggttatatg 240
ggtttaatgg tttttttaat ttatttaggg ggaatgatgg ttgtctttgg atatactaca 300
gcgatggcta ttgaggagta tcctgaggca tgggggtcag gggttgaggt cttggtgagt 360
gttttagtgg ggttagcgat ggaggtagga ttggtgctgt gggtgaaaga gtatgatggg 420
gtggtggttg tggtaaactt taatagtgta ggaagctgga tgatttatga aggagagggg 480
tcagggttga ttcgggagga tcctattggt gcgggggctt tgtatgatta tgggcgttgg 540
ttagtagtag ttactggttg gacattgttt gttggtgtat atattgtaat tgagattgct 600
cgggggaatt aggagcactg ggacgcccac cgcccctttc cctccgctgc caggcgagca 660
tgttgtggta attctggaac acaagaagag aaattgctgg gtttagaaca agattataaa 720
cgaattcggt gctcagtgat cacttgacag tttttttttt ttttaaatat tacccaaaat 780
gctccccaaa taagaaatgc atcagctcag tcagtgaata caaaaaagga attatttttc 840
cctttgaggg tcttttatac atctctcctc caaccccacc ctctattctg tttcttcctc 900
ctcacatggg ggtacacata cacagcttcc tcttttggtt ccatccttac caccacacca 960
cacgcacact ccacatgccc agcagagtgg cacttggtgg ccagaaagtg tgagcctcat 1020
gatctgctgt ctgtagttct gtgagctcag gtccctcaaa ggcctcggag cacccccttc 1080
cttgtgactg agccagggcc tgcatttttg gttttcccca ccccacacat tctcaaccat 1140
agtccttcta acaataccaa tagctaggac ccggctgctg tgcactggga ctggggattc 1200
cacatgtttg ccttgggagt ctcaagctgg actgcca 1237
<210> 65
<211> 2037
<212> DNA
<213> Artificial Sequence
<220>
<223> COX8-opt_ND6-3'UTR
<400> 65
atgtccgtcc tgacgcgcct gctgctgcgg ggcttgacac ggctcggctc ggcggctcca 60
gtgcggcgcg ccagaatcca ttcgttgatg atgtacgccc tgttcctgct gagcgtgggc 120
ctggtgatgg gcttcgtggg cttcagcagc aagcccagcc ccatctacgg cggcctggtg 180
ctgatcgtga gcggcgtggt gggctgcgtg atcatcctga acttcggcgg cggctacatg 240
ggcctgatgg tgttcctgat ctacctgggc ggcatgatgg tggtgttcgg ctacaccacc 300
gccatggcca tcgaggagta ccccgaggcc tggggcagcg gcgtggaggt gctggtgagc 360
gtgctggtgg gcctggccat ggaggtgggc ctggtgctgt gggtgaagga gtacgacggc 420
gtggtggtgg tggtgaactt caacagcgtg ggcagctgga tgatctacga gggcgagggc 480
agcggcctga tccgcgagga ccccatcggc gccggcgccc tgtacgacta cggccgctgg 540
ctggtggtgg tgaccggctg gaccctgttc gtgggcgtgt acatcgtgat cgagatcgcc 600
cgcggcaact aagagcactg ggacgcccac cgcccctttc cctccgctgc caggcgagca 660
tgttgtggta attctggaac acaagaagag aaattgctgg gtttagaaca agattataaa 720
cgaattcggt gctcagtgat cacttgacag tttttttttt ttttaaatat tacccaaaat 780
gctccccaaa taagaaatgc atcagctcag tcagtgaata caaaaaagga attatttttc 840
cctttgaggg tcttttatac atctctcctc caaccccacc ctctattctg tttcttcctc 900
ctcacatggg ggtacacata cacagcttcc tcttttggtt ccatccttac caccacacca 960
cacgcacact ccacatgccc agcagagtgg cacttggtgg ccagaaagtg tgagcctcat 1020
gatctgctgt ctgtagttct gtgagctcag gtccctcaaa ggcctcggag cacccccttc 1080
cttgtgactg agccagggcc tgcatttttg gttttcccca ccccacacat tctcaaccat 1140
agtccttcta acaataccaa tagctaggac ccggctgctg tgcactggga ctggggattc 1200
cacatgtttg ccttgggagt ctcaagctgg actgccagcc cctgtcctcc cttcaccccc 1260
attgcgtatg agcatttcag aactccaagg agtcacaggc atctttatag ttcacgttaa 1320
catatagaca ctgttggaag cagttccttc taaaagggta gccctggact taataccagc 1380
cggatacctc tggcccccac cccattactg tacctctgga gtcactactg tgggtcgcca 1440
ctcctctgct acacagcacg gctttttcaa ggctgtattg agaagggaag ttaggaagaa 1500
gggtgtgctg ggctaaccag cccacagagc tcacattcct gtcccttggg tgaaaaatac 1560
atgtccatcc tgatatctcc tgaattcaga aattagcctc cacatgtgca atggctttaa 1620
gagccagaag cagggttctg ggaattttgc aagttacctg tggccaggtg tggtctcggt 1680
taccaaatac ggttacctgc agctttttag tcctttgtgc tcccacgggt ctacagagtc 1740
ccatctgccc aaaggtcttg aagcttgaca ggatgttttc gattactcag tctcccaggg 1800
cactactggt ccgtaggatt cgattggtcg gggtaggaga gttaaacaac atttaaacag 1860
agttctctca aaaatgtcta aagggattgt aggtagataa catccaatca ctgtttgcac 1920
ttatctgaaa tcttccctct tggctgcccc caggtattta ctgtggagaa cattgcatag 1980
gaatgtctgg aaaaagcttc tacaacttgt tacagccttc acatttgtag aagcttt 2037
<210> 66
<211> 1237
<212> DNA
<213> Artificial Sequence
<220>
<223> COX8-opt_ND6-3'UTR*
<400> 66
atgtccgtcc tgacgcgcct gctgctgcgg ggcttgacac ggctcggctc ggcggctcca 60
gtgcggcgcg ccagaatcca ttcgttgatg atgtacgccc tgttcctgct gagcgtgggc 120
ctggtgatgg gcttcgtggg cttcagcagc aagcccagcc ccatctacgg cggcctggtg 180
ctgatcgtga gcggcgtggt gggctgcgtg atcatcctga acttcggcgg cggctacatg 240
ggcctgatgg tgttcctgat ctacctgggc ggcatgatgg tggtgttcgg ctacaccacc 300
gccatggcca tcgaggagta ccccgaggcc tggggcagcg gcgtggaggt gctggtgagc 360
gtgctggtgg gcctggccat ggaggtgggc ctggtgctgt gggtgaagga gtacgacggc 420
gtggtggtgg tggtgaactt caacagcgtg ggcagctgga tgatctacga gggcgagggc 480
agcggcctga tccgcgagga ccccatcggc gccggcgccc tgtacgacta cggccgctgg 540
ctggtggtgg tgaccggctg gaccctgttc gtgggcgtgt acatcgtgat cgagatcgcc 600
cgcggcaact aagagcactg ggacgcccac cgcccctttc cctccgctgc caggcgagca 660
tgttgtggta attctggaac acaagaagag aaattgctgg gtttagaaca agattataaa 720
cgaattcggt gctcagtgat cacttgacag tttttttttt ttttaaatat tacccaaaat 780
gctccccaaa taagaaatgc atcagctcag tcagtgaata caaaaaagga attatttttc 840
cctttgaggg tcttttatac atctctcctc caaccccacc ctctattctg tttcttcctc 900
ctcacatggg ggtacacata cacagcttcc tcttttggtt ccatccttac caccacacca 960
cacgcacact ccacatgccc agcagagtgg cacttggtgg ccagaaagtg tgagcctcat 1020
gatctgctgt ctgtagttct gtgagctcag gtccctcaaa ggcctcggag cacccccttc 1080
cttgtgactg agccagggcc tgcatttttg gttttcccca ccccacacat tctcaaccat 1140
agtccttcta acaataccaa tagctaggac ccggctgctg tgcactggga ctggggattc 1200
cacatgtttg ccttgggagt ctcaagctgg actgcca 1237
<210> 67
<211> 2463
<212> DNA
<213> Artificial Sequence
<220>
<223> COX8-ND1-3'UTR
<400> 67
atgtccgtcc tgacgcgcct gctgctgcgg ggcttgacac ggctcggctc ggcggctcca 60
gtgcggcgcg ccagaatcca ttcgttgatg gccaacctcc tactcctcat tgtacccatt 120
ctaatcgcaa tggcattcct aatgcttacc gaacgaaaaa ttctaggcta tatgcaacta 180
cgcaaaggcc ccaacgttgt aggcccctac gggctactac aacccttcgc tgacgccata 240
aaactcttca ccaaagagcc cctaaaaccc gccacatcta ccatcaccct ctacatcacc 300
gccccgacct tagctctcac catcgctctt ctactatgga cccccctccc catgcccaac 360
cccctggtca acctcaacct aggcctccta tttattctag ccacctctag cctagccgtt 420
tactcaatcc tctggtcagg gtgggcatca aactcaaact acgccctgat cggcgcactg 480
cgagcagtag cccaaacaat ctcatatgaa gtcaccctag ccatcattct actatcaaca 540
ttactaatga gtggctcctt taacctctcc acccttatca caacacaaga acacctctgg 600
ttactcctgc catcatggcc cttggccatg atgtggttta tctccacact agcagagacc 660
aaccgaaccc ccttcgacct tgccgaaggg gagtccgaac tagtctcagg cttcaacatc 720
gaatacgccg caggcccctt cgccctattc ttcatggccg aatacacaaa cattattatg 780
atgaacaccc tcaccactac aatcttccta ggaacaacat atgacgcact ctcccctgaa 840
ctctacacaa catattttgt caccaagacc ctacttctaa cctccctgtt cttatggatt 900
cgaacagcat acccccgatt ccgctacgac caactcatgc acctcctatg gaaaaacttc 960
ctaccactca ccctagcatt acttatgtgg tatgtctcca tgcccattac aatctccagc 1020
attccccctc aaacctaaga gcactgggac gcccaccgcc cctttccctc cgctgccagg 1080
cgagcatgtt gtggtaattc tggaacacaa gaagagaaat tgctgggttt agaacaagat 1140
tataaacgaa ttcggtgctc agtgatcact tgacagtttt tttttttttt aaatattacc 1200
caaaatgctc cccaaataag aaatgcatca gctcagtcag tgaatacaaa aaaggaatta 1260
tttttccctt tgagggtctt ttatacatct ctcctccaac cccaccctct attctgtttc 1320
ttcctcctca catgggggta cacatacaca gcttcctctt ttggttccat ccttaccacc 1380
acaccacacg cacactccac atgcccagca gagtggcact tggtggccag aaagtgtgag 1440
cctcatgatc tgctgtctgt agttctgtga gctcaggtcc ctcaaaggcc tcggagcacc 1500
cccttccttg tgactgagcc agggcctgca tttttggttt tccccacccc acacattctc 1560
aaccatagtc cttctaacaa taccaatagc taggacccgg ctgctgtgca ctgggactgg 1620
ggattccaca tgtttgcctt gggagtctca agctggactg ccagcccctg tcctcccttc 1680
acccccattg cgtatgagca tttcagaact ccaaggagtc acaggcatct ttatagttca 1740
cgttaacata tagacactgt tggaagcagt tccttctaaa agggtagccc tggacttaat 1800
accagccgga tacctctggc ccccacccca ttactgtacc tctggagtca ctactgtggg 1860
tcgccactcc tctgctacac agcacggctt tttcaaggct gtattgagaa gggaagttag 1920
gaagaagggt gtgctgggct aaccagccca cagagctcac attcctgtcc cttgggtgaa 1980
aaatacatgt ccatcctgat atctcctgaa ttcagaaatt agcctccaca tgtgcaatgg 2040
ctttaagagc cagaagcagg gttctgggaa ttttgcaagt tacctgtggc caggtgtggt 2100
ctcggttacc aaatacggtt acctgcagct ttttagtcct ttgtgctccc acgggtctac 2160
agagtcccat ctgcccaaag gtcttgaagc ttgacaggat gttttcgatt actcagtctc 2220
ccagggcact actggtccgt aggattcgat tggtcggggt aggagagtta aacaacattt 2280
aaacagagtt ctctcaaaaa tgtctaaagg gattgtaggt agataacatc caatcactgt 2340
ttgcacttat ctgaaatctt ccctcttggc tgcccccagg tatttactgt ggagaacatt 2400
gcataggaat gtctggaaaa agcttctaca acttgttaca gccttcacat ttgtagaagc 2460
ttt 2463
<210> 68
<211> 1663
<212> DNA
<213> Artificial Sequence
<220>
<223> COX8-ND1-3'UTR*
<400> 68
atgtccgtcc tgacgcgcct gctgctgcgg ggcttgacac ggctcggctc ggcggctcca 60
gtgcggcgcg ccagaatcca ttcgttgatg gccaacctcc tactcctcat tgtacccatt 120
ctaatcgcaa tggcattcct aatgcttacc gaacgaaaaa ttctaggcta tatgcaacta 180
cgcaaaggcc ccaacgttgt aggcccctac gggctactac aacccttcgc tgacgccata 240
aaactcttca ccaaagagcc cctaaaaccc gccacatcta ccatcaccct ctacatcacc 300
gccccgacct tagctctcac catcgctctt ctactatgga cccccctccc catgcccaac 360
cccctggtca acctcaacct aggcctccta tttattctag ccacctctag cctagccgtt 420
tactcaatcc tctggtcagg gtgggcatca aactcaaact acgccctgat cggcgcactg 480
cgagcagtag cccaaacaat ctcatatgaa gtcaccctag ccatcattct actatcaaca 540
ttactaatga gtggctcctt taacctctcc acccttatca caacacaaga acacctctgg 600
ttactcctgc catcatggcc cttggccatg atgtggttta tctccacact agcagagacc 660
aaccgaaccc ccttcgacct tgccgaaggg gagtccgaac tagtctcagg cttcaacatc 720
gaatacgccg caggcccctt cgccctattc ttcatggccg aatacacaaa cattattatg 780
atgaacaccc tcaccactac aatcttccta ggaacaacat atgacgcact ctcccctgaa 840
ctctacacaa catattttgt caccaagacc ctacttctaa cctccctgtt cttatggatt 900
cgaacagcat acccccgatt ccgctacgac caactcatgc acctcctatg gaaaaacttc 960
ctaccactca ccctagcatt acttatgtgg tatgtctcca tgcccattac aatctccagc 1020
attccccctc aaacctaaga gcactgggac gcccaccgcc cctttccctc cgctgccagg 1080
cgagcatgtt gtggtaattc tggaacacaa gaagagaaat tgctgggttt agaacaagat 1140
tataaacgaa ttcggtgctc agtgatcact tgacagtttt tttttttttt aaatattacc 1200
caaaatgctc cccaaataag aaatgcatca gctcagtcag tgaatacaaa aaaggaatta 1260
tttttccctt tgagggtctt ttatacatct ctcctccaac cccaccctct attctgtttc 1320
ttcctcctca catgggggta cacatacaca gcttcctctt ttggttccat ccttaccacc 1380
acaccacacg cacactccac atgcccagca gagtggcact tggtggccag aaagtgtgag 1440
cctcatgatc tgctgtctgt agttctgtga gctcaggtcc ctcaaaggcc tcggagcacc 1500
cccttccttg tgactgagcc agggcctgca tttttggttt tccccacccc acacattctc 1560
aaccatagtc cttctaacaa taccaatagc taggacccgg ctgctgtgca ctgggactgg 1620
ggattccaca tgtttgcctt gggagtctca agctggactg cca 1663
<210> 69
<211> 2463
<212> DNA
<213> Artificial Sequence
<220>
<223> COX8-opt_ND1-3'UTR
<400> 69
atgtccgtcc tgacgcgcct gctgctgcgg ggcttgacac ggctcggctc ggcggctcca 60
gtgcggcgcg ccagaatcca ttcgttgatg gccaacctgc tgctgctgat cgtgcccatc 120
ctgatcgcca tggccttcct gatgctgacc gagcgcaaga tcctgggcta catgcagctg 180
cgcaagggcc ccaacgtggt gggcccctac ggcctgctgc agcccttcgc cgacgccatc 240
aagctgttca ccaaggagcc cctgaagccc gccaccagca ccatcaccct gtacatcacc 300
gcccccaccc tggccctgac catcgccctg ctgctgtgga cccccctgcc catgcccaac 360
cccctggtga acctgaacct gggcctgctg ttcatcctgg ccaccagcag cctggccgtg 420
tacagcatcc tgtggagcgg ctgggccagc aacagcaact acgccctgat cggcgccctg 480
cgcgccgtgg cccagaccat cagctacgag gtgaccctgg ccatcatcct gctgagcacc 540
ctgctgatga gcggcagctt caacctgagc accctgatca ccacccagga gcacctgtgg 600
ctgctgctgc ccagctggcc cctggccatg atgtggttca tcagcaccct ggccgagacc 660
aaccgcaccc ccttcgacct ggccgagggc gagagcgagc tggtgagcgg cttcaacatc 720
gagtacgccg ccggcccctt cgccctgttc ttcatggccg agtacaccaa catcatcatg 780
atgaacaccc tgaccaccac catcttcctg ggcaccacct acgacgccct gagccccgag 840
ctgtacacca cctacttcgt gaccaagacc ctgctgctga ccagcctgtt cctgtggatc 900
cgcaccgcct acccccgctt ccgctacgac cagctgatgc acctgctgtg gaagaacttc 960
ctgcccctga ccctggccct gctgatgtgg tacgtgagca tgcccatcac catcagcagc 1020
atcccccccc agacctaaga gcactgggac gcccaccgcc cctttccctc cgctgccagg 1080
cgagcatgtt gtggtaattc tggaacacaa gaagagaaat tgctgggttt agaacaagat 1140
tataaacgaa ttcggtgctc agtgatcact tgacagtttt tttttttttt aaatattacc 1200
caaaatgctc cccaaataag aaatgcatca gctcagtcag tgaatacaaa aaaggaatta 1260
tttttccctt tgagggtctt ttatacatct ctcctccaac cccaccctct attctgtttc 1320
ttcctcctca catgggggta cacatacaca gcttcctctt ttggttccat ccttaccacc 1380
acaccacacg cacactccac atgcccagca gagtggcact tggtggccag aaagtgtgag 1440
cctcatgatc tgctgtctgt agttctgtga gctcaggtcc ctcaaaggcc tcggagcacc 1500
cccttccttg tgactgagcc agggcctgca tttttggttt tccccacccc acacattctc 1560
aaccatagtc cttctaacaa taccaatagc taggacccgg ctgctgtgca ctgggactgg 1620
ggattccaca tgtttgcctt gggagtctca agctggactg ccagcccctg tcctcccttc 1680
acccccattg cgtatgagca tttcagaact ccaaggagtc acaggcatct ttatagttca 1740
cgttaacata tagacactgt tggaagcagt tccttctaaa agggtagccc tggacttaat 1800
accagccgga tacctctggc ccccacccca ttactgtacc tctggagtca ctactgtggg 1860
tcgccactcc tctgctacac agcacggctt tttcaaggct gtattgagaa gggaagttag 1920
gaagaagggt gtgctgggct aaccagccca cagagctcac attcctgtcc cttgggtgaa 1980
aaatacatgt ccatcctgat atctcctgaa ttcagaaatt agcctccaca tgtgcaatgg 2040
ctttaagagc cagaagcagg gttctgggaa ttttgcaagt tacctgtggc caggtgtggt 2100
ctcggttacc aaatacggtt acctgcagct ttttagtcct ttgtgctccc acgggtctac 2160
agagtcccat ctgcccaaag gtcttgaagc ttgacaggat gttttcgatt actcagtctc 2220
ccagggcact actggtccgt aggattcgat tggtcggggt aggagagtta aacaacattt 2280
aaacagagtt ctctcaaaaa tgtctaaagg gattgtaggt agataacatc caatcactgt 2340
ttgcacttat ctgaaatctt ccctcttggc tgcccccagg tatttactgt ggagaacatt 2400
gcataggaat gtctggaaaa agcttctaca acttgttaca gccttcacat ttgtagaagc 2460
ttt 2463
<210> 70
<211> 1663
<212> DNA
<213> Artificial Sequence
<220>
<223> COX8-opt_ND1-3'UTR*
<400> 70
atgtccgtcc tgacgcgcct gctgctgcgg ggcttgacac ggctcggctc ggcggctcca 60
gtgcggcgcg ccagaatcca ttcgttgatg gccaacctgc tgctgctgat cgtgcccatc 120
ctgatcgcca tggccttcct gatgctgacc gagcgcaaga tcctgggcta catgcagctg 180
cgcaagggcc ccaacgtggt gggcccctac ggcctgctgc agcccttcgc cgacgccatc 240
aagctgttca ccaaggagcc cctgaagccc gccaccagca ccatcaccct gtacatcacc 300
gcccccaccc tggccctgac catcgccctg ctgctgtgga cccccctgcc catgcccaac 360
cccctggtga acctgaacct gggcctgctg ttcatcctgg ccaccagcag cctggccgtg 420
tacagcatcc tgtggagcgg ctgggccagc aacagcaact acgccctgat cggcgccctg 480
cgcgccgtgg cccagaccat cagctacgag gtgaccctgg ccatcatcct gctgagcacc 540
ctgctgatga gcggcagctt caacctgagc accctgatca ccacccagga gcacctgtgg 600
ctgctgctgc ccagctggcc cctggccatg atgtggttca tcagcaccct ggccgagacc 660
aaccgcaccc ccttcgacct ggccgagggc gagagcgagc tggtgagcgg cttcaacatc 720
gagtacgccg ccggcccctt cgccctgttc ttcatggccg agtacaccaa catcatcatg 780
atgaacaccc tgaccaccac catcttcctg ggcaccacct acgacgccct gagccccgag 840
ctgtacacca cctacttcgt gaccaagacc ctgctgctga ccagcctgtt cctgtggatc 900
cgcaccgcct acccccgctt ccgctacgac cagctgatgc acctgctgtg gaagaacttc 960
ctgcccctga ccctggccct gctgatgtgg tacgtgagca tgcccatcac catcagcagc 1020
atcccccccc agacctaaga gcactgggac gcccaccgcc cctttccctc cgctgccagg 1080
cgagcatgtt gtggtaattc tggaacacaa gaagagaaat tgctgggttt agaacaagat 1140
tataaacgaa ttcggtgctc agtgatcact tgacagtttt tttttttttt aaatattacc 1200
caaaatgctc cccaaataag aaatgcatca gctcagtcag tgaatacaaa aaaggaatta 1260
tttttccctt tgagggtctt ttatacatct ctcctccaac cccaccctct attctgtttc 1320
ttcctcctca catgggggta cacatacaca gcttcctctt ttggttccat ccttaccacc 1380
acaccacacg cacactccac atgcccagca gagtggcact tggtggccag aaagtgtgag 1440
cctcatgatc tgctgtctgt agttctgtga gctcaggtcc ctcaaaggcc tcggagcacc 1500
cccttccttg tgactgagcc agggcctgca tttttggttt tccccacccc acacattctc 1560
aaccatagtc cttctaacaa taccaatagc taggacccgg ctgctgtgca ctgggactgg 1620
ggattccaca tgtttgcctt gggagtctca agctggactg cca 1663
<210> 71
<211> 3071
<212> DNA
<213> Artificial Sequence
<220>
<223> OPA1-ND4-3'UTR
<400> 71
gtgctgcccg cctagaaagg gtgaagtggt tgtttccgtg acggactgag tacgggtgcc 60
tgtcaggctc ttgcggaagt ccatgcgcca ttgggagggc ctcggccgcg gctctgtgcc 120
cttgctgctg agggccactt cctgggtcat tcctggaccg ggagccgggc tggggctcac 180
acgggggctc ccgcgtggcc gtctcggcgc ctgcgtgacc tccccgccgg cgggatgtgg 240
cgactacgtc gggccgctgt ggcctgatgc taaaactaat cgtcccaaca attatgttac 300
taccactgac atggctttcc aaaaaacaca tgatttggat caacacaacc acccacagcc 360
taattattag catcatccct ctactatttt ttaaccaaat caacaacaac ctatttagct 420
gttccccaac cttttcctcc gaccccctaa caacccccct cctaatgcta actacctggc 480
tcctacccct cacaatcatg gcaagccaac gccacttatc cagtgaacca ctatcacgaa 540
aaaaactcta cctctctatg ctaatctccc tacaaatctc cttaattatg acattcacag 600
ccacagaact aatcatgttt tatatcttct tcgaaaccac acttatcccc accttggcta 660
tcatcacccg atggggcaac cagccagaac gcctgaacgc aggcacatac ttcctattct 720
acaccctagt aggctccctt cccctactca tcgcactaat ttacactcac aacaccctag 780
gctcactaaa cattctacta ctcactctca ctgcccaaga actatcaaac tcctgggcca 840
acaacttaat gtggctagct tacacaatgg cttttatggt aaagatgcct ctttacggac 900
tccacttatg gctccctaaa gcccatgtcg aagcccccat cgctgggtca atggtacttg 960
ccgcagtact cttaaaacta ggcggctatg gtatgatgcg cctcacactc attctcaacc 1020
ccctgacaaa acacatggcc taccccttcc ttgtactatc cctatggggc atgattatga 1080
caagctccat ctgcctacga caaacagacc taaaatcgct cattgcatac tcttcaatca 1140
gccacatggc cctcgtagta acagccattc tcatccaaac cccctggagc ttcaccggcg 1200
cagtcattct catgatcgcc cacgggctta catcctcatt actattctgc ctagcaaact 1260
caaactacga acgcactcac agtcgcatca tgatcctctc tcaaggactt caaactctac 1320
tcccactaat ggctttttgg tggcttctag caagcctcgc taacctcgcc ttacccccca 1380
ctattaacct actgggagaa ctctctgtgc tagtaaccac gttctcctgg tcaaatatca 1440
ctctcctact tacaggactc aacatgctag tcacagccct atactccctc tacatgttta 1500
ccacaacaca atggggctca ctcacccacc acattaacaa catgaaaccc tcattcacac 1560
gagaaaacac cctcatgttc atgcacctat cccccattct cctcctatcc ctcaaccccg 1620
acatcattac cgggttttcc tcttaagagc actgggacgc ccaccgcccc tttccctccg 1680
ctgccaggcg agcatgttgt ggtaattctg gaacacaaga agagaaattg ctgggtttag 1740
aacaagatta taaacgaatt cggtgctcag tgatcacttg acagtttttt ttttttttaa 1800
atattaccca aaatgctccc caaataagaa atgcatcagc tcagtcagtg aatacaaaaa 1860
aggaattatt tttccctttg agggtctttt atacatctct cctccaaccc caccctctat 1920
tctgtttctt cctcctcaca tgggggtaca catacacagc ttcctctttt ggttccatcc 1980
ttaccaccac accacacgca cactccacat gcccagcaga gtggcacttg gtggccagaa 2040
agtgtgagcc tcatgatctg ctgtctgtag ttctgtgagc tcaggtccct caaaggcctc 2100
ggagcacccc cttccttgtg actgagccag ggcctgcatt tttggttttc cccaccccac 2160
acattctcaa ccatagtcct tctaacaata ccaatagcta ggacccggct gctgtgcact 2220
gggactgggg attccacatg tttgccttgg gagtctcaag ctggactgcc agcccctgtc 2280
ctcccttcac ccccattgcg tatgagcatt tcagaactcc aaggagtcac aggcatcttt 2340
atagttcacg ttaacatata gacactgttg gaagcagttc cttctaaaag ggtagccctg 2400
gacttaatac cagccggata cctctggccc ccaccccatt actgtacctc tggagtcact 2460
actgtgggtc gccactcctc tgctacacag cacggctttt tcaaggctgt attgagaagg 2520
gaagttagga agaagggtgt gctgggctaa ccagcccaca gagctcacat tcctgtccct 2580
tgggtgaaaa atacatgtcc atcctgatat ctcctgaatt cagaaattag cctccacatg 2640
tgcaatggct ttaagagcca gaagcagggt tctgggaatt ttgcaagtta cctgtggcca 2700
ggtgtggtct cggttaccaa atacggttac ctgcagcttt ttagtccttt gtgctcccac 2760
gggtctacag agtcccatct gcccaaaggt cttgaagctt gacaggatgt tttcgattac 2820
tcagtctccc agggcactac tggtccgtag gattcgattg gtcggggtag gagagttaaa 2880
caacatttaa acagagttct ctcaaaaatg tctaaaggga ttgtaggtag ataacatcca 2940
atcactgttt gcacttatct gaaatcttcc ctcttggctg cccccaggta tttactgtgg 3000
agaacattgc ataggaatgt ctggaaaaag cttctacaac ttgttacagc cttcacattt 3060
gtagaagctt t 3071
<210> 72
<211> 2271
<212> DNA
<213> Artificial Sequence
<220>
<223> OPA1-ND4-3'UTR*
<400> 72
gtgctgcccg cctagaaagg gtgaagtggt tgtttccgtg acggactgag tacgggtgcc 60
tgtcaggctc ttgcggaagt ccatgcgcca ttgggagggc ctcggccgcg gctctgtgcc 120
cttgctgctg agggccactt cctgggtcat tcctggaccg ggagccgggc tggggctcac 180
acgggggctc ccgcgtggcc gtctcggcgc ctgcgtgacc tccccgccgg cgggatgtgg 240
cgactacgtc gggccgctgt ggcctgatgc taaaactaat cgtcccaaca attatgttac 300
taccactgac atggctttcc aaaaaacaca tgatttggat caacacaacc acccacagcc 360
taattattag catcatccct ctactatttt ttaaccaaat caacaacaac ctatttagct 420
gttccccaac cttttcctcc gaccccctaa caacccccct cctaatgcta actacctggc 480
tcctacccct cacaatcatg gcaagccaac gccacttatc cagtgaacca ctatcacgaa 540
aaaaactcta cctctctatg ctaatctccc tacaaatctc cttaattatg acattcacag 600
ccacagaact aatcatgttt tatatcttct tcgaaaccac acttatcccc accttggcta 660
tcatcacccg atggggcaac cagccagaac gcctgaacgc aggcacatac ttcctattct 720
acaccctagt aggctccctt cccctactca tcgcactaat ttacactcac aacaccctag 780
gctcactaaa cattctacta ctcactctca ctgcccaaga actatcaaac tcctgggcca 840
acaacttaat gtggctagct tacacaatgg cttttatggt aaagatgcct ctttacggac 900
tccacttatg gctccctaaa gcccatgtcg aagcccccat cgctgggtca atggtacttg 960
ccgcagtact cttaaaacta ggcggctatg gtatgatgcg cctcacactc attctcaacc 1020
ccctgacaaa acacatggcc taccccttcc ttgtactatc cctatggggc atgattatga 1080
caagctccat ctgcctacga caaacagacc taaaatcgct cattgcatac tcttcaatca 1140
gccacatggc cctcgtagta acagccattc tcatccaaac cccctggagc ttcaccggcg 1200
cagtcattct catgatcgcc cacgggctta catcctcatt actattctgc ctagcaaact 1260
caaactacga acgcactcac agtcgcatca tgatcctctc tcaaggactt caaactctac 1320
tcccactaat ggctttttgg tggcttctag caagcctcgc taacctcgcc ttacccccca 1380
ctattaacct actgggagaa ctctctgtgc tagtaaccac gttctcctgg tcaaatatca 1440
ctctcctact tacaggactc aacatgctag tcacagccct atactccctc tacatgttta 1500
ccacaacaca atggggctca ctcacccacc acattaacaa catgaaaccc tcattcacac 1560
gagaaaacac cctcatgttc atgcacctat cccccattct cctcctatcc ctcaaccccg 1620
acatcattac cgggttttcc tcttaagagc actgggacgc ccaccgcccc tttccctccg 1680
ctgccaggcg agcatgttgt ggtaattctg gaacacaaga agagaaattg ctgggtttag 1740
aacaagatta taaacgaatt cggtgctcag tgatcacttg acagtttttt ttttttttaa 1800
atattaccca aaatgctccc caaataagaa atgcatcagc tcagtcagtg aatacaaaaa 1860
aggaattatt tttccctttg agggtctttt atacatctct cctccaaccc caccctctat 1920
tctgtttctt cctcctcaca tgggggtaca catacacagc ttcctctttt ggttccatcc 1980
ttaccaccac accacacgca cactccacat gcccagcaga gtggcacttg gtggccagaa 2040
agtgtgagcc tcatgatctg ctgtctgtag ttctgtgagc tcaggtccct caaaggcctc 2100
ggagcacccc cttccttgtg actgagccag ggcctgcatt tttggttttc cccaccccac 2160
acattctcaa ccatagtcct tctaacaata ccaatagcta ggacccggct gctgtgcact 2220
gggactgggg attccacatg tttgccttgg gagtctcaag ctggactgcc a 2271
<210> 73
<211> 3071
<212> DNA
<213> Artificial Sequence
<220>
<223> OPA1-opt_ND4-3'UTR
<400> 73
gtgctgcccg cctagaaagg gtgaagtggt tgtttccgtg acggactgag tacgggtgcc 60
tgtcaggctc ttgcggaagt ccatgcgcca ttgggagggc ctcggccgcg gctctgtgcc 120
cttgctgctg agggccactt cctgggtcat tcctggaccg ggagccgggc tggggctcac 180
acgggggctc ccgcgtggcc gtctcggcgc ctgcgtgacc tccccgccgg cgggatgtgg 240
cgactacgtc gggccgctgt ggcctgatgc tgaagctgat cgtgcccacc atcatgctgc 300
tgcctctgac ctggctgagc aagaaacaca tgatctggat caacaccacc acgcacagcc 360
tgatcatcag catcatccct ctgctgttct tcaaccagat caacaacaac ctgttcagct 420
gcagccccac cttcagcagc gaccctctga caacacctct gctgatgctg accacctggc 480
tgctgcccct cacaatcatg gcctctcaga gacacctgag cagcgagccc ctgagccgga 540
agaaactgta cctgagcatg ctgatctccc tgcagatctc tctgatcatg accttcaccg 600
ccaccgagct gatcatgttc tacatctttt tcgagacaac gctgatcccc acactggcca 660
tcatcaccag atggggcaac cagcctgaga gactgaacgc cggcacctac tttctgttct 720
acaccctcgt gggcagcctg ccactgctga ttgccctgat ctacacccac aacaccctgg 780
gctccctgaa catcctgctg ctgacactga cagcccaaga gctgagcaac agctgggcca 840
acaatctgat gtggctggcc tacacaatgg ccttcatggt caagatgccc ctgtacggcc 900
tgcacctgtg gctgcctaaa gctcatgtgg aagcccctat cgccggctct atggtgctgg 960
ctgcagtgct gctgaaactc ggcggctacg gcatgatgcg gctgaccctg attctgaatc 1020
ccctgaccaa gcacatggcc tatccatttc tggtgctgag cctgtggggc atgattatga 1080
ccagcagcat ctgcctgcgg cagaccgatc tgaagtccct gatcgcctac agctccatca 1140
gccacatggc cctggtggtc accgccatcc tgattcagac cccttggagc tttacaggcg 1200
ccgtgatcct gatgattgcc cacggcctga caagcagcct gctgttttgt ctggccaaca 1260
gcaactacga gcggacccac agcagaatca tgatcctgtc tcagggcctg cagaccctcc 1320
tgcctcttat ggctttttgg tggctgctgg cctctctggc caatctggca ctgcctccta 1380
ccatcaatct gctgggcgag ctgagcgtgc tggtcaccac attcagctgg tccaatatca 1440
ccctgctgct caccggcctg aacatgctgg ttacagccct gtactccctg tacatgttca 1500
ccaccacaca gtggggaagc ctgacacacc acatcaacaa tatgaagccc agcttcaccc 1560
gcgagaacac cctgatgttc atgcatctga gccccattct gctgctgtcc ctgaatcctg 1620
atatcatcac cggcttctcc agctgagagc actgggacgc ccaccgcccc tttccctccg 1680
ctgccaggcg agcatgttgt ggtaattctg gaacacaaga agagaaattg ctgggtttag 1740
aacaagatta taaacgaatt cggtgctcag tgatcacttg acagtttttt ttttttttaa 1800
atattaccca aaatgctccc caaataagaa atgcatcagc tcagtcagtg aatacaaaaa 1860
aggaattatt tttccctttg agggtctttt atacatctct cctccaaccc caccctctat 1920
tctgtttctt cctcctcaca tgggggtaca catacacagc ttcctctttt ggttccatcc 1980
ttaccaccac accacacgca cactccacat gcccagcaga gtggcacttg gtggccagaa 2040
agtgtgagcc tcatgatctg ctgtctgtag ttctgtgagc tcaggtccct caaaggcctc 2100
ggagcacccc cttccttgtg actgagccag ggcctgcatt tttggttttc cccaccccac 2160
acattctcaa ccatagtcct tctaacaata ccaatagcta ggacccggct gctgtgcact 2220
gggactgggg attccacatg tttgccttgg gagtctcaag ctggactgcc agcccctgtc 2280
ctcccttcac ccccattgcg tatgagcatt tcagaactcc aaggagtcac aggcatcttt 2340
atagttcacg ttaacatata gacactgttg gaagcagttc cttctaaaag ggtagccctg 2400
gacttaatac cagccggata cctctggccc ccaccccatt actgtacctc tggagtcact 2460
actgtgggtc gccactcctc tgctacacag cacggctttt tcaaggctgt attgagaagg 2520
gaagttagga agaagggtgt gctgggctaa ccagcccaca gagctcacat tcctgtccct 2580
tgggtgaaaa atacatgtcc atcctgatat ctcctgaatt cagaaattag cctccacatg 2640
tgcaatggct ttaagagcca gaagcagggt tctgggaatt ttgcaagtta cctgtggcca 2700
ggtgtggtct cggttaccaa atacggttac ctgcagcttt ttagtccttt gtgctcccac 2760
gggtctacag agtcccatct gcccaaaggt cttgaagctt gacaggatgt tttcgattac 2820
tcagtctccc agggcactac tggtccgtag gattcgattg gtcggggtag gagagttaaa 2880
caacatttaa acagagttct ctcaaaaatg tctaaaggga ttgtaggtag ataacatcca 2940
atcactgttt gcacttatct gaaatcttcc ctcttggctg cccccaggta tttactgtgg 3000
agaacattgc ataggaatgt ctggaaaaag cttctacaac ttgttacagc cttcacattt 3060
gtagaagctt t 3071
<210> 74
<211> 2271
<212> DNA
<213> Artificial Sequence
<220>
<223> OPA1-opt_ND4-3'UTR*
<400> 74
gtgctgcccg cctagaaagg gtgaagtggt tgtttccgtg acggactgag tacgggtgcc 60
tgtcaggctc ttgcggaagt ccatgcgcca ttgggagggc ctcggccgcg gctctgtgcc 120
cttgctgctg agggccactt cctgggtcat tcctggaccg ggagccgggc tggggctcac 180
acgggggctc ccgcgtggcc gtctcggcgc ctgcgtgacc tccccgccgg cgggatgtgg 240
cgactacgtc gggccgctgt ggcctgatgc tgaagctgat cgtgcccacc atcatgctgc 300
tgcctctgac ctggctgagc aagaaacaca tgatctggat caacaccacc acgcacagcc 360
tgatcatcag catcatccct ctgctgttct tcaaccagat caacaacaac ctgttcagct 420
gcagccccac cttcagcagc gaccctctga caacacctct gctgatgctg accacctggc 480
tgctgcccct cacaatcatg gcctctcaga gacacctgag cagcgagccc ctgagccgga 540
agaaactgta cctgagcatg ctgatctccc tgcagatctc tctgatcatg accttcaccg 600
ccaccgagct gatcatgttc tacatctttt tcgagacaac gctgatcccc acactggcca 660
tcatcaccag atggggcaac cagcctgaga gactgaacgc cggcacctac tttctgttct 720
acaccctcgt gggcagcctg ccactgctga ttgccctgat ctacacccac aacaccctgg 780
gctccctgaa catcctgctg ctgacactga cagcccaaga gctgagcaac agctgggcca 840
acaatctgat gtggctggcc tacacaatgg ccttcatggt caagatgccc ctgtacggcc 900
tgcacctgtg gctgcctaaa gctcatgtgg aagcccctat cgccggctct atggtgctgg 960
ctgcagtgct gctgaaactc ggcggctacg gcatgatgcg gctgaccctg attctgaatc 1020
ccctgaccaa gcacatggcc tatccatttc tggtgctgag cctgtggggc atgattatga 1080
ccagcagcat ctgcctgcgg cagaccgatc tgaagtccct gatcgcctac agctccatca 1140
gccacatggc cctggtggtc accgccatcc tgattcagac cccttggagc tttacaggcg 1200
ccgtgatcct gatgattgcc cacggcctga caagcagcct gctgttttgt ctggccaaca 1260
gcaactacga gcggacccac agcagaatca tgatcctgtc tcagggcctg cagaccctcc 1320
tgcctcttat ggctttttgg tggctgctgg cctctctggc caatctggca ctgcctccta 1380
ccatcaatct gctgggcgag ctgagcgtgc tggtcaccac attcagctgg tccaatatca 1440
ccctgctgct caccggcctg aacatgctgg ttacagccct gtactccctg tacatgttca 1500
ccaccacaca gtggggaagc ctgacacacc acatcaacaa tatgaagccc agcttcaccc 1560
gcgagaacac cctgatgttc atgcatctga gccccattct gctgctgtcc ctgaatcctg 1620
atatcatcac cggcttctcc agctgagagc actgggacgc ccaccgcccc tttccctccg 1680
ctgccaggcg agcatgttgt ggtaattctg gaacacaaga agagaaattg ctgggtttag 1740
aacaagatta taaacgaatt cggtgctcag tgatcacttg acagtttttt ttttttttaa 1800
atattaccca aaatgctccc caaataagaa atgcatcagc tcagtcagtg aatacaaaaa 1860
aggaattatt tttccctttg agggtctttt atacatctct cctccaaccc caccctctat 1920
tctgtttctt cctcctcaca tgggggtaca catacacagc ttcctctttt ggttccatcc 1980
ttaccaccac accacacgca cactccacat gcccagcaga gtggcacttg gtggccagaa 2040
agtgtgagcc tcatgatctg ctgtctgtag ttctgtgagc tcaggtccct caaaggcctc 2100
ggagcacccc cttccttgtg actgagccag ggcctgcatt tttggttttc cccaccccac 2160
acattctcaa ccatagtcct tctaacaata ccaatagcta ggacccggct gctgtgcact 2220
gggactgggg attccacatg tttgccttgg gagtctcaag ctggactgcc a 2271
<210> 75
<211> 3071
<212> DNA
<213> Artificial Sequence
<220>
<223> OPA1-opt_ND4*-3'UTR
<400> 75
gtgctgcccg cctagaaagg gtgaagtggt tgtttccgtg acggactgag tacgggtgcc 60
tgtcaggctc ttgcggaagt ccatgcgcca ttgggagggc ctcggccgcg gctctgtgcc 120
cttgctgctg agggccactt cctgggtcat tcctggaccg ggagccgggc tggggctcac 180
acgggggctc ccgcgtggcc gtctcggcgc ctgcgtgacc tccccgccgg cgggatgtgg 240
cgactacgtc gggccgctgt ggcctgatgc tgaagctgat cgtgcccacc atcatgctgc 300
tgcccctgac ctggctgagc aagaagcaca tgatctggat caacaccacc acccacagcc 360
tgatcatcag catcatcccc ctgctgttct tcaaccagat caacaacaac ctgttcagct 420
gcagccccac cttcagcagc gaccccctga ccacccccct gctgatgctg accacctggc 480
tgctgcccct gaccatcatg gccagccagc gccacctgag cagcgagccc ctgagccgca 540
agaagctgta cctgagcatg ctgatcagcc tgcagatcag cctgatcatg accttcaccg 600
ccaccgagct gatcatgttc tacatcttct tcgagaccac cctgatcccc accctggcca 660
tcatcacccg ctggggcaac cagcccgagc gcctgaacgc cggcacctac ttcctgttct 720
acaccctggt gggcagcctg cccctgctga tcgccctgat ctacacccac aacaccctgg 780
gcagcctgaa catcctgctg ctgaccctga ccgcccagga gctgagcaac agctgggcca 840
acaacctgat gtggctggcc tacaccatgg ccttcatggt gaagatgccc ctgtacggcc 900
tgcacctgtg gctgcccaag gcccacgtgg aggcccccat cgccggcagc atggtgctgg 960
ccgccgtgct gctgaagctg ggcggctacg gcatgatgcg cctgaccctg atcctgaacc 1020
ccctgaccaa gcacatggcc taccccttcc tggtgctgag cctgtggggc atgatcatga 1080
ccagcagcat ctgcctgcgc cagaccgacc tgaagagcct gatcgcctac agcagcatca 1140
gccacatggc cctggtggtg accgccatcc tgatccagac cccctggagc ttcaccggcg 1200
ccgtgatcct gatgatcgcc cacggcctga ccagcagcct gctgttctgc ctggccaaca 1260
gcaactacga gcgcacccac agccgcatca tgatcctgag ccagggcctg cagaccctgc 1320
tgcccctgat ggccttctgg tggctgctgg ccagcctggc caacctggcc ctgcccccca 1380
ccatcaacct gctgggcgag ctgagcgtgc tggtgaccac cttcagctgg agcaacatca 1440
ccctgctgct gaccggcctg aacatgctgg tgaccgccct gtacagcctg tacatgttca 1500
ccaccaccca gtggggcagc ctgacccacc acatcaacaa catgaagccc agcttcaccc 1560
gcgagaacac cctgatgttc atgcacctga gccccatcct gctgctgagc ctgaaccccg 1620
acatcatcac cggcttcagc agctaagagc actgggacgc ccaccgcccc tttccctccg 1680
ctgccaggcg agcatgttgt ggtaattctg gaacacaaga agagaaattg ctgggtttag 1740
aacaagatta taaacgaatt cggtgctcag tgatcacttg acagtttttt ttttttttaa 1800
atattaccca aaatgctccc caaataagaa atgcatcagc tcagtcagtg aatacaaaaa 1860
aggaattatt tttccctttg agggtctttt atacatctct cctccaaccc caccctctat 1920
tctgtttctt cctcctcaca tgggggtaca catacacagc ttcctctttt ggttccatcc 1980
ttaccaccac accacacgca cactccacat gcccagcaga gtggcacttg gtggccagaa 2040
agtgtgagcc tcatgatctg ctgtctgtag ttctgtgagc tcaggtccct caaaggcctc 2100
ggagcacccc cttccttgtg actgagccag ggcctgcatt tttggttttc cccaccccac 2160
acattctcaa ccatagtcct tctaacaata ccaatagcta ggacccggct gctgtgcact 2220
gggactgggg attccacatg tttgccttgg gagtctcaag ctggactgcc agcccctgtc 2280
ctcccttcac ccccattgcg tatgagcatt tcagaactcc aaggagtcac aggcatcttt 2340
atagttcacg ttaacatata gacactgttg gaagcagttc cttctaaaag ggtagccctg 2400
gacttaatac cagccggata cctctggccc ccaccccatt actgtacctc tggagtcact 2460
actgtgggtc gccactcctc tgctacacag cacggctttt tcaaggctgt attgagaagg 2520
gaagttagga agaagggtgt gctgggctaa ccagcccaca gagctcacat tcctgtccct 2580
tgggtgaaaa atacatgtcc atcctgatat ctcctgaatt cagaaattag cctccacatg 2640
tgcaatggct ttaagagcca gaagcagggt tctgggaatt ttgcaagtta cctgtggcca 2700
ggtgtggtct cggttaccaa atacggttac ctgcagcttt ttagtccttt gtgctcccac 2760
gggtctacag agtcccatct gcccaaaggt cttgaagctt gacaggatgt tttcgattac 2820
tcagtctccc agggcactac tggtccgtag gattcgattg gtcggggtag gagagttaaa 2880
caacatttaa acagagttct ctcaaaaatg tctaaaggga ttgtaggtag ataacatcca 2940
atcactgttt gcacttatct gaaatcttcc ctcttggctg cccccaggta tttactgtgg 3000
agaacattgc ataggaatgt ctggaaaaag cttctacaac ttgttacagc cttcacattt 3060
gtagaagctt t 3071
<210> 76
<211> 2271
<212> DNA
<213> Artificial Sequence
<220>
<223> OPA1-opt_ND4*-3'UTR*
<400> 76
gtgctgcccg cctagaaagg gtgaagtggt tgtttccgtg acggactgag tacgggtgcc 60
tgtcaggctc ttgcggaagt ccatgcgcca ttgggagggc ctcggccgcg gctctgtgcc 120
cttgctgctg agggccactt cctgggtcat tcctggaccg ggagccgggc tggggctcac 180
acgggggctc ccgcgtggcc gtctcggcgc ctgcgtgacc tccccgccgg cgggatgtgg 240
cgactacgtc gggccgctgt ggcctgatgc tgaagctgat cgtgcccacc atcatgctgc 300
tgcccctgac ctggctgagc aagaagcaca tgatctggat caacaccacc acccacagcc 360
tgatcatcag catcatcccc ctgctgttct tcaaccagat caacaacaac ctgttcagct 420
gcagccccac cttcagcagc gaccccctga ccacccccct gctgatgctg accacctggc 480
tgctgcccct gaccatcatg gccagccagc gccacctgag cagcgagccc ctgagccgca 540
agaagctgta cctgagcatg ctgatcagcc tgcagatcag cctgatcatg accttcaccg 600
ccaccgagct gatcatgttc tacatcttct tcgagaccac cctgatcccc accctggcca 660
tcatcacccg ctggggcaac cagcccgagc gcctgaacgc cggcacctac ttcctgttct 720
acaccctggt gggcagcctg cccctgctga tcgccctgat ctacacccac aacaccctgg 780
gcagcctgaa catcctgctg ctgaccctga ccgcccagga gctgagcaac agctgggcca 840
acaacctgat gtggctggcc tacaccatgg ccttcatggt gaagatgccc ctgtacggcc 900
tgcacctgtg gctgcccaag gcccacgtgg aggcccccat cgccggcagc atggtgctgg 960
ccgccgtgct gctgaagctg ggcggctacg gcatgatgcg cctgaccctg atcctgaacc 1020
ccctgaccaa gcacatggcc taccccttcc tggtgctgag cctgtggggc atgatcatga 1080
ccagcagcat ctgcctgcgc cagaccgacc tgaagagcct gatcgcctac agcagcatca 1140
gccacatggc cctggtggtg accgccatcc tgatccagac cccctggagc ttcaccggcg 1200
ccgtgatcct gatgatcgcc cacggcctga ccagcagcct gctgttctgc ctggccaaca 1260
gcaactacga gcgcacccac agccgcatca tgatcctgag ccagggcctg cagaccctgc 1320
tgcccctgat ggccttctgg tggctgctgg ccagcctggc caacctggcc ctgcccccca 1380
ccatcaacct gctgggcgag ctgagcgtgc tggtgaccac cttcagctgg agcaacatca 1440
ccctgctgct gaccggcctg aacatgctgg tgaccgccct gtacagcctg tacatgttca 1500
ccaccaccca gtggggcagc ctgacccacc acatcaacaa catgaagccc agcttcaccc 1560
gcgagaacac cctgatgttc atgcacctga gccccatcct gctgctgagc ctgaaccccg 1620
acatcatcac cggcttcagc agctaagagc actgggacgc ccaccgcccc tttccctccg 1680
ctgccaggcg agcatgttgt ggtaattctg gaacacaaga agagaaattg ctgggtttag 1740
aacaagatta taaacgaatt cggtgctcag tgatcacttg acagtttttt ttttttttaa 1800
atattaccca aaatgctccc caaataagaa atgcatcagc tcagtcagtg aatacaaaaa 1860
aggaattatt tttccctttg agggtctttt atacatctct cctccaaccc caccctctat 1920
tctgtttctt cctcctcaca tgggggtaca catacacagc ttcctctttt ggttccatcc 1980
ttaccaccac accacacgca cactccacat gcccagcaga gtggcacttg gtggccagaa 2040
agtgtgagcc tcatgatctg ctgtctgtag ttctgtgagc tcaggtccct caaaggcctc 2100
ggagcacccc cttccttgtg actgagccag ggcctgcatt tttggttttc cccaccccac 2160
acattctcaa ccatagtcct tctaacaata ccaatagcta ggacccggct gctgtgcact 2220
gggactgggg attccacatg tttgccttgg gagtctcaag ctggactgcc a 2271
<210> 77
<211> 2216
<212> DNA
<213> Artificial Sequence
<220>
<223> OPA1-ND6-3'UTR
<400> 77
gtgctgcccg cctagaaagg gtgaagtggt tgtttccgtg acggactgag tacgggtgcc 60
tgtcaggctc ttgcggaagt ccatgcgcca ttgggagggc ctcggccgcg gctctgtgcc 120
cttgctgctg agggccactt cctgggtcat tcctggaccg ggagccgggc tggggctcac 180
acgggggctc ccgcgtggcc gtctcggcgc ctgcgtgacc tccccgccgg cgggatgtgg 240
cgactacgtc gggccgctgt ggcctgatga tgtatgcttt gtttctgttg agtgtgggtt 300
tagtaatggg gtttgtgggg ttttcttcta agccttctcc tatttatggg ggtttagtat 360
tgattgttag cggtgtggtc gggtgtgtta ttattctgaa ttttggggga ggttatatgg 420
gtttaatggt ttttttaatt tatttagggg gaatgatggt tgtctttgga tatactacag 480
cgatggctat tgaggagtat cctgaggcat gggggtcagg ggttgaggtc ttggtgagtg 540
ttttagtggg gttagcgatg gaggtaggat tggtgctgtg ggtgaaagag tatgatgggg 600
tggtggttgt ggtaaacttt aatagtgtag gaagctggat gatttatgaa ggagaggggt 660
cagggttgat tcgggaggat cctattggtg cgggggcttt gtatgattat gggcgttggt 720
tagtagtagt tactggttgg acattgtttg ttggtgtata tattgtaatt gagattgctc 780
gggggaatta ggagcactgg gacgcccacc gcccctttcc ctccgctgcc aggcgagcat 840
gttgtggtaa ttctggaaca caagaagaga aattgctggg tttagaacaa gattataaac 900
gaattcggtg ctcagtgatc acttgacagt tttttttttt tttaaatatt acccaaaatg 960
ctccccaaat aagaaatgca tcagctcagt cagtgaatac aaaaaaggaa ttatttttcc 1020
ctttgagggt cttttataca tctctcctcc aaccccaccc tctattctgt ttcttcctcc 1080
tcacatgggg gtacacatac acagcttcct cttttggttc catccttacc accacaccac 1140
acgcacactc cacatgccca gcagagtggc acttggtggc cagaaagtgt gagcctcatg 1200
atctgctgtc tgtagttctg tgagctcagg tccctcaaag gcctcggagc acccccttcc 1260
ttgtgactga gccagggcct gcatttttgg ttttccccac cccacacatt ctcaaccata 1320
gtccttctaa caataccaat agctaggacc cggctgctgt gcactgggac tggggattcc 1380
acatgtttgc cttgggagtc tcaagctgga ctgccagccc ctgtcctccc ttcaccccca 1440
ttgcgtatga gcatttcaga actccaagga gtcacaggca tctttatagt tcacgttaac 1500
atatagacac tgttggaagc agttccttct aaaagggtag ccctggactt aataccagcc 1560
ggatacctct ggcccccacc ccattactgt acctctggag tcactactgt gggtcgccac 1620
tcctctgcta cacagcacgg ctttttcaag gctgtattga gaagggaagt taggaagaag 1680
ggtgtgctgg gctaaccagc ccacagagct cacattcctg tcccttgggt gaaaaataca 1740
tgtccatcct gatatctcct gaattcagaa attagcctcc acatgtgcaa tggctttaag 1800
agccagaagc agggttctgg gaattttgca agttacctgt ggccaggtgt ggtctcggtt 1860
accaaatacg gttacctgca gctttttagt cctttgtgct cccacgggtc tacagagtcc 1920
catctgccca aaggtcttga agcttgacag gatgttttcg attactcagt ctcccagggc 1980
actactggtc cgtaggattc gattggtcgg ggtaggagag ttaaacaaca tttaaacaga 2040
gttctctcaa aaatgtctaa agggattgta ggtagataac atccaatcac tgtttgcact 2100
tatctgaaat cttccctctt ggctgccccc aggtatttac tgtggagaac attgcatagg 2160
aatgtctgga aaaagcttct acaacttgtt acagccttca catttgtaga agcttt 2216
<210> 78
<211> 1416
<212> DNA
<213> Artificial Sequence
<220>
<223> OPA1-ND6-3'UTR*
<400> 78
gtgctgcccg cctagaaagg gtgaagtggt tgtttccgtg acggactgag tacgggtgcc 60
tgtcaggctc ttgcggaagt ccatgcgcca ttgggagggc ctcggccgcg gctctgtgcc 120
cttgctgctg agggccactt cctgggtcat tcctggaccg ggagccgggc tggggctcac 180
acgggggctc ccgcgtggcc gtctcggcgc ctgcgtgacc tccccgccgg cgggatgtgg 240
cgactacgtc gggccgctgt ggcctgatga tgtatgcttt gtttctgttg agtgtgggtt 300
tagtaatggg gtttgtgggg ttttcttcta agccttctcc tatttatggg ggtttagtat 360
tgattgttag cggtgtggtc gggtgtgtta ttattctgaa ttttggggga ggttatatgg 420
gtttaatggt ttttttaatt tatttagggg gaatgatggt tgtctttgga tatactacag 480
cgatggctat tgaggagtat cctgaggcat gggggtcagg ggttgaggtc ttggtgagtg 540
ttttagtggg gttagcgatg gaggtaggat tggtgctgtg ggtgaaagag tatgatgggg 600
tggtggttgt ggtaaacttt aatagtgtag gaagctggat gatttatgaa ggagaggggt 660
cagggttgat tcgggaggat cctattggtg cgggggcttt gtatgattat gggcgttggt 720
tagtagtagt tactggttgg acattgtttg ttggtgtata tattgtaatt gagattgctc 780
gggggaatta ggagcactgg gacgcccacc gcccctttcc ctccgctgcc aggcgagcat 840
gttgtggtaa ttctggaaca caagaagaga aattgctggg tttagaacaa gattataaac 900
gaattcggtg ctcagtgatc acttgacagt tttttttttt tttaaatatt acccaaaatg 960
ctccccaaat aagaaatgca tcagctcagt cagtgaatac aaaaaaggaa ttatttttcc 1020
ctttgagggt cttttataca tctctcctcc aaccccaccc tctattctgt ttcttcctcc 1080
tcacatgggg gtacacatac acagcttcct cttttggttc catccttacc accacaccac 1140
acgcacactc cacatgccca gcagagtggc acttggtggc cagaaagtgt gagcctcatg 1200
atctgctgtc tgtagttctg tgagctcagg tccctcaaag gcctcggagc acccccttcc 1260
ttgtgactga gccagggcct gcatttttgg ttttccccac cccacacatt ctcaaccata 1320
gtccttctaa caataccaat agctaggacc cggctgctgt gcactgggac tggggattcc 1380
acatgtttgc cttgggagtc tcaagctgga ctgcca 1416
<210> 79
<211> 2216
<212> DNA
<213> Artificial Sequence
<220>
<223> OPA1-opt_ND6-3'UTR
<400> 79
gtgctgcccg cctagaaagg gtgaagtggt tgtttccgtg acggactgag tacgggtgcc 60
tgtcaggctc ttgcggaagt ccatgcgcca ttgggagggc ctcggccgcg gctctgtgcc 120
cttgctgctg agggccactt cctgggtcat tcctggaccg ggagccgggc tggggctcac 180
acgggggctc ccgcgtggcc gtctcggcgc ctgcgtgacc tccccgccgg cgggatgtgg 240
cgactacgtc gggccgctgt ggcctgatga tgtacgccct gttcctgctg agcgtgggcc 300
tggtgatggg cttcgtgggc ttcagcagca agcccagccc catctacggc ggcctggtgc 360
tgatcgtgag cggcgtggtg ggctgcgtga tcatcctgaa cttcggcggc ggctacatgg 420
gcctgatggt gttcctgatc tacctgggcg gcatgatggt ggtgttcggc tacaccaccg 480
ccatggccat cgaggagtac cccgaggcct ggggcagcgg cgtggaggtg ctggtgagcg 540
tgctggtggg cctggccatg gaggtgggcc tggtgctgtg ggtgaaggag tacgacggcg 600
tggtggtggt ggtgaacttc aacagcgtgg gcagctggat gatctacgag ggcgagggca 660
gcggcctgat ccgcgaggac cccatcggcg ccggcgccct gtacgactac ggccgctggc 720
tggtggtggt gaccggctgg accctgttcg tgggcgtgta catcgtgatc gagatcgccc 780
gcggcaacta agagcactgg gacgcccacc gcccctttcc ctccgctgcc aggcgagcat 840
gttgtggtaa ttctggaaca caagaagaga aattgctggg tttagaacaa gattataaac 900
gaattcggtg ctcagtgatc acttgacagt tttttttttt tttaaatatt acccaaaatg 960
ctccccaaat aagaaatgca tcagctcagt cagtgaatac aaaaaaggaa ttatttttcc 1020
ctttgagggt cttttataca tctctcctcc aaccccaccc tctattctgt ttcttcctcc 1080
tcacatgggg gtacacatac acagcttcct cttttggttc catccttacc accacaccac 1140
acgcacactc cacatgccca gcagagtggc acttggtggc cagaaagtgt gagcctcatg 1200
atctgctgtc tgtagttctg tgagctcagg tccctcaaag gcctcggagc acccccttcc 1260
ttgtgactga gccagggcct gcatttttgg ttttccccac cccacacatt ctcaaccata 1320
gtccttctaa caataccaat agctaggacc cggctgctgt gcactgggac tggggattcc 1380
acatgtttgc cttgggagtc tcaagctgga ctgccagccc ctgtcctccc ttcaccccca 1440
ttgcgtatga gcatttcaga actccaagga gtcacaggca tctttatagt tcacgttaac 1500
atatagacac tgttggaagc agttccttct aaaagggtag ccctggactt aataccagcc 1560
ggatacctct ggcccccacc ccattactgt acctctggag tcactactgt gggtcgccac 1620
tcctctgcta cacagcacgg ctttttcaag gctgtattga gaagggaagt taggaagaag 1680
ggtgtgctgg gctaaccagc ccacagagct cacattcctg tcccttgggt gaaaaataca 1740
tgtccatcct gatatctcct gaattcagaa attagcctcc acatgtgcaa tggctttaag 1800
agccagaagc agggttctgg gaattttgca agttacctgt ggccaggtgt ggtctcggtt 1860
accaaatacg gttacctgca gctttttagt cctttgtgct cccacgggtc tacagagtcc 1920
catctgccca aaggtcttga agcttgacag gatgttttcg attactcagt ctcccagggc 1980
actactggtc cgtaggattc gattggtcgg ggtaggagag ttaaacaaca tttaaacaga 2040
gttctctcaa aaatgtctaa agggattgta ggtagataac atccaatcac tgtttgcact 2100
tatctgaaat cttccctctt ggctgccccc aggtatttac tgtggagaac attgcatagg 2160
aatgtctgga aaaagcttct acaacttgtt acagccttca catttgtaga agcttt 2216
<210> 80
<211> 1416
<212> DNA
<213> Artificial Sequence
<220>
<223> OPA1-opt_ND6-3'UTR*
<400> 80
gtgctgcccg cctagaaagg gtgaagtggt tgtttccgtg acggactgag tacgggtgcc 60
tgtcaggctc ttgcggaagt ccatgcgcca ttgggagggc ctcggccgcg gctctgtgcc 120
cttgctgctg agggccactt cctgggtcat tcctggaccg ggagccgggc tggggctcac 180
acgggggctc ccgcgtggcc gtctcggcgc ctgcgtgacc tccccgccgg cgggatgtgg 240
cgactacgtc gggccgctgt ggcctgatga tgtacgccct gttcctgctg agcgtgggcc 300
tggtgatggg cttcgtgggc ttcagcagca agcccagccc catctacggc ggcctggtgc 360
tgatcgtgag cggcgtggtg ggctgcgtga tcatcctgaa cttcggcggc ggctacatgg 420
gcctgatggt gttcctgatc tacctgggcg gcatgatggt ggtgttcggc tacaccaccg 480
ccatggccat cgaggagtac cccgaggcct ggggcagcgg cgtggaggtg ctggtgagcg 540
tgctggtggg cctggccatg gaggtgggcc tggtgctgtg ggtgaaggag tacgacggcg 600
tggtggtggt ggtgaacttc aacagcgtgg gcagctggat gatctacgag ggcgagggca 660
gcggcctgat ccgcgaggac cccatcggcg ccggcgccct gtacgactac ggccgctggc 720
tggtggtggt gaccggctgg accctgttcg tgggcgtgta catcgtgatc gagatcgccc 780
gcggcaacta agagcactgg gacgcccacc gcccctttcc ctccgctgcc aggcgagcat 840
gttgtggtaa ttctggaaca caagaagaga aattgctggg tttagaacaa gattataaac 900
gaattcggtg ctcagtgatc acttgacagt tttttttttt tttaaatatt acccaaaatg 960
ctccccaaat aagaaatgca tcagctcagt cagtgaatac aaaaaaggaa ttatttttcc 1020
ctttgagggt cttttataca tctctcctcc aaccccaccc tctattctgt ttcttcctcc 1080
tcacatgggg gtacacatac acagcttcct cttttggttc catccttacc accacaccac 1140
acgcacactc cacatgccca gcagagtggc acttggtggc cagaaagtgt gagcctcatg 1200
atctgctgtc tgtagttctg tgagctcagg tccctcaaag gcctcggagc acccccttcc 1260
ttgtgactga gccagggcct gcatttttgg ttttccccac cccacacatt ctcaaccata 1320
gtccttctaa caataccaat agctaggacc cggctgctgt gcactgggac tggggattcc 1380
acatgtttgc cttgggagtc tcaagctgga ctgcca 1416
<210> 81
<211> 2642
<212> DNA
<213> Artificial Sequence
<220>
<223> OPA1-ND1-3'UTR
<400> 81
gtgctgcccg cctagaaagg gtgaagtggt tgtttccgtg acggactgag tacgggtgcc 60
tgtcaggctc ttgcggaagt ccatgcgcca ttgggagggc ctcggccgcg gctctgtgcc 120
cttgctgctg agggccactt cctgggtcat tcctggaccg ggagccgggc tggggctcac 180
acgggggctc ccgcgtggcc gtctcggcgc ctgcgtgacc tccccgccgg cgggatgtgg 240
cgactacgtc gggccgctgt ggcctgatgg ccaacctcct actcctcatt gtacccattc 300
taatcgcaat ggcattccta atgcttaccg aacgaaaaat tctaggctat atgcaactac 360
gcaaaggccc caacgttgta ggcccctacg ggctactaca acccttcgct gacgccataa 420
aactcttcac caaagagccc ctaaaacccg ccacatctac catcaccctc tacatcaccg 480
ccccgacctt agctctcacc atcgctcttc tactatggac ccccctcccc atgcccaacc 540
ccctggtcaa cctcaaccta ggcctcctat ttattctagc cacctctagc ctagccgttt 600
actcaatcct ctggtcaggg tgggcatcaa actcaaacta cgccctgatc ggcgcactgc 660
gagcagtagc ccaaacaatc tcatatgaag tcaccctagc catcattcta ctatcaacat 720
tactaatgag tggctccttt aacctctcca cccttatcac aacacaagaa cacctctggt 780
tactcctgcc atcatggccc ttggccatga tgtggtttat ctccacacta gcagagacca 840
accgaacccc cttcgacctt gccgaagggg agtccgaact agtctcaggc ttcaacatcg 900
aatacgccgc aggccccttc gccctattct tcatggccga atacacaaac attattatga 960
tgaacaccct caccactaca atcttcctag gaacaacata tgacgcactc tcccctgaac 1020
tctacacaac atattttgtc accaagaccc tacttctaac ctccctgttc ttatggattc 1080
gaacagcata cccccgattc cgctacgacc aactcatgca cctcctatgg aaaaacttcc 1140
taccactcac cctagcatta cttatgtggt atgtctccat gcccattaca atctccagca 1200
ttccccctca aacctaagag cactgggacg cccaccgccc ctttccctcc gctgccaggc 1260
gagcatgttg tggtaattct ggaacacaag aagagaaatt gctgggttta gaacaagatt 1320
ataaacgaat tcggtgctca gtgatcactt gacagttttt ttttttttta aatattaccc 1380
aaaatgctcc ccaaataaga aatgcatcag ctcagtcagt gaatacaaaa aaggaattat 1440
ttttcccttt gagggtcttt tatacatctc tcctccaacc ccaccctcta ttctgtttct 1500
tcctcctcac atgggggtac acatacacag cttcctcttt tggttccatc cttaccacca 1560
caccacacgc acactccaca tgcccagcag agtggcactt ggtggccaga aagtgtgagc 1620
ctcatgatct gctgtctgta gttctgtgag ctcaggtccc tcaaaggcct cggagcaccc 1680
ccttccttgt gactgagcca gggcctgcat ttttggtttt ccccacccca cacattctca 1740
accatagtcc ttctaacaat accaatagct aggacccggc tgctgtgcac tgggactggg 1800
gattccacat gtttgccttg ggagtctcaa gctggactgc cagcccctgt cctcccttca 1860
cccccattgc gtatgagcat ttcagaactc caaggagtca caggcatctt tatagttcac 1920
gttaacatat agacactgtt ggaagcagtt ccttctaaaa gggtagccct ggacttaata 1980
ccagccggat acctctggcc cccaccccat tactgtacct ctggagtcac tactgtgggt 2040
cgccactcct ctgctacaca gcacggcttt ttcaaggctg tattgagaag ggaagttagg 2100
aagaagggtg tgctgggcta accagcccac agagctcaca ttcctgtccc ttgggtgaaa 2160
aatacatgtc catcctgata tctcctgaat tcagaaatta gcctccacat gtgcaatggc 2220
tttaagagcc agaagcaggg ttctgggaat tttgcaagtt acctgtggcc aggtgtggtc 2280
tcggttacca aatacggtta cctgcagctt tttagtcctt tgtgctccca cgggtctaca 2340
gagtcccatc tgcccaaagg tcttgaagct tgacaggatg ttttcgatta ctcagtctcc 2400
cagggcacta ctggtccgta ggattcgatt ggtcggggta ggagagttaa acaacattta 2460
aacagagttc tctcaaaaat gtctaaaggg attgtaggta gataacatcc aatcactgtt 2520
tgcacttatc tgaaatcttc cctcttggct gcccccaggt atttactgtg gagaacattg 2580
cataggaatg tctggaaaaa gcttctacaa cttgttacag ccttcacatt tgtagaagct 2640
tt 2642
<210> 82
<211> 1842
<212> DNA
<213> Artificial Sequence
<220>
<223> OPA1-ND1-3'UTR*
<400> 82
gtgctgcccg cctagaaagg gtgaagtggt tgtttccgtg acggactgag tacgggtgcc 60
tgtcaggctc ttgcggaagt ccatgcgcca ttgggagggc ctcggccgcg gctctgtgcc 120
cttgctgctg agggccactt cctgggtcat tcctggaccg ggagccgggc tggggctcac 180
acgggggctc ccgcgtggcc gtctcggcgc ctgcgtgacc tccccgccgg cgggatgtgg 240
cgactacgtc gggccgctgt ggcctgatgg ccaacctcct actcctcatt gtacccattc 300
taatcgcaat ggcattccta atgcttaccg aacgaaaaat tctaggctat atgcaactac 360
gcaaaggccc caacgttgta ggcccctacg ggctactaca acccttcgct gacgccataa 420
aactcttcac caaagagccc ctaaaacccg ccacatctac catcaccctc tacatcaccg 480
ccccgacctt agctctcacc atcgctcttc tactatggac ccccctcccc atgcccaacc 540
ccctggtcaa cctcaaccta ggcctcctat ttattctagc cacctctagc ctagccgttt 600
actcaatcct ctggtcaggg tgggcatcaa actcaaacta cgccctgatc ggcgcactgc 660
gagcagtagc ccaaacaatc tcatatgaag tcaccctagc catcattcta ctatcaacat 720
tactaatgag tggctccttt aacctctcca cccttatcac aacacaagaa cacctctggt 780
tactcctgcc atcatggccc ttggccatga tgtggtttat ctccacacta gcagagacca 840
accgaacccc cttcgacctt gccgaagggg agtccgaact agtctcaggc ttcaacatcg 900
aatacgccgc aggccccttc gccctattct tcatggccga atacacaaac attattatga 960
tgaacaccct caccactaca atcttcctag gaacaacata tgacgcactc tcccctgaac 1020
tctacacaac atattttgtc accaagaccc tacttctaac ctccctgttc ttatggattc 1080
gaacagcata cccccgattc cgctacgacc aactcatgca cctcctatgg aaaaacttcc 1140
taccactcac cctagcatta cttatgtggt atgtctccat gcccattaca atctccagca 1200
ttccccctca aacctaagag cactgggacg cccaccgccc ctttccctcc gctgccaggc 1260
gagcatgttg tggtaattct ggaacacaag aagagaaatt gctgggttta gaacaagatt 1320
ataaacgaat tcggtgctca gtgatcactt gacagttttt ttttttttta aatattaccc 1380
aaaatgctcc ccaaataaga aatgcatcag ctcagtcagt gaatacaaaa aaggaattat 1440
ttttcccttt gagggtcttt tatacatctc tcctccaacc ccaccctcta ttctgtttct 1500
tcctcctcac atgggggtac acatacacag cttcctcttt tggttccatc cttaccacca 1560
caccacacgc acactccaca tgcccagcag agtggcactt ggtggccaga aagtgtgagc 1620
ctcatgatct gctgtctgta gttctgtgag ctcaggtccc tcaaaggcct cggagcaccc 1680
ccttccttgt gactgagcca gggcctgcat ttttggtttt ccccacccca cacattctca 1740
accatagtcc ttctaacaat accaatagct aggacccggc tgctgtgcac tgggactggg 1800
gattccacat gtttgccttg ggagtctcaa gctggactgc ca 1842
<210> 83
<211> 2642
<212> DNA
<213> Artificial Sequence
<220>
<223> OPA1-opt_ND1-3'UTR
<400> 83
gtgctgcccg cctagaaagg gtgaagtggt tgtttccgtg acggactgag tacgggtgcc 60
tgtcaggctc ttgcggaagt ccatgcgcca ttgggagggc ctcggccgcg gctctgtgcc 120
cttgctgctg agggccactt cctgggtcat tcctggaccg ggagccgggc tggggctcac 180
acgggggctc ccgcgtggcc gtctcggcgc ctgcgtgacc tccccgccgg cgggatgtgg 240
cgactacgtc gggccgctgt ggcctgatgg ccaacctgct gctgctgatc gtgcccatcc 300
tgatcgccat ggccttcctg atgctgaccg agcgcaagat cctgggctac atgcagctgc 360
gcaagggccc caacgtggtg ggcccctacg gcctgctgca gcccttcgcc gacgccatca 420
agctgttcac caaggagccc ctgaagcccg ccaccagcac catcaccctg tacatcaccg 480
cccccaccct ggccctgacc atcgccctgc tgctgtggac ccccctgccc atgcccaacc 540
ccctggtgaa cctgaacctg ggcctgctgt tcatcctggc caccagcagc ctggccgtgt 600
acagcatcct gtggagcggc tgggccagca acagcaacta cgccctgatc ggcgccctgc 660
gcgccgtggc ccagaccatc agctacgagg tgaccctggc catcatcctg ctgagcaccc 720
tgctgatgag cggcagcttc aacctgagca ccctgatcac cacccaggag cacctgtggc 780
tgctgctgcc cagctggccc ctggccatga tgtggttcat cagcaccctg gccgagacca 840
accgcacccc cttcgacctg gccgagggcg agagcgagct ggtgagcggc ttcaacatcg 900
agtacgccgc cggccccttc gccctgttct tcatggccga gtacaccaac atcatcatga 960
tgaacaccct gaccaccacc atcttcctgg gcaccaccta cgacgccctg agccccgagc 1020
tgtacaccac ctacttcgtg accaagaccc tgctgctgac cagcctgttc ctgtggatcc 1080
gcaccgccta cccccgcttc cgctacgacc agctgatgca cctgctgtgg aagaacttcc 1140
tgcccctgac cctggccctg ctgatgtggt acgtgagcat gcccatcacc atcagcagca 1200
tcccccccca gacctaagag cactgggacg cccaccgccc ctttccctcc gctgccaggc 1260
gagcatgttg tggtaattct ggaacacaag aagagaaatt gctgggttta gaacaagatt 1320
ataaacgaat tcggtgctca gtgatcactt gacagttttt ttttttttta aatattaccc 1380
aaaatgctcc ccaaataaga aatgcatcag ctcagtcagt gaatacaaaa aaggaattat 1440
ttttcccttt gagggtcttt tatacatctc tcctccaacc ccaccctcta ttctgtttct 1500
tcctcctcac atgggggtac acatacacag cttcctcttt tggttccatc cttaccacca 1560
caccacacgc acactccaca tgcccagcag agtggcactt ggtggccaga aagtgtgagc 1620
ctcatgatct gctgtctgta gttctgtgag ctcaggtccc tcaaaggcct cggagcaccc 1680
ccttccttgt gactgagcca gggcctgcat ttttggtttt ccccacccca cacattctca 1740
accatagtcc ttctaacaat accaatagct aggacccggc tgctgtgcac tgggactggg 1800
gattccacat gtttgccttg ggagtctcaa gctggactgc cagcccctgt cctcccttca 1860
cccccattgc gtatgagcat ttcagaactc caaggagtca caggcatctt tatagttcac 1920
gttaacatat agacactgtt ggaagcagtt ccttctaaaa gggtagccct ggacttaata 1980
ccagccggat acctctggcc cccaccccat tactgtacct ctggagtcac tactgtgggt 2040
cgccactcct ctgctacaca gcacggcttt ttcaaggctg tattgagaag ggaagttagg 2100
aagaagggtg tgctgggcta accagcccac agagctcaca ttcctgtccc ttgggtgaaa 2160
aatacatgtc catcctgata tctcctgaat tcagaaatta gcctccacat gtgcaatggc 2220
tttaagagcc agaagcaggg ttctgggaat tttgcaagtt acctgtggcc aggtgtggtc 2280
tcggttacca aatacggtta cctgcagctt tttagtcctt tgtgctccca cgggtctaca 2340
gagtcccatc tgcccaaagg tcttgaagct tgacaggatg ttttcgatta ctcagtctcc 2400
cagggcacta ctggtccgta ggattcgatt ggtcggggta ggagagttaa acaacattta 2460
aacagagttc tctcaaaaat gtctaaaggg attgtaggta gataacatcc aatcactgtt 2520
tgcacttatc tgaaatcttc cctcttggct gcccccaggt atttactgtg gagaacattg 2580
cataggaatg tctggaaaaa gcttctacaa cttgttacag ccttcacatt tgtagaagct 2640
tt 2642
<210> 84
<211> 1842
<212> DNA
<213> Artificial Sequence
<220>
<223> OPA1-opt_ND1-3'UTR*
<400> 84
gtgctgcccg cctagaaagg gtgaagtggt tgtttccgtg acggactgag tacgggtgcc 60
tgtcaggctc ttgcggaagt ccatgcgcca ttgggagggc ctcggccgcg gctctgtgcc 120
cttgctgctg agggccactt cctgggtcat tcctggaccg ggagccgggc tggggctcac 180
acgggggctc ccgcgtggcc gtctcggcgc ctgcgtgacc tccccgccgg cgggatgtgg 240
cgactacgtc gggccgctgt ggcctgatgg ccaacctgct gctgctgatc gtgcccatcc 300
tgatcgccat ggccttcctg atgctgaccg agcgcaagat cctgggctac atgcagctgc 360
gcaagggccc caacgtggtg ggcccctacg gcctgctgca gcccttcgcc gacgccatca 420
agctgttcac caaggagccc ctgaagcccg ccaccagcac catcaccctg tacatcaccg 480
cccccaccct ggccctgacc atcgccctgc tgctgtggac ccccctgccc atgcccaacc 540
ccctggtgaa cctgaacctg ggcctgctgt tcatcctggc caccagcagc ctggccgtgt 600
acagcatcct gtggagcggc tgggccagca acagcaacta cgccctgatc ggcgccctgc 660
gcgccgtggc ccagaccatc agctacgagg tgaccctggc catcatcctg ctgagcaccc 720
tgctgatgag cggcagcttc aacctgagca ccctgatcac cacccaggag cacctgtggc 780
tgctgctgcc cagctggccc ctggccatga tgtggttcat cagcaccctg gccgagacca 840
accgcacccc cttcgacctg gccgagggcg agagcgagct ggtgagcggc ttcaacatcg 900
agtacgccgc cggccccttc gccctgttct tcatggccga gtacaccaac atcatcatga 960
tgaacaccct gaccaccacc atcttcctgg gcaccaccta cgacgccctg agccccgagc 1020
tgtacaccac ctacttcgtg accaagaccc tgctgctgac cagcctgttc ctgtggatcc 1080
gcaccgccta cccccgcttc cgctacgacc agctgatgca cctgctgtgg aagaacttcc 1140
tgcccctgac cctggccctg ctgatgtggt acgtgagcat gcccatcacc atcagcagca 1200
tcccccccca gacctaagag cactgggacg cccaccgccc ctttccctcc gctgccaggc 1260
gagcatgttg tggtaattct ggaacacaag aagagaaatt gctgggttta gaacaagatt 1320
ataaacgaat tcggtgctca gtgatcactt gacagttttt ttttttttta aatattaccc 1380
aaaatgctcc ccaaataaga aatgcatcag ctcagtcagt gaatacaaaa aaggaattat 1440
ttttcccttt gagggtcttt tatacatctc tcctccaacc ccaccctcta ttctgtttct 1500
tcctcctcac atgggggtac acatacacag cttcctcttt tggttccatc cttaccacca 1560
caccacacgc acactccaca tgcccagcag agtggcactt ggtggccaga aagtgtgagc 1620
ctcatgatct gctgtctgta gttctgtgag ctcaggtccc tcaaaggcct cggagcaccc 1680
ccttccttgt gactgagcca gggcctgcat ttttggtttt ccccacccca cacattctca 1740
accatagtcc ttctaacaat accaatagct aggacccggc tgctgtgcac tgggactggg 1800
gattccacat gtttgccttg ggagtctcaa gctggactgc ca 1842
<210> 85
<211> 18
<212> DNA
<213> Artificial Sequence
<220>
<223> beta-actin-S primer
<400> 85
cgagatcgtg cgggacat 18
<210> 86
<211> 19
<212> DNA
<213> Artificial Sequence
<220>
<223> beta-actin-A primer
<400> 86
caggaaggag ggctggaac 19
<210> 87
<211> 19
<212> DNA
<213> Artificial Sequence
<220>
<223> ND4-S primer
<400> 87
ctgcctacga caaacagac 19
<210> 88
<211> 19
<212> DNA
<213> Artificial Sequence
<220>
<223> ND4-A primer
<400> 88
agtgcgttcg tagtttgag 19
<210> 89
<211> 21
<212> DNA
<213> Artificial Sequence
<220>
<223> ND6-F primer
<400> 89
atgatgtatg ctttgtttct g 21
<210> 90
<211> 21
<212> DNA
<213> Artificial Sequence
<220>
<223> ND6-R primer
<400> 90
ctaattcccc cgagcaatct c 21
<210> 91
<211> 18
<212> DNA
<213> Artificial Sequence
<220>
<223> ND6-S primer
<400> 91
agtgtgggtt tagtaatg 18
<210> 92
<211> 18
<212> DNA
<213> Artificial Sequence
<220>
<223> ND6-A primer
<400> 92
tgcctcagga tactcctc 18
<210> 93
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> beta-actin-F primer
<400> 93
ctccatcctg gcctcgctgt 20
<210> 94
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> beta-actin-R primer
<400> 94
gctgtcacct tcaccgttcc 20
<210> 95
<211> 23
<212> DNA
<213> Artificial Sequence
<220>
<223> ND6-F primer
<400> 95
gggttttctt ctaagccttc tcc 23
<210> 96
<211> 23
<212> DNA
<213> Artificial Sequence
<220>
<223> ND6-R primer
<400> 96
ccatcatact ctttcaccca cag 23
<210> 97
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_ND6-F primer
<400> 97
cgcctgctga ccggctgcgt 20
<210> 98
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> opt_ND6-R
<400> 98
ccaggcctcg gggtactcct 20
<210> 99
<211> 21
<212> DNA
<213> Artificial Sequence
<220>
<223> ND1-F primer
<400> 99
atggccgcat ctccgcacac t 21
<210> 100
<211> 21
<212> DNA
<213> Artificial Sequence
<220>
<223> ND1-R primer
<400> 100
ttaggtttga gggggaatgc t 21
<210> 101
<211> 21
<212> DNA
<213> Artificial Sequence
<220>
<223> ND1-F primer
<400> 101
aacctcaacc taggcctcct a 21
<210> 102
<211> 21
<212> DNA
<213> Artificial Sequence
<220>
<223> ND1-R primer
<400> 102
tggcaggagt aaccagaggt g 21
<210> 103
<211> 23
<212> DNA
<213> Artificial Sequence
<220>
<223> ND1-F primer
<400> 103
aggaggctct gtctggtatc ttg 23
<210> 104
<211> 21
<212> DNA
<213> Artificial Sequence
<220>
<223> ND1-R primer
<400> 104
ttttaggggc tctttggtga a 21
<210> 105
<211> 22
<212> DNA
<213> Artificial Sequence
<220>
<223> opt-ND1-F primer
<400> 105
gccgcctgct gaccggctgc gt 22
<210> 106
<211> 24
<212> DNA
<213> Artificial Sequence
<220>
<223> opt-ND1-R primer
<400> 106
tgatgtacag ggtgatggtg ctgg 24
<210> 107
<211> 19
<212> DNA
<213> Artificial Sequence
<220>
<223> ND4-S primer
<400> 107
gccaacagca actacgagc 19
<210> 108
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> ND4-A primer
<400> 108
tgatgttgct ccagctgaag 20
<210> 109
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> opt-ND4-S primer
<400> 109
gcctgaccct gatcctgaac 20
<210> 110
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> opt-ND4-A primer
<400> 110
gtgcgctcgt agttgctgtt 20
<210> 111
<211> 376
<212> DNA
<213> Homo sapiens
<400> 111
gggcagtgcc tccccgcccc gccgctggcg tcaagttcag ctccacgtgt gccatcagtg 60
gatccgatcc gtccagccat ggcttcctat tccaagatgg tgtgaccaga catgcttcct 120
gctccccgct tagcccacgg agtgactgtg gttgtggtgg gggggttctt aaaataactt 180
tttagccccc gtcttcctat tttgagtttg gttcagatct taagcagctc catgcaactg 240
tatttatttt tgatgacaag actcccatct aaagtttttc tcctgcctga tcatttcatt 300
ggtggctgaa ggattctaga gaaccttttg ttcttgcaag gaaaacaaga atccaaaacc 360
agtgactgtt ctgtga 376
<210> 112
<211> 146
<212> DNA
<213> Homo sapiens
<400> 112
ggggtctttg tcctctgtac tgtctctctc cttgccccta acccaaaaag cttcattttt 60
ctgtgtaggc tgcacaagag ccttgattga agatatattc tttctgaaca gtatttaagg 120
tttccaataa aatgtacacc cctcag 146
<210> 113
<211> 1956
<212> DNA
<213> Homo sapiens
<400> 113
tgttgggtcc aagaaggaat ttctttccat ccctgtgagg caatgggtgg gaatgatagg 60
acaggcaaag agaagcttcc tcaggctagc aaaaatatca tttgatgtat tgattaaaaa 120
agcacttgct tgatgtatct ttggcgtgtg tgctactctc atctgtgtgt atgtgtgttg 180
tgtgtgtgtg tgtgtgcatg cacatatgtg ttcactctgc tactttgtaa gttttaggct 240
aggttgcttt accagctgtt tacttctttt ttgttgttgt tttgagacaa ggtttcgctc 300
tgccaccctg gctggagtgc agtggcgtga tcttggctca cggcaacctc tgcctcctgg 360
ggctcaagca attatcccac ctcagcctcc tgagcagctg ggactacagg tgcatgccac 420
aacacctggc tgatatttgt attttttgta gagacaggat tttgccaagt tgcccaggct 480
ggtcttgaac tcctaggctt aagcaatcca cccaccttgg cctcctgaag tgccaggatc 540
acagacgtga gccactacac ccagcccagc tgtttacttc tttaaccata cttttgattt 600
tattttttga ccaaaatgaa ctaacccagg taatcttcca gggaccgcaa ttccagaacc 660
tcatagtatt tcttccattt ccagcagctg attagaagtc caggatcatg tgaagtcagg 720
cagggtcaca gttcctgatg gcacattatg gacagagaat tccattttgt tttctaaccc 780
atgatgaaaa cccacgtgag tcagtgtgtg aacagggatc attaattttt tccccctagg 840
tggaaggaaa aaggcactta ctttgcaggt tacagaaatt actgggagag gatatcgtca 900
taaaaagagc caggccaaat tggaatattt ttgtgatctg catcatgatg ctgaaaatag 960
caattatttg ggaattgggt ttgaaaactg aattgttgcc agagaattaa accaggtgaa 1020
aggtcctttt gaattcagat tgtcttctga acatccaggc tgatcatctg agagcagtca 1080
aatctacttc cccaaaaaga gaccagggta ggtttatttg cttttatttt taatgtttgc 1140
ctgtgtttcc aagtgtgaac aaaacagtgt gtgatctatt cttggattca ttttgatcag 1200
tatttattca aacccagtct ctctccagga cataaaactg aaatcagata tgttcttttt 1260
aagcccaaac cctctccttt ctagatccaa cccttcaccc ctaattttat gatggctata 1320
gccatggact tccccaagaa aagatcaccc agaaataaga ccacctgtga cagttaccag 1380
cttttattca taaccttagc ttcccaacta ttgagcattt tctaaggtcc ctgctgtctt 1440
ttggtctctg gtttgatttg tggcaaacag atgaagtaac agactgctat gaaggaccac 1500
aaaaacggca gcctctggaa aaaccattag aaagtcagtg gcagatccag taaataatat 1560
cgccagcctc agcataatct gctgctgact cgattcagtg gactctaaag tgcccagcct 1620
cctgacctga gctctcctgc catctgtgag actaccagag gtcttatctg ctgtccacat 1680
ggcaactggg catgagtacc tggccacctt gcttccctct ttgcctggtc caagtgagtg 1740
tctgctgcct ctgtcctgcc ttgttttcct ggctctaaac caactccacc cactcttaat 1800
ggaaactcag tctggctttg tgtgtttctg ggaagcacat gacttctggg aatgggcaag 1860
gaagaggagt gaaacaaaaa ctgtcagcta tgtgtgcctg gtctgggatc cttctctggg 1920
tgacagtggc atcatgaatc ttagaatcag ctcccc 1956
<210> 114
<211> 411
<212> DNA
<213> Homo sapiens
<400> 114
gaatcatgca agcttcctcc ctcagccatt gatggaaagt tcagcaagat cagcaacaaa 60
accaagaaaa atgatccttg cgtgctgaat atctgaaaag agaaattttt cctacaaaat 120
ctcttgggtc aagaaagttc tagaatttga attgataaac atggtgggtt ggctgagggt 180
aagagtatat gaggaacctt ttaaacgaca acaatactgc tagctttcag gatgattttt 240
aaaaaataga ttcaaatgtg ttatcctctc tctgaaacgc ttcctataac tcgagtttat 300
aggggaagaa aaagctattg tttacaatta tatcaccatt aaggcaactg ctacaccctg 360
ctttgtattc tgggctaaga ttcattaaaa actagctgct cttaacttac a 411
<210> 115
<211> 1465
<212> DNA
<213> Homo sapiens
<400> 115
gagcactggg acgcccaccg cccctttccc tccgctgcca ggcgagcatg ttgtggtaat 60
tctggaacac aagaagagaa attgctgggt ttagaacaag attataaacg aattcggtgc 120
tcagtgatca cttgacagtt tttttttttt ttaaatatta cccaaaatgc tccccaaata 180
agaaatgcat cagctcagtc agtgaataca aaaaaggaat tatttttccc tttgagggtc 240
tttatacatc tctcctccaa ccccaccctc tattctgttt cttcctcctc acatgggggt 300
acacatacac agcttcctct tttggttcca tccttaccac cacaccacac gcacactcca 360
catgcccagc agagtggcac ttggtggcca gaaagtgtga gcctcatgat ctgctgtctg 420
tagttctgtg agctcaggtc cctcaaaggc ctcggagcac ccccttcctg gtgactgagc 480
cagggcctgc atttttggtt ttccccaccc cacacattct caaccatagt ccttctaaca 540
ataccaatag ctaggacccg gctgctgtgc actgggactg gggattccac atgtttgcct 600
tgggagtctc aagctggact gccagcccct gtcctccctt cacccccatt gcgtatgagc 660
atttcagaac tccaaggagt cacaggcatc tttatagttc acgttaacat atagacactg 720
ttggaagcag ttccttctaa aagggtagcc ctggacttaa taccagccgg atacctctgg 780
cccccacccc attactgtac ctctggagtc actactgtgg gtcgccactc ctctgctaca 840
cagcacggct ttttcaaggc tgtattgaga agggaagtta ggaagaaggg tgtgctgggc 900
taaccagccc acagagctca cattcctgtc ccttgggtga aaaatacatg tccatcctga 960
tatctcctga attcagaaat tagcctccac atgtgcaatg gctttaagag ccagaagcag 1020
ggttctggga attttgcaag ttatcctgtg gccaggtgtg gtctcggtta ccaaatacgg 1080
ttacctgcag ctttttagtc ctttgtgctc ccacgggtct gcagagtccc atctgcccaa 1140
aggtcttgaa gcttgacagg atgttttcat tactcagtct cccagggcac tgctggtccg 1200
tagggattca ttggtcgggg tgggagagtt aaacaacatt taaacagagt tctctcaaaa 1260
atgtctaaag ggattgtagg tagataacat ccaatcactg tttgcactta tctgaaatct 1320
tccctcttgg ctgcccccag gtatttactg tggagaacat tgcataggaa tgtctggaaa 1380
aagcctctac aacttgttac agccttcaca tttgtacaat tcattgattc tcttttcctt 1440
ccacaataaa atggtataca agaac 1465
<210> 116
<211> 288
<212> DNA
<213> Homo sapiens
<400> 116
gagacttgga ctcaagtcat aggcttcttt cagtctttat gtcacctcag gagacttatt 60
tgagaggaag ccttctgtac ttgaagttga tttgaaatat gtaagaattg atgatgtatt 120
tgcaaacatt aatgtgaaat aaattgaatt taatgttgaa tactttcagg cattcactta 180
ataaagacac tgttaagcac tgttatgctc agtcatacac gcgaaaggta caatgtcttt 240
tagctaattc taattaaaaa ttacagactg gtgtacaaga tacttgtg 288
<210> 117
<211> 83
<212> DNA
<213> Homo sapiens
<400> 117
cccaccaccc tggcctgctg tcctgcgtct atccatgtgg aatgctggac aataaagcga 60
gtgctgccca ccctccagct gcc 83
<210> 118
<211> 66
<212> DNA
<213> Homo sapiens
<400> 118
tttatattga actgtaaata tgtcactaga gaaataaaat atggacttcc aatctacgta 60
aactta 66
<210> 119
<211> 214
<212> DNA
<213> Homo sapiens
<400> 119
accacgatcg ttatgctgag tatgttaagc tctttatgac tgtttttgta gtggtataga 60
gtactgcaga atacagtaag ctgctctatt gtagcatttc ttgatgttgc ttagtcactt 120
atttcataaa caacttaatg ttctgaataa tttcttacta aacattttgt tattgggcaa 180
gtgattgaaa atagtaaatg ctttgtgtga ttga 214
<210> 120
<211> 286
<212> DNA
<213> Homo sapiens
<400> 120
tcttggaata taaagaattt cttcaggttg aattacctag aagtttgtca ctgacttgtg 60
ttcctgaact atgacacatg aatatgtggg ctaagaaata gttcctcttg ataaataaac 120
aattaacaaa tactttggac agtaagtctt tctcagttct taatgataat gcagggcact 180
tactagcata agaattggtt tgggatttaa ctgtttatga agctaacttg atttccgtgt 240
tttgttaaaa tttcattgtt ctagcacatc tttaactgtg atagtt 286
<210> 121
<211> 721
<212> DNA
<213> Homo sapiens
<400> 121
gagacgtgca cttggtcgtg cgcccaggga ggaagccgca ccaccagcca gcgcaggccc 60
tggtggagag gcctccctgg ctgcctctgg gaggggtgct gccttgtaga tggagcaagt 120
gagcactgag ggtctggtgc caatcctgta ggcacaaaac cagaagtttc tacattctct 180
atttttgtta atcatcttct ctttttccag aatttggaag ctagaatggt gggaatgtca 240
gtagtgccag aaagagagaa ccaagcttgt ctttaaagtt actgatcaca ggacgttgct 300
ttttcactgt ttcctattaa tcttcagctg aacacaagca aaccttctca ggaggtgtct 360
cctaccctct tattgttcct cttacgctct gctcaatgaa accttcctct tgagggtcat 420
tttcctttct gtattaatta taccagtgtt aagtgacata gataagaact ttgcacactt 480
caaatcagag cagtgattct ctcttctctc cccttttcct tcagagtgaa tcatccagac 540
tcctcatgga taggtcgggt gttaaagttg ttttgattat gtaccttttg atagatccac 600
ataaaaagaa atgtgaagtt ttcttttact atcttttcat ttatcaagca gagacctttg 660
ttgggaggcg gtttgggaga acacatttct aatttgaatg aaatgaaatc tattttcagt 720
g 721
<210> 122
<211> 163
<212> DNA
<213> Homo sapiens
<400> 122
cagaagaagt gacggctggg ggcacagtgg gctgggcgcc cctgcagaac atgaaccttc 60
cgctcctggc tgccacaggg tcctccgatg ctggcctttg cgcctctaga ggcagccact 120
catggattca agtcctggct ccgcctcttc catcaggacc act 163
<210> 123
<211> 60
<212> DNA
<213> Homo sapiens
<400> 123
agaggacaca ctctgcaccc ccccacccca cgaccttggc ccgagcccct ccgtgaggaa 60
60
<210> 124
<211> 65
<212> DNA
<213> Rattus norvegicus
<400> 124
agcccttccg ccaggctgtg tgtcaggccc gtggtgggtg ttttgtagta gtgtagagca 60
ttgca 65
<210> 125
<211> 231
<212> DNA
<213> Homo sapiens
<400> 125
cttatgttct gtgcgcattc tggcaggaat tctgtctctt cagagactca tcctcaaaac 60
aagacttgac actgtgtcct tgccccagtc ctaggaactg tggcacacag agatgttcat 120
tttaaaaacg gatttcatga aacactcttg tacttatgtt tataagagag cactgggtag 180
ccaagtgatc ttcccattca cagagttagt aaacctctgt actacatgct g 231
<210> 126
<211> 28
<212> PRT
<213> Homo sapiens
<400> 126
Met Ala Ala Ser Pro His Thr Leu Ser Ser Arg Leu Leu Thr Gly Cys
1 5 10 15
Val Gly Gly Ser Val Trp Tyr Leu Glu Arg Arg Thr
20 25
<210> 127
<211> 29
<212> PRT
<213> Homo sapiens
<400> 127
Met Ser Val Leu Thr Arg Leu Leu Leu Arg Gly Leu Thr Arg Leu Gly
1 5 10 15
Ser Ala Ala Pro Val Arg Arg Ala Arg Ile His Ser Leu
20 25
<210> 128
<211> 10
<212> PRT
<213> Homo sapiens
<400> 128
Met Trp Arg Leu Arg Arg Ala Ala Val Ala
1 5 10
<210> 129
<211> 28
<212> PRT
<213> Homo sapiens
<400> 129
Met Ala Ala Ser Pro His Thr Leu Ser Ser Arg Leu Leu Thr Gly Cys
1 5 10 15
Val Gly Gly Ser Val Trp Tyr Leu Glu Arg Arg Thr
20 25
<210> 130
<211> 122
<212> PRT
<213> Saccharomyces cerevisiae
<400> 130
Met Ala Phe Lys Ser Phe Ile Tyr Ser Lys Gly Tyr His Arg Ser Ala
1 5 10 15
Ala Gln Lys Lys Thr Ala Thr Ser Phe Phe Asp Ser Ser Tyr Gln Tyr
20 25 30
Leu Arg Gln Asn Gln Gly Leu Val Asn Ser Asp Pro Val Leu His Ala
35 40 45
Ser His Leu His Pro His Pro Val Val Val Ala Asn Val Asn Tyr Asn
50 55 60
Asn Val Asp Asp Ile Leu His Pro His Asp Leu Asp Ser Ser Ile Asn
65 70 75 80
Asn Thr Asn Asn Pro Leu Thr His Glu Glu Leu Leu Tyr Asn Gln Asn
85 90 95
Val Ser Leu Arg Ser Leu Lys Gln Gln Gln Ser Thr Asn Tyr Val Asn
100 105 110
Asn Asn Asn Asn Asn Gln His Arg Tyr Tyr
115 120
<210> 131
<211> 174
<212> PRT
<213> Larimichthys crocea
<400> 131
Met Arg Lys Arg Ser Leu Arg Cys His Leu Trp Ser Ala Asn Ala Ser
1 5 10 15
Leu Ser Pro Arg Lys Asp Glu Val Thr Ser Arg Lys Glu Ser Glu Asn
20 25 30
Leu Val Lys Gly Lys Lys Asn Lys Lys Ser His Leu His Leu Leu Leu
35 40 45
Phe Thr Ala Ser Lys Ile Gly Thr Asp Ser Val Phe Asp Val Gln Lys
50 55 60
Ser Lys Glu Cys Cys Lys Glu Leu Gly Leu Leu Phe Thr Ser Leu Ile
65 70 75 80
His Ser Ile Gly Ser Phe Pro Phe Asp Glu Glu Pro Lys Ala Ala Ala
85 90 95
Val Phe Leu Pro Gly Ser Leu Pro Gln Leu Thr Val Leu Val Leu Ala
100 105 110
Pro Gly Ser Gly Ser Cys Pro Thr Gly Lys Ser Thr Pro His Leu Ala
115 120 125
Ala Ser Gly Arg Asn Ala Glu Leu Leu Arg Pro Gln Asn Ser Met Ile
130 135 140
Val Arg Gln Phe Thr Cys Arg Gly Thr Ile Ser Ser His Leu Cys Ala
145 150 155 160
His Leu Arg Lys Pro His Asp Ser Arg Asn Met Ala Arg Pro
165 170
<210> 132
<211> 56
<212> PRT
<213> Trypanosoma brucei
<400> 132
Met Leu Arg Arg Thr Ser Phe Asn Phe Thr Gly Arg Ala Met Ile Ser
1 5 10 15
Arg Gly Ser Pro Glu Trp Ser His Arg Leu Asp Leu Lys Lys Gly Lys
20 25 30
Lys Thr Thr Met Met His Lys Leu Gly Thr Ser Lys Pro Asn Asn Ala
35 40 45
Leu Gln Tyr Ala Gln Met Thr Leu
50 55
<210> 133
<211> 46
<212> PRT
<213> Neurospora crassa
<400> 133
Met Ile Ser Arg Ser Ala Leu Ser Arg Gly Ser Gln Leu Ala Leu Arg
1 5 10 15
Arg Pro Ala Ala Ala Lys Thr Ala Gln Arg Gly Phe Ala Ala Ala Ala
20 25 30
Ala Ser Pro Ala Ala Ser Tyr Glu Pro Thr Thr Ile Ala Gly
35 40 45
<210> 134
<211> 128
<212> PRT
<213> Homo sapiens
<400> 134
Met Pro Glu Leu Ile Leu Tyr Val Ala Ile Thr Leu Ser Val Ala Glu
1 5 10 15
Arg Leu Val Gly Pro Gly His Ala Cys Ala Glu Pro Ser Phe Arg Ser
20 25 30
Ser Arg Cys Ser Ala Pro Leu Cys Leu Leu Cys Ser Gly Ser Ser Ser
35 40 45
Pro Ala Thr Ala Pro His Pro Leu Lys Met Phe Ala Cys Ser Lys Phe
50 55 60
Val Ser Thr Pro Ser Leu Val Lys Ser Thr Ser Gln Leu Leu Ser Arg
65 70 75 80
Pro Leu Ser Ala Val Val Leu Lys Arg Pro Glu Ile Leu Thr Asp Glu
85 90 95
Ser Leu Ser Ser Leu Ala Val Ser Cys Pro Leu Thr Ser Leu Val Ser
100 105 110
Ser Arg Ser Phe Gln Thr Ser Ala Ile Ser Arg Asp Ile Asp Thr Ala
115 120 125
<210> 135
<211> 115
<212> PRT
<213> Homo sapiens
<400> 135
Met Tyr Arg Leu Met Ser Ala Val Thr Ala Arg Ala Ala Ala Pro Gly
1 5 10 15
Gly Leu Ala Ser Ser Cys Gly Arg Arg Gly Val His Gln Arg Ala Gly
20 25 30
Leu Pro Pro Leu Gly His Gly Trp Val Gly Gly Leu Gly Leu Gly Leu
35 40 45
Gly Leu Ala Leu Gly Val Lys Leu Ala Gly Gly Leu Arg Gly Ala Ala
50 55 60
Pro Ala Gln Ser Pro Ala Ala Pro Asp Pro Glu Ala Ser Pro Leu Ala
65 70 75 80
Glu Pro Pro Gln Glu Gln Ser Leu Ala Pro Trp Ser Pro Gln Thr Pro
85 90 95
Ala Pro Pro Cys Ser Arg Cys Phe Ala Arg Ala Ile Glu Ser Ser Arg
100 105 110
Asp Leu Leu
115
<210> 136
<211> 140
<212> PRT
<213> Schizosaccharomyces pombe
<400> 136
Met Thr Val Leu Ala Pro Leu Arg Arg Leu His Thr Arg Ala Ala Phe
1 5 10 15
Ser Ser Tyr Gly Arg Glu Ile Ala Leu Gln Lys Arg Phe Leu Asn Leu
20 25 30
Asn Ser Cys Ser Ala Val Arg Arg Tyr Gly Thr Gly Phe Ser Asn Asn
35 40 45
Leu Arg Ile Lys Lys Leu Lys Asn Ala Phe Gly Val Val Arg Ala Asn
50 55 60
Ser Thr Lys Ser Thr Ser Thr Val Thr Thr Ala Ser Pro Ile Lys Tyr
65 70 75 80
Asp Ser Ser Phe Val Gly Lys Thr Gly Gly Glu Ile Phe His Asp Met
85 90 95
Met Leu Lys His Asn Val Lys His Val Phe Gly Tyr Pro Gly Gly Ala
100 105 110
Ile Leu Pro Val Phe Asp Ala Ile Tyr Arg Ser Pro His Phe Glu Phe
115 120 125
Ile Leu Pro Arg His Glu Gln Ala Ala Gly His Ala
130 135 140
<210> 137
<211> 125
<212> PRT
<213> Glycine max
<400> 137
Met Ile Leu Cys Pro Leu Glu Ala Phe Ile Val Gln His Ile Leu Thr
1 5 10 15
Ile Ser Val Met Gly Leu Leu Ser Cys Phe Arg Ser Thr Val Leu Arg
20 25 30
Lys Cys Ser Lys Gly Ser Ser Gly Met Ser Arg Phe Leu Tyr Thr Asn
35 40 45
Asn Phe Gln Arg Asn Leu Ile Ser Ser Gly Gly Asn Glu Ser Tyr Tyr
50 55 60
Gly Tyr Phe Asn Arg Arg Ser Tyr Thr Ser Leu Tyr Met Gly Thr Gly
65 70 75 80
Thr Val Gly Gly Ile Thr Ser Ala Arg Ile Arg Val Pro Asn Val Gly
85 90 95
Cys Glu Gly Phe Met Cys Ser Ser His Leu Ser Ile Thr Gln Arg Asn
100 105 110
Ser Arg Leu Ile His Ser Thr Ser Lys Ile Val Pro Asn
115 120 125
<210> 138
<211> 107
<212> PRT
<213> Chlamydomonas reinhardtii
<400> 138
Met Ala Leu Gln Gln Ala Ala Pro Arg Val Phe Gly Leu Leu Gly Arg
1 5 10 15
Ala Pro Val Ala Leu Gly Gln Ser Gly Ile Leu Thr Gly Ser Ser Gly
20 25 30
Phe Lys Asn Gln Gly Phe Asn Gly Ser Leu Gln Ser Val Glu Asn His
35 40 45
Val Tyr Ala Gln Ala Phe Ser Thr Ser Ser Gln Glu Glu Gln Ala Ala
50 55 60
Pro Ser Ile Gln Gly Ala Ser Gly Met Lys Leu Pro Gly Met Ala Gly
65 70 75 80
Ser Met Leu Leu Gly Lys Ser Arg Ser Gly Leu Arg Thr Gly Ser Met
85 90 95
Val Pro Phe Ala Ala Gln Gln Ala Met Asn Met
100 105
<210> 139
<211> 87
<212> PRT
<213> Homo sapiens
<400> 139
Met Trp Arg Leu Arg Arg Ala Ala Val Ala Cys Glu Val Cys Gln Ser
1 5 10 15
Leu Val Lys His Ser Ser Gly Ile Lys Gly Ser Leu Pro Leu Gln Lys
20 25 30
Leu His Leu Val Ser Arg Ser Ile Tyr His Ser His His Pro Thr Leu
35 40 45
Lys Leu Gln Arg Pro Gln Leu Arg Thr Ser Phe Gln Gln Phe Ser Ser
50 55 60
Leu Thr Asn Leu Pro Leu Arg Lys Leu Lys Phe Ser Pro Ile Lys Tyr
65 70 75 80
Gly Tyr Gln Pro Arg Arg Asn
85
<210> 140
<211> 56
<212> PRT
<213> Homo sapiens
<400> 140
Met Ala Val Leu Trp Arg Leu Ser Ala Val Cys Gly Ala Leu Gly Gly
1 5 10 15
Arg Ala Leu Leu Leu Arg Thr Pro Val Val Arg Pro Ala His Ile Ser
20 25 30
Ala Phe Leu Gln Asp Arg Pro Ile Pro Glu Trp Cys Gly Val Gln His
35 40 45
Ile His Leu Ser Pro Ser His His
50 55
<210> 141
<211> 162
<212> PRT
<213> Homo sapiens
<400> 141
Met Ala Ala Ile Leu Gly Asp Thr Ile Met Val Ala Lys Gly Leu Val
1 5 10 15
Lys Leu Thr Gln Ala Ala Val Glu Thr His Leu Gln His Leu Gly Ile
20 25 30
Gly Gly Glu Leu Ile Met Ala Ala Arg Ala Leu Gln Ser Thr Ala Val
35 40 45
Glu Gln Ile Gly Met Phe Leu Gly Lys Val Gln Gly Gln Asp Lys His
50 55 60
Glu Glu Tyr Phe Ala Glu Asn Phe Gly Gly Pro Glu Gly Glu Phe His
65 70 75 80
Phe Ser Val Pro His Ala Ala Gly Ala Ser Thr Asp Phe Ser Ser Ala
85 90 95
Ser Ala Pro Asp Gln Ser Ala Pro Pro Ser Leu Gly His Ala His Ser
100 105 110
Glu Gly Pro Ala Pro Ala Tyr Val Ala Ser Gly Pro Phe Arg Glu Ala
115 120 125
Gly Phe Pro Gly Gln Ala Ser Ser Pro Leu Gly Arg Ala Asn Gly Arg
130 135 140
Leu Phe Ala Asn Pro Arg Asp Ser Phe Ser Ala Met Gly Phe Gln Arg
145 150 155 160
Arg Phe
<210> 142
<211> 117
<212> PRT
<213> Oryza sativa
<400> 142
Met Ala Leu Leu Leu Arg His Ser Pro Lys Leu Arg Arg Ala His Ala
1 5 10 15
Ile Leu Gly Cys Glu Arg Gly Thr Val Val Arg His Phe Ser Ser Ser
20 25 30
Thr Cys Ser Ser Leu Val Lys Glu Asp Thr Val Ser Ser Ser Asn Leu
35 40 45
His Pro Glu Tyr Ala Lys Lys Ile Gly Gly Ser Asp Phe Ser His Asp
50 55 60
Arg Gln Ser Gly Lys Glu Leu Gln Asn Phe Lys Val Ser Pro Gln Glu
65 70 75 80
Ala Ser Arg Ala Ser Asn Phe Met Arg Ala Ser Lys Tyr Gly Met Pro
85 90 95
Ile Thr Ala Asn Gly Val His Ser Leu Phe Ser Cys Gly Gln Val Val
100 105 110
Pro Ser Arg Cys Phe
115
<210> 143
<211> 66
<212> PRT
<213> Neurospora crassa
<400> 143
Met Ala Ser Thr Arg Val Leu Ala Ser Arg Leu Ala Ser Gln Met Ala
1 5 10 15
Ala Ser Ala Lys Val Ala Arg Pro Ala Val Arg Val Ala Gln Val Ser
20 25 30
Lys Arg Thr Ile Gln Thr Gly Ser Pro Leu Gln Thr Leu Lys Arg Thr
35 40 45
Gln Met Thr Ser Ile Val Asn Ala Thr Thr Arg Gln Ala Phe Gln Lys
50 55 60
Arg Ala
65
<210> 144
<211> 44
<212> PRT
<213> Homo sapiens
<400> 144
Met Leu Ala Ala Arg Leu Val Cys Leu Arg Thr Leu Pro Ser Arg Val
1 5 10 15
Phe His Pro Ala Phe Thr Lys Ala Ser Pro Val Val Lys Asn Ser Ile
20 25 30
Thr Lys Asn Gln Trp Leu Leu Thr Pro Ser Arg Glu
35 40
<210> 145
<211> 68
<212> PRT
<213> Homo sapiens
<400> 145
Met Ala Ser Arg Val Leu Ser Ala Tyr Val Ser Arg Leu Pro Ala Ala
1 5 10 15
Phe Ala Pro Leu Pro Arg Val Arg Met Leu Ala Val Ala Arg Pro Leu
20 25 30
Ser Thr Ala Leu Cys Ser Ala Gly Thr Gln Thr Arg Leu Gly Thr Leu
35 40 45
Gln Pro Ala Leu Val Leu Ala Gln Val Pro Gly Arg Val Thr Gln Leu
50 55 60
Cys Arg Gln Tyr
65
<210> 146
<211> 67
<212> PRT
<213> Homo sapiens
<400> 146
Met Phe Ala Cys Ala Lys Leu Ala Cys Thr Pro Ser Leu Ile Arg Ala
1 5 10 15
Gly Ser Arg Val Ala Tyr Arg Pro Ile Ser Ala Ser Val Leu Ser Arg
20 25 30
Pro Glu Ala Ser Arg Thr Gly Glu Gly Ser Thr Val Phe Asn Gly Ala
35 40 45
Gln Asn Gly Val Ser Gln Leu Ile Gln Arg Glu Phe Gln Thr Ser Ala
50 55 60
Ile Ser Arg
65
<210> 147
<211> 273
<212> PRT
<213> Artificial Sequence
<220>
<223> crATP6_hsADCK3
<400> 147
Met Ala Leu Gln Gln Ala Ala Pro Arg Val Phe Gly Leu Leu Gly Arg
1 5 10 15
Ala Pro Val Ala Leu Gly Gln Ser Gly Ile Leu Thr Gly Ser Ser Gly
20 25 30
Phe Lys Asn Gln Gly Phe Asn Gly Ser Leu Gln Ser Val Glu Asn His
35 40 45
Val Tyr Ala Gln Ala Phe Ser Thr Ser Ser Gln Glu Glu Gln Ala Ala
50 55 60
Pro Ser Ile Gln Gly Ala Ser Gly Met Lys Leu Pro Gly Met Ala Gly
65 70 75 80
Ser Met Leu Leu Gly Lys Ser Arg Ser Gly Leu Arg Thr Gly Ser Met
85 90 95
Val Pro Phe Ala Ala Gln Gln Ala Met Asn Met Gly Gly Met Ala Ala
100 105 110
Ile Leu Gly Asp Thr Ile Met Val Ala Lys Gly Leu Val Lys Leu Thr
115 120 125
Gln Ala Ala Val Glu Thr His Leu Gln His Leu Gly Ile Gly Gly Glu
130 135 140
Leu Ile Met Ala Ala Arg Ala Leu Gln Ser Thr Ala Val Glu Gln Ile
145 150 155 160
Gly Met Phe Leu Gly Lys Val Gln Gly Gln Asp Lys His Glu Glu Tyr
165 170 175
Phe Ala Glu Asn Phe Gly Gly Pro Glu Gly Glu Phe His Phe Ser Val
180 185 190
Pro His Ala Ala Gly Ala Ser Thr Asp Phe Ser Ser Ala Ser Ala Pro
195 200 205
Asp Gln Ser Ala Pro Pro Ser Leu Gly His Ala His Ser Glu Gly Pro
210 215 220
Ala Pro Ala Tyr Val Ala Ser Gly Pro Phe Arg Glu Ala Gly Phe Pro
225 230 235 240
Gly Gln Ala Ser Ser Pro Leu Gly Arg Ala Asn Gly Arg Leu Phe Ala
245 250 255
Asn Pro Arg Asp Ser Phe Ser Ala Met Gly Phe Gln Arg Arg Phe Gly
260 265 270
Gly
<210> 148
<211> 132
<212> PRT
<213> Artificial Sequence
<220>
<223> ncATP9_ncATP9
<400> 148
Met Ala Ser Thr Arg Val Leu Ala Ser Arg Leu Ala Ser Gln Met Ala
1 5 10 15
Ala Ser Ala Lys Val Ala Arg Pro Ala Val Arg Val Ala Gln Val Ser
20 25 30
Lys Arg Thr Ile Gln Thr Gly Ser Pro Leu Gln Thr Leu Lys Arg Thr
35 40 45
Gln Met Thr Ser Ile Val Asn Ala Thr Thr Arg Gln Ala Phe Gln Lys
50 55 60
Arg Ala Met Ala Ser Thr Arg Val Leu Ala Ser Arg Leu Ala Ser Gln
65 70 75 80
Met Ala Ala Ser Ala Lys Val Ala Arg Pro Ala Val Arg Val Ala Gln
85 90 95
Val Ser Lys Arg Thr Ile Gln Thr Gly Ser Pro Leu Gln Thr Leu Lys
100 105 110
Arg Thr Gln Met Thr Ser Ile Val Asn Ala Thr Thr Arg Gln Ala Phe
115 120 125
Gln Lys Arg Ala
130
<210> 149
<211> 119
<212> PRT
<213> Zea mays
<400> 149
Met Ala Leu Leu Arg Ala Ala Val Ser Glu Leu Arg Arg Arg Gly Arg
1 5 10 15
Gly Ala Leu Thr Pro Leu Pro Ala Leu Ser Ser Leu Leu Ser Ser Leu
20 25 30
Ser Pro Arg Ser Pro Ala Ser Thr Arg Pro Glu Pro Asn Asn Pro His
35 40 45
Ala Asp Arg Arg His Val Ile Ala Leu Arg Arg Cys Pro Pro Leu Pro
50 55 60
Ala Ser Ala Val Leu Ala Pro Glu Leu Leu His Ala Arg Gly Leu Leu
65 70 75 80
Pro Arg His Trp Ser His Ala Ser Pro Leu Ser Thr Ser Ser Ser Ser
85 90 95
Ser Arg Pro Ala Asp Lys Ala Gln Leu Thr Trp Val Asp Lys Trp Ile
100 105 110
Pro Glu Ala Ala Arg Pro Tyr
115
<210> 150
<211> 391
<212> PRT
<213> Artificial Sequence
<220>
<223> ncATP9_zmLOC100282174_spilv1_ncATP9
<400> 150
Met Ala Ser Thr Arg Val Leu Ala Ser Arg Leu Ala Ser Gln Met Ala
1 5 10 15
Ala Ser Ala Lys Val Ala Arg Pro Ala Val Arg Val Ala Gln Val Ser
20 25 30
Lys Arg Thr Ile Gln Thr Gly Ser Pro Leu Gln Thr Leu Lys Arg Thr
35 40 45
Gln Met Thr Ser Ile Val Asn Ala Thr Thr Arg Gln Ala Phe Gln Lys
50 55 60
Arg Ala Met Ala Leu Leu Arg Ala Ala Val Ser Glu Leu Arg Arg Arg
65 70 75 80
Gly Arg Gly Ala Leu Thr Pro Leu Pro Ala Leu Ser Ser Leu Leu Ser
85 90 95
Ser Leu Ser Pro Arg Ser Pro Ala Ser Thr Arg Pro Glu Pro Asn Asn
100 105 110
Pro His Ala Asp Arg Arg His Val Ile Ala Leu Arg Arg Cys Pro Pro
115 120 125
Leu Pro Ala Ser Ala Val Leu Ala Pro Glu Leu Leu His Ala Arg Gly
130 135 140
Leu Leu Pro Arg His Trp Ser His Ala Ser Pro Leu Ser Thr Ser Ser
145 150 155 160
Ser Ser Ser Arg Pro Ala Asp Lys Ala Gln Leu Thr Trp Val Asp Lys
165 170 175
Trp Ile Pro Glu Ala Ala Arg Pro Tyr Met Thr Val Leu Ala Pro Leu
180 185 190
Arg Arg Leu His Thr Arg Ala Ala Phe Ser Ser Tyr Gly Arg Glu Ile
195 200 205
Ala Leu Gln Lys Arg Phe Leu Asn Leu Asn Ser Cys Ser Ala Val Arg
210 215 220
Arg Tyr Gly Thr Gly Phe Ser Asn Asn Leu Arg Ile Lys Lys Leu Lys
225 230 235 240
Asn Ala Phe Gly Val Val Arg Ala Asn Ser Thr Lys Ser Thr Ser Thr
245 250 255
Val Thr Thr Ala Ser Pro Ile Lys Tyr Asp Ser Ser Phe Val Gly Lys
260 265 270
Thr Gly Gly Glu Ile Phe His Asp Met Met Leu Lys His Asn Val Lys
275 280 285
His Val Phe Gly Tyr Pro Gly Gly Ala Ile Leu Pro Val Phe Asp Ala
290 295 300
Ile Tyr Arg Ser Pro His Phe Glu Phe Ile Leu Pro Arg His Glu Gln
305 310 315 320
Ala Ala Gly His Ala Met Ala Ser Thr Arg Val Leu Ala Ser Arg Leu
325 330 335
Ala Ser Gln Met Ala Ala Ser Ala Lys Val Ala Arg Pro Ala Val Arg
340 345 350
Val Ala Gln Val Ser Lys Arg Thr Ile Gln Thr Gly Ser Pro Leu Gln
355 360 365
Thr Leu Lys Arg Thr Gln Met Thr Ser Ile Val Asn Ala Thr Thr Arg
370 375 380
Gln Ala Phe Gln Lys Arg Ala
385 390
<210> 151
<211> 455
<212> PRT
<213> Artificial Sequence
<220>
<223> zmLOC100282174_hsADCK3_crATP6 _hsATP5G3
<400> 151
Met Ala Leu Leu Arg Ala Ala Val Ser Glu Leu Arg Arg Arg Gly Arg
1 5 10 15
Gly Ala Leu Thr Pro Leu Pro Ala Leu Ser Ser Leu Leu Ser Ser Leu
20 25 30
Ser Pro Arg Ser Pro Ala Ser Thr Arg Pro Glu Pro Asn Asn Pro His
35 40 45
Ala Asp Arg Arg His Val Ile Ala Leu Arg Arg Cys Pro Pro Leu Pro
50 55 60
Ala Ser Ala Val Leu Ala Pro Glu Leu Leu His Ala Arg Gly Leu Leu
65 70 75 80
Pro Arg His Trp Ser His Ala Ser Pro Leu Ser Thr Ser Ser Ser Ser
85 90 95
Ser Arg Pro Ala Asp Lys Ala Gln Leu Thr Trp Val Asp Lys Trp Ile
100 105 110
Pro Glu Ala Ala Arg Pro Tyr Met Ala Ala Ile Leu Gly Asp Thr Ile
115 120 125
Met Val Ala Lys Gly Leu Val Lys Leu Thr Gln Ala Ala Val Glu Thr
130 135 140
His Leu Gln His Leu Gly Ile Gly Gly Glu Leu Ile Met Ala Ala Arg
145 150 155 160
Ala Leu Gln Ser Thr Ala Val Glu Gln Ile Gly Met Phe Leu Gly Lys
165 170 175
Val Gln Gly Gln Asp Lys His Glu Glu Tyr Phe Ala Glu Asn Phe Gly
180 185 190
Gly Pro Glu Gly Glu Phe His Phe Ser Val Pro His Ala Ala Gly Ala
195 200 205
Ser Thr Asp Phe Ser Ser Ala Ser Ala Pro Asp Gln Ser Ala Pro Pro
210 215 220
Ser Leu Gly His Ala His Ser Glu Gly Pro Ala Pro Ala Tyr Val Ala
225 230 235 240
Ser Gly Pro Phe Arg Glu Ala Gly Phe Pro Gly Gln Ala Ser Ser Pro
245 250 255
Leu Gly Arg Ala Asn Gly Arg Leu Phe Ala Asn Pro Arg Asp Ser Phe
260 265 270
Ser Ala Met Gly Phe Gln Arg Arg Phe Met Ala Leu Gln Gln Ala Ala
275 280 285
Pro Arg Val Phe Gly Leu Leu Gly Arg Ala Pro Val Ala Leu Gly Gln
290 295 300
Ser Gly Ile Leu Thr Gly Ser Ser Gly Phe Lys Asn Gln Gly Phe Asn
305 310 315 320
Gly Ser Leu Gln Ser Val Glu Asn His Val Tyr Ala Gln Ala Phe Ser
325 330 335
Thr Ser Ser Gln Glu Glu Gln Ala Ala Pro Ser Ile Gln Gly Ala Ser
340 345 350
Gly Met Lys Leu Pro Gly Met Ala Gly Ser Met Leu Leu Gly Lys Ser
355 360 365
Arg Ser Gly Leu Arg Thr Gly Ser Met Val Pro Phe Ala Ala Gln Gln
370 375 380
Ala Met Asn Met Met Phe Ala Cys Ala Lys Leu Ala Cys Thr Pro Ser
385 390 395 400
Leu Ile Arg Ala Gly Ser Arg Val Ala Tyr Arg Pro Ile Ser Ala Ser
405 410 415
Val Leu Ser Arg Pro Glu Ala Ser Arg Thr Gly Glu Gly Ser Thr Val
420 425 430
Phe Asn Gly Ala Gln Asn Gly Val Ser Gln Leu Ile Gln Arg Glu Phe
435 440 445
Gln Thr Ser Ala Ile Ser Arg
450 455
<210> 152
<211> 348
<212> PRT
<213> Artificial Sequence
<220>
<223> zmLOC100282174_hsADCK3_hsATP5G3
<400> 152
Met Ala Leu Leu Arg Ala Ala Val Ser Glu Leu Arg Arg Arg Gly Arg
1 5 10 15
Gly Ala Leu Thr Pro Leu Pro Ala Leu Ser Ser Leu Leu Ser Ser Leu
20 25 30
Ser Pro Arg Ser Pro Ala Ser Thr Arg Pro Glu Pro Asn Asn Pro His
35 40 45
Ala Asp Arg Arg His Val Ile Ala Leu Arg Arg Cys Pro Pro Leu Pro
50 55 60
Ala Ser Ala Val Leu Ala Pro Glu Leu Leu His Ala Arg Gly Leu Leu
65 70 75 80
Pro Arg His Trp Ser His Ala Ser Pro Leu Ser Thr Ser Ser Ser Ser
85 90 95
Ser Arg Pro Ala Asp Lys Ala Gln Leu Thr Trp Val Asp Lys Trp Ile
100 105 110
Pro Glu Ala Ala Arg Pro Tyr Met Ala Ala Ile Leu Gly Asp Thr Ile
115 120 125
Met Val Ala Lys Gly Leu Val Lys Leu Thr Gln Ala Ala Val Glu Thr
130 135 140
His Leu Gln His Leu Gly Ile Gly Gly Glu Leu Ile Met Ala Ala Arg
145 150 155 160
Ala Leu Gln Ser Thr Ala Val Glu Gln Ile Gly Met Phe Leu Gly Lys
165 170 175
Val Gln Gly Gln Asp Lys His Glu Glu Tyr Phe Ala Glu Asn Phe Gly
180 185 190
Gly Pro Glu Gly Glu Phe His Phe Ser Val Pro His Ala Ala Gly Ala
195 200 205
Ser Thr Asp Phe Ser Ser Ala Ser Ala Pro Asp Gln Ser Ala Pro Pro
210 215 220
Ser Leu Gly His Ala His Ser Glu Gly Pro Ala Pro Ala Tyr Val Ala
225 230 235 240
Ser Gly Pro Phe Arg Glu Ala Gly Phe Pro Gly Gln Ala Ser Ser Pro
245 250 255
Leu Gly Arg Ala Asn Gly Arg Leu Phe Ala Asn Pro Arg Asp Ser Phe
260 265 270
Ser Ala Met Gly Phe Gln Arg Arg Phe Met Phe Ala Cys Ala Lys Leu
275 280 285
Ala Cys Thr Pro Ser Leu Ile Arg Ala Gly Ser Arg Val Ala Tyr Arg
290 295 300
Pro Ile Ser Ala Ser Val Leu Ser Arg Pro Glu Ala Ser Arg Thr Gly
305 310 315 320
Glu Gly Ser Thr Val Phe Asn Gly Ala Gln Asn Gly Val Ser Gln Leu
325 330 335
Ile Gln Arg Glu Phe Gln Thr Ser Ala Ile Ser Arg
340 345
<210> 153
<211> 185
<212> PRT
<213> Artificial Sequence
<220>
<223> ncATP9_zmLOC100282174
<400> 153
Met Ala Ser Thr Arg Val Leu Ala Ser Arg Leu Ala Ser Gln Met Ala
1 5 10 15
Ala Ser Ala Lys Val Ala Arg Pro Ala Val Arg Val Ala Gln Val Ser
20 25 30
Lys Arg Thr Ile Gln Thr Gly Ser Pro Leu Gln Thr Leu Lys Arg Thr
35 40 45
Gln Met Thr Ser Ile Val Asn Ala Thr Thr Arg Gln Ala Phe Gln Lys
50 55 60
Arg Ala Met Ala Leu Leu Arg Ala Ala Val Ser Glu Leu Arg Arg Arg
65 70 75 80
Gly Arg Gly Ala Leu Thr Pro Leu Pro Ala Leu Ser Ser Leu Leu Ser
85 90 95
Ser Leu Ser Pro Arg Ser Pro Ala Ser Thr Arg Pro Glu Pro Asn Asn
100 105 110
Pro His Ala Asp Arg Arg His Val Ile Ala Leu Arg Arg Cys Pro Pro
115 120 125
Leu Pro Ala Ser Ala Val Leu Ala Pro Glu Leu Leu His Ala Arg Gly
130 135 140
Leu Leu Pro Arg His Trp Ser His Ala Ser Pro Leu Ser Thr Ser Ser
145 150 155 160
Ser Ser Ser Arg Pro Ala Asp Lys Ala Gln Leu Thr Trp Val Asp Lys
165 170 175
Trp Ile Pro Glu Ala Ala Arg Pro Tyr
180 185
<210> 154
<211> 455
<212> PRT
<213> Artificial Sequence
<220>
<223> hsADCK3_zmLOC100282174_crATP6 _hsATP5G3
<400> 154
Met Ala Ala Ile Leu Gly Asp Thr Ile Met Val Ala Lys Gly Leu Val
1 5 10 15
Lys Leu Thr Gln Ala Ala Val Glu Thr His Leu Gln His Leu Gly Ile
20 25 30
Gly Gly Glu Leu Ile Met Ala Ala Arg Ala Leu Gln Ser Thr Ala Val
35 40 45
Glu Gln Ile Gly Met Phe Leu Gly Lys Val Gln Gly Gln Asp Lys His
50 55 60
Glu Glu Tyr Phe Ala Glu Asn Phe Gly Gly Pro Glu Gly Glu Phe His
65 70 75 80
Phe Ser Val Pro His Ala Ala Gly Ala Ser Thr Asp Phe Ser Ser Ala
85 90 95
Ser Ala Pro Asp Gln Ser Ala Pro Pro Ser Leu Gly His Ala His Ser
100 105 110
Glu Gly Pro Ala Pro Ala Tyr Val Ala Ser Gly Pro Phe Arg Glu Ala
115 120 125
Gly Phe Pro Gly Gln Ala Ser Ser Pro Leu Gly Arg Ala Asn Gly Arg
130 135 140
Leu Phe Ala Asn Pro Arg Asp Ser Phe Ser Ala Met Gly Phe Gln Arg
145 150 155 160
Arg Phe Met Ala Leu Leu Arg Ala Ala Val Ser Glu Leu Arg Arg Arg
165 170 175
Gly Arg Gly Ala Leu Thr Pro Leu Pro Ala Leu Ser Ser Leu Leu Ser
180 185 190
Ser Leu Ser Pro Arg Ser Pro Ala Ser Thr Arg Pro Glu Pro Asn Asn
195 200 205
Pro His Ala Asp Arg Arg His Val Ile Ala Leu Arg Arg Cys Pro Pro
210 215 220
Leu Pro Ala Ser Ala Val Leu Ala Pro Glu Leu Leu His Ala Arg Gly
225 230 235 240
Leu Leu Pro Arg His Trp Ser His Ala Ser Pro Leu Ser Thr Ser Ser
245 250 255
Ser Ser Ser Arg Pro Ala Asp Lys Ala Gln Leu Thr Trp Val Asp Lys
260 265 270
Trp Ile Pro Glu Ala Ala Arg Pro Tyr Met Ala Leu Gln Gln Ala Ala
275 280 285
Pro Arg Val Phe Gly Leu Leu Gly Arg Ala Pro Val Ala Leu Gly Gln
290 295 300
Ser Gly Ile Leu Thr Gly Ser Ser Gly Phe Lys Asn Gln Gly Phe Asn
305 310 315 320
Gly Ser Leu Gln Ser Val Glu Asn His Val Tyr Ala Gln Ala Phe Ser
325 330 335
Thr Ser Ser Gln Glu Glu Gln Ala Ala Pro Ser Ile Gln Gly Ala Ser
340 345 350
Gly Met Lys Leu Pro Gly Met Ala Gly Ser Met Leu Leu Gly Lys Ser
355 360 365
Arg Ser Gly Leu Arg Thr Gly Ser Met Val Pro Phe Ala Ala Gln Gln
370 375 380
Ala Met Asn Met Met Phe Ala Cys Ala Lys Leu Ala Cys Thr Pro Ser
385 390 395 400
Leu Ile Arg Ala Gly Ser Arg Val Ala Tyr Arg Pro Ile Ser Ala Ser
405 410 415
Val Leu Ser Arg Pro Glu Ala Ser Arg Thr Gly Glu Gly Ser Thr Val
420 425 430
Phe Asn Gly Ala Gln Asn Gly Val Ser Gln Leu Ile Gln Arg Glu Phe
435 440 445
Gln Thr Ser Ala Ile Ser Arg
450 455
<210> 155
<211> 455
<212> PRT
<213> Artificial Sequence
<220>
<223> crATP6 _hsADCK3_zmLOC100282174_hsATP5G3
<400> 155
Met Ala Leu Gln Gln Ala Ala Pro Arg Val Phe Gly Leu Leu Gly Arg
1 5 10 15
Ala Pro Val Ala Leu Gly Gln Ser Gly Ile Leu Thr Gly Ser Ser Gly
20 25 30
Phe Lys Asn Gln Gly Phe Asn Gly Ser Leu Gln Ser Val Glu Asn His
35 40 45
Val Tyr Ala Gln Ala Phe Ser Thr Ser Ser Gln Glu Glu Gln Ala Ala
50 55 60
Pro Ser Ile Gln Gly Ala Ser Gly Met Lys Leu Pro Gly Met Ala Gly
65 70 75 80
Ser Met Leu Leu Gly Lys Ser Arg Ser Gly Leu Arg Thr Gly Ser Met
85 90 95
Val Pro Phe Ala Ala Gln Gln Ala Met Asn Met Met Ala Ala Ile Leu
100 105 110
Gly Asp Thr Ile Met Val Ala Lys Gly Leu Val Lys Leu Thr Gln Ala
115 120 125
Ala Val Glu Thr His Leu Gln His Leu Gly Ile Gly Gly Glu Leu Ile
130 135 140
Met Ala Ala Arg Ala Leu Gln Ser Thr Ala Val Glu Gln Ile Gly Met
145 150 155 160
Phe Leu Gly Lys Val Gln Gly Gln Asp Lys His Glu Glu Tyr Phe Ala
165 170 175
Glu Asn Phe Gly Gly Pro Glu Gly Glu Phe His Phe Ser Val Pro His
180 185 190
Ala Ala Gly Ala Ser Thr Asp Phe Ser Ser Ala Ser Ala Pro Asp Gln
195 200 205
Ser Ala Pro Pro Ser Leu Gly His Ala His Ser Glu Gly Pro Ala Pro
210 215 220
Ala Tyr Val Ala Ser Gly Pro Phe Arg Glu Ala Gly Phe Pro Gly Gln
225 230 235 240
Ala Ser Ser Pro Leu Gly Arg Ala Asn Gly Arg Leu Phe Ala Asn Pro
245 250 255
Arg Asp Ser Phe Ser Ala Met Gly Phe Gln Arg Arg Phe Met Ala Leu
260 265 270
Leu Arg Ala Ala Val Ser Glu Leu Arg Arg Arg Gly Arg Gly Ala Leu
275 280 285
Thr Pro Leu Pro Ala Leu Ser Ser Leu Leu Ser Ser Leu Ser Pro Arg
290 295 300
Ser Pro Ala Ser Thr Arg Pro Glu Pro Asn Asn Pro His Ala Asp Arg
305 310 315 320
Arg His Val Ile Ala Leu Arg Arg Cys Pro Pro Leu Pro Ala Ser Ala
325 330 335
Val Leu Ala Pro Glu Leu Leu His Ala Arg Gly Leu Leu Pro Arg His
340 345 350
Trp Ser His Ala Ser Pro Leu Ser Thr Ser Ser Ser Ser Ser Arg Pro
355 360 365
Ala Asp Lys Ala Gln Leu Thr Trp Val Asp Lys Trp Ile Pro Glu Ala
370 375 380
Ala Arg Pro Tyr Met Phe Ala Cys Ala Lys Leu Ala Cys Thr Pro Ser
385 390 395 400
Leu Ile Arg Ala Gly Ser Arg Val Ala Tyr Arg Pro Ile Ser Ala Ser
405 410 415
Val Leu Ser Arg Pro Glu Ala Ser Arg Thr Gly Glu Gly Ser Thr Val
420 425 430
Phe Asn Gly Ala Gln Asn Gly Val Ser Gln Leu Ile Gln Arg Glu Phe
435 440 445
Gln Thr Ser Ala Ile Ser Arg
450 455
<210> 156
<211> 285
<212> PRT
<213> Artificial Sequence
<220>
<223> hsADCK3_zmLOC100282174
<400> 156
Met Ala Ala Ile Leu Gly Asp Thr Ile Met Val Ala Lys Gly Leu Val
1 5 10 15
Lys Leu Thr Gln Ala Ala Val Glu Thr His Leu Gln His Leu Gly Ile
20 25 30
Gly Gly Glu Leu Ile Met Ala Ala Arg Ala Leu Gln Ser Thr Ala Val
35 40 45
Glu Gln Ile Gly Met Phe Leu Gly Lys Val Gln Gly Gln Asp Lys His
50 55 60
Glu Glu Tyr Phe Ala Glu Asn Phe Gly Gly Pro Glu Gly Glu Phe His
65 70 75 80
Phe Ser Val Pro His Ala Ala Gly Ala Ser Thr Asp Phe Ser Ser Ala
85 90 95
Ser Ala Pro Asp Gln Ser Ala Pro Pro Ser Leu Gly His Ala His Ser
100 105 110
Glu Gly Pro Ala Pro Ala Tyr Val Ala Ser Gly Pro Phe Arg Glu Ala
115 120 125
Gly Phe Pro Gly Gln Ala Ser Ser Pro Leu Gly Arg Ala Asn Gly Arg
130 135 140
Leu Phe Ala Asn Pro Arg Asp Ser Phe Ser Ala Met Gly Phe Gln Arg
145 150 155 160
Arg Phe Gly Gly Met Ala Leu Leu Arg Ala Ala Val Ser Glu Leu Arg
165 170 175
Arg Arg Gly Arg Gly Ala Leu Thr Pro Leu Pro Ala Leu Ser Ser Leu
180 185 190
Leu Ser Ser Leu Ser Pro Arg Ser Pro Ala Ser Thr Arg Pro Glu Pro
195 200 205
Asn Asn Pro His Ala Asp Arg Arg His Val Ile Ala Leu Arg Arg Cys
210 215 220
Pro Pro Leu Pro Ala Ser Ala Val Leu Ala Pro Glu Leu Leu His Ala
225 230 235 240
Arg Gly Leu Leu Pro Arg His Trp Ser His Ala Ser Pro Leu Ser Thr
245 250 255
Ser Ser Ser Ser Ser Arg Pro Ala Asp Lys Ala Gln Leu Thr Trp Val
260 265 270
Asp Lys Trp Ile Pro Glu Ala Ala Arg Pro Tyr Gly Gly
275 280 285
<210> 157
<211> 394
<212> PRT
<213> Artificial Sequence
<220>
<223> hsADCK3_zmLOC100282174_crATP6
<400> 157
Met Ala Ala Ile Leu Gly Asp Thr Ile Met Val Ala Lys Gly Leu Val
1 5 10 15
Lys Leu Thr Gln Ala Ala Val Glu Thr His Leu Gln His Leu Gly Ile
20 25 30
Gly Gly Glu Leu Ile Met Ala Ala Arg Ala Leu Gln Ser Thr Ala Val
35 40 45
Glu Gln Ile Gly Met Phe Leu Gly Lys Val Gln Gly Gln Asp Lys His
50 55 60
Glu Glu Tyr Phe Ala Glu Asn Phe Gly Gly Pro Glu Gly Glu Phe His
65 70 75 80
Phe Ser Val Pro His Ala Ala Gly Ala Ser Thr Asp Phe Ser Ser Ala
85 90 95
Ser Ala Pro Asp Gln Ser Ala Pro Pro Ser Leu Gly His Ala His Ser
100 105 110
Glu Gly Pro Ala Pro Ala Tyr Val Ala Ser Gly Pro Phe Arg Glu Ala
115 120 125
Gly Phe Pro Gly Gln Ala Ser Ser Pro Leu Gly Arg Ala Asn Gly Arg
130 135 140
Leu Phe Ala Asn Pro Arg Asp Ser Phe Ser Ala Met Gly Phe Gln Arg
145 150 155 160
Arg Phe Gly Gly Met Ala Leu Leu Arg Ala Ala Val Ser Glu Leu Arg
165 170 175
Arg Arg Gly Arg Gly Ala Leu Thr Pro Leu Pro Ala Leu Ser Ser Leu
180 185 190
Leu Ser Ser Leu Ser Pro Arg Ser Pro Ala Ser Thr Arg Pro Glu Pro
195 200 205
Asn Asn Pro His Ala Asp Arg Arg His Val Ile Ala Leu Arg Arg Cys
210 215 220
Pro Pro Leu Pro Ala Ser Ala Val Leu Ala Pro Glu Leu Leu His Ala
225 230 235 240
Arg Gly Leu Leu Pro Arg His Trp Ser His Ala Ser Pro Leu Ser Thr
245 250 255
Ser Ser Ser Ser Ser Arg Pro Ala Asp Lys Ala Gln Leu Thr Trp Val
260 265 270
Asp Lys Trp Ile Pro Glu Ala Ala Arg Pro Tyr Gly Gly Met Ala Leu
275 280 285
Gln Gln Ala Ala Pro Arg Val Phe Gly Leu Leu Gly Arg Ala Pro Val
290 295 300
Ala Leu Gly Gln Ser Gly Ile Leu Thr Gly Ser Ser Gly Phe Lys Asn
305 310 315 320
Gln Gly Phe Asn Gly Ser Leu Gln Ser Val Glu Asn His Val Tyr Ala
325 330 335
Gln Ala Phe Ser Thr Ser Ser Gln Glu Glu Gln Ala Ala Pro Ser Ile
340 345 350
Gln Gly Ala Ser Gly Met Lys Leu Pro Gly Met Ala Gly Ser Met Leu
355 360 365
Leu Gly Lys Ser Arg Ser Gly Leu Arg Thr Gly Ser Met Val Pro Phe
370 375 380
Ala Ala Gln Gln Ala Met Asn Met Gly Gly
385 390
<210> 158
<211> 574
<212> PRT
<213> Artificial Sequence
<220>
<223> ncATP9_zmLOC100282174_spilv1_GNFP_ncATP9
<400> 158
Met Ala Ser Thr Arg Val Leu Ala Ser Arg Leu Ala Ser Gln Met Ala
1 5 10 15
Ala Ser Ala Lys Val Ala Arg Pro Ala Val Arg Val Ala Gln Val Ser
20 25 30
Lys Arg Thr Ile Gln Thr Gly Ser Pro Leu Gln Thr Leu Lys Arg Thr
35 40 45
Gln Met Thr Ser Ile Val Asn Ala Thr Thr Arg Gln Ala Phe Gln Lys
50 55 60
Arg Ala Met Ala Leu Leu Arg Ala Ala Val Ser Glu Leu Arg Arg Arg
65 70 75 80
Gly Arg Gly Ala Leu Thr Pro Leu Pro Ala Leu Ser Ser Leu Leu Ser
85 90 95
Ser Leu Ser Pro Arg Ser Pro Ala Ser Thr Arg Pro Glu Pro Asn Asn
100 105 110
Pro His Ala Asp Arg Arg His Val Ile Ala Leu Arg Arg Cys Pro Pro
115 120 125
Leu Pro Ala Ser Ala Val Leu Ala Pro Glu Leu Leu His Ala Arg Gly
130 135 140
Leu Leu Pro Arg His Trp Ser His Ala Ser Pro Leu Ser Thr Ser Ser
145 150 155 160
Ser Ser Ser Arg Pro Ala Asp Lys Ala Gln Leu Thr Trp Val Asp Lys
165 170 175
Trp Ile Pro Glu Ala Ala Arg Pro Tyr Met Thr Val Leu Ala Pro Leu
180 185 190
Arg Arg Leu His Thr Arg Ala Ala Phe Ser Ser Tyr Gly Arg Glu Ile
195 200 205
Ala Leu Gln Lys Arg Phe Leu Asn Leu Asn Ser Cys Ser Ala Val Arg
210 215 220
Arg Tyr Gly Thr Gly Phe Ser Asn Asn Leu Arg Ile Lys Lys Leu Lys
225 230 235 240
Asn Ala Phe Gly Val Val Arg Ala Asn Ser Thr Lys Ser Thr Ser Thr
245 250 255
Val Thr Thr Ala Ser Pro Ile Lys Tyr Asp Ser Ser Phe Val Gly Lys
260 265 270
Thr Gly Gly Glu Ile Phe His Asp Met Met Leu Lys His Asn Val Lys
275 280 285
His Val Phe Gly Tyr Pro Gly Gly Ala Ile Leu Pro Val Phe Asp Ala
290 295 300
Ile Tyr Arg Ser Pro His Phe Glu Phe Ile Leu Pro Arg His Glu Gln
305 310 315 320
Ala Ala Gly His Ala Val Ser Gly Glu Gly Asp Ala Thr Tyr Gly Lys
325 330 335
Leu Thr Leu Lys Phe Ile Cys Thr Thr Gly Lys Leu Pro Val Pro Trp
340 345 350
Pro Thr Leu Val Thr Thr Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg
355 360 365
Tyr Pro Asp His Met Lys Gln His Asp Phe Phe Lys Ser Ala Met Pro
370 375 380
Glu Gly Tyr Val Gln Glu Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn
385 390 395 400
Tyr Lys Thr Arg Ala Glu Val Lys Phe Glu Gly Asp Thr Leu Val Asn
405 410 415
Arg Ile Glu Leu Lys Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu
420 425 430
Gly His Lys Leu Glu Tyr Asn Tyr Asn Ser His Asn Val Tyr Ile Met
435 440 445
Ala Asp Lys Gln Lys Asn Gly Ile Lys Val Asn Phe Lys Ile Arg His
450 455 460
Asn Ile Glu Asp Gly Ser Val Gln Leu Ala Asp His Tyr Gln Gln Asn
465 470 475 480
Thr Pro Ile Gly Asp Gly Pro Val Leu Leu Pro Asp Asn His Tyr Leu
485 490 495
Ser Thr Gln Ser Ala Leu Ser Lys Asp Pro Asn Glu Met Ala Ser Thr
500 505 510
Arg Val Leu Ala Ser Arg Leu Ala Ser Gln Met Ala Ala Ser Ala Lys
515 520 525
Val Ala Arg Pro Ala Val Arg Val Ala Gln Val Ser Lys Arg Thr Ile
530 535 540
Gln Thr Gly Ser Pro Leu Gln Thr Leu Lys Arg Thr Gln Met Thr Ser
545 550 555 560
Ile Val Asn Ala Thr Thr Arg Gln Ala Phe Gln Lys Arg Ala
565 570
<210> 159
<211> 810
<212> PRT
<213> Artificial Sequence
<220>
<223> ncATP9_zmLOC100282174_spilv1_lcSirt5_osP0644B06.24-2_hsATP5G2_ncA
TP9
<400> 159
Met Ala Ser Thr Arg Val Leu Ala Ser Arg Leu Ala Ser Gln Met Ala
1 5 10 15
Ala Ser Ala Lys Val Ala Arg Pro Ala Val Arg Val Ala Gln Val Ser
20 25 30
Lys Arg Thr Ile Gln Thr Gly Ser Pro Leu Gln Thr Leu Lys Arg Thr
35 40 45
Gln Met Thr Ser Ile Val Asn Ala Thr Thr Arg Gln Ala Phe Gln Lys
50 55 60
Arg Ala Met Ala Leu Leu Arg Ala Ala Val Ser Glu Leu Arg Arg Arg
65 70 75 80
Gly Arg Gly Ala Leu Thr Pro Leu Pro Ala Leu Ser Ser Leu Leu Ser
85 90 95
Ser Leu Ser Pro Arg Ser Pro Ala Ser Thr Arg Pro Glu Pro Asn Asn
100 105 110
Pro His Ala Asp Arg Arg His Val Ile Ala Leu Arg Arg Cys Pro Pro
115 120 125
Leu Pro Ala Ser Ala Val Leu Ala Pro Glu Leu Leu His Ala Arg Gly
130 135 140
Leu Leu Pro Arg His Trp Ser His Ala Ser Pro Leu Ser Thr Ser Ser
145 150 155 160
Ser Ser Ser Arg Pro Ala Asp Lys Ala Gln Leu Thr Trp Val Asp Lys
165 170 175
Trp Ile Pro Glu Ala Ala Arg Pro Tyr Met Thr Val Leu Ala Pro Leu
180 185 190
Arg Arg Leu His Thr Arg Ala Ala Phe Ser Ser Tyr Gly Arg Glu Ile
195 200 205
Ala Leu Gln Lys Arg Phe Leu Asn Leu Asn Ser Cys Ser Ala Val Arg
210 215 220
Arg Tyr Gly Thr Gly Phe Ser Asn Asn Leu Arg Ile Lys Lys Leu Lys
225 230 235 240
Asn Ala Phe Gly Val Val Arg Ala Asn Ser Thr Lys Ser Thr Ser Thr
245 250 255
Val Thr Thr Ala Ser Pro Ile Lys Tyr Asp Ser Ser Phe Val Gly Lys
260 265 270
Thr Gly Gly Glu Ile Phe His Asp Met Met Leu Lys His Asn Val Lys
275 280 285
His Val Phe Gly Tyr Pro Gly Gly Ala Ile Leu Pro Val Phe Asp Ala
290 295 300
Ile Tyr Arg Ser Pro His Phe Glu Phe Ile Leu Pro Arg His Glu Gln
305 310 315 320
Ala Ala Gly His Ala Met Arg Lys Arg Ser Leu Arg Cys His Leu Trp
325 330 335
Ser Ala Asn Ala Ser Leu Ser Pro Arg Lys Asp Glu Val Thr Ser Arg
340 345 350
Lys Glu Ser Glu Asn Leu Val Lys Gly Lys Lys Asn Lys Lys Ser His
355 360 365
Leu His Leu Leu Leu Phe Thr Ala Ser Lys Ile Gly Thr Asp Ser Val
370 375 380
Phe Asp Val Gln Lys Ser Lys Glu Cys Cys Lys Glu Leu Gly Leu Leu
385 390 395 400
Phe Thr Ser Leu Ile His Ser Ile Gly Ser Phe Pro Phe Asp Glu Glu
405 410 415
Pro Lys Ala Ala Ala Val Phe Leu Pro Gly Ser Leu Pro Gln Leu Thr
420 425 430
Val Leu Val Leu Ala Pro Gly Ser Gly Ser Cys Pro Thr Gly Lys Ser
435 440 445
Thr Pro His Leu Ala Ala Ser Gly Arg Asn Ala Glu Leu Leu Arg Pro
450 455 460
Gln Asn Ser Met Ile Val Arg Gln Phe Thr Cys Arg Gly Thr Ile Ser
465 470 475 480
Ser His Leu Cys Ala His Leu Arg Lys Pro His Asp Ser Arg Asn Met
485 490 495
Ala Arg Pro Met Ala Leu Leu Leu Arg His Ser Pro Lys Leu Arg Arg
500 505 510
Ala His Ala Ile Leu Gly Cys Glu Arg Gly Thr Val Val Arg His Phe
515 520 525
Ser Ser Ser Thr Cys Ser Ser Leu Val Lys Glu Asp Thr Val Ser Ser
530 535 540
Ser Asn Leu His Pro Glu Tyr Ala Lys Lys Ile Gly Gly Ser Asp Phe
545 550 555 560
Ser His Asp Arg Gln Ser Gly Lys Glu Leu Gln Asn Phe Lys Val Ser
565 570 575
Pro Gln Glu Ala Ser Arg Ala Ser Asn Phe Met Arg Ala Ser Lys Tyr
580 585 590
Gly Met Pro Ile Thr Ala Asn Gly Val His Ser Leu Phe Ser Cys Gly
595 600 605
Gln Val Val Pro Ser Arg Cys Phe Met Pro Glu Leu Ile Leu Tyr Val
610 615 620
Ala Ile Thr Leu Ser Val Ala Glu Arg Leu Val Gly Pro Gly His Ala
625 630 635 640
Cys Ala Glu Pro Ser Phe Arg Ser Ser Arg Cys Ser Ala Pro Leu Cys
645 650 655
Leu Leu Cys Ser Gly Ser Ser Ser Pro Ala Thr Ala Pro His Pro Leu
660 665 670
Lys Met Phe Ala Cys Ser Lys Phe Val Ser Thr Pro Ser Leu Val Lys
675 680 685
Ser Thr Ser Gln Leu Leu Ser Arg Pro Leu Ser Ala Val Val Leu Lys
690 695 700
Arg Pro Glu Ile Leu Thr Asp Glu Ser Leu Ser Ser Leu Ala Val Ser
705 710 715 720
Cys Pro Leu Thr Ser Leu Val Ser Ser Arg Ser Phe Gln Thr Ser Ala
725 730 735
Ile Ser Arg Asp Ile Asp Thr Ala Met Ala Ser Thr Arg Val Leu Ala
740 745 750
Ser Arg Leu Ala Ser Gln Met Ala Ala Ser Ala Lys Val Ala Arg Pro
755 760 765
Ala Val Arg Val Ala Gln Val Ser Lys Arg Thr Ile Gln Thr Gly Ser
770 775 780
Pro Leu Gln Thr Leu Lys Arg Thr Gln Met Thr Ser Ile Val Asn Ala
785 790 795 800
Thr Thr Arg Gln Ala Phe Gln Lys Arg Ala
805 810
<210> 160
<211> 459
<212> PRT
<213> Homo sapiens
<400> 160
Met Leu Lys Leu Ile Val Pro Thr Ile Met Leu Leu Pro Leu Thr Trp
1 5 10 15
Leu Ser Lys Lys His Met Ile Trp Ile Asn Thr Thr Thr His Ser Leu
20 25 30
Ile Ile Ser Ile Ile Pro Leu Leu Phe Phe Asn Gln Ile Asn Asn Asn
35 40 45
Leu Phe Ser Cys Ser Pro Thr Phe Ser Ser Asp Pro Leu Thr Thr Pro
50 55 60
Leu Leu Met Leu Thr Thr Trp Leu Leu Pro Leu Thr Ile Met Ala Ser
65 70 75 80
Gln Arg His Leu Ser Ser Glu Pro Leu Ser Arg Lys Lys Leu Tyr Leu
85 90 95
Ser Met Leu Ile Ser Leu Gln Ile Ser Leu Ile Met Thr Phe Thr Ala
100 105 110
Thr Glu Leu Ile Met Phe Tyr Ile Phe Phe Glu Thr Thr Leu Ile Pro
115 120 125
Thr Leu Ala Ile Ile Thr Arg Trp Gly Asn Gln Pro Glu Arg Leu Asn
130 135 140
Ala Gly Thr Tyr Phe Leu Phe Tyr Thr Leu Val Gly Ser Leu Pro Leu
145 150 155 160
Leu Ile Ala Leu Ile Tyr Thr His Asn Thr Leu Gly Ser Leu Asn Ile
165 170 175
Leu Leu Leu Thr Leu Thr Ala Gln Glu Leu Ser Asn Ser Trp Ala Asn
180 185 190
Asn Leu Met Trp Leu Ala Tyr Thr Met Ala Phe Met Val Lys Met Pro
195 200 205
Leu Tyr Gly Leu His Leu Trp Leu Pro Lys Ala His Val Glu Ala Pro
210 215 220
Ile Ala Gly Ser Met Val Leu Ala Ala Val Leu Leu Lys Leu Gly Gly
225 230 235 240
Tyr Gly Met Met Arg Leu Thr Leu Ile Leu Asn Pro Leu Thr Lys His
245 250 255
Met Ala Tyr Pro Phe Leu Val Leu Ser Leu Trp Gly Met Ile Met Thr
260 265 270
Ser Ser Ile Cys Leu Arg Gln Thr Asp Leu Lys Ser Leu Ile Ala Tyr
275 280 285
Ser Ser Ile Ser His Met Ala Leu Val Val Thr Ala Ile Leu Ile Gln
290 295 300
Thr Pro Trp Ser Phe Thr Gly Ala Val Ile Leu Met Ile Ala His Gly
305 310 315 320
Leu Thr Ser Ser Leu Leu Phe Cys Leu Ala Asn Ser Asn Tyr Glu Arg
325 330 335
Thr His Ser Arg Ile Met Ile Leu Ser Gln Gly Leu Gln Thr Leu Leu
340 345 350
Pro Leu Met Ala Phe Trp Trp Leu Leu Ala Ser Leu Ala Asn Leu Ala
355 360 365
Leu Pro Pro Thr Ile Asn Leu Leu Gly Glu Leu Ser Val Leu Val Thr
370 375 380
Thr Phe Ser Trp Ser Asn Ile Thr Leu Leu Leu Thr Gly Leu Asn Met
385 390 395 400
Leu Val Thr Ala Leu Tyr Ser Leu Tyr Met Phe Thr Thr Thr Gln Trp
405 410 415
Gly Ser Leu Thr His His Ile Asn Asn Met Lys Pro Ser Phe Thr Arg
420 425 430
Glu Asn Thr Leu Met Phe Met His Leu Ser Pro Ile Leu Leu Leu Ser
435 440 445
Leu Asn Pro Asp Ile Ile Thr Gly Phe Ser Ser
450 455
<210> 161
<211> 174
<212> PRT
<213> Homo sapiens
<400> 161
Met Met Tyr Ala Leu Phe Leu Leu Ser Val Gly Leu Val Met Gly Phe
1 5 10 15
Val Gly Phe Ser Ser Lys Pro Ser Pro Ile Tyr Gly Gly Leu Val Leu
20 25 30
Ile Val Ser Gly Val Val Gly Cys Val Ile Ile Leu Asn Phe Gly Gly
35 40 45
Gly Tyr Met Gly Leu Met Val Phe Leu Ile Tyr Leu Gly Gly Met Met
50 55 60
Val Val Phe Gly Tyr Thr Thr Ala Met Ala Ile Glu Glu Tyr Pro Glu
65 70 75 80
Ala Trp Gly Ser Gly Val Glu Val Leu Val Ser Val Leu Val Gly Leu
85 90 95
Ala Met Glu Val Gly Leu Val Leu Trp Val Lys Glu Tyr Asp Gly Val
100 105 110
Val Val Val Val Asn Phe Asn Ser Val Gly Ser Trp Met Ile Tyr Glu
115 120 125
Gly Glu Gly Ser Gly Leu Ile Arg Glu Asp Pro Ile Gly Ala Gly Ala
130 135 140
Leu Tyr Asp Tyr Gly Arg Trp Leu Val Val Val Thr Gly Trp Thr Leu
145 150 155 160
Phe Val Gly Val Tyr Ile Val Ile Glu Ile Ala Arg Gly Asn
165 170
<210> 162
<211> 316
<212> PRT
<213> Homo sapiens
<400> 162
Met Ala Asn Leu Leu Leu Leu Ile Val Pro Ile Leu Ile Ala Met Ala
1 5 10 15
Phe Leu Met Leu Thr Glu Arg Lys Ile Leu Gly Tyr Met Gln Leu Arg
20 25 30
Lys Gly Pro Asn Val Val Gly Pro Tyr Gly Leu Leu Gln Pro Phe Ala
35 40 45
Asp Ala Ile Lys Leu Phe Thr Lys Glu Pro Leu Lys Pro Ala Thr Ser
50 55 60
Thr Ile Thr Leu Tyr Ile Thr Ala Pro Thr Leu Ala Leu Thr Ile Ala
65 70 75 80
Leu Leu Leu Trp Thr Pro Leu Pro Met Pro Asn Pro Leu Val Asn Leu
85 90 95
Asn Leu Gly Leu Leu Phe Ile Leu Ala Thr Ser Ser Leu Ala Val Tyr
100 105 110
Ser Ile Leu Trp Ser Gly Trp Ala Ser Asn Ser Asn Tyr Ala Leu Ile
115 120 125
Gly Ala Leu Arg Ala Val Ala Gln Thr Ile Ser Tyr Glu Val Thr Leu
130 135 140
Ala Ile Ile Leu Leu Ser Thr Leu Leu Met Ser Gly Ser Phe Asn Leu
145 150 155 160
Ser Thr Leu Ile Thr Thr Gln Glu His Leu Trp Leu Leu Leu Pro Ser
165 170 175
Trp Pro Leu Ala Met Met Trp Phe Ile Ser Thr Leu Ala Glu Thr Asn
180 185 190
Arg Thr Pro Phe Asp Leu Ala Glu Gly Glu Ser Glu Leu Val Ser Gly
195 200 205
Phe Asn Ile Glu Tyr Ala Ala Gly Pro Phe Ala Leu Phe Phe Met Ala
210 215 220
Glu Tyr Thr Asn Ile Ile Met Met Asn Thr Leu Thr Thr Thr Ile Phe
225 230 235 240
Leu Gly Thr Thr Tyr Asp Ala Leu Ser Pro Glu Leu Tyr Thr Thr Tyr
245 250 255
Phe Val Thr Lys Thr Leu Leu Leu Thr Ser Leu Phe Leu Trp Ile Arg
260 265 270
Thr Ala Tyr Pro Arg Phe Arg Tyr Asp Gln Leu Met His Leu Leu Trp
275 280 285
Lys Asn Phe Leu Pro Leu Thr Leu Ala Leu Leu Met Trp Tyr Val Ser
290 295 300
Met Pro Ile Thr Ile Ser Ser Ile Pro Pro Gln Thr
305 310 315
Claims (25)
- 서열 번호: 15에 기재된 서열과 적어도 90% 동일한 서열을 포함하는 재조합 핵산을 포함하는 아데노-관련 바이러스 (AAV); 및
인산염 완충 식염수 (PBS), α,α-트레할로스 탈수화물, L-히스티딘 모노히드로클로라이드 일수화물, 폴리소르베이트 20, 폴록사머 188, 또는 임의의 이들의 조합을 포함하는 약제학적으로 허용가능한 부형제
를 포함하는 약제학적 조성물. - 제1항에 있어서, 상기 약제학적으로 허용가능한 부형제가 폴록사머 188을 포함하는 것인, 약제학적 조성물.
- 제2항에 있어서, 상기 약제학적으로 허용가능한 부형제가 0.0001% 내지 0.01% 폴록사머 188을 포함하는 것인, 약제학적 조성물.
- 제3항에 있어서, 상기 약제학적으로 허용가능한 부형제가 0.001% 폴록사머 188을 포함하는 것인, 약제학적 조성물.
- 제1항에 있어서, 상기 약제학적으로 허용가능한 부형제가 하나 이상의 염을 추가로 포함하는 것인, 약제학적 조성물.
- 제5항에 있어서, 상기 하나 이상의 염이 NaCl, NaH2PO4, Na2HPO4, 또는 KH2PO4를 포함하는 것인, 약제학적 조성물.
- 제6항에 있어서, 상기 하나 이상의 염이 NaCl, NaH2PO4, Na2HPO4, 및 KH2PO4를 포함하는 것인, 약제학적 조성물.
- 제7항에 있어서, 상기 하나 이상의 염이 80 mM NaCl, 5 mM NaH2PO4, 40 mM Na2HPO4, 및 5 mM KH2PO4를 포함하는 것인, 약제학적 조성물.
- 제1항에 있어서, 상기 약제학적 조성물이 6 내지 8의 pH를 갖는 것인, 약제학적 조성물.
- 제9항에 있어서, 상기 약제학적 조성물이 7.2 내지 7.4의 pH를 갖는 것인, 약제학적 조성물.
- 제10항에 있어서, 상기 약제학적 조성물이 7.3의 pH를 갖는 것인, 약제학적 조성물.
- 제1항에 있어서, 상기 약제학적 조성물이 적어도 1.0 × 1010 vg/mL의 바이러스 역가를 갖는 것인, 약제학적 조성물.
- 제12항에 있어서, 상기 약제학적 조성물이 적어도 5.0 × 1010 vg/mL의 바이러스 역가를 갖는 것인, 약제학적 조성물.
- 제1항에 있어서, 상기 약제학적 조성물이 5회의 동결/해동 사이클에 적용될 때, 상기 약제학적 조성물이 5회의 동결/해동 사이클 전의 바이러스 역가에 비해 적어도 60%의 바이러스 역가를 보유하는 것인, 약제학적 조성물.
- 제1항에 있어서, 상기 약제학적 조성물이 레버 유전성 시신경병증을 갖는 환자에게 투여될 때 상기 재조합 핵산을 갖지 않는 유사 약제학적 조성물에 비해 더 높은 시력의 평균 회복을 생성하는 것인, 약제학적 조성물.
- 제1항 내지 제15항 중 어느 한 항에 있어서, 이를 필요로 하는 환자에서 레버 유전성 시신경병증(LHON)을 치료하기 위한 약제학적 조성물.
- 제16항에 있어서, 상기 약제학적 조성물이 유리체내 주사를 통해 투여하기 위한 것인, 약제학적 조성물.
- 제17항에 있어서, 유리체내 주사를 통해 투여하기 위해 약 0.01 내지 0.1 mL의 상기 약제학적 조성물을 포함하는 것인, 약제학적 조성물.
- 제18항에 있어서, 유리체내 주사를 통해 투여하기 위해 약 0.05 mL의 상기 약제학적 조성물을 포함하는 것인, 약제학적 조성물.
- 제16항에 있어서, 메틸프레드니솔론이 상기 환자에게 투여하기 위해 병용되는 것인, 약제학적 조성물.
- 제20항에 있어서, 상기 메틸프레드니솔론이 정맥내 투여 또는 경구 투여하기 위한 것인, 약제학적 조성물.
- 제20항에 있어서, 상기 메틸프레드니솔론이 상기 약제학적 조성물의 투여 전에 적어도 2일 동안 매일 투여하기 위한 것인, 약제학적 조성물.
- 제16항에 있어서, 크레아틴 인산염 나트륨이 상기 환자에게 투여하기 위해 병용되는 것인, 약제학적 조성물.
- 제23항에 있어서, 상기 크레아틴 인산염 나트륨이 정맥내 투여하기 위한 것인, 약제학적 조성물.
- 제16항에 있어서, 상기 약제학적 조성물의 상기 투여가 상기 재조합 핵산이 없는 유사 약제학적 조성물에 비해 더 높은 시력의 평균 회복을 생성하는 것인, 약제학적 조성물.
Applications Claiming Priority (22)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810702492.7A CN110656117A (zh) | 2018-06-29 | 2018-06-29 | 一种编码人nadh脱氢酶亚单位6蛋白的核酸及其应用 |
CN201810702492.7 | 2018-06-29 | ||
CN201810703168.7 | 2018-06-29 | ||
CN201810703168.7A CN110724695A (zh) | 2018-06-29 | 2018-06-29 | 一种编码人nadh脱氢酶亚单位1蛋白的核酸及其应用 |
CNPCT/CN2018/095023 | 2018-07-09 | ||
PCT/CN2018/095023 WO2020010491A1 (zh) | 2018-07-09 | 2018-07-09 | 编码人nadh脱氢酶亚单位4蛋白的核酸及其应用 |
CN201810948193.1 | 2018-08-20 | ||
CN201810948193.1A CN110846392A (zh) | 2018-08-20 | 2018-08-20 | 一种重组腺相关病毒或含其的试剂盒及其应用 |
PCT/CN2018/103937 WO2020000641A1 (zh) | 2018-06-29 | 2018-09-04 | 编码人nadh脱氢酶亚单位蛋白的核酸及其应用 |
CNPCT/CN2018/103937 | 2018-09-04 | ||
CN201811221305.XA CN111073899B (zh) | 2018-10-19 | 2018-10-19 | 一种编码人nadh脱氢酶亚单位4蛋白的核酸及其应用 |
CN201811221305.X | 2018-10-19 | ||
CN201811230856.2 | 2018-10-22 | ||
CN201811230856.2A CN111068071A (zh) | 2018-10-22 | 2018-10-22 | 基因治疗Leber遗传学视神经病变 |
PCT/CN2018/113799 WO2020082417A1 (zh) | 2018-10-22 | 2018-11-02 | 基因治疗Leber遗传性视神经病变 |
CNPCT/CN2018/113799 | 2018-11-02 | ||
CNPCT/CN2018/118662 | 2018-11-30 | ||
PCT/CN2018/118662 WO2020077756A1 (zh) | 2018-10-19 | 2018-11-30 | Nd4蛋白的编码序列及其应用 |
PCT/CN2019/070461 WO2020037938A1 (zh) | 2018-08-20 | 2019-01-04 | 一种重组腺相关病毒或含其的试剂盒及其应用 |
CNPCT/CN2019/070461 | 2019-01-04 | ||
KR1020217001385A KR102627561B1 (ko) | 2018-06-29 | 2019-07-01 | 레버 유전성 시신경병증의 치료를 위한 조성물 및 방법 |
PCT/CN2019/094136 WO2020001657A1 (en) | 2018-06-29 | 2019-07-01 | Compositions and methods for treating leber's hereditary optic neuropathy |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020217001385A Division KR102627561B1 (ko) | 2018-06-29 | 2019-07-01 | 레버 유전성 시신경병증의 치료를 위한 조성물 및 방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20240014102A true KR20240014102A (ko) | 2024-01-31 |
Family
ID=72041345
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020217001385A KR102627561B1 (ko) | 2018-06-29 | 2019-07-01 | 레버 유전성 시신경병증의 치료를 위한 조성물 및 방법 |
KR1020247001775A KR20240014102A (ko) | 2018-06-29 | 2019-07-01 | 레버 유전성 시신경병증의 치료를 위한 조성물 및 방법 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020217001385A KR102627561B1 (ko) | 2018-06-29 | 2019-07-01 | 레버 유전성 시신경병증의 치료를 위한 조성물 및 방법 |
Country Status (9)
Country | Link |
---|---|
US (3) | US11034954B2 (ko) |
EP (1) | EP3814492A4 (ko) |
JP (2) | JP2021529001A (ko) |
KR (2) | KR102627561B1 (ko) |
AU (3) | AU2019296451B2 (ko) |
BR (1) | BR112020026361A2 (ko) |
CA (1) | CA3103740A1 (ko) |
MX (1) | MX2020013772A (ko) |
SG (1) | SG11202012044QA (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2021529001A (ja) | 2018-06-29 | 2021-10-28 | ウーハン ニューロフス バイオテクノロジー リミテッド カンパニーWuhan Neurophth Biotechnology Limited Company | レーベル遺伝性視神経症を治療するための組成物及び方法 |
KR20210068014A (ko) | 2018-08-20 | 2021-06-08 | 우한 뉴로프스 바이오테크놀로지 리미티드 컴퍼니 | 레버 유전성 시신경병증의 치료를 위한 조성물 및 방법 |
CN113025633A (zh) | 2019-12-09 | 2021-06-25 | 武汉纽福斯生物科技有限公司 | 编码人nadh脱氢酶亚单位1蛋白的核酸及其应用 |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3625214A (en) | 1970-05-18 | 1971-12-07 | Alza Corp | Drug-delivery device |
US4906474A (en) | 1983-03-22 | 1990-03-06 | Massachusetts Institute Of Technology | Bioerodible polyanhydrides for controlled drug delivery |
US4789734A (en) | 1985-08-06 | 1988-12-06 | La Jolla Cancer Research Foundation | Vitronectin specific cell receptor derived from mammalian mesenchymal tissue |
EP0318512B1 (en) | 1986-08-18 | 1998-06-17 | Emisphere Technologies, Inc. | Delivery systems for pharmacological agents |
US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
US5811128A (en) | 1986-10-24 | 1998-09-22 | Southern Research Institute | Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor |
US4897268A (en) | 1987-08-03 | 1990-01-30 | Southern Research Institute | Drug delivery system and method of making the same |
CA2153391C (en) | 1993-01-11 | 2000-08-15 | Kenneth Rock | Inducing cytotoxic t lymphocyte responses |
AU2668897A (en) | 1996-04-19 | 1997-11-12 | Genetic Therapy, Inc. | Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents |
US6207392B1 (en) | 1997-11-25 | 2001-03-27 | The Regents Of The University Of California | Semiconductor nanocrystal probes for biological applications and process for making and using such probes |
US20010006948A1 (en) * | 1998-11-25 | 2001-07-05 | James D. Kang | Gene transfer to intervertebral disc cells |
CA2403804A1 (en) | 2000-03-21 | 2001-09-27 | Curagen Corporation | Vegf-modulated genes and methods employing them |
CA2442670A1 (en) | 2001-04-13 | 2002-10-24 | The Trustees Of The University Of Pennsylvania | Method of treating or retarding the development of blindness |
US20040072774A1 (en) * | 2002-02-23 | 2004-04-15 | Giovanni Manfredi | Methods for expressing and targeting mitochondrial-DNA-encoded peptides and uses thereof |
US7405284B2 (en) * | 2002-10-18 | 2008-07-29 | University Of Florida Research Foundation, Inc. | Reducing cellular dysfunction caused by mitochondrial gene mutations |
ES2647477T3 (es) * | 2004-06-01 | 2017-12-21 | Genzyme Corporation | Composiciones y métodos para prevenir la agregación del vector AAV |
US20130022979A1 (en) | 2005-04-18 | 2013-01-24 | Genesis Genomics Inc. | 3.4kb MITOCHONDRIAL DNA DELETION FOR USE IN THE DETECTION OF CANCER |
PL1880008T3 (pl) * | 2005-05-03 | 2015-10-30 | Inst Nat Sante Rech Med | Wyrażanie białek mitochondrialnych przez wzmocnienie podejścia allotopowego |
US20100041741A1 (en) | 2006-10-23 | 2010-02-18 | John Guy | Suppression of mitochondrial oxidative stress |
US20100022517A1 (en) * | 2006-12-18 | 2010-01-28 | Richards Lori A | Ophthalmic formulation of rho kinase inhibitor compound |
MX2009013766A (es) | 2007-06-20 | 2010-02-01 | Galapagos Nv | Objetivos moleculares y compuestos, y metodos para identificar los mismos, utiles en el tratamiento de enfermedades degenerativas de los huesos y las articulaciones. |
NZ591391A (en) | 2008-10-22 | 2012-10-26 | Quark Pharmaceuticals Inc | Non-invasive methods for treating eye disorders using a topical oligonucleotide composition |
DK2529020T3 (en) | 2010-01-28 | 2018-08-06 | Childrens Hospital Philadelphia | SCALABLE PREPARATION PLATF FOR CLEANING VIRAL VECTORS AND CLEANED VIRAL VECTORS FOR USE IN GENTHERAPY |
CN102517304B (zh) | 2011-12-16 | 2013-08-28 | 中国农业科学院生物技术研究所 | 重组葡萄糖氧化酶的优化基因及其表达载体和应用 |
AU2013243947A1 (en) * | 2012-04-02 | 2014-10-30 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of proteins |
US20160289674A1 (en) | 2012-04-02 | 2016-10-06 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of membrane proteins |
CN102634527B (zh) | 2012-04-11 | 2013-11-06 | 华中科技大学同济医学院附属同济医院 | 重组人nadh脱氢酶亚单位4基因及其表达载体构建方法 |
TWI690322B (zh) | 2012-10-02 | 2020-04-11 | 法商傳斯堅公司 | 含病毒的調配物及其使用 |
US9066966B2 (en) * | 2013-02-01 | 2015-06-30 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Methods and pharmaceutical compositions for the treatment of cardiomyopathy due to friedreich ataxia |
DK2954051T3 (da) * | 2013-02-08 | 2019-07-08 | Univ Pennsylvania | Modificeret kapsid til genoverførsel til behandling af nethinden |
EP2992892A1 (en) * | 2014-09-05 | 2016-03-09 | Universität zu Köln | Fusion protein for use in the treatment of mitochondrial diseases |
KR20170066433A (ko) | 2014-09-17 | 2017-06-14 | 더 유니버시티 오브 아이오와 리서치 파운데이션 | 면역조절제 및 백신 성분으로서 바이러스 rna 분절 |
CN104450747B (zh) * | 2014-09-23 | 2018-02-09 | 武汉纽福斯生物科技有限公司 | 用于治疗Leber遗传性视神经病变的重组腺相关病毒‑NADH脱氢酶亚单位4基因全长以及药剂 |
US11052094B2 (en) * | 2015-05-29 | 2021-07-06 | Sydnexis, Inc. | D2O stabilized pharmaceutical formulations |
JP6954890B2 (ja) | 2015-07-13 | 2021-10-27 | サンガモ セラピューティクス, インコーポレイテッド | ヌクレアーゼ媒介ゲノム遺伝子操作のための送達方法及び組成物 |
EP3548039B1 (en) | 2016-12-04 | 2023-07-19 | Alavi Khorassani Moghadam, Marcel Victor | Ribavirin for use in the treatment of a mitochondrial disease |
US20180207293A1 (en) | 2017-01-25 | 2018-07-26 | 2C Tech Corp. | Nanoparticles for sustained ophthalmic drug delivery and methods of use |
CA3054136A1 (en) * | 2017-03-01 | 2018-09-07 | The Trustees Of The University Of Pennsylvania | Gene therapy for ocular disorders |
AU2018314280B2 (en) | 2017-08-11 | 2023-07-20 | Rsem, Société En Commandite | Treatment of ophthalmic conditions such as macular degeneration, glaucoma, and diabetic retinopathy using pharmaceutical agents that eliminate senescent cells |
US20210163898A1 (en) | 2018-04-16 | 2021-06-03 | The Children's Hospital Of Philadelphia | Mitochondrial rna import for treating mitochondrial disease |
AU2019286386A1 (en) | 2018-06-11 | 2021-01-28 | Gensight Biologics Sa | Recombinant AAV vectors and methods of using the same |
CN111073899B (zh) | 2018-10-19 | 2021-01-01 | 武汉纽福斯生物科技有限公司 | 一种编码人nadh脱氢酶亚单位4蛋白的核酸及其应用 |
JP2021529001A (ja) | 2018-06-29 | 2021-10-28 | ウーハン ニューロフス バイオテクノロジー リミテッド カンパニーWuhan Neurophth Biotechnology Limited Company | レーベル遺伝性視神経症を治療するための組成物及び方法 |
CN110846392A (zh) | 2018-08-20 | 2020-02-28 | 武汉纽福斯生物科技有限公司 | 一种重组腺相关病毒或含其的试剂盒及其应用 |
CN111068071A (zh) | 2018-10-22 | 2020-04-28 | 武汉纽福斯生物科技有限公司 | 基因治疗Leber遗传学视神经病变 |
WO2020010491A1 (zh) | 2018-07-09 | 2020-01-16 | 武汉纽福斯生物科技有限公司 | 编码人nadh脱氢酶亚单位4蛋白的核酸及其应用 |
KR20210068014A (ko) | 2018-08-20 | 2021-06-08 | 우한 뉴로프스 바이오테크놀로지 리미티드 컴퍼니 | 레버 유전성 시신경병증의 치료를 위한 조성물 및 방법 |
WO2020038352A1 (en) | 2018-08-20 | 2020-02-27 | Wuhan Neurophth Biological Technology Limited Company | Compositions and methods for treating leber's hereditary optic neuropathy |
CN113025633A (zh) | 2019-12-09 | 2021-06-25 | 武汉纽福斯生物科技有限公司 | 编码人nadh脱氢酶亚单位1蛋白的核酸及其应用 |
-
2019
- 2019-07-01 JP JP2021521870A patent/JP2021529001A/ja active Pending
- 2019-07-01 BR BR112020026361-3A patent/BR112020026361A2/pt unknown
- 2019-07-01 CA CA3103740A patent/CA3103740A1/en active Pending
- 2019-07-01 KR KR1020217001385A patent/KR102627561B1/ko active IP Right Grant
- 2019-07-01 EP EP19826653.8A patent/EP3814492A4/en active Pending
- 2019-07-01 MX MX2020013772A patent/MX2020013772A/es unknown
- 2019-07-01 AU AU2019296451A patent/AU2019296451B2/en active Active
- 2019-07-01 SG SG11202012044QA patent/SG11202012044QA/en unknown
- 2019-07-01 KR KR1020247001775A patent/KR20240014102A/ko active Application Filing
-
2020
- 2020-03-31 US US16/836,644 patent/US11034954B2/en active Active
-
2021
- 2021-05-11 US US17/317,295 patent/US20220340895A1/en active Pending
- 2021-05-14 US US17/320,388 patent/US11332741B1/en active Active
- 2021-07-05 AU AU2021204690A patent/AU2021204690A1/en not_active Abandoned
-
2023
- 2023-02-28 JP JP2023029170A patent/JP2023078173A/ja active Pending
- 2023-12-20 AU AU2023285773A patent/AU2023285773A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US11034954B2 (en) | 2021-06-15 |
KR102627561B1 (ko) | 2024-01-24 |
JP2021529001A (ja) | 2021-10-28 |
CA3103740A1 (en) | 2020-01-02 |
BR112020026361A2 (pt) | 2021-03-30 |
AU2023285773A1 (en) | 2024-01-18 |
AU2021204690A1 (en) | 2021-07-29 |
SG11202012044QA (en) | 2021-01-28 |
KR20210027374A (ko) | 2021-03-10 |
US11332741B1 (en) | 2022-05-17 |
US20220340895A1 (en) | 2022-10-27 |
MX2020013772A (es) | 2021-05-27 |
US20200263172A1 (en) | 2020-08-20 |
AU2019296451A1 (en) | 2021-01-07 |
EP3814492A4 (en) | 2022-02-23 |
AU2019296451B2 (en) | 2021-04-29 |
EP3814492A1 (en) | 2021-05-05 |
JP2023078173A (ja) | 2023-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2764587C2 (ru) | Способы и композиции для лечения хореи гентингтона | |
KR102652994B1 (ko) | 조절성 폴리뉴클레오티드 | |
KR20210068014A (ko) | 레버 유전성 시신경병증의 치료를 위한 조성물 및 방법 | |
KR102627561B1 (ko) | 레버 유전성 시신경병증의 치료를 위한 조성물 및 방법 | |
KR20220112262A (ko) | Nadh 탈수소효소 단백질을 이용한 레버 유전성 시신경병증 치료용 조성물 및 방법 | |
CN110876269B (zh) | 治疗遗传性视神经病变的组合物和方法 | |
WO2020001657A1 (en) | Compositions and methods for treating leber's hereditary optic neuropathy | |
WO2020038352A1 (en) | Compositions and methods for treating leber's hereditary optic neuropathy | |
KR20240042489A (ko) | Nd4 돌연변이에 의해 야기되는 레베르 유전성 시신경병증을 치료하기 위한 조성물 및 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent |